Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23428.Concentration of VLDL Particles,AGRP,Agouti-related protein,29786,0.231774962252783,0.00326300735306629,0.225379467840773,0.238170456664792,0
NMR metabolomics,X23428.Concentration of VLDL Particles,APCS,Serum amyloid P-component,24726,0.110781785508839,0.00221882685574498,0.106432884871578,0.115130686146099,0
NMR metabolomics,X23428.Concentration of VLDL Particles,APOC1,Apolipoprotein C-I,24914,0.0977475871523801,0.002434309541748,0.092976340450554,0.102518833854206,0
NMR metabolomics,X23428.Concentration of VLDL Particles,APOM,Apolipoprotein M,29545,0.0785818964905327,0.00179501742742741,0.0750636623327749,0.0821001306482904,0
NMR metabolomics,X23428.Concentration of VLDL Particles,BCHE,Cholinesterase,24528,0.074420097997518,0.00182046211560186,0.0708519922509384,0.0779882037440977,0
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL23,C-C motif chemokine 23,29581,0.122194527733011,0.00268098505992884,0.116939797015551,0.127449258450472,0
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL27,C-C motif chemokine 27,29478,0.21168709553448,0.0038992070245285,0.204044649766404,0.219329541302556,0
NMR metabolomics,X23428.Concentration of VLDL Particles,CCN1,CCN family member 1,29301,0.333416000529198,0.00464818166764041,0.324305564460623,0.342526436597774,0
NMR metabolomics,X23428.Concentration of VLDL Particles,CD4,T-cell surface glycoprotein CD4,29383,0.0800367612875514,0.00194011037792097,0.0762341449468263,0.0838393776282765,0
NMR metabolomics,X23428.Concentration of VLDL Particles,CDKN1A,Cyclin-dependent kinase inhibitor 1,29349,0.274569724017103,0.00687704503839746,0.261090715741844,0.288048732292362,0
NMR metabolomics,X23428.Concentration of VLDL Particles,CES1,Liver carboxylesterase 1,29489,0.24003766074891,0.00520637905185768,0.229833157807269,0.250242163690551,0
NMR metabolomics,X23428.Concentration of VLDL Particles,CFP,Properdin,24966,0.0671060281176384,0.00148564489613379,0.0641941641212162,0.0700178921140606,0
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL6,C-X-C motif chemokine 6,29786,0.197587444149754,0.00499895120516923,0.187789499787623,0.207385388511886,0
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFB4A_DEFB4B,Beta-defensin 4A,29036,0.379378834784081,0.00958622787096978,0.36058982815698,0.398167841411182,0
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJB1,DnaJ homolog subfamily B member 1,29349,0.23781774602179,0.00563218798352899,0.226778657574073,0.248856834469506,0
NMR metabolomics,X23428.Concentration of VLDL Particles,ERBB3,Receptor tyrosine-protein kinase erbB-3,29369,0.0608048772291758,0.00125171541937649,0.0583515150071979,0.0632582394511538,0
NMR metabolomics,X23428.Concentration of VLDL Particles,F7,Coagulation factor VII,29544,0.107142676088535,0.00194706271597318,0.103326433165228,0.110958919011843,0
NMR metabolomics,X23428.Concentration of VLDL Particles,FGFBP1,Fibroblast growth factor-binding protein 1,29566,0.129899925530115,0.0020555315041125,0.125871083782054,0.133928767278175,0
NMR metabolomics,X23428.Concentration of VLDL Particles,FGFBP3,Fibroblast growth factor-binding protein 3,24845,0.0947849605038446,0.00239593381163779,0.0900889302330345,0.0994809907746546,0
NMR metabolomics,X23428.Concentration of VLDL Particles,FURIN,Furin,29566,0.101832573083271,0.00215621338359298,0.0976063948514287,0.106058751315113,0
NMR metabolomics,X23428.Concentration of VLDL Particles,GHR,Growth hormone receptor,24381,0.0863839595834801,0.00184511541610882,0.0827675333679068,0.0900003857990534,0
NMR metabolomics,X23428.Concentration of VLDL Particles,HHEX,Hematopoietically-expressed homeobox protein HHEX,24845,0.252182512499048,0.00485097512838865,0.242674601247406,0.26169042375069,0
NMR metabolomics,X23428.Concentration of VLDL Particles,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29725,0.098485446972772,0.00221086549267031,0.0941521506071381,0.102818743338406,0
NMR metabolomics,X23428.Concentration of VLDL Particles,KLKB1,Plasma kallikrein,24454,0.0644027504174666,0.00163605140923538,0.0611960896553652,0.0676094111795679,0
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMP2,Lysosome-associated membrane glycoprotein 2,28595,0.0526706116895959,0.00127276586774277,0.0501759905888201,0.0551652327903718,0
NMR metabolomics,X23428.Concentration of VLDL Particles,LCAT,Phosphatidylcholine-sterol acyltransferase,24951,0.0794345929636457,0.00140181339026076,0.0766870387187346,0.0821821472085568,0
NMR metabolomics,X23428.Concentration of VLDL Particles,LDLR,Low-density lipoprotein receptor,29500,0.381076961839966,0.00273257941320536,0.375721106190084,0.386432817489849,0
NMR metabolomics,X23428.Concentration of VLDL Particles,LPL,Lipoprotein lipase,29478,-0.122367041586906,0.00305481338010549,-0.128354475811913,-0.1163796073619,0
NMR metabolomics,X23428.Concentration of VLDL Particles,MFGE8,Lactadherin,29443,0.175031066530929,0.00274327082029773,0.169654255723146,0.180407877338713,0
NMR metabolomics,X23428.Concentration of VLDL Particles,NPY,Pro-neuropeptide Y,29725,0.295489592707708,0.00404450577656349,0.287562361385644,0.303416824029773,0
NMR metabolomics,X23428.Concentration of VLDL Particles,NRP1,Neuropilin-1,29628,-0.0734938937779013,0.00180571238381201,-0.0770330900501729,-0.0699546975056298,0
NMR metabolomics,X23428.Concentration of VLDL Particles,P4HB,Protein disulfide-isomerase,29313,0.104283175204088,0.00251192293736818,0.0993598062468465,0.10920654416133,0
NMR metabolomics,X23428.Concentration of VLDL Particles,PAMR1,Inactive serine protease PAMR1,29443,0.0799408645199193,0.00178133963429607,0.076449438836699,0.0834322902031396,0
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G10,Group 10 secretory phospholipase A2,29218,-0.17400422203739,0.00381003013935718,-0.18147188111053,-0.16653656296425,0
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G7,Platelet-activating factor acetylhydrolase,29443,0.191540910187948,0.00180841543486869,0.187996415935605,0.19508540444029,0
NMR metabolomics,X23428.Concentration of VLDL Particles,PROC,Vitamin K-dependent protein C,29545,0.0952472795168522,0.00163488329296052,0.0920429082626496,0.0984516507710548,0
NMR metabolomics,X23428.Concentration of VLDL Particles,PROS1,Vitamin K-dependent protein S,24966,0.064933077195548,0.00166106887583187,0.0616773821989175,0.0681887721921785,0
NMR metabolomics,X23428.Concentration of VLDL Particles,PTH,Parathyroid hormone,24195,0.237482316074548,0.00520941192134352,0.227271868708715,0.247692763440382,0
NMR metabolomics,X23428.Concentration of VLDL Particles,RARRES2,Retinoic acid receptor responder protein 2,29628,0.141803010316102,0.00304045139493874,0.135843725582022,0.147762295050182,0
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA4,Kallistatin,24557,0.0615250927173599,0.00155241097976432,0.0584823671970219,0.064567818237698,0
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA5,Plasma serine protease inhibitor,24644,0.0862014969728642,0.00206443299487285,0.0821552083029135,0.090247785642815,0
NMR metabolomics,X23428.Concentration of VLDL Particles,SMAD1,Mothers against decapentaplegic homolog 1,28797,0.230212157943339,0.0053153761625861,0.21979402066467,0.240630295222008,0
NMR metabolomics,X23428.Concentration of VLDL Particles,SMOC1,SPARC-related modular calcium-binding protein 1,29725,0.106366336067745,0.00210231718821735,0.102245794378839,0.110486877756651,0
NMR metabolomics,X23428.Concentration of VLDL Particles,SNCA,Alpha-synuclein,24381,0.302539587797904,0.00752078350738222,0.287798852123435,0.317280323472373,0
NMR metabolomics,X23428.Concentration of VLDL Particles,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29594,0.146097582166748,0.00270720108346718,0.140791468043152,0.151403696290344,0
NMR metabolomics,X23428.Concentration of VLDL Particles,TFPI,Tissue factor pathway inhibitor,29435,0.1297932313128,0.00197393518516393,0.125924318349878,0.133662144275721,0
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29786,0.0689258423491552,0.00169044499217067,0.0656125701645006,0.0722391145338097,0
NMR metabolomics,X23428.Concentration of VLDL Particles,TTR,Transthyretin,24707,0.0685105310420213,0.00164475225123853,0.0652868166295938,0.0717342454544488,0
NMR metabolomics,X23428.Concentration of VLDL Particles,VMO1,Vitelline membrane outer layer protein 1 homolog,29349,0.183160979258191,0.00441613963814552,0.174505345567426,0.191816612948956,0
NMR metabolomics,X23428.Concentration of VLDL Particles,VPS37A,Vacuolar protein sorting-associated protein 37A,29349,0.2025023908869,0.00517744710064389,0.192354594569637,0.212650187204162,0
NMR metabolomics,X23428.Concentration of VLDL Particles,CHMP6,Charged multivesicular body protein 6,24922,0.142714891942946,0.00367606441782033,0.135509805684018,0.149919978201874,1.11253692925542e-308
NMR metabolomics,X23428.Concentration of VLDL Particles,SYAP1,Synapse-associated protein 1,24381,0.145154250151317,0.00374237513190931,0.137819194892775,0.152489305409859,1.11253692926444e-308
NMR metabolomics,X23428.Concentration of VLDL Particles,ERBB2,Receptor tyrosine-protein kinase erbB-2,29566,0.0622764134050078,0.00161544052964783,0.0591101499668981,0.0654426768431176,1.11253693070693e-308
NMR metabolomics,X23428.Concentration of VLDL Particles,KDR,Vascular endothelial growth factor receptor 2,29566,0.0636853529715985,0.00165319996882213,0.0604450810327071,0.0669256249104899,1.11253693335522e-308
NMR metabolomics,X23428.Concentration of VLDL Particles,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28916,0.209690367406331,0.00544921692361834,0.199009902236039,0.220370832576623,1.11253695720288e-308
NMR metabolomics,X23428.Concentration of VLDL Particles,CFH,Complement factor H,23693,0.058229336769861,0.00152082026706172,0.0552485290464201,0.061210144493302,1.11399090502082e-308
NMR metabolomics,X23428.Concentration of VLDL Particles,MEGF9,Multiple epidermal growth factor-like domains protein 9,29736,0.0508785007229366,0.00133632547108167,0.0482593027996166,0.0534976986462567,1.16172155782338e-308
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTN3,Contactin-3,29443,0.0800347361374078,0.00210237186916907,0.0759140872738364,0.0841553850009792,1.1812424874941e-308
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP3,Insulin-like growth factor-binding protein 3,29594,0.0734827122830989,0.00194230869816268,0.0696757872347,0.0772896373314977,6.52227439030405e-306
NMR metabolomics,X23428.Concentration of VLDL Particles,CFI,Complement factor I,24966,0.0490055810129371,0.00129934377401571,0.0464588672158663,0.0515522948100079,8.61790435862652e-303
NMR metabolomics,X23428.Concentration of VLDL Particles,ATRN,"Attractin, Isoform 2",24966,0.0408590585362902,0.00108419448085706,0.0387340373538103,0.04298407971877,2.47374788828746e-302
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINF2,Alpha-2-antiplasmin,24515,0.0334463143416869,0.000889207509441547,0.0317034676231815,0.0351891610601924,4.61904744206616e-301
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC39A5,Zinc transporter ZIP5,29434,0.129990762732437,0.00347960603840445,0.123170734897165,0.13681079056771,1.79655339342419e-298
NMR metabolomics,X23428.Concentration of VLDL Particles,GCG,Pro-glucagon,28797,0.300646259454837,0.00811908520757669,0.284732852447986,0.316559666461687,2.93731259279834e-293
NMR metabolomics,X23428.Concentration of VLDL Particles,KYNU,Kynureninase,29786,0.108615358507876,0.00296201743671338,0.102809804331918,0.114420912683835,5.79279874265971e-288
NMR metabolomics,X23428.Concentration of VLDL Particles,IGSF9,Protein turtle homolog A,24922,0.198425042454582,0.00540881833375469,0.187823758520423,0.209026326388741,5.35145895316575e-287
NMR metabolomics,X23428.Concentration of VLDL Particles,PLAT,Tissue-type plasminogen activator,29736,0.119258031772741,0.00328207875337985,0.112825157416116,0.125690906129365,6.81680807162617e-283
NMR metabolomics,X23428.Concentration of VLDL Particles,FLI1,Friend leukemia integration 1 transcription factor,28797,0.260517563728205,0.00719183176621036,0.246421573466433,0.274613553989978,5.23715841338028e-281
NMR metabolomics,X23428.Concentration of VLDL Particles,F10,Coagulation factor X,24951,0.0643009454876415,0.00179995606555538,0.060773031599153,0.0678288593761301,1.25624412504483e-272
NMR metabolomics,X23428.Concentration of VLDL Particles,GPR37,Prosaposin receptor GPR37,28916,0.154271533891391,0.00432858226515351,0.14578751265169,0.162755555131092,2.64632987433632e-272
NMR metabolomics,X23428.Concentration of VLDL Particles,GUSB,Beta-glucuronidase,29604,0.13899124834055,0.00390304388732289,0.131341282321397,0.146641214359703,5.28437405121319e-272
NMR metabolomics,X23428.Concentration of VLDL Particles,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29433,0.265697232032377,0.00746309880959629,0.251069558365568,0.280324905699186,7.88482332983682e-272
NMR metabolomics,X23428.Concentration of VLDL Particles,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24381,0.050924257229964,0.00142925467395013,0.0481229180690217,0.0537255963909062,4.3142203260513e-271
NMR metabolomics,X23428.Concentration of VLDL Particles,NCS1,Neuronal calcium sensor 1,29725,0.0662347736759806,0.00187018447972891,0.062569212095712,0.0699003352562493,3.84489399497499e-269
NMR metabolomics,X23428.Concentration of VLDL Particles,SORT1,Sortilin,29433,0.0860735971270661,0.00243349815981839,0.081303940733822,0.0908432535203101,2.0680566880751e-268
NMR metabolomics,X23428.Concentration of VLDL Particles,CPB2,Carboxypeptidase B2,24914,0.0523726064559033,0.00147887306890331,0.0494740152408528,0.0552711976709538,4.63550640411953e-268
NMR metabolomics,X23428.Concentration of VLDL Particles,AGR3,Anterior gradient protein 3,28764,0.136787246836105,0.00389073693636361,0.129161402440832,0.144413091231377,3.7539532573134e-265
NMR metabolomics,X23428.Concentration of VLDL Particles,CRIP2,Cysteine-rich protein 2,29218,0.0832516088468506,0.00237484833595799,0.078596906108373,0.0879063115853283,9.48802784742553e-264
NMR metabolomics,X23428.Concentration of VLDL Particles,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29694,0.119509038034785,0.00341391194842206,0.112817770615878,0.126200305453692,4.06662735848909e-263
NMR metabolomics,X23428.Concentration of VLDL Particles,DSG2,Desmoglein-2,29443,-0.0617889767591322,0.00176605068355343,-0.065250436098897,-0.0583275174193675,8.64607827134502e-263
NMR metabolomics,X23428.Concentration of VLDL Particles,ENO3,Beta-enolase,24240,0.137891448259271,0.00393682965347392,0.130175262138463,0.14560763438008,3.11129259081319e-262
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPTL2,Angiopoietin-related protein 2,29491,0.0908304308988759,0.00260376846594627,0.0857270447056212,0.0959338170921305,2.68076312280349e-261
NMR metabolomics,X23428.Concentration of VLDL Particles,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,29218,0.167228075372366,0.00482092452462232,0.157779063304107,0.176677087440626,2.11774745750794e-258
NMR metabolomics,X23428.Concentration of VLDL Particles,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24805,0.31671232041364,0.00915470415126758,0.298769100277155,0.334655540550124,3.61282332192881e-256
NMR metabolomics,X23428.Concentration of VLDL Particles,TMPRSS15,Enteropeptidase,29349,0.203522123589711,0.00591541286932099,0.191927914365842,0.21511633281358,2.40031907256507e-254
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPIND1,Heparin cofactor 2,24914,0.0634720986440852,0.0018478566934142,0.0598502995249934,0.0670938977631771,1.14260772223081e-252
NMR metabolomics,X23428.Concentration of VLDL Particles,SNAPIN,SNARE-associated protein Snapin,24867,0.129847794365197,0.00378900484545428,0.122421344868107,0.137274243862288,1.58253902735213e-251
NMR metabolomics,X23428.Concentration of VLDL Particles,INHBC,Inhibin beta C chain,29443,0.0922215916128926,0.00270364853979937,0.0869224404748859,0.0975207427508994,3.9239641156511e-250
NMR metabolomics,X23428.Concentration of VLDL Particles,FCN2,Ficolin-2,29381,0.0916475662301906,0.00268684639181713,0.086381347302229,0.0969137851581522,4.06020761179555e-250
NMR metabolomics,X23428.Concentration of VLDL Particles,LATS1,Serine/threonine-protein kinase LATS1,24229,0.190903087509727,0.00559468839571176,0.179937498254132,0.201868676765322,2.74878273578159e-249
NMR metabolomics,X23428.Concentration of VLDL Particles,FN1,Fibronectin,24966,0.059809114315683,0.00175444430226874,0.0563704034832362,0.0632478251481297,5.31285263109941e-249
NMR metabolomics,X23428.Concentration of VLDL Particles,SMAD2,Mothers against decapentaplegic homolog 2,24793,0.154660646021845,0.00453991618460862,0.145762410300012,0.163558881743678,1.23715443226714e-248
NMR metabolomics,X23428.Concentration of VLDL Particles,GSTA3,Glutathione S-transferase A3,28797,0.16931499527009,0.00501482104875356,0.159485946014533,0.179144044525647,4.20632746181189e-245
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPTL3,Angiopoietin-related protein 3,29518,0.078750092104256,0.00233379479872026,0.0741758542987643,0.0833243299097478,6.11088821246935e-245
NMR metabolomics,X23428.Concentration of VLDL Particles,STAB2,Stabilin-2,24938,0.0621234058721591,0.00184616757519398,0.0585049174247789,0.0657418943195393,8.43761418997119e-243
NMR metabolomics,X23428.Concentration of VLDL Particles,CPM,Carboxypeptidase M,29584,0.0753882592094718,0.00224473236956795,0.0709885837651186,0.079787934653825,1.03407692531408e-242
NMR metabolomics,X23428.Concentration of VLDL Particles,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",24240,0.0574960631162809,0.00171023616608344,0.0541440002307574,0.0608481260018045,3.25840350529416e-242
NMR metabolomics,X23428.Concentration of VLDL Particles,NUMB,Protein numb homolog,24229,0.184234615191992,0.00548336275022432,0.173487224201553,0.194982006182432,6.22140203314573e-242
NMR metabolomics,X23428.Concentration of VLDL Particles,CDHR2,Cadherin-related family member 2,29349,0.159027040027455,0.00475340534462732,0.149710365551985,0.168343714502924,7.28203947340415e-241
NMR metabolomics,X23428.Concentration of VLDL Particles,LAT2,Linker for activation of T-cells family member 2,29349,0.271530296366025,0.00813452043986608,0.255586636303887,0.287473956428162,8.26490396667973e-240
NMR metabolomics,X23428.Concentration of VLDL Particles,AFM,Afamin,24966,0.042582817328138,0.00127817760366706,0.0400775892249505,0.0450880454313254,3.8170205886012e-238
NMR metabolomics,X23428.Concentration of VLDL Particles,ERP44,Endoplasmic reticulum resident protein 44,29301,0.0563101509198832,0.0016940219565484,0.0529898678850483,0.059630433954718,7.42097062966726e-238
NMR metabolomics,X23428.Concentration of VLDL Particles,GSTA1,Glutathione S-transferase A1,29426,0.182595032934423,0.00551417202021999,0.171787255774792,0.193402810094054,4.11095711454693e-236
NMR metabolomics,X23428.Concentration of VLDL Particles,SOST,Sclerostin,29433,0.0837108853009936,0.00253653690252911,0.0787392729720366,0.0886824976299507,1.44893277224198e-234
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28797,0.146140086129242,0.00444500624472989,0.137427873889572,0.154852298368913,9.41099054322139e-233
NMR metabolomics,X23428.Concentration of VLDL Particles,GRP,Gastrin-releasing peptide,24240,0.116169596452184,0.00354036730560703,0.109230476533195,0.123108716371174,4.38898153446983e-231
NMR metabolomics,X23428.Concentration of VLDL Particles,PSRC1,Proline/serine-rich coiled-coil protein 1,28797,0.126724902202747,0.00388081693192137,0.119118501016181,0.134331303389313,1.09182618978558e-229
NMR metabolomics,X23428.Concentration of VLDL Particles,NAA80,N-alpha-acetyltransferase 80,24195,0.258654144284015,0.00793034614207289,0.243110665845552,0.274197622722478,2.16734741237766e-228
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL22,C-C motif chemokine 22,29169,0.109727482351005,0.00338673095237558,0.103089489684349,0.116365475017661,2.91431159710406e-226
NMR metabolomics,X23428.Concentration of VLDL Particles,F9,Coagulation factor IX,29545,0.0384390180389372,0.00119244196222702,0.0361018317929722,0.0407762042849022,4.32123653947277e-224
NMR metabolomics,X23428.Concentration of VLDL Particles,DTYMK,Thymidylate kinase,24922,0.144990213626712,0.00449339994898157,0.136183149726708,0.153797277526715,8.11473476138208e-224
NMR metabolomics,X23428.Concentration of VLDL Particles,CDHR5,Cadherin-related family member 5,29478,0.0820990319816438,0.00255194904824911,0.0770972118470756,0.0871008521162121,3.27821652352976e-223
NMR metabolomics,X23428.Concentration of VLDL Particles,IL13RA1,Interleukin-13 receptor subunit alpha-1,29019,0.0471786443005752,0.00146872636730682,0.0442999406206538,0.0500573479804965,1.72215794788751e-222
NMR metabolomics,X23428.Concentration of VLDL Particles,ACY1,Aminoacylase-1,29478,0.129868488706825,0.0040435348461121,0.121943160408445,0.137793817005204,1.73185151871497e-222
NMR metabolomics,X23428.Concentration of VLDL Particles,PRAP1,Proline-rich acidic protein 1,24938,0.0859753896185956,0.00268184260405653,0.0807189781146448,0.0912318011225464,5.16078773873859e-221
NMR metabolomics,X23428.Concentration of VLDL Particles,NOMO1,Nodal modulator 1,29443,0.0492246455297078,0.00154353307257187,0.0461993207074669,0.0522499703519487,1.95232175097151e-219
NMR metabolomics,X23428.Concentration of VLDL Particles,IGSF8,Immunoglobulin superfamily member 8,29478,0.0636662648791632,0.00199879810403916,0.0597486205952465,0.06758390916308,6.35963534399983e-219
NMR metabolomics,X23428.Concentration of VLDL Particles,RBP5,Retinol-binding protein 5,29349,0.11709713342565,0.00368522629557439,0.109874089886324,0.124320176964975,7.17543548299569e-218
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24922,0.0617150931454966,0.00194008525207174,0.057912526051436,0.0655176602395572,1.04856259683868e-217
NMR metabolomics,X23428.Concentration of VLDL Particles,FGFR2,Fibroblast growth factor receptor 2,29566,0.0460132422639641,0.00144882230412893,0.0431735505478714,0.0488529339800568,1.0932555579205e-217
NMR metabolomics,X23428.Concentration of VLDL Particles,HEG1,Protein HEG homolog 1,24381,0.0569236196287043,0.00179084009728229,0.053413573038031,0.0604336662193776,2.75502640600681e-217
NMR metabolomics,X23428.Concentration of VLDL Particles,F13B,Coagulation factor XIII B chain,24833,0.0539050793146988,0.00169960485687144,0.0505738537952308,0.0572363048341668,1.93452718327203e-216
NMR metabolomics,X23428.Concentration of VLDL Particles,EEF1D,Elongation factor 1-delta,24922,0.189774497041236,0.00599791912604372,0.17801857555419,0.201530418528282,1.90588208662068e-215
NMR metabolomics,X23428.Concentration of VLDL Particles,SNAP29,Synaptosomal-associated protein 29,29566,0.189316072490141,0.00599515377256721,0.177565571095909,0.201066573884373,2.80030643962704e-215
NMR metabolomics,X23428.Concentration of VLDL Particles,IL16,Pro-interleukin-16,29786,0.0854869605621066,0.00271375538844819,0.0801680000007482,0.0908059211234651,2.75899678699858e-214
NMR metabolomics,X23428.Concentration of VLDL Particles,SMAD5,Mothers against decapentaplegic homolog 5,29349,0.0420352251300131,0.00133581733355964,0.0394170231562362,0.04465342710379,8.63635448874513e-214
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP2,Insulin-like growth factor-binding protein 2,29757,-0.128551434183657,0.00408620255909014,-0.136560391199474,-0.12054247716784,9.84891768152064e-214
NMR metabolomics,X23428.Concentration of VLDL Particles,ELN,Elastin,24922,0.0727155748364264,0.00230843333311002,0.0681910455035308,0.0772401041693221,1.34510571971058e-213
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29361,0.0556607512463976,0.00177360697862058,0.0521844815683012,0.0591370209244939,1.14361657817559e-212
NMR metabolomics,X23428.Concentration of VLDL Particles,ADH1B,All-trans-retinol dehydrogenase,24381,0.155998211327936,0.00496918922123977,0.146258600454306,0.165737822201566,4.2017730150074e-212
NMR metabolomics,X23428.Concentration of VLDL Particles,AP1G2,AP-1 complex subunit gamma-like 2,24793,0.163967219006854,0.00522589637633545,0.153724462109236,0.174209975904471,6.03344210459004e-212
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL17,C-X-C motif chemokine 17,29786,0.0860220114279141,0.00275808278936859,0.0806161691607517,0.0914278536950765,3.63358097864512e-210
NMR metabolomics,X23428.Concentration of VLDL Particles,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29349,0.0811738433858988,0.00260239810615429,0.0760731430978364,0.0862745436739612,3.73155331593236e-210
NMR metabolomics,X23428.Concentration of VLDL Particles,MAPK9,Mitogen-activated protein kinase 9,29434,0.0872436489939226,0.00282034707433932,0.0817157687282175,0.0927715292596277,8.69656262171701e-207
NMR metabolomics,X23428.Concentration of VLDL Particles,PRCP,Lysosomal Pro-X carboxypeptidase,29655,0.063810997862723,0.00206314155806945,0.0597672404089069,0.0678547553165391,9.44568482665624e-207
NMR metabolomics,X23428.Concentration of VLDL Particles,COL4A1,Collagen alpha-1(IV) chain,29478,-0.0802397758950559,0.00260500629175947,-0.0853455882269044,-0.0751339635632073,4.40665217127034e-205
NMR metabolomics,X23428.Concentration of VLDL Particles,YTHDF3,YTH domain-containing family protein 3,28931,0.1714746263195,0.0055962814743973,0.160505914629681,0.182443338009319,6.18004383643777e-203
NMR metabolomics,X23428.Concentration of VLDL Particles,ADIPOQ,Adiponectin,24966,-0.136360877403494,0.00444489952500319,-0.1450728804725,-0.127648874334488,6.54583092158938e-203
NMR metabolomics,X23428.Concentration of VLDL Particles,BTD,Biotinidase,24966,0.04174579740352,0.0013627330110394,0.0390748407018828,0.0444167541051572,2.41762014553532e-202
NMR metabolomics,X23428.Concentration of VLDL Particles,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24845,0.0819599945730999,0.0026755319902049,0.0767159518722983,0.0872040372739015,2.5730178641594e-202
NMR metabolomics,X23428.Concentration of VLDL Particles,YES1,Tyrosine-protein kinase Yes,29349,0.228243392336184,0.00747751116042976,0.213587470461742,0.242899314210627,1.78296078019005e-201
NMR metabolomics,X23428.Concentration of VLDL Particles,CREG1,Protein CREG1,29079,0.0762356820828749,0.00250301550700754,0.0713297716891401,0.0811415924766097,1.35930708706595e-200
NMR metabolomics,X23428.Concentration of VLDL Particles,NT5E,5'-nucleotidase,29566,0.112189450914566,0.00369069582493459,0.104955687097695,0.119423214731438,7.03326862349548e-200
NMR metabolomics,X23428.Concentration of VLDL Particles,ABL1,Tyrosine-protein kinase ABL1,29349,0.135021632607857,0.00445167613385596,0.1262963473855,0.143746917830215,5.39627565713033e-199
NMR metabolomics,X23428.Concentration of VLDL Particles,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29820,0.0580555676091479,0.00191650031516245,0.0542992269914295,0.0618119082268663,1.48116288576205e-198
NMR metabolomics,X23428.Concentration of VLDL Particles,MYH9,Myosin-9,24938,0.225083340469198,0.0074253995697364,0.210529557312514,0.239637123625881,3.09588788276936e-198
NMR metabolomics,X23428.Concentration of VLDL Particles,UPB1,Beta-ureidopropionase,24922,0.182302961558604,0.00601954401703729,0.170504655285211,0.194101267831997,6.94587828517604e-198
NMR metabolomics,X23428.Concentration of VLDL Particles,FYB1,FYN-binding protein 1,29400,0.182249639884712,0.00604194956891233,0.170407418729643,0.19409186103978,7.07855025835206e-197
NMR metabolomics,X23428.Concentration of VLDL Particles,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24805,0.0594253015196097,0.00197300574569823,0.0555582102580412,0.0632923927811782,9.13482416696042e-196
NMR metabolomics,X23428.Concentration of VLDL Particles,MLN,Promotilin,29434,0.175278348452784,0.00585368383175596,0.163805128142542,0.186751568763026,4.42154166310792e-194
NMR metabolomics,X23428.Concentration of VLDL Particles,TJAP1,Tight junction-associated protein 1,29566,0.162852588540875,0.0054441781489751,0.152181999368883,0.173523177712866,1.03004615406452e-193
NMR metabolomics,X23428.Concentration of VLDL Particles,SARG,Specifically androgen-regulated gene protein,24820,0.214868168068496,0.00718795898288066,0.20077976846205,0.228956567674942,6.43437550715516e-193
NMR metabolomics,X23428.Concentration of VLDL Particles,IPCEF1,Interactor protein for cytohesin exchange factors 1,29169,0.175177080230078,0.00588183933876374,0.163648675126101,0.186705485334055,4.94574674088646e-192
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINF1,Pigment epithelium-derived factor,24579,0.0512369233780567,0.00172296745469549,0.0478599071668535,0.0546139395892598,6.06390399571749e-191
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29349,0.0850290592378416,0.00287388898263983,0.0793962368318676,0.0906618816438157,1.35562107719202e-189
NMR metabolomics,X23428.Concentration of VLDL Particles,DPY30,Protein dpy-30 homolog,29604,0.116275400090738,0.00393175579554425,0.108569158731472,0.123981641450005,1.8854207384702e-189
NMR metabolomics,X23428.Concentration of VLDL Particles,GGT1,Glutathione hydrolase 1 proenzyme,29390,0.0975589635214787,0.0033083975823976,0.0910745042599794,0.104043422782978,2.27265948383146e-188
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL17,C-C motif chemokine 17,29414,0.176245003776674,0.00598060082903344,0.164523026151769,0.18796698140158,3.87986529657025e-188
NMR metabolomics,X23428.Concentration of VLDL Particles,CANT1,Soluble calcium-activated nucleotidase 1,29370,0.0390513029010962,0.00133073165067329,0.0364430688657765,0.0416595369364158,1.34697707710153e-186
NMR metabolomics,X23428.Concentration of VLDL Particles,EHBP1,EH domain-binding protein 1,24922,0.144180745402913,0.00492121163787746,0.134535170592673,0.153826320213153,1.55144197475626e-185
NMR metabolomics,X23428.Concentration of VLDL Particles,SORD,Sorbitol dehydrogenase,29595,0.130329331866815,0.00447868138863636,0.121551116345087,0.139107547388542,1.3958203303725e-183
NMR metabolomics,X23428.Concentration of VLDL Particles,FTCD,Formimidoyltransferase-cyclodeaminase,24804,0.163455729756751,0.00561217152658551,0.152455873564644,0.174455585948859,2.11152183678829e-183
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL13,C-X-C motif chemokine 13,29694,0.116197031986563,0.00400241591232778,0.108352296798401,0.124041767174725,9.43061949143928e-183
NMR metabolomics,X23428.Concentration of VLDL Particles,GLA,Alpha-galactosidase A,24329,0.0716805661967291,0.00247890720593331,0.0668219080730998,0.0765392243203584,8.56710625398493e-181
NMR metabolomics,X23428.Concentration of VLDL Particles,DKK1,Dickkopf-related protein 1,29694,0.112509024398934,0.00390421896879976,0.104856755220087,0.120161293577782,3.9575953672129e-180
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL16,C-C motif chemokine 16,29820,0.0989137991738094,0.00344223611131441,0.0921670163956332,0.105660581951986,3.84538492630387e-179
NMR metabolomics,X23428.Concentration of VLDL Particles,MTSS1,Protein MTSS 1,24805,0.210233177838916,0.00731781817051366,0.19589025422471,0.224576101453123,1.39971423347367e-178
NMR metabolomics,X23428.Concentration of VLDL Particles,DAB2,Disabled homolog 2,29725,0.208074657943221,0.00727386738863223,0.193817877861502,0.22233143802494,1.4594765881036e-177
NMR metabolomics,X23428.Concentration of VLDL Particles,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24867,0.183540405203469,0.0064306629067169,0.170936305906304,0.196144504500634,2.5056499643148e-176
NMR metabolomics,X23428.Concentration of VLDL Particles,SCLY,Selenocysteine lyase,29632,0.0909009627718409,0.00318904587845247,0.084650432850074,0.0971514926936077,2.51194783009483e-176
NMR metabolomics,X23428.Concentration of VLDL Particles,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29434,0.182871374357875,0.00641786874172286,0.170292351624098,0.195450397091652,3.44103017219146e-176
NMR metabolomics,X23428.Concentration of VLDL Particles,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29349,0.0595804638265937,0.00209439941551525,0.0554754409721838,0.0636854866810036,1.27247378215659e-175
NMR metabolomics,X23428.Concentration of VLDL Particles,DCXR,L-xylulose reductase,29566,0.100444542935068,0.00353213932065458,0.093521549866585,0.107367536003551,1.6229695753958e-175
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL5,C-X-C motif chemokine 5,29384,0.212761536335125,0.00748871642356064,0.198083652144946,0.227439420525304,3.48185701398894e-175
NMR metabolomics,X23428.Concentration of VLDL Particles,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24445,0.210973710759068,0.00742690069541955,0.196416985396045,0.22553043612209,1.15281177599025e-174
NMR metabolomics,X23428.Concentration of VLDL Particles,TCTN3,Tectonic-3,24922,0.0556061125356574,0.00196519471807074,0.0517543308882387,0.059457894183076,2.17191217058008e-173
NMR metabolomics,X23428.Concentration of VLDL Particles,GHRL,Appetite-regulating hormone,29478,0.150287381416393,0.00532145424093355,0.139857331104164,0.160717431728623,3.65377470198042e-173
NMR metabolomics,X23428.Concentration of VLDL Particles,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,29100,0.0882562193772887,0.00312543431916693,0.0821303681117215,0.0943820706428558,4.33207134793595e-173
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJA2,DnaJ homolog subfamily A member 2,29704,0.152107997495751,0.0053903957668659,0.141542821792694,0.162673173198808,6.69633286546374e-173
NMR metabolomics,X23428.Concentration of VLDL Particles,VEGFC,Vascular endothelial growth factor C,29566,0.103327636587049,0.00366488298297072,0.0961444659404263,0.110510807233672,1.34033239419451e-172
NMR metabolomics,X23428.Concentration of VLDL Particles,MASP1,Mannan-binding lectin serine protease 1,29163,0.0437425310057627,0.00155736086212013,0.0406901037160072,0.0467949582955181,2.66417141018629e-171
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL10,C-X-C motif chemokine 10,29581,0.123562622390941,0.00440032046702888,0.114937994275564,0.132187250506318,3.01908013842484e-171
NMR metabolomics,X23428.Concentration of VLDL Particles,SELPLG,P-selectin glycoprotein ligand 1,29434,0.0513467053139796,0.00182972582482411,0.0477604426973243,0.0549329679306349,5.04881172649888e-171
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP20,Centrosomal protein 20,28797,0.137357271462371,0.00489642014510849,0.127760287977958,0.146954254946783,7.4135918923895e-171
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24805,0.150498297705593,0.00536507103525326,0.139982758476496,0.161013836934689,1.76061020639546e-170
NMR metabolomics,X23428.Concentration of VLDL Particles,TARBP2,RISC-loading complex subunit TARBP2,28774,0.145782335370822,0.00520274002835319,0.13558496491525,0.155979705826394,1.79903796867944e-170
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJC6,Putative tyrosine-protein phosphatase auxilin,24240,0.156377596186453,0.00557601099303241,0.14544861464011,0.167306577732797,2.43617589516082e-170
NMR metabolomics,X23428.Concentration of VLDL Particles,C9,Complement component C9,24951,-0.0982424686550157,0.00350928605571764,-0.105120669324222,-0.0913642679858092,7.90442175862881e-170
NMR metabolomics,X23428.Concentration of VLDL Particles,GCC1,GRIP and coiled-coil domain-containing protein 1,24845,0.199141215867411,0.00712237835236116,0.185181354296783,0.213101077438039,2.10118878803952e-169
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB11FIP3,Rab11 family-interacting protein 3,24922,0.197762213776448,0.00707844886560173,0.183888453999869,0.211635973553028,3.67674248581632e-169
NMR metabolomics,X23428.Concentration of VLDL Particles,TPD52L2,Tumor protein D54,24381,0.199585128709286,0.00714921869507569,0.185572660066937,0.213597597351634,7.51877352975717e-169
NMR metabolomics,X23428.Concentration of VLDL Particles,ASGR1,Asialoglycoprotein receptor 1,29218,0.0545505050578049,0.00196303361096648,0.0507029591803106,0.0583980509352992,9.03669158383602e-168
NMR metabolomics,X23428.Concentration of VLDL Particles,PLIN1,Perilipin-1,28774,0.0638156483585502,0.00229767536672461,0.0593122046397699,0.0683190920773304,1.45928446640932e-167
NMR metabolomics,X23428.Concentration of VLDL Particles,PDLIM7,PDZ and LIM domain protein 7,29581,0.228605847897196,0.00824267158397182,0.212450211592611,0.244761484201781,3.7171880278566e-167
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM20A,Pseudokinase FAM20A,24922,0.051913156904479,0.00187143938233,0.0482451357151122,0.0555811780938458,7.96479527685575e-167
NMR metabolomics,X23428.Concentration of VLDL Particles,AXIN1,Axin-1,29434,0.17353786907347,0.00626752876268518,0.161253512698607,0.185822225448333,1.32230207214068e-166
NMR metabolomics,X23428.Concentration of VLDL Particles,RTBDN,Retbindin,29349,0.0541390944092097,0.00195557206771033,0.0503061731564975,0.057972015661922,1.48891364096072e-166
NMR metabolomics,X23428.Concentration of VLDL Particles,NOS3,"Nitric oxide synthase, endothelial",28774,0.0963779454935329,0.0034822061224665,0.0895528214934986,0.103203069493567,1.99588713963775e-166
NMR metabolomics,X23428.Concentration of VLDL Particles,SKAP1,Src kinase-associated phosphoprotein 1,29163,0.132831687312161,0.00479994524689274,0.123423794628252,0.142239579996071,2.06391181637235e-166
NMR metabolomics,X23428.Concentration of VLDL Particles,TXLNA,Alpha-taxilin,29218,0.161356144179972,0.0058419594722973,0.14990590361427,0.172806384745675,8.63051838583474e-166
NMR metabolomics,X23428.Concentration of VLDL Particles,KAZN,Kazrin,24805,0.190090295191711,0.00687700068772567,0.176611373843769,0.203569216539654,1.14915690771574e-165
NMR metabolomics,X23428.Concentration of VLDL Particles,CD63,CD63 antigen,29169,0.0932951561165545,0.00338481244395689,0.086660923726399,0.09992938850671,4.07384955461657e-165
NMR metabolomics,X23428.Concentration of VLDL Particles,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,29218,0.0971934604198987,0.00352711244633363,0.0902803200250847,0.104106600814713,4.84883090259732e-165
NMR metabolomics,X23428.Concentration of VLDL Particles,ARF6,ADP-ribosylation factor 6,24805,0.194506114121566,0.00705411809304719,0.180680042659194,0.208332185583939,7.12636433564178e-165
NMR metabolomics,X23428.Concentration of VLDL Particles,MTSS2,Protein MTSS 2,24793,0.180487027397854,0.00654707177405187,0.167654766720712,0.193319288074996,8.35071528016016e-165
NMR metabolomics,X23428.Concentration of VLDL Particles,HBEGF,Proheparin-binding EGF-like growth factor,29632,0.131729292677389,0.00478517138256297,0.122350356767566,0.141108228587213,9.48836849528516e-165
NMR metabolomics,X23428.Concentration of VLDL Particles,KHK,Ketohexokinase,24240,0.116530785785885,0.00423016062831266,0.108239670954392,0.124821900617378,1.62044906756498e-164
NMR metabolomics,X23428.Concentration of VLDL Particles,BANK1,B-cell scaffold protein with ankyrin repeats,29434,0.192235519114136,0.0069939735844868,0.178527330888542,0.20594370733973,3.08797117590869e-164
NMR metabolomics,X23428.Concentration of VLDL Particles,LECT2,Leukocyte cell-derived chemotaxin-2,24922,0.119413587903349,0.00435211461794672,0.110883443252174,0.127943732554525,2.58630386902955e-163
NMR metabolomics,X23428.Concentration of VLDL Particles,MINK1,Misshapen-like kinase 1,24845,0.167784828814303,0.00612519021579175,0.155779455991351,0.179790201637255,8.83569869695126e-163
NMR metabolomics,X23428.Concentration of VLDL Particles,DAAM1,Disheveled-associated activator of morphogenesis 1,24381,0.150124781604346,0.00548084392656059,0.139382327508287,0.160867235700404,1.02782495455068e-162
NMR metabolomics,X23428.Concentration of VLDL Particles,GP1BA,Platelet glycoprotein Ib alpha chain,29374,0.0591661884911799,0.00216344656749541,0.0549258332188889,0.0634065437634709,1.24559661693491e-162
NMR metabolomics,X23428.Concentration of VLDL Particles,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29594,-0.0686462916043653,0.00251335501134718,-0.0735724674266058,-0.0637201157821248,3.1048304853731e-162
NMR metabolomics,X23428.Concentration of VLDL Particles,C1S,Complement C1s subcomponent,24966,0.0377520345545566,0.00138235725362452,0.0350426143374526,0.0404614547716607,7.7569111755514e-162
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29786,0.0514651681178148,0.00188923511418951,0.0477622672940033,0.0551680689416262,2.01777638939339e-161
NMR metabolomics,X23428.Concentration of VLDL Particles,F11R,Junctional adhesion molecule A,29443,0.100782072157344,0.00370185699294908,0.0935264324511641,0.108037711863524,3.30087194213802e-161
NMR metabolomics,X23428.Concentration of VLDL Particles,PBLD,Phenazine biosynthesis-like domain-containing protein,28774,0.0927265954044454,0.00340585613036933,0.0860511173889215,0.0994020734199693,3.58050287567213e-161
NMR metabolomics,X23428.Concentration of VLDL Particles,CD6,T-cell differentiation antigen CD6,29760,0.0942741913897075,0.00347186641760327,0.087469333211205,0.10107904956821,2.07322293127444e-160
NMR metabolomics,X23428.Concentration of VLDL Particles,DPP4,Dipeptidyl peptidase 4,28990,0.0537094144417853,0.00197983211264578,0.0498289435009995,0.057589885382571,4.58264165313937e-160
NMR metabolomics,X23428.Concentration of VLDL Particles,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24867,0.150804110241592,0.00555457031541122,0.139917152423386,0.161691068059798,5.5296165722892e-160
NMR metabolomics,X23428.Concentration of VLDL Particles,PCSK9,Proprotein convertase subtilisin/kexin type 9,29820,0.0706122161516965,0.00260423740542572,0.0655079108370621,0.0757165214663309,5.84024128275043e-160
NMR metabolomics,X23428.Concentration of VLDL Particles,NOTCH3,Neurogenic locus notch homolog protein 3,29820,-0.0609463790853415,0.0022493684495388,-0.0653551412464376,-0.0565376169242455,9.78151309378432e-160
NMR metabolomics,X23428.Concentration of VLDL Particles,EZR,Ezrin,29694,0.0429183349005478,0.00158420326814007,0.0398132964949933,0.0460233733061024,1.09193820145852e-159
NMR metabolomics,X23428.Concentration of VLDL Particles,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29349,0.173776228980142,0.00642160569095049,0.161189881825879,0.186362576134405,2.55986653008786e-159
NMR metabolomics,X23428.Concentration of VLDL Particles,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24805,0.0492425750801531,0.00181819393130039,0.0456789149748043,0.0528062351855019,3.22072588583015e-159
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGA5,Integrin alpha-5,29443,0.0445840670095029,0.0016509182193769,0.0413482672995241,0.0478198667194816,1.09509521167282e-158
NMR metabolomics,X23428.Concentration of VLDL Particles,NPL,N-acetylneuraminate lyase,24922,0.0800806505662418,0.00296314344147041,0.0742728894209598,0.0858884117115238,1.43332048275603e-158
NMR metabolomics,X23428.Concentration of VLDL Particles,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,24111,0.121714376552674,0.00450441046209051,0.112885732046976,0.130543021058371,1.91510082695203e-158
NMR metabolomics,X23428.Concentration of VLDL Particles,PLXNA4,Plexin-A4,29434,0.145119054401722,0.00538067495076909,0.134572931498215,0.15566517730523,2.77451037215254e-158
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF41,E3 ubiquitin-protein ligase NRDP1,28797,0.118561402712503,0.00439866946462749,0.109940010561833,0.127182794863172,4.71799086497583e-158
NMR metabolomics,X23428.Concentration of VLDL Particles,ACP5,Tartrate-resistant acid phosphatase type 5,29604,0.0581809227966082,0.00216250811633613,0.0539424068885894,0.062419438704627,1.53992439780021e-157
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA3F,Semaphorin-3F,29478,0.046741474174795,0.00173748699695394,0.0433359996607653,0.0501469486888247,1.679592670976e-157
NMR metabolomics,X23428.Concentration of VLDL Particles,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29478,-0.185301204287298,0.00689063877666576,-0.198806856289562,-0.171795552285033,2.18680043928167e-157
NMR metabolomics,X23428.Concentration of VLDL Particles,ATG16L1,Autophagy-related protein 16-1,24805,0.151703545355963,0.00563507407523499,0.140658800168502,0.162748290543423,2.2655846893577e-157
NMR metabolomics,X23428.Concentration of VLDL Particles,OTUD7B,OTU domain-containing protein 7B,24867,0.111699729617616,0.00417250288341989,0.103521623966113,0.119877835269119,1.15184213982981e-155
NMR metabolomics,X23428.Concentration of VLDL Particles,PLTP,Phospholipid transfer protein,29702,-0.0633179593491916,0.00236855049365496,-0.0679603183167553,-0.0586756003816279,1.36531317195529e-155
NMR metabolomics,X23428.Concentration of VLDL Particles,GH1,Somatotropin,29433,-0.312616352040571,0.0117035375228965,-0.335555285585448,-0.289677418495694,2.48868230740861e-155
NMR metabolomics,X23428.Concentration of VLDL Particles,IL18R1,Interleukin-18 receptor 1,29786,0.0577935388471022,0.00216400696982967,0.053552085186236,0.0620349925079683,2.66618386392483e-155
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC1B,C-type lectin domain family 1 member B,29694,0.168676568941638,0.00632479811009981,0.156279964645843,0.181073173237434,7.2132167274508e-155
NMR metabolomics,X23428.Concentration of VLDL Particles,GPD1,Glycerol-3-phosphate dehydrogenase,24793,0.0924317871604527,0.00346201556093206,0.0856462366610258,0.0992173376598795,7.5340077253543e-155
NMR metabolomics,X23428.Concentration of VLDL Particles,MME,Neprilysin,29349,0.141110311482228,0.00529666113686685,0.130728855653969,0.151491767310487,1.55932497487159e-154
NMR metabolomics,X23428.Concentration of VLDL Particles,ZBTB16,Zinc finger and BTB domain-containing protein 16,28797,0.125437047973783,0.00471329584710625,0.116198988113455,0.134675107834111,3.49343521381582e-154
NMR metabolomics,X23428.Concentration of VLDL Particles,CD99L2,CD99 antigen-like protein 2,29443,0.0425119166822577,0.00159773840456471,0.0393803494093109,0.0456434839552046,3.7107814337982e-154
NMR metabolomics,X23428.Concentration of VLDL Particles,F2,Prothrombin,24966,0.026066303538463,0.000979640758772899,0.0241462076512681,0.0279863994256579,7.68531935189755e-154
NMR metabolomics,X23428.Concentration of VLDL Particles,IGF2R,Cation-independent mannose-6-phosphate receptor,29443,0.0411322116400178,0.00154755113961891,0.0380990114063648,0.0441654118736709,7.81799858665883e-154
NMR metabolomics,X23428.Concentration of VLDL Particles,SELP,P-selectin,29594,0.0995483560523996,0.00374627668322877,0.0922056537532713,0.106891058351528,9.01531418645822e-154
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP6V1G1,V-type proton ATPase subunit G 1,24240,0.127490593547901,0.00479179202854988,0.118098681171943,0.136882505923858,9.35627789450274e-154
NMR metabolomics,X23428.Concentration of VLDL Particles,AMBP,Protein AMBP,29683,0.0351182526909337,0.00132669420466039,0.0325179320497993,0.0377185733320681,1.25959235214179e-152
NMR metabolomics,X23428.Concentration of VLDL Particles,AP3S2,AP-3 complex subunit sigma-2,24845,0.0823449330939417,0.00312516936589122,0.0762196011367949,0.0884702650510885,6.27233076272812e-151
NMR metabolomics,X23428.Concentration of VLDL Particles,LEFTY2,Left-right determination factor 2,29674,0.0901213020177987,0.00342534321998164,0.0834076293066347,0.0968349747289628,7.9229416182931e-151
NMR metabolomics,X23428.Concentration of VLDL Particles,GPC5,Glypican-5,29218,0.097691162754529,0.00371413653196659,0.0904114551518745,0.104970870357184,1.02513280636781e-150
NMR metabolomics,X23428.Concentration of VLDL Particles,BECN1,Beclin-1,24240,0.104893644006189,0.00398340260809919,0.0970861748943143,0.112701113118063,1.07041793214654e-150
NMR metabolomics,X23428.Concentration of VLDL Particles,NCK2,Cytoplasmic protein NCK2,29581,0.182614580232174,0.00696200225329055,0.168969055815725,0.196260104648624,6.26787299623345e-150
NMR metabolomics,X23428.Concentration of VLDL Particles,THPO,Thrombopoietin,28916,0.0667719920429411,0.00254843857096811,0.0617770524438436,0.0717669316420386,1.44362567392114e-149
NMR metabolomics,X23428.Concentration of VLDL Particles,SUGP1,SURP and G-patch domain-containing protein 1,24805,0.0693660923140803,0.00264869208457728,0.0641746558283088,0.0745575287998518,3.80860822762972e-149
NMR metabolomics,X23428.Concentration of VLDL Particles,CIRBP,Cold-inducible RNA-binding protein,24805,0.165863200640857,0.00633457649102922,0.15344743071844,0.178278970563275,4.32941880328486e-149
NMR metabolomics,X23428.Concentration of VLDL Particles,ERBIN,Erbin,29349,0.176454534245231,0.00676046543908226,0.163204021984629,0.189705046505832,1.76877574373007e-148
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL3,C-X-C motif chemokine 3,29453,0.162008509715062,0.0062079637669618,0.149840900731817,0.174176118698307,1.93562733963191e-148
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24740,0.188295600273924,0.00721006440298427,0.174163874044075,0.202427326503773,2.4866766253485e-148
NMR metabolomics,X23428.Concentration of VLDL Particles,FUOM,Fucose mutarotase,24381,0.110005070216979,0.00421263422412804,0.101748307137688,0.11826183329627,2.83577627137128e-148
NMR metabolomics,X23428.Concentration of VLDL Particles,CMIP,C-Maf-inducing protein,24793,0.142952165847425,0.00547815763524911,0.132214976882337,0.153689354812513,4.17276983687554e-148
NMR metabolomics,X23428.Concentration of VLDL Particles,RBPMS2,RNA-binding protein with multiple splicing 2,24240,0.177194986266649,0.00678972290924945,0.163887129364521,0.190502843168778,4.33146465448398e-148
NMR metabolomics,X23428.Concentration of VLDL Particles,PDGFC,Platelet-derived growth factor C,28797,0.0497724191661401,0.00190958280863212,0.0460296368612212,0.0535152014710591,4.81977766455836e-148
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R9B,Neurabin-2,29786,0.16191745428803,0.00622075200008076,0.149724780367871,0.174110128208188,1.05923623121477e-147
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK10,Kallikrein-10,29466,0.0687297263309997,0.00264041485176668,0.0635545132215371,0.0739049394404624,1.06738054457593e-147
NMR metabolomics,X23428.Concentration of VLDL Particles,CES3,Carboxylesterase 3,29349,0.119908110279613,0.00460672834271242,0.110878922727897,0.128937297831329,1.11128133421868e-147
NMR metabolomics,X23428.Concentration of VLDL Particles,THOP1,Thimet oligopeptidase,29343,0.0529376766070867,0.00203613233807412,0.0489468572244615,0.056928495989712,2.37382638281052e-147
NMR metabolomics,X23428.Concentration of VLDL Particles,NUCB2,Nucleobindin-2,29652,0.0639284485120472,0.00246003425343874,0.0591067813753073,0.0687501156487871,3.12232842684475e-147
NMR metabolomics,X23428.Concentration of VLDL Particles,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28916,0.0943170880686693,0.00363055848998498,0.0872011934282988,0.10143298270904,4.22438038541945e-147
NMR metabolomics,X23428.Concentration of VLDL Particles,AAMDC,Mth938 domain-containing protein,24240,0.0916370206338308,0.0035300917634203,0.084718040777527,0.0985560004901346,1.4593434414658e-146
NMR metabolomics,X23428.Concentration of VLDL Particles,PHACTR2,Phosphatase and actin regulator 2,24867,0.195355426926637,0.00753661086337937,0.180583669634413,0.21012718421886,3.40015706098806e-146
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29566,0.16248892919173,0.00627770685309363,0.150184623759666,0.174793234623793,4.35338139626724e-146
NMR metabolomics,X23428.Concentration of VLDL Particles,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29497,0.0456395031037992,0.00176358958199061,0.0421828675230976,0.0490961386845008,4.95038670796777e-146
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP10,Stromelysin-2,29439,-0.100750725786825,0.00389834178761014,-0.108391475690541,-0.0931099758831092,1.18705012602635e-145
NMR metabolomics,X23428.Concentration of VLDL Particles,TNIP1,TNFAIP3-interacting protein 1,24845,0.151037959153267,0.00584474634275391,0.13958225632147,0.162493661985065,2.5192922744957e-145
NMR metabolomics,X23428.Concentration of VLDL Particles,CSNK2A1,Casein kinase II subunit alpha,24867,-0.0766857747675661,0.0029698328261068,-0.0825066471067354,-0.0708649024283968,4.16235220157215e-145
NMR metabolomics,X23428.Concentration of VLDL Particles,CES2,Cocaine esterase,29349,0.0930585189036972,0.0036112090553883,0.0859805491551361,0.100136488652258,8.0213727443998e-145
NMR metabolomics,X23428.Concentration of VLDL Particles,DOK2,Docking protein 2,29478,0.206583791798001,0.00802993626678697,0.190845116715099,0.222322466880904,2.3142241551735e-144
NMR metabolomics,X23428.Concentration of VLDL Particles,BPIFB1,BPI fold-containing family B member 1,29333,-0.107006487834836,0.00416149100868753,-0.115163010211864,-0.0988499654578086,3.28593360798337e-144
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGEF12,Rho guanine nucleotide exchange factor 12,29434,0.176056725836117,0.00685097756757091,0.162628809803678,0.189484641868556,4.78879589093409e-144
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP85,Centrosomal protein of 85 kDa,28797,0.108478985586819,0.00422094448282781,0.100205934400477,0.116752036773162,4.91685051761057e-144
NMR metabolomics,X23428.Concentration of VLDL Particles,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",24240,0.0974928078246212,0.00378991948754894,0.0900645656290253,0.104921050020217,5.3702817557431e-144
NMR metabolomics,X23428.Concentration of VLDL Particles,CCN2,CCN family member 2,29478,0.0964302397823631,0.00376614071746496,0.0890486039761318,0.103811875588594,4.9947148423515e-143
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF21,Fibroblast growth factor 21,29674,0.200192540711167,0.00782230353214598,0.184860825788161,0.215524255634174,6.59123286190138e-143
NMR metabolomics,X23428.Concentration of VLDL Particles,NFX1,Transcriptional repressor NF-X1,24111,0.114328802326351,0.00447995932009287,0.105548082058969,0.123109522593733,9.02365681735601e-142
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL5,C-C motif chemokine 5,29594,0.168811873472248,0.00662750810951819,0.155821957577592,0.181801789366904,1.37832913392145e-141
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINC1,Antithrombin-III,24914,0.0249386654067403,0.000978953356645519,0.023019916827715,0.0268574139857655,2.42397722486104e-141
NMR metabolomics,X23428.Concentration of VLDL Particles,NPPC,C-type natriuretic peptide,29434,0.0804201862307857,0.00316012074868666,0.0742263495633599,0.0866140228982116,2.48950779655122e-141
NMR metabolomics,X23428.Concentration of VLDL Particles,DCTN1,Dynactin subunit 1,29725,0.108964122139096,0.00428457147184592,0.100566362054278,0.117361882223914,3.65010096869247e-141
NMR metabolomics,X23428.Concentration of VLDL Particles,PAK4,Serine/threonine-protein kinase PAK 4,28774,0.102790879579343,0.00404242129415951,0.0948677338427906,0.110714025315896,4.48264963334376e-141
NMR metabolomics,X23428.Concentration of VLDL Particles,IRAK1,Interleukin-1 receptor-associated kinase 1,28931,0.116545476789187,0.00458507405504216,0.107558731641304,0.125532221937069,5.58463434167053e-141
NMR metabolomics,X23428.Concentration of VLDL Particles,BCR,Breakpoint cluster region protein,29434,0.153648602660139,0.00604679681825985,0.141796880896349,0.165500324423928,6.50422724358643e-141
NMR metabolomics,X23428.Concentration of VLDL Particles,SLA2,Src-like-adapter 2,24867,0.176044556120585,0.0069224162032939,0.162476620362129,0.189612491879041,7.24167507791103e-141
NMR metabolomics,X23428.Concentration of VLDL Particles,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24365,0.0795056700431227,0.00312672370856001,0.0733772915743451,0.0856340485119003,8.54786249774382e-141
NMR metabolomics,X23428.Concentration of VLDL Particles,CLIP2,CAP-Gly domain-containing linker protein 2,29434,0.18823396428341,0.0074137071025725,0.173703098362368,0.202764830204452,1.06807163233951e-140
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF4B,Eukaryotic translation initiation factor 4B,29218,0.0968954076612198,0.00382255958021057,0.0894031908840071,0.104387624438432,3.08841846803031e-140
NMR metabolomics,X23428.Concentration of VLDL Particles,SHBG,Sex hormone-binding globulin,24951,-0.0865487341996638,0.00341495339481354,-0.0932420428534983,-0.0798554255458292,6.17748844188577e-140
NMR metabolomics,X23428.Concentration of VLDL Particles,PCBP2,Poly(rC)-binding protein 2,24867,0.12118196194744,0.0047833226936353,0.111806649467915,0.130557274426965,7.97605563816807e-140
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A4,Protein S100-A4,29566,0.0951812083342702,0.00376273672339097,0.0878062443564239,0.102556172312117,1.09345638590337e-139
NMR metabolomics,X23428.Concentration of VLDL Particles,USO1,General vesicular transport factor p115,29349,0.149977983528858,0.00593515143986987,0.138345086706713,0.161610880351003,2.15103693881314e-139
NMR metabolomics,X23428.Concentration of VLDL Particles,STAT5B,Signal transducer and activator of transcription 5B,29349,0.229320789106878,0.00907577282549895,0.2115322743689,0.247109303844856,2.26523356035028e-139
NMR metabolomics,X23428.Concentration of VLDL Particles,SDC4,Syndecan-4,29478,0.0772532180106517,0.00306060654899134,0.0712544291746287,0.0832520068466747,4.27063017089044e-139
NMR metabolomics,X23428.Concentration of VLDL Particles,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28643,0.0917009604137524,0.00363418730862857,0.0845779532888404,0.0988239675386644,5.78001961773082e-139
NMR metabolomics,X23428.Concentration of VLDL Particles,HMOX2,Heme oxygenase 2,28774,0.0776472362000653,0.00308454587766971,0.0716015262798327,0.083692946120298,2.49656723207734e-138
NMR metabolomics,X23428.Concentration of VLDL Particles,NFE2,Transcription factor NF-E2 45 kDa subunit,24240,0.124122600428937,0.00492751622426891,0.11446466862937,0.133780532228504,3.12456383060468e-138
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJB6,DnaJ homolog subfamily B member 6,24170,0.140853342165485,0.00561124209735323,0.129855307654673,0.151851376676298,2.72039378963014e-137
NMR metabolomics,X23428.Concentration of VLDL Particles,STC1,Stanniocalcin-1,29694,0.0719135575269559,0.00287046304321684,0.0662874499622509,0.0775396650916609,4.32058237837298e-137
NMR metabolomics,X23428.Concentration of VLDL Particles,NFKBIE,NF-kappa-B inhibitor epsilon,28797,0.0818767303967467,0.00326775215706989,0.0754719361688897,0.0882815246246037,4.43600913603728e-137
NMR metabolomics,X23428.Concentration of VLDL Particles,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29349,0.0630008887771676,0.00251837592146587,0.0580648719710944,0.0679369055832407,1.09883026894586e-136
NMR metabolomics,X23428.Concentration of VLDL Particles,PAXX,Protein PAXX,24381,0.0759124240296374,0.00303156880668317,0.0699705491685384,0.0818542988907364,1.1799936833481e-136
NMR metabolomics,X23428.Concentration of VLDL Particles,ZFYVE19,Abscission/NoCut checkpoint regulator,24805,0.150164418723776,0.00600111812818199,0.13840222719254,0.161926610255013,1.70968460623221e-136
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1R2,Interleukin-1 receptor type 2,29404,0.032792727728766,0.00131491995181055,0.0302154846232174,0.0353699708343147,7.2954053475201e-136
NMR metabolomics,X23428.Concentration of VLDL Particles,SRPK2,SRSF protein kinase 2,29434,0.138067278542336,0.00553632247482519,0.127216086491678,0.148918470592993,7.3624408964765e-136
NMR metabolomics,X23428.Concentration of VLDL Particles,ISM1,Isthmin-1,29434,0.0647597047601473,0.00259692905402989,0.0596697238142487,0.0698496857060459,7.62139333626043e-136
NMR metabolomics,X23428.Concentration of VLDL Particles,HJV,Hemojuvelin,24867,0.0729501883854613,0.00292851881545882,0.067210291507162,0.0786900852637606,2.63231426297606e-135
NMR metabolomics,X23428.Concentration of VLDL Particles,FOXO1,Forkhead box protein O1,29434,0.140505047842908,0.00564664875498928,0.129437616283129,0.151572479402687,2.86011984817793e-135
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH2,Cadherin-2,29478,0.0581358823318527,0.00233906164967843,0.0535513214984829,0.0627204431652224,5.71216403285922e-135
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29566,0.0588680983238972,0.00237100635666362,0.0542209258648365,0.0635152707829579,1.06753170615209e-134
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24805,0.178350887600011,0.00718209291857491,0.164273985479604,0.192427789720417,1.74987125838484e-134
NMR metabolomics,X23428.Concentration of VLDL Particles,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24381,0.0812484436402347,0.00327552298102516,0.0748284185974254,0.087668468683044,3.68050129425372e-134
NMR metabolomics,X23428.Concentration of VLDL Particles,NFKB1,Nuclear factor NF-kappa-B p105 subunit,24111,0.122062424372174,0.00492728863284704,0.112404938651794,0.131719910092555,8.32891978967552e-134
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29786,0.16159208174959,0.00653530600425274,0.148782881981255,0.174401281517926,1.25499593332283e-133
NMR metabolomics,X23428.Concentration of VLDL Particles,CKB,Creatine kinase B-type,24938,-0.096910127216195,0.00391879422332958,-0.104590963893921,-0.0892292905384691,2.08673676549305e-133
NMR metabolomics,X23428.Concentration of VLDL Particles,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28797,0.103441204156481,0.0041874727563681,0.0952337575539997,0.111648650758963,2.46331886518365e-133
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMP4,Metalloproteinase inhibitor 4,29443,-0.0656886743964435,0.00266102087271427,-0.0709042753069635,-0.0604730734859235,3.47187145837569e-133
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINH1,Serpin H1,24445,0.209791403972493,0.00851158376610671,0.193108699790923,0.226474108154062,1.6172881881083e-132
NMR metabolomics,X23428.Concentration of VLDL Particles,PLXNB3,Plexin-B3,29383,0.0770165015522372,0.00312802377905627,0.0708855749452869,0.0831474281591875,1.64578062485691e-132
NMR metabolomics,X23428.Concentration of VLDL Particles,IKBKG,NF-kappa-B essential modulator,29434,0.148896362415978,0.00605413661530228,0.137030254649985,0.16076247018197,3.16556922635401e-132
NMR metabolomics,X23428.Concentration of VLDL Particles,CMC1,COX assembly mitochondrial protein homolog,24922,0.14758098771332,0.005995816437855,0.135829187495124,0.159332787931515,3.39926609707175e-132
NMR metabolomics,X23428.Concentration of VLDL Particles,GFER,FAD-linked sulfhydryl oxidase ALR,28797,0.103900149688461,0.00423242005484671,0.095604606380962,0.112195692995961,1.01420161387557e-131
NMR metabolomics,X23428.Concentration of VLDL Particles,SEC31A,Protein transport protein Sec31A,24240,0.12485614827053,0.00509105676094373,0.114877677019081,0.13483461952198,3.21587548861181e-131
NMR metabolomics,X23428.Concentration of VLDL Particles,SNAP23,Synaptosomal-associated protein 23,29478,0.140452504784248,0.00574188428893894,0.129198411577928,0.151706597990569,7.76747178480369e-131
NMR metabolomics,X23428.Concentration of VLDL Particles,CRHBP,Corticotropin-releasing factor-binding protein,29454,0.0448866941855489,0.00183785054014651,0.0412845071268617,0.048488881244236,1.9182367652685e-130
NMR metabolomics,X23428.Concentration of VLDL Particles,C4BPB,C4b-binding protein beta chain,29566,0.0645561829892106,0.00265277647902954,0.0593567410903127,0.0697556248881085,1.56480400068568e-129
NMR metabolomics,X23428.Concentration of VLDL Particles,AHNAK,Neuroblast differentiation-associated protein AHNAK,24240,0.0510468541966485,0.00209630832786413,0.0469380898740348,0.0551556185192622,2.04261586303419e-129
NMR metabolomics,X23428.Concentration of VLDL Particles,EGFR,Epidermal growth factor receptor,29820,0.026340556705423,0.00108483846122572,0.0242142733214206,0.0284668400894254,5.63545927853272e-129
NMR metabolomics,X23428.Concentration of VLDL Particles,RILPL2,RILP-like protein 2,24922,0.157426423559511,0.00648345971894509,0.144718842510379,0.170134004608643,9.71343875750846e-129
NMR metabolomics,X23428.Concentration of VLDL Particles,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24445,0.170048775009353,0.0070038654493061,0.156321198728713,0.183776351289993,1.08736303455329e-128
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL13,C-C motif chemokine 13,29732,0.11059434556194,0.0045616717472006,0.101653468937427,0.119535222186453,1.35206755087689e-128
NMR metabolomics,X23428.Concentration of VLDL Particles,BID,BH3-interacting domain death agonist,29434,0.106645352899508,0.00440567557404718,0.0980102287743756,0.11528047702464,3.42860487506799e-128
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGEF1,Rho guanine nucleotide exchange factor 1,24845,0.144958043653451,0.00598304773427923,0.133231270094264,0.156684817212638,3.46227054802626e-128
NMR metabolomics,X23428.Concentration of VLDL Particles,PDGFB,Platelet-derived growth factor subunit B,29581,0.13685402157347,0.00565841672644051,0.125763524789647,0.147944518357293,5.49396303965971e-128
NMR metabolomics,X23428.Concentration of VLDL Particles,AGRN,Agrin,29581,0.0549729413691142,0.00227509936089097,0.0505137466217679,0.0594321361164604,9.49641444091217e-128
NMR metabolomics,X23428.Concentration of VLDL Particles,RGCC,Regulator of cell cycle RGCC,24867,0.121030982925395,0.00500541516287654,0.111220369206157,0.130841596644633,1.07910833906807e-127
NMR metabolomics,X23428.Concentration of VLDL Particles,F11,Coagulation factor XI,24606,0.0497152374999256,0.00205687191039512,0.0456837685555512,0.0537467064443,1.40632953553533e-127
NMR metabolomics,X23428.Concentration of VLDL Particles,NAGK,N-acetyl-D-glucosamine kinase,24209,0.091033501926768,0.00376756388169645,0.0836490767186429,0.098417927134893,1.79075704763639e-127
NMR metabolomics,X23428.Concentration of VLDL Particles,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",29307,0.167004876714312,0.00692943594360014,0.153423182264856,0.180586571163769,4.24706470839284e-127
NMR metabolomics,X23428.Concentration of VLDL Particles,DAG1,Dystroglycan,29581,0.075508702003823,0.00313401769263303,0.0693660273262623,0.0816513766813838,4.94510391978783e-127
NMR metabolomics,X23428.Concentration of VLDL Particles,CTBS,Di-N-acetylchitobiase,24653,0.0434739133605912,0.00180567678808813,0.0399347868559385,0.0470130398652439,1.28745471499688e-126
NMR metabolomics,X23428.Concentration of VLDL Particles,SDCCAG8,Serologically defined colon cancer antigen 8,24793,0.181651145505143,0.00755043229230304,0.166852298212229,0.196449992798057,1.92479737063661e-126
NMR metabolomics,X23428.Concentration of VLDL Particles,PLSCR3,Phospholipid scramblase 3,24804,0.0937180125042319,0.00389719392848345,0.0860795124044043,0.101356512604059,2.47935099269827e-126
NMR metabolomics,X23428.Concentration of VLDL Particles,PON2,Serum paraoxonase/arylesterase 2,28916,0.0550208879217418,0.00229625126644616,0.0505202354395073,0.0595215404039763,1.19012184196995e-125
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGAP45,Rho GTPase-activating protein 45,24381,0.131261781679674,0.0054744792313619,0.120531802386205,0.141991760973144,1.37655604562387e-125
NMR metabolomics,X23428.Concentration of VLDL Particles,GDF2,Growth/differentiation factor 2,29478,0.0564865629112345,0.00235832213191568,0.0518642515326798,0.0611088742897892,1.40023739147403e-125
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,29163,0.176833819663497,0.00738788294946574,0.162353569082544,0.19131407024445,2.11898560639505e-125
NMR metabolomics,X23428.Concentration of VLDL Particles,YOD1,Ubiquitin thioesterase OTU1,24111,0.0988674794256673,0.00413717614664749,0.0907586141782382,0.106976344673096,9.23772356632357e-125
NMR metabolomics,X23428.Concentration of VLDL Particles,HCLS1,Hematopoietic lineage cell-specific protein,29786,0.0877284222162989,0.00367593548783373,0.0805235886601448,0.094933255772453,1.03701192259639e-124
NMR metabolomics,X23428.Concentration of VLDL Particles,CRELD2,Protein disulfide isomerase CRELD2,29536,0.0819749840907491,0.00343699062054012,0.0752384824744905,0.0887114857070077,1.50078586116091e-124
NMR metabolomics,X23428.Concentration of VLDL Particles,HYOU1,Hypoxia up-regulated protein 1,29820,0.0351165501297461,0.00147336821786741,0.032228748422726,0.0380043518367662,2.15889966952157e-124
NMR metabolomics,X23428.Concentration of VLDL Particles,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24922,0.100573718628871,0.00421997740324117,0.0923025629185179,0.108844874339223,3.75350586270863e-124
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBPL,FK506-binding protein-like,24805,0.0933989056580324,0.00392038642221241,0.085714948270496,0.101082863045569,4.68474568000076e-124
NMR metabolomics,X23428.Concentration of VLDL Particles,MPRIP,Myosin phosphatase Rho-interacting protein,24729,0.0699613475957664,0.00293707875659804,0.0642046732328342,0.0757180219586985,5.17604513103648e-124
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC4G,C-type lectin domain family 4 member G,29434,0.0523141528005459,0.0021998235229795,0.0480024986955061,0.0566258069055857,7.74867369398475e-124
NMR metabolomics,X23428.Concentration of VLDL Particles,NIT2,Omega-amidase NIT2,24813,0.117362734081894,0.0049309970319126,0.107697979899345,0.127027488264442,7.98100022702943e-124
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29510,0.0358571251286752,0.00150849284416159,0.0329004791541185,0.0388137711032319,9.92889374994992e-124
NMR metabolomics,X23428.Concentration of VLDL Particles,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,29218,0.148861991257468,0.00626447042247227,0.136583629229422,0.161140353285514,1.20805746083798e-123
NMR metabolomics,X23428.Concentration of VLDL Particles,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28797,0.129649295231948,0.00545976614122478,0.118948153595148,0.140350436868749,1.85021177191653e-123
NMR metabolomics,X23428.Concentration of VLDL Particles,PDCD5,Programmed cell death protein 5,29694,0.0907367189446338,0.00382622229217142,0.0832373232519778,0.0982361146372897,3.58638609900662e-123
NMR metabolomics,X23428.Concentration of VLDL Particles,FST,Follistatin,29536,0.0791992792045012,0.003341618544651,0.0726497068569853,0.0857488515520172,4.98918878386672e-123
NMR metabolomics,X23428.Concentration of VLDL Particles,GOLM2,Protein GOLM2,29694,0.0354197476531788,0.0014944889106815,0.032490549388243,0.0383489459181145,4.99326718302819e-123
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29478,0.0440006724785269,0.00185703113703837,0.0403608914499317,0.0476404535071221,5.87279958513071e-123
NMR metabolomics,X23428.Concentration of VLDL Particles,CD2AP,CD2-associated protein,29478,0.0994086757054918,0.00419977417509998,0.0911771183222958,0.107640233088688,1.02900152824695e-122
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24805,0.160773283405754,0.00679459650303021,0.147455874259815,0.174090692551693,2.0257432618209e-122
NMR metabolomics,X23428.Concentration of VLDL Particles,TACC3,Transforming acidic coiled-coil-containing protein 3,29349,0.18185259134633,0.00769615634343302,0.166768124913201,0.196937057779458,2.6993455861793e-122
NMR metabolomics,X23428.Concentration of VLDL Particles,CNPY4,Protein canopy homolog 4,29349,0.11713903471335,0.00495892008794184,0.107419551340984,0.126858518085716,3.18555505975824e-122
NMR metabolomics,X23428.Concentration of VLDL Particles,GIT1,ARF GTPase-activating protein GIT1,24229,0.152299157235292,0.0064566331796667,0.139644156203145,0.164954158267439,1.20512824473779e-121
NMR metabolomics,X23428.Concentration of VLDL Particles,IST1,IST1 homolog,24636,0.155293733668397,0.00658441482869147,0.142388280604162,0.168199186732632,1.22593296645435e-121
NMR metabolomics,X23428.Concentration of VLDL Particles,FETUB,Fetuin-B,29545,0.0514438436606883,0.0021837449513874,0.047163703555969,0.0557239837654076,1.38998760360126e-121
NMR metabolomics,X23428.Concentration of VLDL Particles,ASAH2,Neutral ceramidase,29218,0.082226682883457,0.0035037958586761,0.0753592430004518,0.0890941227664621,1.13861212357745e-120
NMR metabolomics,X23428.Concentration of VLDL Particles,STK11,Serine/threonine-protein kinase STK11,28916,0.1131371303742,0.00482683943244019,0.103676525086617,0.122597735661783,2.26683996209841e-120
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP1,Insulin-like growth factor-binding protein 1,29761,-0.188826773452271,0.0080617981024717,-0.204627897733115,-0.173025649171426,3.10203706637297e-120
NMR metabolomics,X23428.Concentration of VLDL Particles,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24867,0.120198215788979,0.00513047802878306,0.110142478852564,0.130253952725394,4.41212692912215e-120
NMR metabolomics,X23428.Concentration of VLDL Particles,BIRC2,Baculoviral IAP repeat-containing protein 2,28797,0.0979294008852721,0.00418614922034188,0.0897245484134021,0.106134253357142,6.53019238312776e-120
NMR metabolomics,X23428.Concentration of VLDL Particles,OGFR,Opioid growth factor receptor,29349,0.0505924657688227,0.00216330753802288,0.0463523829942978,0.0548325485433475,7.31976840026665e-120
NMR metabolomics,X23428.Concentration of VLDL Particles,AP3B1,AP-3 complex subunit beta-1,24805,0.118723816192865,0.00507881585096374,0.108769337124976,0.128678295260754,1.46476813620806e-119
NMR metabolomics,X23428.Concentration of VLDL Particles,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29608,0.159085260814388,0.00681537094816028,0.145727133755994,0.172443387872782,1.99144457217914e-119
NMR metabolomics,X23428.Concentration of VLDL Particles,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24922,0.11923254959511,0.00510420503835297,0.109228307719938,0.129236791470281,2.11355610652322e-119
NMR metabolomics,X23428.Concentration of VLDL Particles,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24845,0.10713080540817,0.00459111238044979,0.0981322251424888,0.116129385673852,3.80389264800014e-119
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASE4,Ribonuclease 4,24194,0.0424918831499718,0.00182391972310733,0.0389170004926814,0.0460667658072622,9.66196255765122e-119
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFB1,Transforming growth factor beta-1 proprotein,29760,0.0589747440713627,0.00253501216314736,0.0540061202315939,0.0639433679111315,1.17701975407003e-118
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMP3,Metalloproteinase inhibitor 3,29581,0.199810387738712,0.00859109352087844,0.18297184443779,0.216648931039634,1.37749282416535e-118
NMR metabolomics,X23428.Concentration of VLDL Particles,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29434,0.155332710374882,0.00668334777405763,0.142233348737729,0.168432072012035,2.01504477953991e-118
NMR metabolomics,X23428.Concentration of VLDL Particles,LZTFL1,Leucine zipper transcription factor-like protein 1,24381,0.110389083973388,0.00475320692497666,0.101072798400434,0.119705369546343,4.9750643917325e-118
NMR metabolomics,X23428.Concentration of VLDL Particles,TBC1D23,TBC1 domain family member 23,29349,0.137613538141012,0.00594203877812435,0.125967142135888,0.149259934146136,1.33205745116097e-117
NMR metabolomics,X23428.Concentration of VLDL Particles,AHSG,Alpha-2-HS-glycoprotein,24951,0.041333469097436,0.00178350077008607,0.0378378075880673,0.0448291306068047,1.40826850012687e-117
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP43,Centrosomal protein 43,28705,0.106562042669807,0.00460730927472167,0.0975317164913526,0.115592368848262,2.80855117090288e-117
NMR metabolomics,X23428.Concentration of VLDL Particles,METAP2,Methionine aminopeptidase 2,29674,0.0877514161992922,0.00380016476343957,0.0803030932629506,0.0951997391356337,6.07532934774768e-117
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC3B,Tetranectin,24381,0.0328205269370301,0.00142099976658502,0.0300353673945235,0.0356056864795367,8.96191676535587e-117
NMR metabolomics,X23428.Concentration of VLDL Particles,VAMP8,Vesicle-associated membrane protein 8,24229,0.135299919903694,0.00585826171704147,0.123817726938293,0.146782112869095,9.37714188418115e-117
NMR metabolomics,X23428.Concentration of VLDL Particles,SUSD1,Sushi domain-containing protein 1,28916,0.074788400521683,0.00324150638470811,0.0684350480076551,0.0811417530357109,1.00293073112447e-116
NMR metabolomics,X23428.Concentration of VLDL Particles,MITD1,MIT domain-containing protein 1,29218,0.147459405244284,0.00639236186938065,0.134930375980298,0.15998843450827,1.07253215051264e-116
NMR metabolomics,X23428.Concentration of VLDL Particles,BACH1,Transcription regulator protein BACH1,29434,0.112371701532249,0.00487274760063268,0.102821116235009,0.121922286829489,1.22995574258051e-116
NMR metabolomics,X23428.Concentration of VLDL Particles,DLK1,Protein delta homolog 1,29820,0.0849720817398202,0.00368709722260621,0.0777453711835121,0.0921987922961284,1.69459411533957e-116
NMR metabolomics,X23428.Concentration of VLDL Particles,TANK,TRAF family member-associated NF-kappa-B activator,28931,0.106993186169069,0.00464678555219216,0.0978854864867728,0.116100885851366,2.90183992981944e-116
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP5IF1,"ATPase inhibitor, mitochondrial",29581,0.167387813914149,0.00727335364585271,0.153132040768277,0.18164358706002,3.56233296692753e-116
NMR metabolomics,X23428.Concentration of VLDL Particles,TBCC,Tubulin-specific chaperone C,29218,0.123146628464929,0.00535079624958565,0.112659067815741,0.133634189114117,3.6014475639676e-116
NMR metabolomics,X23428.Concentration of VLDL Particles,RAPGEF2,Rap guanine nucleotide exchange factor 2,24445,0.081304619355587,0.00353017216029509,0.0743854819214086,0.0882237567897654,3.90722774854182e-116
NMR metabolomics,X23428.Concentration of VLDL Particles,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",24240,0.0693312877370922,0.0030121954844584,0.0634273845875538,0.0752351908866307,5.54869565073553e-116
NMR metabolomics,X23428.Concentration of VLDL Particles,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29566,0.110001256877608,0.00478738514514567,0.100617981993122,0.119384531762093,8.15270247366877e-116
NMR metabolomics,X23428.Concentration of VLDL Particles,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29349,0.116502428853029,0.00507886242470429,0.106547858500608,0.126456999205449,1.98518159913436e-115
NMR metabolomics,X23428.Concentration of VLDL Particles,SKAP2,Src kinase-associated phosphoprotein 2,29581,0.158012169549524,0.00688973509506087,0.144508288763205,0.171516050335844,2.1459287665141e-115
NMR metabolomics,X23428.Concentration of VLDL Particles,BTN3A2,Butyrophilin subfamily 3 member A2,29434,0.0573847996403504,0.00250348667330857,0.0524779657606656,0.0622916335200352,2.87694433194091e-115
NMR metabolomics,X23428.Concentration of VLDL Particles,TIA1,Nucleolysin TIA-1 isoform p40,28538,0.185016825394411,0.00807341375141017,0.169192934441647,0.200840716347174,3.47310182374807e-115
NMR metabolomics,X23428.Concentration of VLDL Particles,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24922,0.110089969564229,0.0048084661105777,0.100665375987497,0.119514563140961,7.98558943576053e-115
NMR metabolomics,X23428.Concentration of VLDL Particles,SH2B3,SH2B adapter protein 3,28797,0.148352752371453,0.00648612751112072,0.135639942449657,0.16106556229325,9.2620946920245e-115
NMR metabolomics,X23428.Concentration of VLDL Particles,WASF1,Wiskott-Aldrich syndrome protein family member 1,28916,0.141245734192057,0.0061874115862695,0.129118407482969,0.153373060901145,2.4895350980248e-114
NMR metabolomics,X23428.Concentration of VLDL Particles,GIGYF2,GRB10-interacting GYF protein 2,24867,0.115085017387303,0.00503843549241484,0.10520968382217,0.124960350952436,2.67510097042914e-114
NMR metabolomics,X23428.Concentration of VLDL Particles,DBNL,Drebrin-like protein,29581,0.139557943601046,0.00611602751680211,0.127570529668114,0.151545357533978,2.92788240800729e-114
NMR metabolomics,X23428.Concentration of VLDL Particles,SPOCK1,Testican-1,29218,0.0389149295897808,0.00170664180516781,0.0355699116516519,0.0422599475279097,4.34619337284557e-114
NMR metabolomics,X23428.Concentration of VLDL Particles,PLG,Plasminogen,24421,0.0335399555272894,0.00147087058032307,0.0306570491898562,0.0364228618647226,6.67000989402738e-114
NMR metabolomics,X23428.Concentration of VLDL Particles,PDLIM5,PDZ and LIM domain protein 5,24867,0.17893574547654,0.00784800428456185,0.163553657078799,0.194317833874281,6.73970812057246e-114
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA11,Annexin A11,29373,0.100651978869047,0.00442030202378428,0.0919881869024298,0.109315770835664,8.73763104798378e-114
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24793,0.125496253826464,0.00550703097242843,0.114702473120504,0.136290034532424,8.84341934423694e-114
NMR metabolomics,X23428.Concentration of VLDL Particles,APPL2,DCC-interacting protein 13-beta,24381,0.169471223427692,0.00743890447952695,0.154890970647819,0.184051476207565,1.07258106946806e-113
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF19,Fibroblast growth factor 19,29581,0.11603781371367,0.00509890599983549,0.106043957953992,0.126031669473348,1.15078698323549e-113
NMR metabolomics,X23428.Concentration of VLDL Particles,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24805,0.134372482012226,0.0059023280933711,0.122803918949218,0.145941045075233,1.45573974762261e-113
NMR metabolomics,X23428.Concentration of VLDL Particles,LAT,Linker for activation of T-cells family member 1,29786,0.113795587361636,0.00500581231269283,0.103984195228758,0.123606979494514,1.97083247735878e-113
NMR metabolomics,X23428.Concentration of VLDL Particles,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28916,0.14422498739127,0.00634645260635808,0.131785940282809,0.156664034499732,2.48485795874139e-113
NMR metabolomics,X23428.Concentration of VLDL Particles,AKT1S1,Proline-rich AKT1 substrate 1,28774,0.1008115679375,0.00443746261675906,0.0921141412086523,0.109508994666348,2.93863538083958e-113
NMR metabolomics,X23428.Concentration of VLDL Particles,RABEP1,Rab GTPase-binding effector protein 1,24381,0.117689204818175,0.00517825821561483,0.10753981871557,0.12783859092078,3.59506242396383e-113
NMR metabolomics,X23428.Concentration of VLDL Particles,OPHN1,Oligophrenin-1,24845,0.16185771904542,0.00712637253833813,0.147890028870277,0.175825409220562,4.78574237839655e-113
NMR metabolomics,X23428.Concentration of VLDL Particles,CRKL,Crk-like protein,29491,0.159141605692924,0.00701330464793474,0.145395528582972,0.172887682802876,5.07457398970983e-113
NMR metabolomics,X23428.Concentration of VLDL Particles,EREG,Proepiregulin,29163,0.120569510169843,0.00531320008402139,0.110155638005161,0.130983382334525,5.08029558514884e-113
NMR metabolomics,X23428.Concentration of VLDL Particles,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28797,0.127268983376758,0.00561496616898397,0.116263649685549,0.138274317067966,9.42620930643959e-113
NMR metabolomics,X23428.Concentration of VLDL Particles,MYDGF,Myeloid-derived growth factor,24922,0.150243740529766,0.00662503607383167,0.137258669825056,0.163228811234476,1.0197714737661e-112
NMR metabolomics,X23428.Concentration of VLDL Particles,DNMBP,Dynamin-binding protein,29218,0.0917071936911462,0.00404729185131756,0.0837745016625638,0.0996398857197286,1.0698281555794e-112
NMR metabolomics,X23428.Concentration of VLDL Particles,SNX15,Sorting nexin-15,24381,0.0813539094119498,0.00358869854437388,0.074320060264977,0.0883877585589226,1.31096375987661e-112
NMR metabolomics,X23428.Concentration of VLDL Particles,HAVCR1,Hepatitis A virus cellular receptor 1,29683,0.0941346907687302,0.00416674985386082,0.085967861055163,0.102301520482297,4.60214245157968e-112
NMR metabolomics,X23428.Concentration of VLDL Particles,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24867,0.160400029833289,0.00709850819961616,0.146486953762041,0.174313105904537,6.32710848796368e-112
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM21,E3 ubiquitin-protein ligase TRIM21,29434,0.114816511325403,0.00508672304940081,0.104846534148578,0.124786488502229,7.32397457149154e-112
NMR metabolomics,X23428.Concentration of VLDL Particles,SCAMP3,Secretory carrier-associated membrane protein 3,29349,0.126187040525711,0.00559685654670459,0.11521720169417,0.137156879357252,1.30588705915429e-111
NMR metabolomics,X23428.Concentration of VLDL Particles,GMPR,GMP reductase 1,29786,0.0740413221526801,0.0032850447950434,0.0676026343543951,0.0804800099509652,1.48275439221134e-111
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP5,Fatty acid-binding protein 5,29624,0.101403198149001,0.00450121929267998,0.0925808083353485,0.110225587962654,1.91361252508657e-111
NMR metabolomics,X23428.Concentration of VLDL Particles,HEXIM1,Protein HEXIM1,29434,0.120939468070484,0.00537454213798029,0.110405365480043,0.131473570660926,3.42731412547807e-111
NMR metabolomics,X23428.Concentration of VLDL Particles,HDGFL2,Hepatoma-derived growth factor-related protein 2,24845,0.0942489282027442,0.00418511929856222,0.0860460943775622,0.102451762027926,3.43583592095214e-111
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29434,0.0909773468939886,0.00404407995692045,0.0830509501784246,0.0989037436095527,3.90232772680932e-111
NMR metabolomics,X23428.Concentration of VLDL Particles,MPHOSPH8,M-phase phosphoprotein 8,28916,0.112779463822717,0.00501339034264626,0.10295321875113,0.122605708894304,4.1251077892293e-111
NMR metabolomics,X23428.Concentration of VLDL Particles,COL18A1,Collagen alpha-1(XVIII) chain,29559,0.0348413501240828,0.00154940064618542,0.0318045248575594,0.0378781753906062,4.76696356404805e-111
NMR metabolomics,X23428.Concentration of VLDL Particles,STAMBP,STAM-binding protein,29163,0.0951778743897977,0.00423347429381914,0.0868802647739122,0.103475484005683,5.45332726330119e-111
NMR metabolomics,X23428.Concentration of VLDL Particles,LYN,Tyrosine-protein kinase Lyn,29349,0.125514160643852,0.00558622713975425,0.114565155449934,0.13646316583777,7.28729398831571e-111
NMR metabolomics,X23428.Concentration of VLDL Particles,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24867,0.119264511907979,0.00530498990388485,0.108866731696365,0.129662292119594,8.0149382926372e-111
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA4D,Semaphorin-4D,29694,0.0445519885707584,0.00198338557951079,0.0406645528349173,0.0484394243065996,8.10188862713483e-111
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24867,0.0981101835794559,0.00436415858126159,0.0895564327601832,0.106663934398729,8.13590689743176e-111
NMR metabolomics,X23428.Concentration of VLDL Particles,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29349,0.0414642507505282,0.00185104605592467,0.0378362004809158,0.0450923010201405,3.27940261010778e-110
NMR metabolomics,X23428.Concentration of VLDL Particles,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",24240,0.103156499967313,0.00460115219942734,0.0941382416564354,0.112174758278191,3.34314141246433e-110
NMR metabolomics,X23428.Concentration of VLDL Particles,SYTL4,Synaptotagmin-like protein 4,24922,0.108422703576787,0.00483721620889927,0.0989417598073449,0.11790364734623,3.51408828740019e-110
NMR metabolomics,X23428.Concentration of VLDL Particles,AZI2,5-azacytidine-induced protein 2,24867,0.0821117117826646,0.0036648410567711,0.0749286233113932,0.089294800253936,4.3091813469563e-110
NMR metabolomics,X23428.Concentration of VLDL Particles,SPON2,Spondin-2,29311,-0.0516586395484398,0.00230876586645722,-0.056183820646696,-0.0471334584501837,5.76320340165434e-110
NMR metabolomics,X23428.Concentration of VLDL Particles,DUSP13,Dual specificity protein phosphatase 13 isoform A,24793,0.06244896729666,0.00279036586783397,0.0569798501957054,0.0679180843976146,7.53136155645487e-110
NMR metabolomics,X23428.Concentration of VLDL Particles,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29349,0.0660974267897918,0.00296354749114027,0.0602888737071569,0.0719059798724268,2.77402312542389e-109
NMR metabolomics,X23428.Concentration of VLDL Particles,COMMD1,COMM domain-containing protein 1,24240,0.0907076684216652,0.00406575221152079,0.0827387940870844,0.0986765427562459,3.70308691512628e-109
NMR metabolomics,X23428.Concentration of VLDL Particles,VWA1,von Willebrand factor A domain-containing protein 1,29674,0.0621825400722638,0.00278996418660964,0.0567142102665089,0.0676508698780187,3.81600205127913e-109
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINE1,Plasminogen activator inhibitor 1,29820,0.0985900216530559,0.0044356231756324,0.0898962002288164,0.107283843077295,1.44226587048241e-108
NMR metabolomics,X23428.Concentration of VLDL Particles,HS1BP3,HCLS1-binding protein 3,24240,0.13313738340214,0.00598705652435374,0.121402752614407,0.144872014189874,1.8137322057819e-108
NMR metabolomics,X23428.Concentration of VLDL Particles,FAP,Prolyl endopeptidase FAP,29820,0.040412567925127,0.00182097428385145,0.0368434583287782,0.0439816775214759,3.03891115077569e-108
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM13A,Protein FAM13A,24805,0.099561010980058,0.00448274930877832,0.0907748223348525,0.108347199625264,3.14089368423507e-108
NMR metabolomics,X23428.Concentration of VLDL Particles,CD22,B-cell receptor CD22,29786,0.061222771077055,0.00277144400886216,0.0557907408196852,0.0666548013344248,2.8384183945862e-107
NMR metabolomics,X23428.Concentration of VLDL Particles,TOP2B,DNA topoisomerase 2-beta,24229,0.116865014784029,0.00528825035859615,0.106500044081181,0.127229985486878,3.70674614875661e-107
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS1,Galectin-1,29478,0.0499916331732008,0.00226942098707421,0.0455435680385354,0.0544396983078663,1.12055998266854e-106
NMR metabolomics,X23428.Concentration of VLDL Particles,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24793,0.105397653641182,0.00478707965609134,0.0960149775152434,0.114780329767121,2.07058947801653e-106
NMR metabolomics,X23428.Concentration of VLDL Particles,QDPR,Dihydropteridine reductase,29345,0.0627502556226236,0.0028544842836239,0.0571554664267207,0.0683450448185264,3.02178338494085e-106
NMR metabolomics,X23428.Concentration of VLDL Particles,DDHD2,Phospholipase DDHD2,24867,0.0966710757340329,0.00439619287070608,0.088054537707449,0.105287613760617,3.71785914373081e-106
NMR metabolomics,X23428.Concentration of VLDL Particles,GTPBP2,GTP-binding protein 2,24195,0.117980899295568,0.00536753482708026,0.107460531034491,0.128501267556645,4.84120603214443e-106
NMR metabolomics,X23428.Concentration of VLDL Particles,ARSB,Arylsulfatase B,29349,0.0801582490961351,0.00365385428516971,0.0729966946972025,0.0873198034950678,8.01113724255816e-106
NMR metabolomics,X23428.Concentration of VLDL Particles,SETMAR,Histone-lysine N-methyltransferase SETMAR,29132,0.0437415202327825,0.00199453915461721,0.0398322234897328,0.0476508169758323,9.52948224789864e-106
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNLR1,Interferon lambda receptor 1,29434,0.0538250417044988,0.00245483453505169,0.0490135660157975,0.0586365173932001,1.02952914574794e-105
NMR metabolomics,X23428.Concentration of VLDL Particles,BRAP,BRCA1-associated protein,24565,0.159536413653367,0.00727581902463338,0.145275808365085,0.173797018941648,1.48272479527272e-105
NMR metabolomics,X23428.Concentration of VLDL Particles,TWF2,Twinfilin-2,24938,0.121750839898983,0.00556352429676046,0.110846332277332,0.132655347520633,3.62988548229369e-105
NMR metabolomics,X23428.Concentration of VLDL Particles,AFP,Alpha-fetoprotein,29132,0.0985978614288596,0.00451166514476301,0.0897549977451241,0.107440725112595,4.98394354117981e-105
NMR metabolomics,X23428.Concentration of VLDL Particles,EVI5,Ecotropic viral integration site 5 protein homolog,24229,0.130642288829945,0.00599220409835988,0.118897568797159,0.14238700886273,2.24045657225331e-104
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29478,0.120033416644912,0.00551350005671501,0.10922695653375,0.130839876756073,2.91529294040319e-104
NMR metabolomics,X23428.Concentration of VLDL Particles,VNN1,Pantetheinase,24951,0.104992800642254,0.00483102875485449,0.0955239842827391,0.114461617001769,9.1916714932535e-104
NMR metabolomics,X23428.Concentration of VLDL Particles,MAX,Protein max,28774,0.151286766938507,0.00696899662643722,0.13762753355069,0.164946000326324,1.15954470946734e-103
NMR metabolomics,X23428.Concentration of VLDL Particles,LEP,Leptin,29478,0.0965135304363406,0.0044489485084883,0.0877935913597035,0.105233469512978,1.52716219852538e-103
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKG1,cGMP-dependent protein kinase 1,24381,0.181097142040868,0.0083414437393295,0.164747912311782,0.197446371769954,1.56370279948018e-103
NMR metabolomics,X23428.Concentration of VLDL Particles,MARS1,"Methionine--tRNA ligase, cytoplasmic",24329,0.123498798584075,0.00569327751203366,0.112339974660489,0.134657622507661,2.33089949226451e-103
NMR metabolomics,X23428.Concentration of VLDL Particles,SH3GLB2,Endophilin-B2,24845,0.0956908581475341,0.00441233442635774,0.087042682671873,0.104339033623195,2.47121552214393e-103
NMR metabolomics,X23428.Concentration of VLDL Particles,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29349,0.0632757228937702,0.00292011047291209,0.0575523063668626,0.0689991394206779,2.60606233702018e-103
NMR metabolomics,X23428.Concentration of VLDL Particles,IGSF3,Immunoglobulin superfamily member 3,29349,0.0514919349101734,0.002379176467671,0.0468287490335382,0.0561551207868085,4.56001027928665e-103
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM5,Tripartite motif-containing protein 5,29434,0.123044725575057,0.00568616787786702,0.111899836534438,0.134189614615676,4.88249818058271e-103
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24867,0.113729837166313,0.00525444047455726,0.103431133836181,0.124028540496445,6.11490480409945e-103
NMR metabolomics,X23428.Concentration of VLDL Particles,CD36,Platelet glycoprotein 4,24229,0.0651102222646572,0.00301160207396724,0.0592074821996814,0.071012962329633,1.09515790232687e-102
NMR metabolomics,X23428.Concentration of VLDL Particles,SPART,Spartin,24381,0.111120910834606,0.00514090426685324,0.101044738471574,0.121197083197638,1.19478707717741e-102
NMR metabolomics,X23428.Concentration of VLDL Particles,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24805,0.210105086874431,0.00973881290942459,0.191017013571959,0.229193160176904,2.75266991494921e-102
NMR metabolomics,X23428.Concentration of VLDL Particles,GORASP2,Golgi reassembly-stacking protein 2,24805,0.0676725020611684,0.0031375357630448,0.0615229319656006,0.0738220721567362,3.08126296349036e-102
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24381,0.0909358778120452,0.0042175424310808,0.0826694946471268,0.0992022609769636,3.73637312934392e-102
NMR metabolomics,X23428.Concentration of VLDL Particles,DIABLO,"Diablo homolog, mitochondrial",29395,0.156259087260275,0.00725448080283565,0.142040304886717,0.170477869633833,4.08623543921662e-102
NMR metabolomics,X23428.Concentration of VLDL Particles,MVK,Mevalonate kinase,28931,0.113610887441572,0.00527459826791944,0.10327267483645,0.123949100046694,4.24337276052394e-102
NMR metabolomics,X23428.Concentration of VLDL Particles,STAT2,Signal transducer and activator of transcription 2,24229,0.111103414000093,0.00515433577391202,0.101000915883226,0.121205912116961,4.30242338192053e-102
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC27,Cell division cycle protein 27 homolog,28797,0.0867355489496523,0.00402974881421443,0.078837241273792,0.0946338566255125,5.94016141392008e-102
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT18,"Keratin, type I cytoskeletal 18",29349,0.115824118254421,0.00538529986352037,0.105268930521921,0.126379305986921,8.11992435819047e-102
NMR metabolomics,X23428.Concentration of VLDL Particles,HTRA2,"Serine protease HTRA2, mitochondrial",29566,0.0870865757080351,0.00405336382779127,0.0791419826055642,0.095031168810506,1.29003153392163e-101
NMR metabolomics,X23428.Concentration of VLDL Particles,PSIP1,PC4 and SFRS1-interacting protein,29434,0.0907298417688811,0.00422639642250504,0.0824461047807713,0.099013578756991,1.88769719549618e-101
NMR metabolomics,X23428.Concentration of VLDL Particles,MGLL,Monoglyceride lipase,29536,0.123269738937131,0.00574272626012013,0.112013995467295,0.134525482406966,1.95959712090847e-101
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS8,Galectin-8,29694,0.086162913624817,0.00401619932205443,0.0782911629535903,0.0940346642960437,2.47786035188619e-101
NMR metabolomics,X23428.Concentration of VLDL Particles,ORM1,Alpha-1-acid glycoprotein 1,24846,0.02853442531119,0.0013291990050803,0.0259291952612326,0.0311396553611474,2.62111489328025e-101
NMR metabolomics,X23428.Concentration of VLDL Particles,SCPEP1,Retinoid-inducible serine carboxypeptidase,24138,0.0714070753828185,0.00332900302959391,0.0648822294448145,0.0779319213208226,4.02355956890833e-101
NMR metabolomics,X23428.Concentration of VLDL Particles,FIS1,Mitochondrial fission 1 protein,29453,0.109402432084392,0.00510628908371939,0.0993941054803024,0.119410758688482,4.62371052892461e-101
NMR metabolomics,X23428.Concentration of VLDL Particles,CNST,Consortin,29478,0.153626186086283,0.00717258140705473,0.139567926528455,0.16768444564411,5.29703513668263e-101
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1RL2,Interleukin-1 receptor-like 2,28931,0.0557763090267457,0.00260673132790989,0.0506671156240423,0.0608855024294491,8.62398441536846e-101
NMR metabolomics,X23428.Concentration of VLDL Particles,VASP,Vasodilator-stimulated phosphoprotein,24951,0.103195452839072,0.00482179568178684,0.0937447333027699,0.112646172375374,1.03458811461244e-100
NMR metabolomics,X23428.Concentration of VLDL Particles,DOK1,Docking protein 1,24845,0.194001453657689,0.00906798537005042,0.17622820233239,0.211774704982988,1.22911113166314e-100
NMR metabolomics,X23428.Concentration of VLDL Particles,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29536,0.122007841418449,0.0057092897905905,0.110817633428892,0.133198049408006,1.46913768414108e-100
NMR metabolomics,X23428.Concentration of VLDL Particles,CASC3,Protein CASC3,24195,0.0596114465059809,0.00278749013660268,0.0541479658382396,0.0650749271737221,1.56225927708822e-100
NMR metabolomics,X23428.Concentration of VLDL Particles,RBM17,Splicing factor 45,24867,0.108515406752892,0.00507695658753966,0.0985645718413144,0.11846624166447,1.86893373815258e-100
NMR metabolomics,X23428.Concentration of VLDL Particles,MED18,Mediator of RNA polymerase II transcription subunit 18,28797,0.107940756689306,0.00505612084782792,0.0980307598275628,0.117850753551048,2.41774804639173e-100
NMR metabolomics,X23428.Concentration of VLDL Particles,TAX1BP1,Tax1-binding protein 1,24845,0.089498373876413,0.00419075254612512,0.0812844988860077,0.0977122488668182,2.73066221416248e-100
NMR metabolomics,X23428.Concentration of VLDL Particles,GAS6,Growth arrest-specific protein 6,29639,-0.0360311134645557,0.00168849144952741,-0.0393405567056294,-0.0327216702234819,2.79621700565868e-100
NMR metabolomics,X23428.Concentration of VLDL Particles,BAG4,BAG family molecular chaperone regulator 4,24229,0.0702677798594377,0.00329196412052626,0.0638155301832062,0.0767200295356691,3.61812851631622e-100
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPING1,Plasma protease C1 inhibitor,24914,0.0266113167102445,0.00124922275599864,0.0241628401084871,0.0290597933120018,8.41052181321613e-100
NMR metabolomics,X23428.Concentration of VLDL Particles,GYS1,"Glycogen [starch] synthase, muscle",28916,0.131068795738217,0.00615897872455221,0.118997197438094,0.143140394038339,9.94680040084738e-100
NMR metabolomics,X23428.Concentration of VLDL Particles,MXRA8,Matrix remodeling-associated protein 8,24381,-0.0431969324317349,0.00203419781117942,-0.0471839601416465,-0.0392099047218232,3.56788627127942e-99
NMR metabolomics,X23428.Concentration of VLDL Particles,MAMDC4,Apical endosomal glycoprotein,24793,0.078271751705711,0.00368687223222913,0.0710454821305419,0.0854980212808801,3.86970261502306e-99
NMR metabolomics,X23428.Concentration of VLDL Particles,CRADD,Death domain-containing protein CRADD,29163,0.106475764631212,0.00502368805389094,0.0966293360455858,0.116322193216838,5.96817496940917e-99
NMR metabolomics,X23428.Concentration of VLDL Particles,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29443,0.0341335146345747,0.00161136203892368,0.0309752450382843,0.0372917842308652,7.50360521444691e-99
NMR metabolomics,X23428.Concentration of VLDL Particles,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29434,0.101540866700259,0.00479528221624433,0.0921421135564201,0.110939619844098,8.84843938989138e-99
NMR metabolomics,X23428.Concentration of VLDL Particles,KIFBP,KIF-binding protein,29349,0.115450321744265,0.00546290942559595,0.104743019270097,0.126157624218433,2.12290595751367e-98
NMR metabolomics,X23428.Concentration of VLDL Particles,HAO1,Hydroxyacid oxidase 1,29725,0.179029572153229,0.00848121106939503,0.162406398457214,0.195652745849243,3.46613597367258e-98
NMR metabolomics,X23428.Concentration of VLDL Particles,SIAE,Sialate O-acetylesterase,29495,0.0651794426290101,0.00308818544892513,0.0591265991491168,0.0712322861089033,3.72949619388147e-98
NMR metabolomics,X23428.Concentration of VLDL Particles,ASPSCR1,Tether containing UBX domain for GLUT4,24867,0.0946238279554779,0.00448294932243967,0.0858372472834961,0.10341040862746,4.926023093082e-98
NMR metabolomics,X23428.Concentration of VLDL Particles,ACE2,Angiotensin-converting enzyme 2,28916,0.0722665023436244,0.00342667898156428,0.0655502115397584,0.0789827931474904,5.45814546117497e-98
NMR metabolomics,X23428.Concentration of VLDL Particles,NHLRC3,NHL repeat-containing protein 3,23825,0.0449139028540554,0.00213115186613107,0.0407368451964386,0.0490909605116723,1.05453190485412e-97
NMR metabolomics,X23428.Concentration of VLDL Particles,COCH,Cochlin,24922,0.0647296351474765,0.00307300553546292,0.0587065442979691,0.0707527259969838,1.21131250772308e-97
NMR metabolomics,X23428.Concentration of VLDL Particles,ST13,Hsc70-interacting protein,24381,0.0781301749549229,0.00371068156051731,0.0708572390963089,0.0854031108135368,1.50734882597782e-97
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDC,Nuclear migration protein nudC,29786,0.0882065227611285,0.00419720306095233,0.079980004761662,0.0964330407605951,2.41109308185028e-97
NMR metabolomics,X23428.Concentration of VLDL Particles,PHLDB1,Pleckstrin homology-like domain family B member 1,24805,0.0740257180639267,0.00352003275405947,0.0671264538659701,0.0809249822618833,2.47884046461831e-97
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R2,Protein phosphatase inhibitor 2,29478,0.111166492324282,0.00529119428419231,0.100795751527265,0.121537233121299,2.76749308498439e-97
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK13,Kallikrein-13,28845,0.0613766374507598,0.00292382819040583,0.0556459341975644,0.0671073407039552,4.1518099401069e-97
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDH9,Protocadherin-9,24805,0.047245382530426,0.0022499574742747,0.0428354658808476,0.0516552991800044,4.75632485766917e-97
NMR metabolomics,X23428.Concentration of VLDL Particles,A1BG,Alpha-1B-glycoprotein,24966,0.0238344765988151,0.0011364249052045,0.0216070837846143,0.0260618694130159,7.89779970867583e-97
NMR metabolomics,X23428.Concentration of VLDL Particles,MPI,Mannose-6-phosphate isomerase,29349,0.118860890057027,0.00567190750680522,0.107743951343689,0.129977828770365,8.47081505264055e-97
NMR metabolomics,X23428.Concentration of VLDL Particles,TXNDC5,Thioredoxin domain-containing protein 5,29694,0.0939696062976385,0.00449239499457625,0.0851645121082691,0.102774700487008,1.84616540741312e-96
NMR metabolomics,X23428.Concentration of VLDL Particles,OGA,Protein O-GlcNAcase,24805,0.0982487411757811,0.00469641582382866,0.0890437661610769,0.107453716190485,2.39939069605119e-96
NMR metabolomics,X23428.Concentration of VLDL Particles,WASHC3,WASH complex subunit 3,24845,0.104647741017051,0.00500572148389405,0.0948365269086185,0.114458955125483,3.21238370912273e-96
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDT5,ADP-sugar pyrophosphatase,29443,0.0707560577147571,0.00339136478079021,0.0641089827444083,0.0774031326851059,5.68913185870804e-96
NMR metabolomics,X23428.Concentration of VLDL Particles,MAVS,Mitochondrial antiviral-signaling protein,28797,0.126704822981204,0.00607995120568091,0.11478811861807,0.138621527344339,9.62636909560475e-96
NMR metabolomics,X23428.Concentration of VLDL Particles,LBR,Delta(14)-sterol reductase LBR,29694,0.0921058483810073,0.00442039465477883,0.0834418748576408,0.100769821904374,9.7943183720512e-96
NMR metabolomics,X23428.Concentration of VLDL Particles,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28797,0.0614794689096058,0.0029536853483848,0.0556902456267716,0.06726869219244,1.61903605771518e-95
NMR metabolomics,X23428.Concentration of VLDL Particles,AMN,Protein amnionless,28931,0.0654600069839514,0.00314603448933352,0.0592937793848578,0.0716262345830451,1.86893049299371e-95
NMR metabolomics,X23428.Concentration of VLDL Particles,RWDD1,RWD domain-containing protein 1,29694,0.0874927831335759,0.00420540785234339,0.0792501837429829,0.095735382524169,1.88144923859314e-95
NMR metabolomics,X23428.Concentration of VLDL Particles,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29426,0.0844010942052056,0.00405736875744658,0.0764486514406103,0.0923535369698009,2.02541822410637e-95
NMR metabolomics,X23428.Concentration of VLDL Particles,CHMP1A,Charged multivesicular body protein 1a,29218,0.109332876413709,0.00526107539204407,0.0990211686453028,0.119644584182116,3.11766443684524e-95
NMR metabolomics,X23428.Concentration of VLDL Particles,ICA1,Islet cell autoantigen 1,28931,0.10945630281643,0.00527483827232508,0.0991176198026729,0.119794985830187,5.95849197473577e-95
NMR metabolomics,X23428.Concentration of VLDL Particles,FLT4,Vascular endothelial growth factor receptor 3,29566,0.0461612558946273,0.00222654374936951,0.0417972301458631,0.0505252816433916,8.39716899845819e-95
NMR metabolomics,X23428.Concentration of VLDL Particles,TRAF2,TNF receptor-associated factor 2,29434,0.0966935756333058,0.00466435079830677,0.0875514480686246,0.105835703197987,8.79232591516338e-95
NMR metabolomics,X23428.Concentration of VLDL Particles,DRG2,Developmentally-regulated GTP-binding protein 2,29349,0.0775360693103411,0.00374210799994773,0.0702015376304435,0.0848706009902386,1.09383980367406e-94
NMR metabolomics,X23428.Concentration of VLDL Particles,PACS2,Phosphofurin acidic cluster sorting protein 2,24111,0.0858114224247807,0.0041406929548164,0.0776956642333406,0.0939271806162208,1.4092470058515e-94
NMR metabolomics,X23428.Concentration of VLDL Particles,CETN3,Centrin-3,24805,0.106718288861389,0.00515437004633209,0.096615723570578,0.1168208541522,1.9905747415249e-94
NMR metabolomics,X23428.Concentration of VLDL Particles,IL7,Interleukin-7,29434,0.0883767307527066,0.00427182077745428,0.0800039620288962,0.096749499476517,2.07775050661e-94
NMR metabolomics,X23428.Concentration of VLDL Particles,IRAK4,Interleukin-1 receptor-associated kinase 4,29434,0.143078442560515,0.00691793342198822,0.129519293053418,0.156637592067612,2.35133552038072e-94
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB6A,Ras-related protein Rab-6A,29434,0.0635279925069501,0.00307225441512755,0.0575063738533001,0.0695496111606001,2.5661796178194e-94
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS9,Galectin-9,29453,0.0436151176556249,0.00211362392894299,0.0394724147548966,0.0477578205563532,6.13337410071122e-94
NMR metabolomics,X23428.Concentration of VLDL Particles,CD300LG,CMRF35-like molecule 9,29443,-0.0512930475373114,0.00248838098080333,-0.056170274259686,-0.0464158208149369,9.64909986089795e-94
NMR metabolomics,X23428.Concentration of VLDL Particles,NSFL1C,NSFL1 cofactor p47,29694,0.0886877789632391,0.00430712318690641,0.0802458175169025,0.0971297404095757,1.49291006844282e-93
NMR metabolomics,X23428.Concentration of VLDL Particles,CDNF,Cerebral dopamine neurotrophic factor,29349,0.0445008690341899,0.00216171491800321,0.0402639077949036,0.0487378302734762,1.68355144330086e-93
NMR metabolomics,X23428.Concentration of VLDL Particles,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29349,0.120361710942189,0.00585715513837054,0.108881686870983,0.131841735013395,3.52724755763912e-93
NMR metabolomics,X23428.Concentration of VLDL Particles,PPY,Pancreatic prohormone,29400,0.138616911912997,0.00674721117637507,0.125392378007301,0.151841445818692,3.9090828685088e-93
NMR metabolomics,X23428.Concentration of VLDL Particles,LSP1,Lymphocyte-specific protein 1,29434,0.0547079313191169,0.00266339087548688,0.0494876852031626,0.0599281774350712,4.1999011950981e-93
NMR metabolomics,X23428.Concentration of VLDL Particles,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28797,0.10596534518704,0.00516026832916739,0.0958512192618719,0.116079471112208,4.88834065141884e-93
NMR metabolomics,X23428.Concentration of VLDL Particles,PMVK,Phosphomevalonate kinase,28757,0.149398801968863,0.00727677086477319,0.135136331073907,0.163661272863818,5.30536182206447e-93
NMR metabolomics,X23428.Concentration of VLDL Particles,C2,Complement C2,29545,0.0317873137755246,0.00154876108361675,0.0287517420516357,0.0348228854994134,5.82039655606636e-93
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1RN,Interleukin-1 receptor antagonist protein,29379,0.0733192120867567,0.00357634519141985,0.0663095755115738,0.0803288486619396,9.39224093156763e-93
NMR metabolomics,X23428.Concentration of VLDL Particles,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23850,0.0451771817014365,0.00220285603683022,0.0408595838692492,0.0494947795336237,1.14224920266924e-92
NMR metabolomics,X23428.Concentration of VLDL Particles,CA5A,"Carbonic anhydrase 5A, mitochondrial",28916,0.124730234151012,0.00608892734025318,0.112795936564115,0.136664531737908,1.34039981675619e-92
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM172A,Cotranscriptional regulator FAM172A,24240,0.0836819696350448,0.00408482921280268,0.0756757043779515,0.091688234892138,1.7444760085272e-92
NMR metabolomics,X23428.Concentration of VLDL Particles,KYAT1,Kynurenine--oxoglutarate transaminase 1,29444,0.0769134415977589,0.00376102688337145,0.0695418289063509,0.084285054289167,2.62963681445316e-92
NMR metabolomics,X23428.Concentration of VLDL Particles,GRAP2,GRB2-related adapter protein 2,29478,0.172914537687959,0.00847467236401644,0.156304179854487,0.189524895521431,6.70351073969971e-92
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB27B,Ras-related protein Rab-27B,24922,0.111425332758327,0.00545798369541865,0.100727684715307,0.122122980801348,6.94179332621049e-92
NMR metabolomics,X23428.Concentration of VLDL Particles,NACC1,Nucleus accumbens-associated protein 1,24793,0.0747284174038089,0.00366262608623246,0.0675496702747933,0.0819071645328246,8.94320738189049e-92
NMR metabolomics,X23428.Concentration of VLDL Particles,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24845,0.132310836562211,0.00648543559212679,0.119599382801643,0.14502229032278,9.22757761718592e-92
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSD,Cathepsin D,27442,0.0549809926218101,0.00269752687300341,0.0496938399507234,0.0602681452928968,1.1551888395326e-91
NMR metabolomics,X23428.Concentration of VLDL Particles,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24445,0.0670479250071914,0.00329016123374268,0.0605992089890557,0.073496641025327,1.50411580172145e-91
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSO,Cathepsin O,29786,0.0409537682848313,0.00201162387687096,0.0370109854861642,0.0448965510834984,1.63920301017889e-91
NMR metabolomics,X23428.Concentration of VLDL Particles,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",29132,0.0552977050309313,0.00271693114912336,0.0499725199786495,0.060622890083213,1.89271499840622e-91
NMR metabolomics,X23428.Concentration of VLDL Particles,UBXN1,UBX domain-containing protein 1,24381,0.0933578999583899,0.00458681599835148,0.084367740601621,0.102348059315159,2.48470553104897e-91
NMR metabolomics,X23428.Concentration of VLDL Particles,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29434,0.123658227066439,0.00608306371878839,0.111735422177614,0.135581031955264,3.06535182429941e-91
NMR metabolomics,X23428.Concentration of VLDL Particles,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29443,0.0620431975807044,0.00305366471312769,0.0560580147429742,0.0680283804184347,3.79585466070921e-91
NMR metabolomics,X23428.Concentration of VLDL Particles,GASK1A,Golgi-associated kinase 1A,24111,0.0582504741170335,0.00286562771695887,0.0526338437917941,0.0638671044422729,4.28591510760222e-91
NMR metabolomics,X23428.Concentration of VLDL Particles,PENK,Proenkephalin-A,24381,0.0417033836799859,0.00205552107152959,0.0376745623797879,0.0457322049801839,9.14578539553153e-91
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHA1,Ephrin type-A receptor 1,29536,0.0447148063352724,0.00220581853628676,0.0403914020041503,0.0490382106663944,9.57133350919407e-91
NMR metabolomics,X23428.Concentration of VLDL Particles,SPRY2,Protein sprouty homolog 2,28931,0.123924202327734,0.00612750170131356,0.11191429899316,0.135934105662309,2.52702111409972e-90
NMR metabolomics,X23428.Concentration of VLDL Particles,BLMH,Bleomycin hydrolase,29820,0.0426466163247758,0.00210970856423219,0.0385115875388806,0.0467816451106709,2.94616566694871e-90
NMR metabolomics,X23428.Concentration of VLDL Particles,DGKA,Diacylglycerol kinase alpha,24229,0.0736483887699657,0.00364276084358434,0.0665085775165404,0.080788200023391,3.79453756162916e-90
NMR metabolomics,X23428.Concentration of VLDL Particles,GOLGA3,Golgin subfamily A member 3,24867,0.104699701759476,0.00518011081963085,0.0945466845529998,0.114852718965953,4.08425194740702e-90
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24381,0.11463864253356,0.00567407587209716,0.103517453824249,0.12575983124287,4.94369237588428e-90
NMR metabolomics,X23428.Concentration of VLDL Particles,YJU2,Splicing factor YJU2,24793,0.0435467934718951,0.00215750923956451,0.0393180753623487,0.0477755115814416,7.1747235821501e-90
NMR metabolomics,X23428.Concentration of VLDL Particles,FGFBP2,Fibroblast growth factor-binding protein 2,24938,0.0676808254132579,0.00335601415667002,0.0611030376661847,0.0742586131603312,9.92760126016663e-90
NMR metabolomics,X23428.Concentration of VLDL Particles,PPIB,Peptidyl-prolyl cis-trans isomerase B,29467,0.126823278352922,0.0062939268757146,0.114487181676521,0.139159375029322,1.08190633054143e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",29301,0.10108743805929,0.00501677154572554,0.0912545658296677,0.110920310288912,1.09486779345518e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL8,C-C motif chemokine 8,29683,0.0806344763658662,0.00401071234769774,0.0727734801643787,0.0884954725673538,2.64033370962697e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29694,0.0756093481912131,0.00376285725797376,0.0682341479655846,0.0829845484168417,3.2955623582267e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,GFRA1,GDNF family receptor alpha-1,29674,0.0377028995896997,0.00187650058801489,0.0340249584371906,0.0413808407422089,3.39613661845729e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,NEXN,Nexilin,24951,0.092078323992862,0.00458046739169079,0.0831006079051481,0.101056040080576,3.58126294771218e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,APOL1,Apolipoprotein L1,24951,0.0802221566331945,0.00399388601841259,0.0723941400371058,0.0880501732292832,4.93207446084155e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,GPKOW,G-patch domain and KOW motifs-containing protein,28774,0.0372284569009883,0.00185455052043616,0.0335935378809334,0.0408633759210432,5.06739795004422e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP2,Microtubule-associated protein 2,24845,0.0617075949214122,0.00307249843302877,0.0556854979926758,0.0677296918501485,5.20697745776038e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL16,C-X-C motif chemokine 16,29786,0.031353561849539,0.00156289043149363,0.0282902966038115,0.0344168270952665,6.23678017395942e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT5,"Keratin, type II cytoskeletal 5",28774,0.0677732375458035,0.00337889488994045,0.0611506035615202,0.0743958715300867,7.002107656561e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,CD40,Tumor necrosis factor receptor superfamily member 5,29453,0.0663404175407179,0.00330946328763027,0.0598538694969626,0.0728269655844733,8.62715985899753e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM58,E3 ubiquitin-protein ligase TRIM58,24793,0.115120848987535,0.00574180648770275,0.103866908271637,0.126374789703432,1.02942501642567e-88
NMR metabolomics,X23428.Concentration of VLDL Particles,TP53,Cellular tumor antigen p53,28797,0.0580239471689948,0.00289707414868071,0.0523456818375806,0.063702212500409,1.25115192731543e-88
NMR metabolomics,X23428.Concentration of VLDL Particles,DLG4,Disks large homolog 4,24845,0.0944230613042603,0.00471549908609421,0.0851806830955156,0.103665439513005,1.70200092847695e-88
NMR metabolomics,X23428.Concentration of VLDL Particles,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28774,0.148404939901392,0.00742331794059126,0.133855236737833,0.162954643064951,2.59092345119675e-88
NMR metabolomics,X23428.Concentration of VLDL Particles,EHD3,EH domain-containing protein 3,24240,0.156154065259832,0.00780824730601898,0.140849900540035,0.171458229979629,2.92211876455306e-88
NMR metabolomics,X23428.Concentration of VLDL Particles,MTDH,Protein LYRIC,24229,0.1238881278147,0.00619559500943821,0.111744761596201,0.136031494033199,3.06864185894337e-88
NMR metabolomics,X23428.Concentration of VLDL Particles,MOCS2,Molybdopterin synthase catalytic subunit,24381,0.0892989694242135,0.00447355828263058,0.0805307951902576,0.0980671436581695,6.01355595435798e-88
NMR metabolomics,X23428.Concentration of VLDL Particles,SMAD3,Mothers against decapentaplegic homolog 3,24793,0.0679350106369682,0.00341043598790656,0.0612505561006714,0.0746194651732651,1.3317487318967e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,NIT1,Deaminated glutathione amidase,24240,0.0626729181686683,0.00314614838334092,0.0565064673373201,0.0688393690000165,1.35916493847426e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,F12,Coagulation factor XII,24966,0.0550844120055362,0.00276558496487232,0.0496638654743864,0.0605049585366859,1.36827181674407e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24381,0.0769514949303342,0.00386339378561672,0.0693792431105255,0.084523746750143,1.41206667007873e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,NT5C1A,Cytosolic 5'-nucleotidase 1A,24845,0.0415998331185321,0.00208889370752123,0.0375056014517905,0.0456940647852737,1.46376434906165e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,GP1BB,Platelet glycoprotein Ib beta chain,24111,0.0906498135945017,0.00455145686648911,0.0817289581361831,0.0995706690528204,1.47892980489192e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,HARS1,"Histidine--tRNA ligase, cytoplasmic",29443,0.101773616770447,0.00511568933735784,0.0917468656692254,0.111800367871668,1.71256064826494e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,XIAP,E3 ubiquitin-protein ligase XIAP,24229,0.0766189646828618,0.00384976643027029,0.069073422479532,0.0841645068861915,1.94781181357778e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,LPP,Lipoma-preferred partner,24111,0.0881475909994771,0.00443005918725127,0.0794646749924646,0.0968305070064896,2.14968869191244e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,ATXN2L,Ataxin-2-like protein,24867,0.0636089252836894,0.00319931676248107,0.0573382644292265,0.0698795861381523,2.77978860865725e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,HSPA1A,Heat shock 70 kDa protein 1A,29536,0.0933187922039624,0.00469997167845231,0.0841068477141959,0.102530736693729,3.68816821982553e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,KITLG,Kit ligand,29478,-0.0491373856007366,0.00247529170364344,-0.0539889573398778,-0.0442858138615955,4.00236530628171e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,CRELD1,Protein disulfide isomerase CRELD1,24381,0.0495579851770695,0.00249523760391013,0.0446673194734057,0.0544486508807334,4.32760834411196e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,C3,Complement C3,23779,0.061484059741663,0.00309639998707242,0.055415115767001,0.0675530037163249,4.90858506773367e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,IGBP1,Immunoglobulin-binding protein 1,24867,0.0800477194497077,0.00403276521153307,0.0721434996351029,0.0879519392643126,5.27705335783327e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,TMED8,Protein TMED8,24805,0.135720741402497,0.00683957898495302,0.122315166591989,0.149126316213005,5.94660839073591e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,EGLN1,Egl nine homolog 1,29434,0.071429959786557,0.00360322448915746,0.0643676397878084,0.0784922797853056,6.84568560892215e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,GLB1,Beta-galactosidase,29218,0.0550389281831477,0.00277777480934978,0.0495944895568221,0.0604833668094733,8.38624514033652e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,SMOC2,SPARC-related modular calcium-binding protein 2,29581,0.0508122283717828,0.00256661898715961,0.04578165515695,0.0558428015866156,1.14473714805233e-86
NMR metabolomics,X23428.Concentration of VLDL Particles,ELAC1,Zinc phosphodiesterase ELAC protein 1,24867,0.111925841663685,0.00566857028960057,0.100815443896068,0.123036239431302,4.05415481981385e-86
NMR metabolomics,X23428.Concentration of VLDL Particles,PKD2,Polycystin-2,24111,0.077570448749447,0.00393136275193936,0.0698649777556459,0.0852759197432482,5.56053229379936e-86
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC8,Sialic acid-binding Ig-like lectin 8,24240,0.0602476942946999,0.00305486349698836,0.0542601618406027,0.0662352267487971,6.60820008747196e-86
NMR metabolomics,X23428.Concentration of VLDL Particles,TALDO1,Transaldolase,24888,0.0583362660171067,0.00295854675792444,0.0525375143715748,0.0641350176626386,6.86504797977445e-86
NMR metabolomics,X23428.Concentration of VLDL Particles,BAG6,Large proline-rich protein BAG6,28916,0.0475957583549746,0.00241654441648495,0.0428593312986641,0.0523321854112851,8.56978713367399e-86
NMR metabolomics,X23428.Concentration of VLDL Particles,FNDC1,Fibronectin type III domain-containing protein 1,24845,0.0610466519733521,0.00310296970159313,0.0549648313582295,0.0671284725884746,1.62728952562162e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,GNPDA2,Glucosamine-6-phosphate isomerase 2,24381,0.0483224114977918,0.00245688572488258,0.0435069154770219,0.0531379075185616,1.86134314810022e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,29218,0.102205763449596,0.00520165908547037,0.0920105116420745,0.112401015257118,2.11552729259154e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,STXBP1,Syntaxin-binding protein 1,24867,0.101343373726734,0.00515630473607111,0.0912370164440351,0.111449731009434,2.36643634090679e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24922,0.115539242770656,0.00588663633393913,0.104001435556135,0.127077049985177,3.97270784652014e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28595,0.112532346020475,0.00573810317729865,0.101285663792969,0.12377902824798,4.48368125248963e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,VAV3,Guanine nucleotide exchange factor VAV3,24101,0.129571685720301,0.00660290841218249,0.116629985232423,0.142513386208179,4.50859149377492e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL24,C-C motif chemokine 24,29536,0.107674369502613,0.00549344176904391,0.0969072236352872,0.118441515369939,5.31749698427534e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,CD1C,T-cell surface glycoprotein CD1c,29566,0.0316251773028959,0.00161353841750101,0.0284626420045939,0.0347877126011978,5.37705096142954e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24867,0.0616382825107455,0.00314353265116034,0.0554769585144712,0.0677996065070198,5.80481801747535e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23623,0.141004233651054,0.0071905313903071,0.126910792126052,0.155097675176056,6.0622643117269e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM40,E3 ubiquitin ligase TRIM40,24195,0.094300495730267,0.00481010420479681,0.0848726914888652,0.103728299971669,6.44429744101101e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,CD207,C-type lectin domain family 4 member K,28835,0.0502670689291982,0.00256707874849925,0.0452355945821396,0.0552985432762567,7.93502784885805e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,GMPR2,GMP reductase 2,24381,0.0875800360939678,0.00447090675274335,0.0788170588585909,0.0963430133293448,8.64677930063344e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,SCARA5,Scavenger receptor class A member 5,29694,0.0390825504082799,0.00199660338666018,0.035169207770426,0.0429958930461339,8.74711684512375e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRD1,Adhesion G-protein coupled receptor D1,24381,0.0506287803740355,0.00258667013320178,0.04555890691296,0.055698653835111,1.17620306477193e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,SNCG,Gamma-synuclein,29218,0.0866982223433186,0.00443579693301938,0.0780040603546007,0.0953923843320366,1.57610735318061e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,TDRKH,Tudor and KH domain-containing protein,28774,0.110113454389168,0.00563784177451101,0.0990632845111259,0.121163624267209,2.10544065695779e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,SMNDC1,Survival of motor neuron-related-splicing factor 30,24805,0.0774349593344932,0.00396306601024492,0.0696673499544132,0.0852025687145733,2.2025217711977e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,CTF1,Cardiotrophin-1,28916,0.109442365855555,0.00560729051552056,0.098452076445135,0.120432655265976,2.70390825680925e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,PARP1,Poly [ADP-ribose] polymerase 1,29434,0.0729791204608226,0.00373934784958122,0.0656499986756435,0.0803082422460018,2.71450143043184e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,STIP1,Stress-induced-phosphoprotein 1,29386,0.0838492833464748,0.00429644020275954,0.0754282605490661,0.0922703061438835,2.74880824745264e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,SH2D1A,SH2 domain-containing protein 1A,29434,0.0739370236696111,0.00378983753718888,0.0665089420967209,0.0813651052425012,3.12256980715613e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL7,C-C motif chemokine 7,29434,0.0758839978100681,0.00389416641973515,0.0682514316273872,0.083516563992749,4.83947979970985e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29434,0.128985489293901,0.00663229800347483,0.11598618520709,0.141984793380711,1.01623743666644e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,FARSA,Phenylalanine--tRNA ligase alpha subunit,24195,0.0893160100838716,0.00459044351882318,0.0803187407869782,0.098313279380765,1.11155671311468e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,SULT2A1,Bile salt sulfotransferase,29434,0.0722381326083089,0.00371584547106161,0.0649550754850281,0.0795211897315896,1.17450868007379e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,HGF,Hepatocyte growth factor,29786,0.0443544937268502,0.0022817146619019,0.0398823329895224,0.0488266544641779,1.19092124157211e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,EGF,Pro-epidermal growth factor,29379,0.13308597316008,0.00684663990059503,0.119666558954914,0.146505387365247,1.23326710892702e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24793,0.0623192788430492,0.00320420869694748,0.0560390297970321,0.0685995278890662,1.24538383112114e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,TREM2,Triggering receptor expressed on myeloid cells 2,29454,0.0670645225565577,0.00345062231263128,0.0603013028238004,0.073827742289315,1.29401104915073e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,MESD,LRP chaperone MESD,29443,0.156422801112766,0.00804897695088013,0.140646806289041,0.172198795936491,1.33538446147095e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,ERP29,Endoplasmic reticulum resident protein 29,24381,0.15381038573541,0.00791334728197715,0.138300225062735,0.169320546408085,1.61744116589602e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP4,"Fatty acid-binding protein, adipocyte",29820,0.0643258566568958,0.00331439430946101,0.0578296438103522,0.0708220695034393,2.16205026408445e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,PXN,Paxillin,28774,0.0662822129158745,0.00341645690079056,0.059585957390325,0.072978468441424,2.5893922295747e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29434,0.123562546660359,0.00637179961059304,0.111073819423596,0.136051273897121,2.98165851910528e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,ATOX1,Copper transport protein ATOX1,29566,0.0917795361735926,0.00473652197254175,0.0824959531074108,0.101063119239774,3.96334110235681e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,BGLAP,Osteocalcin,24938,0.114254159374035,0.00589389182732529,0.102702131392478,0.125806187355593,4.21582327279377e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGA2,Integrin alpha-2,24381,0.044282632878668,0.00228446252423736,0.0398050863311628,0.0487601794261733,4.42923688217787e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP7,Caspase-7,24845,0.10814844755844,0.00558670051003827,0.0971985145587648,0.119098380558115,7.10205778674839e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,CD244,Natural killer cell receptor 2B4,29786,0.0347038021457182,0.00179588379712381,0.0311838699033555,0.0382237343880809,1.08283745979472e-82
NMR metabolomics,X23428.Concentration of VLDL Particles,FOXJ3,Forkhead box protein J3,24229,0.0571017187601119,0.00295404191089174,0.0513117966147641,0.0628916409054598,1.26014859010375e-82
NMR metabolomics,X23428.Concentration of VLDL Particles,RRAS,Ras-related protein R-Ras,24195,0.168113542661151,0.00870121598292727,0.151059159334614,0.185167925987689,1.50885635841992e-82
NMR metabolomics,X23428.Concentration of VLDL Particles,MAPKAPK2,MAP kinase-activated protein kinase 2,24445,0.0944043755277326,0.00489554819475363,0.0848091010660155,0.10399964998945,3.00930683906551e-82
NMR metabolomics,X23428.Concentration of VLDL Particles,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28787,0.100385674587805,0.00521350094182436,0.090167212741829,0.110604136433781,4.22003608711386e-82
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP3R1,Calcineurin subunit B type 1,29218,0.0523440244008551,0.00271880516426563,0.0470151662788945,0.0576728825228158,4.33809012392876e-82
NMR metabolomics,X23428.Concentration of VLDL Particles,SUGT1,Protein SGT1 homolog,28797,0.103031170519382,0.00535277069830301,0.0925397399507084,0.113522601088056,4.79747417011414e-82
NMR metabolomics,X23428.Concentration of VLDL Particles,VEGFA,Vascular endothelial growth factor A,29683,0.0736268609340083,0.00382979623770484,0.0661204603081068,0.0811332615599098,7.23976251870978e-82
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINB6,Serpin B6,29623,0.0753818522559691,0.00392734553868524,0.067684255000146,0.0830794495117921,1.30002045663516e-81
NMR metabolomics,X23428.Concentration of VLDL Particles,CACYBP,Calcyclin-binding protein,24329,0.131487210910774,0.00685141246613206,0.118058442477155,0.144915979344393,1.75518007615989e-81
NMR metabolomics,X23428.Concentration of VLDL Particles,NUB1,NEDD8 ultimate buster 1,29434,0.106511064781167,0.00555560999340175,0.0956220691940995,0.117400060368234,2.00005305364736e-81
NMR metabolomics,X23428.Concentration of VLDL Particles,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29349,0.119704086112681,0.00625133800783307,0.107451463617329,0.131956708608034,3.11930876909215e-81
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29573,0.141943770880306,0.00741609833620996,0.127408218141334,0.156479323619277,3.64050986076589e-81
NMR metabolomics,X23428.Concentration of VLDL Particles,VSNL1,Visinin-like protein 1,24845,0.0485769010192244,0.00254009593377053,0.0435983129890341,0.0535554890494146,6.08820000671849e-81
NMR metabolomics,X23428.Concentration of VLDL Particles,TBCB,Tubulin-folding cofactor B,29218,0.127449719323597,0.00667464137463207,0.114367422229318,0.140532016417876,8.70662765945445e-81
NMR metabolomics,X23428.Concentration of VLDL Particles,C19orf12,Protein C19orf12,28774,0.0816654447193361,0.00427953841169788,0.0732775494324083,0.090053340006264,1.10827373731874e-80
NMR metabolomics,X23428.Concentration of VLDL Particles,PAEP,Glycodelin,29218,-0.167072812780745,0.00875725536977827,-0.184237033305511,-0.14990859225598,1.18709870300129e-80
NMR metabolomics,X23428.Concentration of VLDL Particles,CFHR5,Complement factor H-related protein 5,24623,0.0530716915857826,0.0027822557274787,0.0476184703599244,0.0585249128116409,1.55293712437926e-80
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF5,E3 ubiquitin-protein ligase RNF5,24240,0.0931143788970012,0.00488598014894779,0.0835378578050636,0.102690899988939,2.20906246797766e-80
NMR metabolomics,X23428.Concentration of VLDL Particles,MATN2,Matrilin-2,29497,0.0375768163224596,0.00197437471254281,0.0337070418858757,0.0414465907590435,2.79627826073445e-80
NMR metabolomics,X23428.Concentration of VLDL Particles,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24805,0.0647468564112687,0.003401423910296,0.0580800655470886,0.0714136472754489,3.25637471946718e-80
NMR metabolomics,X23428.Concentration of VLDL Particles,SPARC,SPARC,29566,0.0887611316135413,0.00466683672612094,0.0796141316303443,0.0979081315967384,3.54420263769421e-80
NMR metabolomics,X23428.Concentration of VLDL Particles,SDHB,Succinate dehydrogenase,24805,0.0870859681465447,0.00457861074440818,0.0781118910875046,0.0960600452055847,4.32149517080544e-80
NMR metabolomics,X23428.Concentration of VLDL Particles,OTUD6B,Deubiquitinase OTUD6B,24805,0.0739159985923142,0.0038868738156646,0.0662977259136116,0.0815342712710168,4.60219651855286e-80
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28797,0.123920047427524,0.00652044495262871,0.111139975320371,0.136700119534676,4.8134708295648e-80
NMR metabolomics,X23428.Concentration of VLDL Particles,CD69,Early activation antigen CD69,29344,0.110384719528456,0.0058208937138111,0.0989757678493867,0.121793671207526,1.02510865552843e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,CD226,CD226 antigen,24229,0.0532312467165041,0.00280753089356048,0.0477284861651256,0.0587340072678827,1.37427028409009e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,PDIA4,Protein disulfide-isomerase A4,24938,0.0766209532064354,0.00404209838910505,0.0686984403637895,0.0845434660490813,1.43829742688992e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,IDUA,Alpha-L-iduronidase,29725,0.057946921735045,0.00305886529402042,0.051951545758765,0.063942297711325,1.46085342105675e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL11,Eotaxin,29786,0.0472680701486846,0.00249955970588794,0.0423689331251442,0.0521672071722249,2.72542663372294e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,C1R,Complement C1r subcomponent,24966,0.0244497116872789,0.00129246200878155,0.0219164861500671,0.0269829372244907,2.95697294257262e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,CERT,Ceramide transfer protein,28774,0.0770801730970152,0.00407759763975084,0.0690880817231035,0.0850722644709268,3.23938457299528e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29725,0.0785549208310401,0.00415810225662319,0.0704050404080586,0.0867048012540215,3.86571085170466e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24922,0.0774637574462974,0.00410427973266181,0.0694193691702803,0.0855081457223145,6.64966746597023e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,AP2B1,AP-2 complex subunit beta,24195,0.0612457971026928,0.00324636742140604,0.054882916956737,0.0676086772486486,8.00931703320852e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,HSPB1,Heat shock protein beta-1,29039,0.0860245816801372,0.00456493150316419,0.0770773159339354,0.094971847426339,9.60536675824416e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,SEPTIN9,Septin-9,29349,0.0354987587854587,0.00188737821580398,0.0317994974824829,0.0391980200884345,1.86423336969535e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24445,0.0833080181021567,0.00442686595516218,0.0746313608300388,0.0919846753742745,1.90428010105339e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,PF4,Platelet factor 4,24822,0.12166900462153,0.00647659088054657,0.108974886495658,0.134363122747401,3.43522536158935e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28797,0.105752852764367,0.00563544028738383,0.0947073898010951,0.11679831572764,4.221355438397e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,STK24,Serine/threonine-protein kinase 24,28774,0.0770896842576405,0.00410955632741269,0.0690349538559116,0.0851444146593693,4.81543978459676e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,BAG3,BAG family molecular chaperone regulator 3,29169,0.0499147977829724,0.00266381674324891,0.0446937169662046,0.0551358785997403,6.95475700798489e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24793,0.0473275343174382,0.00252485301487889,0.0423788224082756,0.0522762462266008,7.40198004921823e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29581,0.148378155487448,0.00792458304772277,0.132845972713911,0.163910338260984,8.93698339027159e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,YWHAQ,14-3-3 protein theta,24381,0.092157982814353,0.00492115551647568,0.0825125180020607,0.101803447626645,1.05030656972187e-77
NMR metabolomics,X23428.Concentration of VLDL Particles,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24922,0.111632030968319,0.00596267895026619,0.0999451802257974,0.123318881710841,1.12368476251263e-77
NMR metabolomics,X23428.Concentration of VLDL Particles,FHIT,Bis(5'-adenosyl)-triphosphatase,28774,0.0918038588380886,0.00490615657351791,0.0821877919539934,0.101419925722184,1.14509939479649e-77
NMR metabolomics,X23428.Concentration of VLDL Particles,ASRGL1,Isoaspartyl peptidase/L-asparaginase,24240,0.127274625980512,0.00680423876575932,0.113938317999623,0.1406109339614,1.58067916515174e-77
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL18,C-C motif chemokine 18,29166,0.0871137337805611,0.00466627685118615,0.0779678311522363,0.096259636408886,2.51211150048987e-77
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDT16,U8 snoRNA-decapping enzyme,24769,0.108758501741485,0.00582478215593927,0.0973419287158437,0.120175074767126,2.85916667305377e-77
NMR metabolomics,X23428.Concentration of VLDL Particles,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28797,0.0717971349081209,0.00384785141970414,0.0642553461255008,0.079338923690741,3.04955475128276e-77
NMR metabolomics,X23428.Concentration of VLDL Particles,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28797,0.0629291661554389,0.00338490846782151,0.0562947455585087,0.069563586752369,1.06818972961366e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,CST3,Cystatin-C,29530,0.0349795045416742,0.00188169429342305,0.0312913837265651,0.0386676253567834,1.07505309206577e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,LACTB2,Endoribonuclease LACTB2,29478,0.0813688366581409,0.00437805610778411,0.0727878466868841,0.0899498266293978,1.15416386842334e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,ALDH1A1,Retinal dehydrogenase 1,29443,0.0655924750172146,0.00353229052460401,0.0586691855889908,0.0725157644454385,1.55777767801174e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINB9,Serpin B9,29218,0.0409458817727123,0.00220537759774423,0.0366233416811336,0.045268421864291,1.65915436576626e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,RABGAP1L,Rab GTPase-activating protein 1-like,28931,0.0737680108791209,0.0039738049530579,0.0659793531711274,0.0815566685871144,1.76475564030892e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,SELE,E-selectin,29820,0.062036260417719,0.00334221240260148,0.0554855241086201,0.0685869967268178,1.78066695611552e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29349,0.0666224453938373,0.00359333813522016,0.0595795026488057,0.0736653881388688,2.65643482502241e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGEF10,Rho guanine nucleotide exchange factor 10,24867,0.115276054155951,0.006215317524292,0.103094031808339,0.127458076503564,2.81937427385571e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,COMT,Catechol O-methyltransferase,28591,0.103633027198837,0.00559702577981495,0.0926628566703999,0.114603197727275,4.3017686134952e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,MEGF10,Multiple epidermal growth factor-like domains protein 10,29454,0.0487026749905308,0.00263072114548154,0.043546461545387,0.0538588884356746,4.38583343542776e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRC59,Leucine-rich repeat-containing protein 59,24922,0.058600943397801,0.00316573652034135,0.052396099817932,0.06480578697767,5.44927885070098e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,BIN2,Bridging integrator 2,29443,0.11027692122542,0.00597447518388431,0.0985669498650069,0.121986892585833,1.20307371626845e-75
NMR metabolomics,X23428.Concentration of VLDL Particles,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28738,0.0713732895643193,0.00387236992410756,0.0637834445130685,0.0789631346155702,2.00351423328142e-75
NMR metabolomics,X23428.Concentration of VLDL Particles,SNAP25,Synaptosomal-associated protein 25,24101,0.0581394663888181,0.00315289907963559,0.0519597841927323,0.0643191485849039,2.07442478894681e-75
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL4,C-C motif chemokine 4,29498,0.0797907848533616,0.00433175381398653,0.071300547377948,0.0882810223287752,2.40719783930139e-75
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28931,0.0668924685550523,0.00363318619721465,0.0597714236085116,0.074013513501593,2.86274608343087e-75
NMR metabolomics,X23428.Concentration of VLDL Particles,BPIFB2,BPI fold-containing family B member 2,24852,0.079557684032811,0.00432043448732701,0.0710896324376501,0.088025735627972,3.19901675833118e-75
NMR metabolomics,X23428.Concentration of VLDL Particles,RP2,Protein XRP2,29349,0.0511153928386149,0.00278237109546194,0.0456619454915095,0.0565688401857203,5.89212500836076e-75
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL2L1,Bcl-2-like protein 1,24845,0.121453252973371,0.00663119538029298,0.108456110027997,0.134450395918745,1.92844285885619e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,DFFA,DNA fragmentation factor subunit alpha,29786,0.0818225048785637,0.00447172820329831,0.073057917600099,0.0905870921570284,2.20792197937581e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,HPGDS,Hematopoietic prostaglandin D synthase,28797,0.0459290903376925,0.00251002385554429,0.0410094435808257,0.0508487370945593,2.25793424624548e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29604,0.0703623418645019,0.00384598608015263,0.0628242091474028,0.0779004745816011,2.33338829812e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,CETN2,Centrin-2,28774,0.0820335126532952,0.00448507025603433,0.0732427749514679,0.0908242503551225,2.60859406080041e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,GLOD4,Glyoxalase domain-containing protein 4,29408,0.0430124474810273,0.00235254939059093,0.0384014506754691,0.0476234442865855,2.90164879584006e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,VPS4B,Vacuolar protein sorting-associated protein 4B,24793,0.11489845224798,0.00628178114573186,0.102586161202345,0.127210743293614,3.02328116672923e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,PDGFA,Platelet-derived growth factor subunit A,29820,0.0870721531696586,0.00476663570543578,0.0777295471870045,0.0964147591523127,3.85077898461133e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28797,0.0818841588429934,0.00448312791792081,0.0730972281238686,0.0906710895621182,4.12949939319758e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,SCRG1,Scrapie-responsive protein 1,24922,0.0334411362759107,0.00183142751884045,0.0298515383389834,0.037030734212838,5.27958315083667e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,APOE,Apolipoprotein E,24966,0.0884451485895025,0.00484410742527439,0.0789506980359647,0.0979395991430403,5.39507504597582e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,MARCO,Macrophage receptor MARCO,29478,0.0318661765790864,0.00174853228366996,0.0284390533030933,0.0352932998550795,8.39506426243384e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,GP5,Platelet glycoprotein V,24381,0.0439490249182229,0.00241029001952142,0.0392248564799609,0.0486731933564849,8.60262614749546e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,INPP1,Inositol polyphosphate 1-phosphatase,29349,0.0647586604724197,0.00355807628816436,0.0577848309476175,0.0717324899972218,1.30174506986231e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,GSR,"Glutathione reductase, mitochondrial",24867,0.0274702098530776,0.00150947191339158,0.0245116449028301,0.0304287748033251,1.59216615105927e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,GPI,Glucose-6-phosphate isomerase,24951,0.0572690005193085,0.00314710381198162,0.0511006770478245,0.0634373239907924,1.62070708675838e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,DPT,Dermatopontin,29820,0.0318266797833456,0.00175061589198364,0.0283954726350576,0.0352578869316335,1.84679998325087e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,NT5C3A,Cytosolic 5'-nucleotidase 3A,29373,0.105992692844728,0.00583132558853935,0.0945632946911905,0.117422090998265,2.00689470846829e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,FUS,RNA-binding protein FUS,28765,0.0477092373704233,0.00262572561484813,0.042562815165321,0.0528556595755256,2.30096670681138e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,AKT3,RAC-gamma serine/threonine-protein kinase,28662,0.0695422794816297,0.00382913112421628,0.0620371824781657,0.0770473764850935,2.69324527677146e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,ACAN,Aggrecan core protein,29192,0.034141107983005,0.00188070102578632,0.0304549339724638,0.0378272819935462,3.05671453842624e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,DTD1,D-aminoacyl-tRNA deacylase 1,24381,0.105539197098967,0.00581423718733789,0.0941432922117852,0.11693510198615,3.76895605183164e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,24240,0.058023980319207,0.00319729595186304,0.0517572802535555,0.0642906803848586,4.07769859860425e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,DNER,Delta and Notch-like epidermal growth factor-related receptor,29382,0.030733919073106,0.0016945866847027,0.0274125291710887,0.0340553089751233,4.11622860130856e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,TMEM106A,Transmembrane protein 106A,24793,0.0853179277127699,0.00470710908093107,0.076091993914145,0.0945438615113948,5.95770708568718e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,CIAPIN1,Anamorsin,29566,0.0753187282495747,0.00416025475321352,0.0671646289332762,0.0834728275658732,7.29789346913809e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24922,0.0886738092828106,0.00489860081803482,0.0790725516794623,0.0982750668861588,9.02483879106346e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGAP25,Rho GTPase-activating protein 25,28797,0.0719649171126448,0.00398209410149478,0.0641600126737151,0.0797698215515746,1.33266716179435e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINE2,Glia-derived nexin,24922,0.0775159322938014,0.00428780150784047,0.0691118413384341,0.0859200232491687,1.37766737299006e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP2,Caspase-2,29434,0.0814159827961764,0.00450770391252838,0.0725808831276208,0.090251082464732,1.58002876394774e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,AKT2,RAC-beta serine/threonine-protein kinase,24867,0.152053460041467,0.00841857012419067,0.135553062598053,0.168553857484881,1.85750906887758e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24867,0.119330140025595,0.00661648766259654,0.106361824206906,0.132298455844285,2.9773766697812e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24381,0.125117473159799,0.00693784081282287,0.111519305166666,0.138715641152932,3.10661639283351e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,PPBP,Platelet basic protein,24816,0.101632583050976,0.00563603171591033,0.0905859608877914,0.11267920521416,3.12675672179976e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,DCTD,Deoxycytidylate deaminase,24381,0.113992489003321,0.00632650071605324,0.101592547599857,0.126392430406786,4.11928624429238e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,TPK1,Thiamin pyrophosphokinase 1,24922,0.0330368804439246,0.00183416675960774,0.0294419135950934,0.0366318472927557,4.50536073470811e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,THTPA,Thiamine-triphosphatase,24755,0.105616880065856,0.00586725318679528,0.0941170638197373,0.117116696311975,5.50561699561427e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,RFC4,Replication factor C subunit 4,24793,0.0254767737902447,0.00141560033814033,0.0227021971274896,0.0282513504529997,5.89513879157378e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24867,0.0575478120728629,0.00319923796190632,0.0512773056675265,0.0638183184781993,6.92058463632688e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29434,0.0976009161154191,0.00542980809939771,0.0869584922405996,0.108243339990239,7.4164596151497e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,PSME1,Proteasome activator complex subunit 1,29192,0.0442876212219113,0.00246430937972844,0.0394575748376436,0.0491176676061791,7.93848466095656e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,SRP14,Signal recognition particle 14 kDa protein,29349,0.0709937901291181,0.0039536030779988,0.0632447280962404,0.0787428521619957,1.03012142678479e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,DTNB,Dystrobrevin beta,24752,0.051977601317191,0.00289330565388154,0.0463067222355831,0.0576484803987988,1.05084547443297e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINB1,Leukocyte elastase inhibitor,29354,0.106334625013996,0.00592376624309563,0.0947240431775284,0.117945206850463,1.15068586671497e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,ANG,Angiogenin,29435,0.0401739299384407,0.00223938566026409,0.0357847340443231,0.0445631258325583,1.39129901192567e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,TBC1D5,TBC1 domain family member 5,29434,0.0930068053977032,0.0051876435108801,0.0828390241163782,0.103174586679028,1.69770684564501e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,CHM,Rab proteins geranylgeranyltransferase component A 1,24195,0.0729719352473294,0.00407257069983656,0.0649896966756497,0.0809541738190091,2.47463531411671e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,GMFG,Glia maturation factor gamma,24922,0.0855896500074739,0.00477852774965301,0.076223735618154,0.0949555643967938,2.69795799650666e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,TADA3,Transcriptional adapter 3,24793,0.0471837365740144,0.00263457025259218,0.0420199788789337,0.052347494269095,2.80227363118509e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24793,0.041943042794043,0.00234506951631403,0.0373467065420675,0.0465393790460185,4.27530412652766e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,DNM3,Dynamin-3,24867,0.0652615847058256,0.00365384405288299,0.058100050362175,0.0724231190494763,6.58267265043001e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,ELOA,Elongin-A,29349,0.0619878825658013,0.00347279188839114,0.0551812104645546,0.0687945546670479,6.91125576665952e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,CLUL1,Clusterin-like protein 1,29435,-0.053399037544495,0.00299380550873837,-0.0592668963416222,-0.0475311787473678,8.68963665220413e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,PRDX5,"Peroxiredoxin-5, mitochondrial",29786,0.0803932612994213,0.00450863273062753,0.0715563411473913,0.0892301814514512,9.49000025122943e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRN1,Leucine-rich repeat neuronal protein 1,28931,0.0468138460450209,0.00262598030494289,0.0416669246473328,0.0519607674427089,1.04009540057076e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29349,0.0286614514072281,0.00160782531529509,0.0255101137892497,0.0318127890252065,1.04505153670827e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM24,Transcription intermediary factor 1-alpha,24396,0.0771476568023549,0.00432900083884746,0.0686628151582139,0.085632498446496,1.35964599729637e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,PLPBP,Pyridoxal phosphate homeostasis protein,29478,0.0798335282423337,0.00448808780542529,0.0710368761437002,0.0886301803409673,2.05051696296797e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,FSHB,Follitropin subunit beta,24240,0.076635670551458,0.00431173584248426,0.0681846683001888,0.0850866728027271,3.15453566807368e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,HNMT,Histamine N-methyltransferase,29082,0.0556213316361526,0.00313147184450835,0.0494836468209163,0.061759016451389,3.27132114526408e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPTL7,Angiopoietin-related protein 7,29725,0.0435669095377385,0.00245323062563282,0.0387585775114982,0.0483752415639789,3.38895179079193e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G4A,Cytosolic phospholipase A2,29581,0.103117490425446,0.00581141752683641,0.0917271120728464,0.114507868778045,4.43568451562434e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,MSTN,Growth/differentiation factor 8,28916,0.0620279257702956,0.00349760026353568,0.0551726292537657,0.0688832222868256,5.34666106608574e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJB14,DnaJ homolog subfamily B member 14,24805,0.0758264817810638,0.0042775182016802,0.0674425461057706,0.084210417456357,7.0419710646384e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,CRYBB1,Beta-crystallin B1,24922,0.0771029545858414,0.00435031551158155,0.0685763361831416,0.0856295729885413,7.41655870624492e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24381,0.0497677172174634,0.00280841162912887,0.0442632304243708,0.055272204010556,7.93129635534602e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,PALM2,Paralemmin-2,24845,0.0446770601421985,0.0025220743234642,0.0397337944682086,0.0496203258161883,8.73079986221563e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,ROBO2,Roundabout homolog 2,29694,0.0272289699722559,0.00153880104758269,0.0242129199189939,0.030245020025518,1.04729205476163e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24793,0.126992679880714,0.00717710990089939,0.112925544474952,0.141059815286477,1.24870920602514e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,IMPACT,Protein IMPACT,24845,0.0655736487957487,0.0037088849404029,0.058304234312559,0.0728430632789384,1.59186626757837e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,MYO9B,Unconventional myosin-IXb,28931,0.0775117059584521,0.00439041639233773,0.0689064898294701,0.086116922087434,2.16530331856108e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29434,0.140975902385585,0.00799224505271078,0.125311102082272,0.156640702688898,2.80866371615273e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29536,0.0893556553547142,0.00506723403329859,0.079423876649449,0.0992874340599794,3.06109203189701e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL1,Growth-regulated alpha protein,29420,0.111539771238525,0.00632678109245973,0.0991392802973038,0.123940262179746,3.30679886673742e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,CNDP1,Beta-Ala-His dipeptidase,29594,0.0537869821880236,0.00305276909948724,0.0478035547530286,0.0597704096230186,3.96871998896568e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,24240,0.0896148587053628,0.00510150495157155,0.0796159090002825,0.099613808410443,1.18888109777548e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,CFHR4,Complement factor H-related protein 4,24892,0.085750798231141,0.00488550418361685,0.076175210031252,0.09532638643103,1.48559172617898e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29434,0.141411941164017,0.00806098677878984,0.125612407077589,0.157211475250446,1.51040373695242e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF4E,Eukaryotic translation initiation factor 4E,24229,0.106133226455869,0.00604857683680952,0.0942780158557219,0.117988437056015,1.67100085526323e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,PNMA1,Paraneoplastic antigen Ma1,24240,0.0659855834470707,0.00376342658580599,0.058609267338891,0.0733618995552505,2.1093095506822e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,JPT2,Jupiter microtubule associated homolog 2,24805,0.102310612324149,0.00583999406600545,0.0908642239547779,0.113757000693519,2.65065510163177e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,MSR1,Macrophage scavenger receptor types I and II,29694,0.0534233940804919,0.00305108341161274,0.047443270593731,0.0594035175672529,2.66872407030177e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP6AP2,Renin receptor,28797,0.0472064521816728,0.00269675804268765,0.041920806418005,0.0524920979453406,2.97062418994914e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP3,Caspase-3,29820,0.102255523950602,0.0058437707374383,0.0908017333052227,0.113709314595981,3.24491600645619e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,UROD,Uroporphyrinogen decarboxylase,24381,0.0807353915182095,0.00461165477413121,0.0716965481609123,0.0897742348755067,3.3262778571973e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24381,0.0704458817072466,0.00402435447351443,0.0625581469391583,0.0783336164753349,3.43927953105602e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,TSC22D1,TSC22 domain family protein 1,24867,0.0775982582999988,0.00443806771400808,0.068899645580543,0.0862968710194547,4.7910930809174e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,29218,0.109382450177552,0.0062600378432368,0.0971127760048075,0.121652124350296,5.09669142456136e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,F2R,Proteinase-activated receptor 1,29536,0.0663953144737994,0.00380714536615996,0.0589333095561259,0.0738573193914729,9.02731765229355e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP10,Caspase-10,28774,0.0828501259038359,0.0047511243741104,0.0735379221305795,0.0921623296770923,9.48299499362117e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,STX8,Syntaxin-8,29434,0.0558592774108534,0.00321199135830128,0.0495637743485829,0.0621547804731239,2.1051041457394e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,CRYZL1,Quinone oxidoreductase-like protein 1,24240,0.106663055957472,0.00613277078082731,0.0946428252270506,0.118683286687894,2.42182663388954e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28931,0.0506857816308671,0.00291615152165135,0.0449701246484304,0.0564014386133037,2.52696813496951e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,MICALL2,MICAL-like protein 2,24195,0.079147425411932,0.00455691139121302,0.0702158790851544,0.0880789717387095,3.64611177863843e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,MUC13,Mucin-13,28774,0.059349130589686,0.00342022023916054,0.0526454989209314,0.0660527622584407,4.15719062888115e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL3,C-C motif chemokine 3,29434,0.0696565086010005,0.0040198163422624,0.0617776685701662,0.0775353486318348,6.19135893604885e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPT1,Angiopoietin-1,29322,0.0965976140427264,0.00559011088044128,0.0856409967170614,0.107554231368391,1.42149588165384e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24966,0.0297866312372511,0.00172670288486887,0.0264022935829081,0.0331709688915941,2.68726790560225e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,ESYT2,Extended synaptotagmin-2,24845,0.0944846541190176,0.00548033526707464,0.0837431969955513,0.105226111242484,3.19726866084832e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,DBN1,Drebrin,24229,0.0587971817311472,0.00342477314560578,0.0520846263657598,0.0655097370965345,1.12531396839633e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,GGCT,Gamma-glutamylcyclotransferase,24904,0.0548147289432705,0.00319409386530552,0.0485543049672717,0.0610751529192693,1.23584820578553e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,KCTD5,BTB/POZ domain-containing protein KCTD5,24429,0.0503143696176153,0.00293339046528909,0.0445649243056487,0.0560638149295819,1.46430817506456e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,LAP3,Cytosol aminopeptidase,28931,0.0553707464674942,0.00323267423324514,0.0490347049703338,0.0617067879646547,1.91584802062831e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,GIPC3,PDZ domain-containing protein GIPC3,24805,0.112118075378792,0.00654492213317654,0.0992900279977656,0.124946122759818,2.09119247055337e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,SFRP1,Secreted frizzled-related protein 1,29120,0.0493459286797147,0.00288202480813494,0.0436971600557702,0.0549946973036592,2.12958457049553e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,CA13,Carbonic anhydrase 13,29114,0.118678582912952,0.00693185895257832,0.105092139365898,0.132265026460005,2.17460870231726e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,PPCDC,Phosphopantothenoylcysteine decarboxylase,29694,0.0531396338867154,0.00310748492406054,0.0470489634355567,0.059230304337874,3.02286229233665e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,NECAP2,Adaptin ear-binding coat-associated protein 2,24111,0.0760369771722428,0.00444462927070033,0.0673255038016701,0.0847484505428154,3.16371788356846e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24922,0.111644498806272,0.0065320627368156,0.098841655842113,0.12444734177043,4.02172678184839e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,FAS,Tumor necrosis factor receptor superfamily member 6,29736,0.0370325036977349,0.00216873451023494,0.0327817840576744,0.0412832233377954,4.60887925362017e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,TST,Thiosulfate sulfurtransferase,28706,0.0858973777164334,0.00503020786115003,0.0760381703085793,0.0957565851242874,4.67374707883349e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,24229,0.0912549006164975,0.00534220545787255,0.0807841779190673,0.101725623313928,4.87221419906461e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,HPSE,Heparanase,24688,0.10676786544642,0.00625383099758696,0.0945103566911492,0.11902537420169,5.62913167678914e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,IL18,Interleukin-18,29335,0.0520981690857036,0.00305467285704178,0.0461110102859017,0.0580853278855055,6.57608627718853e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,ATXN3,Ataxin-3,24845,0.070176767696855,0.004113719463489,0.0621138775484165,0.0782396578452934,6.99959578043409e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,FGL1,Fibrinogen-like protein 1,24951,-0.0724666594030501,0.00425225532753314,-0.0808010798450151,-0.0641322389610851,9.33952954680307e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,MIF,Macrophage migration inhibitory factor,29386,0.0769763670791643,0.0045199064508378,0.0681173504355222,0.0858353837228064,9.98122371912376e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC37,Hsp90 co-chaperone Cdc37,29566,0.0945288821052346,0.00555575788973275,0.0836395966413584,0.105418167569111,1.3014305219039e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,ESM1,Endothelial cell-specific molecule 1,29454,-0.0387212827744938,0.00227605209766497,-0.0431823448859172,-0.0342602206630705,1.35214355116768e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,FADD,FAS-associated death domain protein,29478,0.086251745708397,0.00507029399831354,0.0763139694717024,0.0961895219450915,1.38102361009881e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB1BP2,Integrin beta-1-binding protein 2,28916,0.125541146180067,0.00738419513295553,0.111068123719474,0.14001416864066,1.65394711300249e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,NRGN,Neurogranin,24951,0.103356956397769,0.00608475418934907,0.0914308381866445,0.115283074608893,2.39167979680711e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA3,Annexin A3,29640,0.0784918002163119,0.00462954083033605,0.0694179001888532,0.0875657002437705,3.57815763166447e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,NID1,Nidogen-1,29518,0.0427517123164726,0.00252170056750594,0.0378091792041609,0.0476942454287842,3.65121770323402e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,APOA2,Apolipoprotein A-II,24951,-0.0545966796710897,0.00322358203118411,-0.0609149004522106,-0.0482784588899689,5.50695800407154e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,MFAP5,Microfibrillar-associated protein 5,29820,0.0458858358890161,0.00271407591348212,0.0405662470985911,0.0512054246794411,7.9833325780112e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,LTBP3,Latent-transforming growth factor beta-binding protein 3,28797,0.0604249913892086,0.00357614585982995,0.0534157455039419,0.0674342372744753,9.66404446439734e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB33A,Ras-related protein Rab-33A,24111,0.0749405528915422,0.00443668763574328,0.0662446451254854,0.083636460657599,1.21639838357014e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,AIF1,Allograft inflammatory factor 1,28797,0.0588558731438237,0.00348881232278389,0.0520178009911673,0.0656939452964801,1.51480216281683e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,STX4,Syntaxin-4,29349,0.066499607548827,0.00394530919464692,0.058766801527319,0.074232413570335,1.90712879269506e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,SCGB3A2,Secretoglobin family 3A member 2,29536,-0.0917117182558923,0.00544340637072541,-0.102380794742514,-0.0810426417692705,2.14005370940094e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,ECHS1,"Enoyl-CoA hydratase, mitochondrial",24240,0.10918497665489,0.00647852640210783,0.0964870649067587,0.121882888403021,2.27723726045791e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,MEP1B,Meprin A subunit beta,29478,0.13065993453749,0.00776902329766966,0.115432648874058,0.145887220200923,3.54925294543057e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,SMTN,Smoothelin,24776,0.105963162175387,0.00629847644154428,0.0936181483499599,0.118308176000814,3.676883491087e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,GP6,Platelet glycoprotein VI,29400,0.0982272091451162,0.0058470134531336,0.0867670627769744,0.109687355513258,4.84435155562103e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,TXNDC9,Thioredoxin domain-containing protein 9,24845,0.059542525430478,0.00354878058673852,0.0525869154804705,0.0664981353804855,7.80855091399829e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP170,Centrosomal protein of 170 kDa,24240,0.0861835077333424,0.00514285899672624,0.0761035040997589,0.0962635113669258,1.11835738025812e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,FOXO3,Forkhead box protein O3,28797,0.107359825328128,0.00641017743118541,0.0947958775630047,0.119923773093252,1.1538198369935e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB2B,Ras-related protein Rab-2B,24793,0.0689246406474005,0.0041161488651342,0.0608569888717375,0.0769922924230636,1.36253094271737e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,TP53I3,Quinone oxidoreductase PIG3,23906,0.0595732791584059,0.00355998479389138,0.0525957089623788,0.066550849354433,1.67832823866336e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,PGF,Placenta growth factor,29786,0.0291383003617687,0.00174355087824398,0.0257209406404105,0.0325556600831268,2.06306260294704e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,ANKRD54,Ankyrin repeat domain-containing protein 54,28797,0.0634986784566601,0.00380430108512785,0.0560422483298095,0.0709551085835107,2.97775768143762e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,DYNLT1,Dynein light chain Tctex-type 1,24195,0.0892338962514971,0.0053468932693403,0.0787539854435901,0.099713807059404,3.51733917577955e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,DXO,Decapping and exoribonuclease protein,24845,0.0506618786676555,0.00303640568362501,0.0447105235277505,0.0566132338075605,3.68718495098111e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,XPNPEP2,Xaa-Pro aminopeptidase 2,29566,0.109047863546658,0.00654332570961811,0.0962229451558069,0.12187278193751,4.48677141375251e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,ADD1,Alpha-adducin,24381,0.077787320555167,0.00466817767005109,0.0686376923218668,0.0869369487884671,5.34072901200378e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRF5,Adhesion G protein-coupled receptor F5,24922,0.0316262066049032,0.00189924307274406,0.0279036901823248,0.0353487230274816,6.33006420620728e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP7,Matrilysin,28870,0.0551908503552162,0.00332321889413407,0.0486773413227134,0.061704359387719,1.18661947595136e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24381,0.0319285781597889,0.0019217645343012,0.0281619196725585,0.0356952366470192,1.20170947629515e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,RTN4R,Reticulon-4 receptor,29725,0.037307900715333,0.00224674665221287,0.0329042772769958,0.0417115241536702,1.21049424124997e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC26,Anaphase-promoting complex subunit CDC26,24764,0.0777089457691498,0.00468270866256798,0.0685308367905166,0.086887054747783,1.63277261597663e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29652,0.0309985174361763,0.00187172452668599,0.0273299373638718,0.0346670975084808,2.49748418106691e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,CFB,Complement factor B,24538,0.0362984454901063,0.00219095458155278,0.0320041745102629,0.0405927164699498,2.58358268441082e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24922,0.044228829993154,0.00267024618939335,0.0389951474619431,0.049462512524365,2.7195475423017e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL26,C-C motif chemokine 26,29434,0.0980668655316755,0.00592757578676522,0.0864488169896157,0.109684914073735,3.33562000591558e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,CD164,Sialomucin core protein 24,29443,0.0294366553564554,0.00178056601573632,0.0259467459656122,0.0329265647472986,4.06171589880847e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,CBLN4,Cerebellin-4,29725,0.0348528883681294,0.0021118929226049,0.0307135782398238,0.038992198496435,6.50535948392077e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,ARL13B,ADP-ribosylation factor-like protein 13B,24111,0.0762669381726146,0.00462237775244964,0.0672070777778133,0.0853267985674159,7.97943952359203e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,DBI,Acyl-CoA-binding protein,29329,0.0858283414324073,0.00521119736032898,0.0756143946061624,0.0960422882586521,1.12996586634364e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,GZMA,Granzyme A,29786,0.0379441696834376,0.00230423335353791,0.0334278723105033,0.0424604670563719,1.17226710694913e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,PARK7,Parkinson disease protein 7,29443,0.0571369995014695,0.00346991129478863,0.0503359733636838,0.0639380256392552,1.19510369306066e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,BRSK2,Serine/threonine-protein kinase BRSK2,24867,0.0420991816553203,0.00255641315893774,0.0370886118638023,0.0471097514468383,1.30413423056499e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,ABHD14B,Protein ABHD14B,29121,0.0627509871425096,0.00381415582861354,0.055275241718427,0.0702267325665921,1.52031308912227e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,JAM3,Junctional adhesion molecule C,24381,0.0556019180475433,0.0033794103892774,0.0489782736845596,0.062225562410527,1.68884758370199e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,PTX3,Pentraxin-related protein PTX3,29434,-0.0540778474892299,0.00328836239547127,-0.0605230377843536,-0.0476326571941063,1.690912526376e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,REEP4,Receptor expression-enhancing protein 4,24867,0.0681409216111889,0.0041421250364035,0.060022356539838,0.0762594866825397,1.7316524938705e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,GGACT,Gamma-glutamylaminecyclotransferase,24922,0.0776254080435424,0.00472434569541959,0.06836569048052,0.0868851256065648,2.38785166670174e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,PEBP1,Phosphatidylethanolamine-binding protein 1,29443,0.0624490627044742,0.00380963470996595,0.054982178672941,0.0699159467360075,4.00525247240001e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,TTF2,Transcription termination factor 2,24195,0.053651480077543,0.00327470362503559,0.0472330609724732,0.0600698991826127,5.27454043913674e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,MOG,Myelin-oligodendrocyte glycoprotein,29725,0.0357070900500395,0.00218808206266144,0.0314184492072231,0.0399957308928559,1.31667069224163e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,APP,Amyloid-beta precursor protein,29395,0.072173289458609,0.00442297504545062,0.0635042583695258,0.0808423205476922,1.34900872760726e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,GET3,ATPase GET3,24922,0.0599891960724993,0.00367503264019394,0.0527861320977192,0.0671922600472794,1.37141144544435e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASEH2A,Ribonuclease H2 subunit A,24867,0.0530142427561349,0.0032482863505542,0.0466476015090486,0.0593808840032211,1.43653577944283e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJB2,DnaJ homolog subfamily B member 2,24381,0.0582705124345487,0.00357374236931372,0.0512659773906938,0.0652750474784036,1.87278702606123e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",24209,0.0866500963921979,0.00532051048405846,0.0762218958434433,0.0970782969409525,2.56525965234713e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,GPRC5C,G-protein coupled receptor family C group 5 member C,24793,0.0617961253562734,0.00379795265719389,0.0543521381481734,0.0692401125643734,3.22161721769002e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMP1,Lysosome-associated membrane glycoprotein 1,24256,0.0305289849921118,0.00187963149809135,0.0268449072558527,0.0342130627283708,5.21698070829329e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,RBKS,Ribokinase,28795,0.0537318918818265,0.00331115702075218,0.0472420241211522,0.0602217596425008,5.88950134744951e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28797,0.0704437774992737,0.00434549826204224,0.0619266009056709,0.0789609540928765,7.72013478304028e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,MZT1,Mitotic-spindle organizing protein 1,28797,0.0566818074958923,0.00349721164657932,0.0498272726685968,0.0635363423231877,8.10713558787429e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28797,0.0472152100429375,0.00291472608212511,0.0415023469219723,0.0529280731639028,9.35227335478349e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,POMC,Pro-opiomelanocortin,24240,0.0763718786043613,0.00471389379399288,0.0671326467681352,0.0856111104405873,1.00319694812067e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,CPPED1,Serine/threonine-protein phosphatase CPPED1,29694,0.0703585606723457,0.00434787824212236,0.0618367193177859,0.0788804020269055,1.19967841808099e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,BTC,Probetacellulin,28797,0.0800730110979472,0.00494815038783034,0.0703746363377998,0.0897713858580947,1.2186699543362e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,BLNK,B-cell linker protein,24229,0.0431145518147985,0.00266340193019663,0.0378942840316131,0.0483348195979839,1.25019987229231e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,ABRAXAS2,BRISC complex subunit Abraxas 2,24111,0.0720196926313673,0.00445154380561373,0.0632946667723644,0.0807447184903703,1.45410579561557e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,NPPB,Natriuretic peptides B,28916,-0.144107909675186,0.008919054784144,-0.161589257052108,-0.126626562298264,1.82057727527855e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,PRDX6,Peroxiredoxin-6,29725,-0.0642164418491403,0.00397895642573287,-0.0720151964435767,-0.0564176872547038,2.40387988186773e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,29218,0.0472873496436117,0.00293182914786747,0.0415409645137914,0.0530337347734319,2.85310710370621e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,CEMIP2,Cell surface hyaluronidase,24229,0.0356785841680763,0.00221179199891568,0.0313434718502016,0.0400136964859511,3.10559513877761e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,24190,0.0386410486235431,0.00239558176242676,0.0339457083691866,0.0433363888778995,3.15646569394428e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,LRP11,Low-density lipoprotein receptor-related protein 11,29478,0.0386841290033844,0.00239963069392409,0.0339808528432932,0.0433874051634756,3.23208450488294e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,FXYD5,FXYD domain-containing ion transport regulator 5,28931,0.0702996324675929,0.00436702065738983,0.0617402719791089,0.078858992956077,4.72501625164699e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,CCDC80,Coiled-coil domain-containing protein 80,29478,0.0376772145335002,0.00234249986989317,0.0330859147885096,0.0422685142784908,5.81714333440145e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,FRMD4B,FERM domain-containing protein 4B,24111,0.0754573278719291,0.00469262482432204,0.0662597832162579,0.0846548725276003,7.05566272943494e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,SCRN1,Secernin-1,29434,0.0596645231751602,0.00371395363370025,0.0523851740531077,0.0669438722972127,7.91877875775667e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,CCT5,T-complex protein 1 subunit epsilon,28797,0.0481970915848555,0.00301293789082759,0.0422917333188335,0.0541024498508776,2.38160945063012e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,CYB5R2,NADH-cytochrome b5 reductase 2,24523,0.0595286212566192,0.00372201640990268,0.05223346909321,0.0668237734200285,2.7596533293758e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,REN,Renin,29478,-0.0808567218981117,0.00505913617839744,-0.0907726288077707,-0.0709408149884527,2.9555998529395e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29398,0.0259533628572835,0.00162502669253599,0.0227683105399129,0.029138415174654,3.54153601239018e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,SFTPA2,Pulmonary surfactant-associated protein A2,28797,0.0538045175805438,0.00337048335724219,0.0471983702003491,0.0604106649607385,4.04205647165034e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,MCFD2,Multiple coagulation factor deficiency protein 2,29327,0.0467404646247847,0.00293611808714645,0.0409856731739777,0.0524952560755917,8.08130937782861e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,SCARF1,Scavenger receptor class F member 1,29820,0.0448452543931977,0.00281801584897601,0.0393219433292047,0.0503685654571907,8.71951262990464e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,RGS10,Regulator of G-protein signaling 10,24867,0.0633347325280039,0.00397821436593935,0.0555374323707627,0.071132032685245,8.73664214506861e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF14,Tumor necrosis factor ligand superfamily member 14,29218,0.0608920084311483,0.00382964352259273,0.0533859071268666,0.0683981097354301,1.09333331281267e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24922,0.0795078803849104,0.00500447880300045,0.0696991019310295,0.0893166588387912,1.47087710336128e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,ARFIP1,Arfaptin-1,24867,0.0728658391408227,0.00459021256725531,0.0638690225090023,0.0818626557726431,1.81325038153399e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,MDH1,"Malate dehydrogenase, cytoplasmic",24852,0.042352378941255,0.00267119013022326,0.0371168462860174,0.0475879115964926,2.44478902289484e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,RAD23B,UV excision repair protein RAD23 homolog B,28797,0.0494720409824861,0.00312387074281601,0.0433492543265667,0.0555948276384054,2.99960726164453e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,MIA,Melanoma-derived growth regulatory protein,29566,0.0387724079308609,0.00245678121978518,0.0339571167400819,0.0435876991216398,7.02669227183544e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24922,0.0344545817467418,0.00218385145005387,0.0301742329046362,0.0387349305888474,8.35285099650533e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,IGF1R,Insulin-like growth factor 1 receptor,29349,0.0228464056403818,0.00144869565542721,0.0200069621557445,0.0256858491250192,8.44539459594103e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,WDR46,WD repeat-containing protein 46,24793,0.0378774131052749,0.00240196572242836,0.0331695602893153,0.0425852659212345,9.44629612466795e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24805,0.0678995757963252,0.00431120184937399,0.0594496201715522,0.0763495314210983,1.28715569381826e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,24229,0.0588899165945183,0.00374080438575739,0.0515579399984339,0.0662218931906028,1.45715194090477e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,CD40LG,CD40 ligand,29786,0.0812890107581806,0.00516832653402627,0.0711590907514891,0.0914189307648721,1.61984327530255e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,24111,0.0425245331871104,0.0027057211938654,0.0372213196471342,0.0478277467270865,2.19656234518944e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,ICAM1,Intercellular adhesion molecule 1,29391,0.0301282562134481,0.00191833104605302,0.0263683273631842,0.033888185063712,2.33220597156909e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,PRSS2,Trypsin-2,29594,0.055727537658995,0.00355871908645271,0.0487524482495477,0.0627026270684423,4.76756115226235e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,SUOX,"Sulfite oxidase, mitochondrial",24867,0.0652086196652351,0.00416911110894531,0.0570371618917023,0.0733800774387679,7.0053328534415e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,NPDC1,Neural proliferation differentiation and control protein 1,29478,0.0333228404229322,0.00213146793602654,0.0291451632683202,0.0375005175775442,7.12794022226126e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,GBP1,Guanylate-binding protein 1,24816,0.0673104054901957,0.00430823426664986,0.058866266327562,0.0757545446528294,9.16763754355855e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,TBCA,Tubulin-specific chaperone A,24381,0.0892565320608083,0.00571808375492851,0.0780490879011484,0.100463976220468,1.15416451833859e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,LARP1,La-related protein 1,24793,0.0653620606420243,0.00418859238934946,0.0571524195588993,0.0735717017251492,1.2297786732738e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRR,Receptor-type tyrosine-protein phosphatase R,24845,0.0381966468467453,0.00244926615508934,0.0333960851827702,0.0429972085107204,1.42635421046518e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,CDCP1,CUB domain-containing protein 1,29218,0.0538989227040417,0.00346514451445478,0.0471072394557103,0.0606906059523731,2.44759287998983e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,TMSB10,Thymosin beta-10,29443,0.0784730772397762,0.00504566341109496,0.0685835769540301,0.0883625775255223,2.5156496443423e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29655,0.0316137370448568,0.00203600193982498,0.0276231732427999,0.0356043008469138,3.70357231991139e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,IFT20,Intraflagellar transport protein 20 homolog,24195,0.0448849128367052,0.00289015200434942,0.0392202149081804,0.0505496107652301,3.95226923138831e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,CALCA,Calcitonin,29163,0.0641648553459312,0.00413628629113314,0.0560577342153102,0.0722719764765522,4.68598620280243e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,CD5,T-cell surface glycoprotein CD5,29683,0.0354092272464225,0.00228644279487217,0.0309277993684731,0.039890655124372,6.94765896824576e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,MEP1A,Meprin A subunit alpha,24805,0.0744031217294436,0.00480430498965492,0.0649866839497199,0.0838195595091672,7.62157579492213e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,SRC,Proto-oncogene tyrosine-protein kinase Src,29525,0.122921679841134,0.0079464677054982,0.107346603138357,0.13849675654391,9.17667729574158e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,MCEMP1,Mast cell-expressed membrane protein 1,24229,0.0934291114144633,0.00604482364183368,0.0815812570764693,0.105276965752457,1.23927959473866e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29434,0.0627544113266017,0.00406551834571487,0.0547859953690006,0.0707228272842029,1.52607526472112e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,AGXT,Serine--pyruvate aminotransferase,29478,0.0791435698377049,0.00512788268158697,0.0690929197817944,0.0891942198936154,1.56788534998081e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGA6,Integrin alpha-6,29434,0.05344779581935,0.00346688465009466,0.0466527019051645,0.0602428897335356,2.04685735001908e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,CCS,Copper chaperone for superoxide dismutase,29218,0.0486780476173107,0.00315789502055424,0.0424885733770244,0.054867521857597,2.11656558729811e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,RILP,Rab-interacting lysosomal protein,29632,0.0608395242132687,0.00395263209931319,0.0530923652986148,0.0685866831279226,2.97196097299683e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSL,Cathepsin L1,29478,0.0249093447396894,0.00161958830060329,0.021734951670507,0.0280837378088719,3.586816582753e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,STXBP3,Syntaxin-binding protein 3,28797,0.0448328043763062,0.0029153941851563,0.0391186317733999,0.0505469769792126,3.74529792322526e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,DNM1,Dynamin-1,24805,0.117360418821246,0.00762937454206316,0.102406844718802,0.13231399292369,3.76520903567353e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,ZNRD2,Protein ZNRD2,24805,0.0704385385405018,0.00458522683700301,0.0614514939399759,0.0794255831410277,5.16270909789436e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,24240,0.054246515282281,0.00353270681908834,0.0473224099168679,0.0611706206476941,5.78101448660707e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDH7,Protocadherin-7,24805,0.0356815317327309,0.00232388255970149,0.031126721915716,0.0402363415497458,5.81491435126466e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,SWAP70,Switch-associated protein 70,24805,0.0366981961958835,0.00239071498894135,0.0320123948175585,0.0413839975742086,6.17868253480191e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,AK2,"Adenylate kinase 2, mitochondrial",24845,0.10854627462367,0.00707578417276628,0.0946777376450482,0.122414811602292,7.16625846224551e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,CD72,B-cell differentiation antigen CD72,24381,0.0438397696239712,0.00285903848611231,0.0382360541911911,0.0494434850567514,8.03200856050437e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,CD274,Programmed cell death 1 ligand 1,29218,0.0349154958034575,0.00228030323807468,0.0304461014568311,0.0393848901500838,1.02281198087394e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,ASPN,Asporin,24922,0.0281400554936948,0.00183784363780956,0.024537881963588,0.0317422290238015,1.11450937960766e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNAR1,Interferon alpha/beta receptor 1,24805,0.0261872172187053,0.00171070629711017,0.0228342328763693,0.0295402015610412,1.18061576375964e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29349,0.033876412117367,0.00221468828884412,0.0295356230712325,0.0382172011635014,1.29343497049296e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJC9,DnaJ homolog subfamily C member 9,24805,0.0776663379703114,0.00509128098645567,0.0676874272368583,0.0876452487037645,2.64533286924432e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,MRI1,Methylthioribose-1-phosphate isomerase,24195,0.0692032597478649,0.00454523515986316,0.0602945988345331,0.0781119206611967,4.18295294310731e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,BMPER,BMP-binding endothelial regulator protein,24381,0.0232137144314455,0.00152487859270592,0.0202249523897419,0.0262024764731492,4.30203133048222e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,ASS1,Argininosuccinate synthase,24111,0.0805509573798474,0.00530022922149591,0.0701625081057154,0.0909394066539794,6.3842455620089e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,SLMAP,Sarcolemmal membrane-associated protein,24805,0.0842118277360934,0.00555208087076805,0.0733297492293881,0.0950939062427988,9.89413925493072e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,IMPA1,Inositol monophosphatase 1,29218,0.0614036893543319,0.0040602961410974,0.053445508917781,0.0693618697908828,1.79122871043408e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,ENO2,Gamma-enolase,29694,0.0658008628841607,0.00435676313701199,0.0572616071356172,0.0743401186327042,2.39658706919324e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29497,0.0306697816828092,0.00203099595844395,0.026689029604259,0.0346505337613593,2.48810289753611e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGAL,Integrin alpha-L,24229,0.0439997475353107,0.00291393684211528,0.0382884313247647,0.0497110637458566,2.78343941988042e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS3,Galectin-3,29544,0.0299105834059549,0.00198349223107246,0.0260229386330529,0.033798228178857,3.4149431489959e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,MTIF3,"Translation initiation factor IF-3, mitochondrial",24805,0.0882417082056426,0.00585073430870929,0.0767742689605724,0.0997091474507128,3.58085370453643e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,PKN3,Serine/threonine-protein kinase N3,24445,0.0759471824415947,0.00503573033706108,0.066077150980955,0.0858172139022344,3.63544410896622e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29434,0.0826982073265188,0.00548799623552016,0.0719417347048993,0.0934546799481383,4.02508156967166e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,BST2,Bone marrow stromal antigen 2,29694,0.0526303649714471,0.0034930045717449,0.0457840760108271,0.0594766539320671,4.10495384353739e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28774,0.0642565130003391,0.00426538145664904,0.055896365345307,0.0726166606553712,4.33472751775532e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,BDNF,Brain-derived neurotrophic factor,24938,0.0835217990073678,0.00554452451787129,0.07265453095234,0.0943890670623955,4.70083656511231e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,ACRBP,Acrosin-binding protein,24793,0.0389501233236518,0.00258603798004909,0.0338814888827556,0.044018757764548,4.86846325630847e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSZ,Cathepsin Z,29487,0.0315951635669031,0.00210149450313764,0.0274762343407534,0.0357140927930529,6.72934439106747e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,AKR1B1,Aldo-keto reductase family 1 member B1,28797,0.0755638938046012,0.0050273270942014,0.0657103326999664,0.0854174549092359,7.21794010511865e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,IL6R,Interleukin-6 receptor subunit alpha,29361,0.0339167838697029,0.00225663712935924,0.0294937750961588,0.0383397926432471,7.24735327138793e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24701,0.0303816206828932,0.00202849663887378,0.0264057672707006,0.0343574740950858,1.71974838539119e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,SLAMF6,SLAM family member 6,28797,0.03802425148508,0.00254650513094036,0.0330331014284369,0.0430154015417231,3.15058607586046e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,24229,0.0486971581002951,0.00326633468030933,0.0422951421268888,0.0550991740737013,4.81772862013698e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,NFAT5,Nuclear factor of activated T-cells 5,24229,0.0860550443097741,0.00577235116924251,0.0747412360180588,0.0973688526014895,4.86544162506056e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,BAP18,Chromatin complexes subunit BAP18,24845,0.065951730483787,0.00442460269035324,0.0572795092106946,0.0746239517568793,4.98311084631571e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL2,C-C motif chemokine 2,29169,0.0519572501193006,0.0034943669741582,0.0451082908499505,0.0588062093886507,7.99660618768013e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,NTRK2,BDNF/NT-3 growth factors receptor,29478,0.0254470248158411,0.00171359468809557,0.0220883792271738,0.0288056704045084,1.05148007229987e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,BMP6,Bone morphogenetic protein 6,28884,0.040695023856141,0.00274769150022116,0.0353095485157075,0.0460804991965745,1.90044094535107e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,CORO1A,Coronin-1A,28847,0.0880914258703046,0.00594871931497723,0.0764319360129492,0.09975091572766,1.96290651353875e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,CCDC134,Coiled-coil domain-containing protein 134,24793,0.0481068874169299,0.00324955569694778,0.0417377582509123,0.0544760165829476,2.23959374714077e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB10,Ras-related protein Rab-10,24922,0.0528196953769841,0.00357146328170343,0.0458196273448453,0.0598197634091228,2.77720883570716e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,GRK5,G protein-coupled receptor kinase 5,28916,0.0511992203464917,0.00346460146725419,0.0444086014706735,0.0579898392223099,3.08210726578726e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,GRPEL1,"GrpE protein homolog 1, mitochondrial",29349,0.0595224772533353,0.00403110591167963,0.0516215096664432,0.0674234448402273,3.65654009354268e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24805,0.0464547640889628,0.00314608289369387,0.0402884416173228,0.0526210865606028,3.93140314116994e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,ASGR2,Asialoglycoprotein receptor 2,24951,0.0257011425273537,0.00174106663611338,0.0222886519205715,0.0291136331341359,4.16911389537209e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,DYNLT3,Dynein light chain Tctex-type 3,24793,0.0428640765488022,0.00291027404849768,0.0371599394137468,0.0485682136838577,6.80748533805991e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24805,0.0749725152137176,0.00509715627437197,0.0649820889159486,0.0849629415114867,9.10321255071417e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,PARD3,Partitioning defective 3 homolog,24445,0.0726145702600665,0.00494663067852949,0.0629191741301487,0.0823099663899843,1.40307967508414e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,PTP4A3,Protein tyrosine phosphatase type IVA 3,24229,0.0512870435133441,0.00350276355931979,0.0444216269370773,0.0581524600896109,2.44389740562432e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF2,Fibroblast growth factor 2,29434,0.0656244344044138,0.00449052241060029,0.0568230104796372,0.0744258583291903,3.37608007658956e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,NOTCH1,Neurogenic locus notch homolog protein 1,29820,0.015423958621827,0.00105556202532166,0.0133550570521965,0.0174928601914574,3.45375843693985e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,COL15A1,Collagen alpha-1(XV) chain,24938,0.025819374672691,0.00176692662427173,0.0223561984891184,0.0292825508562636,3.6946122222782e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,FMNL1,Formin-like protein 1,28774,0.0596833017690511,0.00408649940648413,0.0516737629323422,0.06769284060576,3.88301676065317e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,DDT,D-dopachrome decarboxylase,24938,0.0397300019525484,0.00272406816636708,0.0343908283464689,0.0450691755586279,5.53415887031689e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,OCLN,Occludin,24867,0.0426592346862713,0.00292990624308444,0.0369166184498258,0.0484018509227169,7.95099644489192e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,C5,Complement C5,24966,0.0147397068734968,0.00101272970714561,0.0127547566474914,0.0167246570995023,8.59556369440835e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,PYY,Peptide YY,24111,0.094205545090699,0.00649180139866184,0.0814816143493218,0.106929475832076,1.62664726462949e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL11,C-X-C motif chemokine 11,29694,0.0758767204908668,0.00524099379001704,0.0656043726624334,0.0861490683193002,2.43652014794917e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28931,0.0409583864910584,0.0028304128441443,0.0354107773165356,0.0465059956655813,2.71139867525389e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,EGFL7,Epidermal growth factor-like protein 7,28797,0.0381158751007242,0.00263733058987939,0.0329467071445606,0.0432850430568878,3.54044775650321e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,CD34,Hematopoietic progenitor cell antigen CD34,29593,0.0233555899981549,0.00161628965338153,0.0201876622775271,0.0265235177187827,3.62365125543415e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGAV,Integrin alpha-V,29725,0.0159520567738837,0.00110557125008382,0.0137851371237194,0.018118976424048,4.91957049340641e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,LONP1,"Lon protease homolog, mitochondrial",24240,0.0838434428992381,0.00581208635259075,0.0724517536481602,0.095235132150316,5.58500611195309e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24381,0.0856363817060184,0.00594185276469107,0.0739903502872239,0.0972824131248129,6.74348529615163e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,PPM1F,Protein phosphatase 1F,24922,0.0506483977756383,0.00351915106933335,0.0437508616797449,0.0575459338715317,8.92308735461927e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,CLU,Clusterin,24966,0.0305269665381647,0.00212146554440475,0.0263688940711314,0.034685039005198,9.26239397370027e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,CHAD,Chondroadherin,24381,0.0497839094914244,0.00346324589513176,0.0429959475369661,0.0565718714458826,1.15421443751124e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,ACYP1,Acylphosphatase-1,24297,0.0629881763183277,0.00438434072669921,0.0543948684939973,0.0715814841426582,1.30189386926969e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMA4,Laminin subunit alpha-4,29581,0.0319221239385146,0.00222465835393362,0.0275617935648047,0.0362824543122245,1.54460079244454e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,CEBPB,CCAAT/enhancer-binding protein beta,28916,0.0360065405396138,0.00250970356272019,0.0310875215566822,0.0409255595225454,1.60942656039969e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29561,-0.0298033296728698,0.0020829922602071,-0.0338859945028757,-0.0257206648428639,2.78796084377975e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRG2,Adhesion G-protein coupled receptor G2,29478,0.0258254440659174,0.00180597997029708,0.0222857233241351,0.0293651648076997,3.12740905753531e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA4,Annexin A4,29341,0.0685341409093583,0.00479372123574332,0.0591384472873014,0.0779298345314153,3.28429888699228e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,SNX9,Sorting nexin-9,29478,0.0649646583780084,0.00454534065871539,0.0560557906869262,0.0738735260690905,3.47457381057134e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,RASSF2,Ras association domain-containing protein 2,28797,0.0531553058759608,0.00371995662777998,0.045864190885512,0.0604464208664096,3.67554183136728e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,VCAM1,Vascular cell adhesion protein 1,29545,-0.0259859160050504,0.00181959080219753,-0.0295523139773575,-0.0224195180327432,4.08430472194364e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28916,0.0838949890621314,0.00587711495637324,0.0723758437476398,0.0954141343766229,4.50399658310824e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK7,Kallikrein-7,23801,0.0373195250233027,0.00261509301108954,0.0321939427215672,0.0424451073250382,5.15297421084723e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,CPA1,Carboxypeptidase A1,29820,0.0576700716330529,0.00404622192928788,0.0497394766516487,0.0656006666144572,6.09716282039989e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,29218,0.0533025749006487,0.00374333966441724,0.045965629158391,0.0606395206429065,7.44113873478197e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,PRG2,Bone marrow proteoglycan,24938,-0.0492786457011691,0.00345998093814258,-0.0560602083399286,-0.0424970830624097,7.55879904884204e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24867,0.0869734621972765,0.00610798997248163,0.0750018018512125,0.0989451225433405,7.91579107670722e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,ENAH,Protein enabled homolog,28931,0.045201763041139,0.00317539186045931,0.0389779949946387,0.0514255310876393,7.93661693837523e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,AMIGO2,Amphoterin-induced protein 2,29349,0.0217616768706274,0.00152950017880772,0.0187638565201643,0.0247594972210905,8.7285107517464e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB1,Integrin beta-1,29474,0.0205869422634443,0.00144699777936695,0.0177508266158851,0.0234230579110035,8.79231124649582e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,CD84,SLAM family member 5,29434,0.0295297370987652,0.0020808315292793,0.0254513073013778,0.0336081668961526,1.46635222443561e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,OPLAH,5-oxoprolinase,24240,0.0650215221614378,0.0045814534601973,0.0560418733794511,0.0740011709434245,1.55619055048362e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,ATG4A,Cysteine protease ATG4A,28797,0.0555746668517171,0.00391941411449717,0.0478926151873027,0.0632567185161316,1.75081131308886e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,KLRD1,Natural killer cells antigen CD94,29786,0.0437626617254291,0.00308798058916139,0.0377102197706728,0.0498151036801854,1.92137651332782e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,CPXM1,Probable carboxypeptidase X1,29566,0.0647587182127283,0.0045697609572572,0.0558019867365042,0.0737154496889524,1.94805405384555e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB6,Integrin beta-6,28931,0.028676830931012,0.00202579055992364,0.0247062814335617,0.0326473804284624,2.43547356066705e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,PECAM1,Platelet endothelial cell adhesion molecule,29443,0.0282687124282991,0.00200308113239341,0.0243426734088081,0.0321947514477902,4.45659596889851e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,PALM,Paralemmin-1,24657,0.0281543875423693,0.00199660974951008,0.0242410324333296,0.0320677426514091,5.59470011315713e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,FXN,"Frataxin, mitochondrial",29725,0.0687474395682582,0.00488055656963262,0.0591815486917783,0.0783133304447381,6.46257347600393e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,PRSS27,Serine protease 27,29395,0.0377692979683951,0.00268158167041239,0.0325133978943868,0.0430251980424034,6.60396965299028e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,HRG,Histidine-rich glycoprotein,24833,0.029543828074318,0.00209755384738093,0.0254326225334514,0.0336550336151847,7.00490856068473e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,C1RL,Complement C1r subcomponent-like protein,24925,0.0183196405600542,0.00130364644349928,0.0157644935307956,0.0208747875893128,1.10010182741249e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,FUT8,"Alpha-(1,6)-fucosyltransferase",29218,0.0544820009308514,0.00388083139057038,0.0468755714053335,0.0620884304563693,1.26153072302004e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJC21,DnaJ homolog subfamily C member 21,24845,0.0359659832405002,0.00256277738653079,0.0309429395628998,0.0409890269181005,1.42974974688491e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGAP1,Rho GTPase-activating protein 1,28797,0.0430084827946569,0.00307476295482725,0.0369819474031955,0.0490350181861183,2.59334994336363e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,ANPEP,Aminopeptidase N,29531,0.0261451789573442,0.00186949428904878,0.0224809701508086,0.0298093877638798,2.66020868756213e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,DSCAM,Down syndrome cell adhesion molecule,24867,0.0333309995040456,0.00238570742985891,0.0286550129415221,0.038006986066569,3.43836317888396e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,TLR3,Toll-like receptor 3,29786,0.0568172836704133,0.00406857271933794,0.0488428811405109,0.0647916862003156,3.5187587790182e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSS,Cathepsin S,23389,0.0228036754222322,0.00163273399111809,0.0196035167996407,0.0260038340448236,3.75350735427309e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24381,0.0639436788145566,0.00457956953035482,0.0549677225350612,0.0729196350940521,3.88947622791402e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK2,Serine protease inhibitor Kazal-type 2,24381,0.0345622215289233,0.00247595636181384,0.0297093470597682,0.0394150959980784,4.09358925642728e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,CTRB1,Chymotrypsinogen B,29443,0.0515808008875663,0.00370501448305223,0.0443189725007839,0.0588426292743487,6.42951655385136e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,VGF,Neurosecretory protein VGF,24867,0.0282182157562012,0.00202654369001105,0.0242461901237795,0.0321902413886228,6.59379734429998e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,KLB,Beta-klotho,28774,-0.0686687087152556,0.00493570230081171,-0.0783426852248465,-0.0589947322056646,7.36457071236127e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,FGA,Fibrinogen alpha chain,24407,0.0287474911633746,0.00206608744571134,0.0246979597697804,0.0327970225569688,7.66487464883776e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,PDZD2,PDZ domain-containing protein 2,24111,0.055922889545727,0.0040256722700592,0.048032571896411,0.063813207195043,1.05069676632953e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,DARS1,"Aspartate--tRNA ligase, cytoplasmic",29163,0.0676646848177728,0.00487643902517635,0.0581068643284272,0.0772225053071185,1.22197355240478e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,ITPA,Inosine triphosphate pyrophosphatase,24111,0.0626263761759422,0.00451378218968849,0.0537793630841527,0.0714733892677316,1.33107979899717e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,TSNAX,Translin-associated protein X,24111,0.0364622749218628,0.00263298115753069,0.0313016318531026,0.0416229179906229,1.91181156146669e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,CR1,Complement receptor type 1,24903,0.0332282113190523,0.00240091926676163,0.0285224095561995,0.0379340130819051,2.12392905096103e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,CLSTN3,Calsyntenin-3,24845,0.0281606880791203,0.0020383513482407,0.0241655194365685,0.032155856721672,2.97477247268965e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,KLF4,Krueppel-like factor 4,24101,0.0366855446583515,0.00265573529400732,0.0314803034820971,0.0418907858346058,3.08075804111636e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,UNC79,Protein unc-79 homolog,24016,0.0516790460922406,0.00375405884973743,0.0443210907467553,0.059037001437726,5.93063302904439e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,FRZB,Secreted frizzled-related protein 3,29123,0.0236108882863528,0.00171681882772266,0.0202459233840164,0.0269758531886892,6.68401707554508e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,TCL1A,T-cell leukemia/lymphoma protein 1A,29194,0.0898485266352951,0.00653491367945881,0.0770400958235559,0.102656957447034,7.02686422011496e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,PON3,Serum paraoxonase/lactonase 3,29581,-0.0258415078788245,0.00188595340574186,-0.0295379765540786,-0.0221450392035705,1.33142981589704e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23721,0.0453392684045368,0.00330797060036789,0.0388556460278158,0.0518228907812579,1.35754184998671e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24938,0.0570627377799441,0.00416774454076769,0.0488939584800395,0.0652315170798488,1.6264522208273e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,ASAH1,Acid ceramidase,24732,0.0425575227363162,0.00311006235183361,0.0364618005267223,0.04865324494591,1.8120819927997e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,DCTN6,Dynactin subunit 6,28774,0.0647940606642237,0.00475193347274435,0.0554802710576448,0.0741078502708027,3.34158982207632e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,GGH,Gamma-glutamyl hydrolase,28984,0.0309495948000641,0.00227090755586854,0.0264986159905617,0.0354005736095664,3.64639742797662e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRC,Receptor-type tyrosine-protein phosphatase C,24938,0.0207403585062503,0.00152211600878932,0.0177570111290232,0.0237237058834774,3.97199435708228e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,WAS,Wiskott-Aldrich syndrome protein,28931,0.060710522500611,0.00446104303290627,0.0519668781561147,0.0694541668451073,4.76920302746793e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,NBN,Nibrin,28931,0.04756217968377,0.00349547618122628,0.0407110463685665,0.0544133129989735,4.91805296478528e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,ARAF,Serine/threonine-protein kinase A-Raf,24445,0.0614909592882779,0.00451856065914444,0.0526345803963548,0.070347338180201,5.07177493137753e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,SIT1,Signaling threshold-regulating transmembrane adapter 1,28931,0.0499543522858192,0.00367464041429782,0.0427520570737955,0.0571566474978429,5.82286400854147e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,SH3BP1,SH3 domain-binding protein 1,24805,0.0434204481358791,0.00320062938691973,0.0371472145375164,0.0496936817342418,8.95516014906413e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,TREML2,Trem-like transcript 2 protein,29443,0.0306368289227797,0.00225923565792777,0.0262087270332413,0.0350649308123181,9.14368969776892e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,GNAS,Neuroendocrine secretory protein 55,24867,0.0799196965853363,0.00590530895407769,0.068345291035344,0.0914941021353286,1.39213049017859e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,LY75,Lymphocyte antigen 75,29434,0.0350225961990256,0.0025886797993332,0.0299487837923325,0.0400964086057186,1.40191244702792e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,PAGR1,PAXIP1-associated glutamate-rich protein 1,24240,0.0393879531278884,0.00291047939100531,0.033683413521518,0.0450924927342588,1.41165234721977e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QA,Complement C1q subcomponent subunit A,29646,-0.0204549840514588,0.00151218289040359,-0.0234188625166498,-0.0174911055862678,1.44404677985644e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28931,0.0648885288627898,0.00479879557267743,0.0554828895403421,0.0742941681852376,1.55490812890278e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29694,-0.0412361351659088,0.00305112870114099,-0.0472163474201452,-0.0352559229116725,1.69170694556302e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,CLTA,Clathrin light chain A,28916,0.0423695807278258,0.00313647960832015,0.0362220806955183,0.0485170807601333,1.85842671014566e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,PQBP1,Polyglutamine-binding protein 1,28797,0.0499655150433435,0.0037118373460307,0.0426903138451234,0.0572407162415637,3.52929418803729e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,ECE1,Endothelin-converting enzyme 1,28774,0.0316556432262226,0.00235176285402515,0.0270461880323333,0.0362650984201119,3.56532151847116e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,AMOTL2,Angiomotin-like protein 2,24711,0.0434425355435427,0.00323037786257345,0.0371109949328987,0.0497740761541866,4.40590447863229e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,24111,0.0251469276606826,0.00187391705565949,0.02147405023159,0.0288198050897752,6.52570339601705e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,THBD,Thrombomodulin,29478,0.0255978175085585,0.00190886974785834,0.0218564328027562,0.0293392022143609,6.97166645783747e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC27A4,Long-chain fatty acid transport protein 4,28774,0.059894974652277,0.00447838545054212,0.0511173391692145,0.0686726101353396,1.13174605024145e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,BOLA2_BOLA2B,BolA-like protein 2,24240,0.0486722361866153,0.00364799893635057,0.0415221582713681,0.0558223141018624,1.82834240366775e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17D,Interleukin-17D,28931,0.0303293357992593,0.00227667844344836,0.0258670460501005,0.0347916255484181,2.27597402654073e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,CGA,Glycoprotein hormones alpha chain,29443,0.0711555880104335,0.00534409192619472,0.0606811678350918,0.0816300081857751,2.48423418335166e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24445,0.0772329528599905,0.00581460302414716,0.0658363309326621,0.0886295747873189,4.0254133843019e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,EPPK1,Epiplakin,24240,0.0653533080538203,0.00492582422837017,0.0556986925662148,0.0750079235414259,4.93035705429802e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,ING1,Inhibitor of growth protein 1,28719,0.040570927872057,0.00306467861412683,0.0345641577883684,0.0465776979557456,6.90962499849084e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28797,0.0526136024395514,0.00398078158055675,0.0448112705416602,0.0604159343374426,9.154176369738e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA6,Corticosteroid-binding globulin,24966,0.014886564080513,0.00112669277144595,0.0126782462484789,0.017094881912547,1.00897978624596e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP8,Caspase-8,29632,0.0540837119640904,0.00409867550776486,0.0460503079688713,0.0621171159593095,1.20668126925157e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,AMOT,Angiomotin,24381,0.0355430994301006,0.00269321196489321,0.0302644039789099,0.0408217948812913,1.24411598030656e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRL1,Fc receptor-like protein 1,29478,0.0398936006404967,0.00302604696062231,0.033962548597677,0.0458246526833164,1.41560261286722e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,CPB1,Carboxypeptidase B,29820,0.0517453198280455,0.00393043751290279,0.044041662302756,0.0594489773533349,1.79197494229277e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,CRIM1,Cysteine-rich motor neuron 1 protein,29581,-0.0179386552386479,0.00136371077977884,-0.0206115283670145,-0.0152657821102814,2.07491525905407e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINI1,Neuroserpin,24329,0.0269166881361763,0.00204627277905079,0.0229059934892367,0.0309273827831158,2.20019433492441e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,TNF,Tumor necrosis factor,28868,0.0335009367282794,0.00254914384359382,0.0285046147948355,0.0384972586617233,2.45314085237808e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29349,0.0607210851808051,0.00462180802403949,0.0516623414536877,0.0697798289079225,2.57737864879106e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,LGMN,Legumain,29581,0.0312886975849284,0.00238644147116613,0.0266112723014427,0.035966122868414,3.66235288027593e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,STK4,Serine/threonine-protein kinase 4,29478,0.0753969378200893,0.00576291531305779,0.064101623806496,0.0866922518336826,5.2824959287883e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,PPL,Periplakin,24229,0.0286166988337347,0.00218847427737722,0.0243272892500753,0.032906108417394,6.11207903710249e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,SOD1,Superoxide dismutase [Cu-Zn],28826,0.0420013561290464,0.00321415532547506,0.0357016116911153,0.0483011005669775,6.50621622569211e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRG1,Adhesion G-protein coupled receptor G1,29349,-0.0599130901333118,0.00460437851996609,-0.0689376720324453,-0.0508885082341783,1.33418778789488e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29349,-0.0170953369947651,0.00131722712031074,-0.0196771021505742,-0.0145135718389561,2.07343184599364e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,TFPI2,Tissue factor pathway inhibitor 2,29473,0.0337296798896247,0.00260166145992663,0.0286304234281685,0.0388289363510809,2.47122062163087e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,IMMT,MICOS complex subunit MIC60,24793,0.0384827222726828,0.00297097656170349,0.032659608211744,0.0443058363336217,3.01230784857387e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,COX6B1,Cytochrome c oxidase subunit 6B1,24922,0.0279298384799868,0.00215952344445359,0.0236971725288577,0.0321625044311158,3.87323974458605e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMB1,Laminin subunit beta-1,24240,0.0262691904100284,0.00203290622366211,0.0222846942116506,0.0302536866084061,4.52018297074188e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,CD83,CD83 antigen,29434,0.0292348162026493,0.00226563439828952,0.0247941727820019,0.0336754596232968,5.44782635170996e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,SF3B4,Splicing factor 3B subunit 4,29349,0.0625752483420189,0.00485766589800973,0.0530542231819199,0.072096273502118,7.22481379425456e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,CALB2,Calretinin,28774,0.0262182240434032,0.00203561873492692,0.0222284113229464,0.03020803676386,7.45033053598312e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,CD46,Membrane cofactor protein,29331,0.0245744933289386,0.00190922808510032,0.020832406282142,0.0283165803757352,8.25349511067168e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,ACP6,Lysophosphatidic acid phosphatase type 6,29674,0.0571783476156488,0.00445105797146489,0.0484542739915776,0.06590242123972,1.14142835973421e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,TREML1,Trem-like transcript 1 protein,24951,0.0452976533615858,0.00352700545404306,0.0383847226716614,0.0522105840515102,1.23791107993717e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS3BP,Galectin-3-binding protein,24966,0.0260633387144179,0.00202983828665137,0.0220848556725813,0.0300418217562546,1.28604906509147e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,TSPYL1,Testis-specific Y-encoded-like protein 1,24229,0.0345577846742484,0.00271066545243553,0.0292448803874748,0.0398706889610221,4.16622424880053e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,MAGED1,Melanoma-associated antigen D1,28797,0.0409702944313978,0.00322313969740981,0.0346529406244746,0.047287648238321,6.43276749667571e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,CPXM2,Inactive carboxypeptidase-like protein X2,24922,0.0214733690685926,0.001690136238287,0.0181607020415501,0.0247860360956351,7.20983344661712e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,STX16,Syntaxin-16,28797,0.0491570362811755,0.00387031313929745,0.0415712225281525,0.0567428500341985,7.3281195805237e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,CHRDL1,Chordin-like protein 1,29536,0.0265860707963969,0.00209889324103348,0.0224722400439713,0.0306999015488225,1.12671277210928e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,GDNF,Glial cell line-derived neurotrophic factor,28774,0.0323345637762945,0.00255265538813397,0.0273313592155519,0.037337768337037,1.12866946728321e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINT2,Kunitz-type protease inhibitor 2,29581,0.0344107012276392,0.00271682368191485,0.0290857268110861,0.0397356756441923,1.13963069213589e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,DMD,Dystrophin,24240,0.0436940279747581,0.00345388150815872,0.036924420218767,0.0504636357307492,1.44730431405083e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,C7orf50,Uncharacterized protein C7orf50,24845,0.0188490717915717,0.00149049498320941,0.0159277016244813,0.0217704419586621,1.52256224601083e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24922,0.0254324517953238,0.00201220946480775,0.0214885212443006,0.0293763823463469,1.66450035969939e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,ROBO1,Roundabout homolog 1,29497,0.0202095408278794,0.0016049781726852,0.0170637836094164,0.0233552980463424,2.90538077447378e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA9,Serpin A9,29227,0.060658529981039,0.004823537180987,0.0512043971063045,0.0701126628557735,3.57255731185157e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,PEPD,Xaa-Pro dipeptidase,24951,0.0219904987413525,0.00175064630858832,0.0185592319765194,0.0254217655061856,4.42919244869419e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,NID2,Nidogen-2,29443,0.0613172722966219,0.00488374363266472,0.0517451347765991,0.0708894098166448,4.59543904713153e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28797,0.0396671565054868,0.00315964676793356,0.033474248840337,0.0458600641706366,4.68059088052114e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24805,0.0359477022940345,0.00286310262209228,0.0303360211547337,0.0415593834333354,4.77409350189832e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,CELA3A,Chymotrypsin-like elastase family member 3A,29789,0.0480806588022037,0.00383612383867502,0.0405618560784006,0.0555994615260067,6.02197394842257e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29725,0.0215712657693764,0.00172559114375882,0.0181891071276091,0.0249534244111437,9.09375112888553e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,ALCAM,CD166 antigen,29820,0.0162979617570975,0.00130422552330685,0.013741679731416,0.0188542437827789,9.61675899892339e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,PTN,Pleiotrophin,28916,0.0416426322358071,0.00333619221059674,0.0351036955030374,0.0481815689685767,1.15576260129619e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,24229,0.0372535194450236,0.00298677538414473,0.0313994396920999,0.0431075991979472,1.3514159370782e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,C8B,Complement component C8 beta chain,24966,0.0253573160838086,0.00203401036276075,0.0213706557727975,0.0293439763948196,1.44859252901252e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,TCOF1,Treacle protein,24922,0.0260668534346222,0.00209115213052345,0.0219681952587962,0.0301655116104481,1.47387087234259e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,SCARB2,Lysosome membrane protein 2,28762,0.0263963690591577,0.0021198665093076,0.0222414307009148,0.0305513074174006,1.68629417737691e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPTL1,Angiopoietin-related protein 1,29030,0.0242097680021987,0.00194478636634243,0.0203979867241675,0.0280215492802299,1.75483776122632e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24845,0.0396444641452162,0.00319028346729585,0.0333915085493163,0.045897419741116,2.38719080291812e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,PKD1,Polycystin-1,24922,0.0220595956770295,0.00177619725941422,0.0185782490485776,0.0255409423054813,2.6042333872485e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,24195,0.0446713767237866,0.00359700610930343,0.0376212447495519,0.0517215086980213,2.6400841131852e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,ARSA,Arylsulfatase A,29443,0.0369332193239361,0.0029835670593564,0.0310854278875976,0.0427810107602747,4.15914276911764e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,TPMT,Thiopurine S-methyltransferase,28797,0.0600392831572529,0.00485166402658759,0.0505300216651412,0.0695485446493646,4.38435683732493e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMP1,Metalloproteinase inhibitor 1,29173,0.0233847868957001,0.00189244332674737,0.0196755979752753,0.0270939758161249,5.46842385936993e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,IL10RB,Interleukin-10 receptor subunit beta,29581,0.0238961398792314,0.00193434490911251,0.0201048238573709,0.0276874559010919,5.68190712341067e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,TSHB,Thyrotropin subunit beta,29478,0.0633357064532191,0.00512702565255645,0.0532867361742085,0.0733846767322297,5.70730670668048e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,RGMB,RGM domain family member B,29694,0.0221632691172097,0.00179477384725214,0.0186455123765955,0.0256810258578239,6.02693428822616e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24845,0.0656513655215259,0.00532177100793107,0.055220694345981,0.0760820366970708,7.29995154336724e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,NPHS1,Nephrin,24229,0.0281319714181295,0.00228156570649699,0.0236601026333954,0.0326038402028636,7.93303340456762e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,ERI1,3'-5' exoribonuclease 1,24445,0.0279554424272422,0.00226732863642263,0.0235114782998539,0.0323994065546306,7.95873100621656e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,EFCAB2,Dynein regulatory complex protein 8,24445,0.0288177051912277,0.0023375853258053,0.0242360379526493,0.033399372429806,8.12760287518802e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,IDS,Iduronate 2-sulfatase,29786,0.00730088292835613,0.000592608116543099,0.00613937101993166,0.00846239483678061,8.60319430427682e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,PODXL,Podocalyxin,29349,0.012452102919392,0.00101108898717372,0.0104703685045315,0.0144338373342525,9.10724474112415e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC4A,C-type lectin domain family 4 member A,29434,-0.0286724490189467,0.00233008393611372,-0.0332394135337296,-0.0241054845041638,1.03225062519791e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,EPCAM,Epithelial cell adhesion molecule,29457,-0.0792275420632577,0.00645767031961651,-0.0918845758897061,-0.0665705082368094,1.61876883893901e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24805,0.084714796723759,0.0069079499964587,0.0711752147307,0.0982543787168181,1.79303066288435e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,IL5RA,Interleukin-5 receptor subunit alpha,29434,-0.0457672346591193,0.00374310342372666,-0.0531037173696236,-0.0384307519486151,2.69906899296846e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,24229,0.0365454012483827,0.00299037217498235,0.0306842717854173,0.0424065307113481,3.02859051644121e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,HPCAL1,Hippocalcin-like protein 1,29786,0.0597017071952045,0.00488837033883146,0.0501205013310948,0.0692829130593141,3.19922446891693e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,SCRIB,Protein scribble homolog,24240,0.0737892152144227,0.00604696240828635,0.0619371688941814,0.0856412615346639,3.788370038176e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,PMM2,Phosphomannomutase 2,24111,0.0490442570941783,0.00402532361861065,0.0411546228017014,0.0569338913866551,4.76857508348226e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,NGRN,Neugrin,24845,0.0179847868493517,0.00148127780186709,0.0150814823576922,0.0208880913410112,7.94769223094869e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24867,0.0542544902803162,0.00448150238537897,0.0454707456049734,0.063038234955659,1.21626000995069e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,ADA,Adenosine deaminase,29786,0.0280407719425547,0.00231922173491778,0.0234950973421159,0.0325864465429936,1.41964721713723e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,CCN4,CCN family member 4,29725,0.032218185482927,0.00267112455104032,0.026982781362888,0.0374535896029661,2.01557133388376e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,SNRPB2,U2 small nuclear ribonucleoprotein B'',24845,0.0336113892019422,0.0027870762153119,0.0281487198199309,0.0390740585839536,2.13692987768606e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,TREH,Trehalase,24938,0.0603424560576154,0.0050058181262523,0.0505310525301609,0.0701538595850699,2.27534302573633e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,ZHX2,Zinc fingers and homeoboxes protein 2,24845,0.025616884803425,0.00212526710284424,0.0214513612818503,0.0297824083249997,2.30409915244976e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,C7,Complement component C7,24374,-0.0262040357810581,0.00217469346710193,-0.0304664349765779,-0.0219416365855383,2.42679557401909e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,BRDT,Bromodomain testis-specific protein,24111,0.0296973682299378,0.00246779222791036,0.0248604954632335,0.0345342409966421,2.93386918833982e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,ESAM,Endothelial cell-selective adhesion molecule,29820,0.0255280882352,0.00212223419301904,0.0213685092168827,0.0296876672535173,2.99203940267337e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,DKK4,Dickkopf-related protein 4,29169,0.0367491204061161,0.00306010337608737,0.0307513177889848,0.0427469230232473,3.81097381675289e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,SPAG1,Sperm-associated antigen 1,24867,0.0464453124404811,0.00386826281710805,0.0388635173189493,0.0540271075620129,4.04381931130726e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,RELT,Tumor necrosis factor receptor superfamily member 19L,29443,0.0229111034862856,0.00191237970723395,0.0191628392601071,0.0266593677124641,5.37134946044917e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24845,0.0320221995673851,0.00267500280773111,0.0267791940642321,0.0372652050705381,6.21984802738479e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,XRCC4,DNA repair protein XRCC4,28774,0.0295098978055352,0.00246967350710741,0.0246693377316046,0.0343504578794657,7.86869291924424e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,VIT,Vitrin,24922,0.0300480100369828,0.00251708226973886,0.0251145287882946,0.0349814912856709,9.25585782628212e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,ENTR1,Endosome-associated-trafficking regulator 1,24240,0.0473116980137186,0.00396352983650343,0.0395431795341719,0.0550802164932653,9.40751368693828e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,PER3,Period circadian protein homolog 3,24229,0.0957892192448351,0.00803429508943259,0.0800420008695472,0.111536437620123,1.11493438531847e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,24178,0.0221332363651611,0.00185706371273206,0.0184933914882062,0.0257730812421159,1.1718812535382e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,BPIFA2,BPI fold-containing family A member 2,23405,-0.0882920615035891,0.00741578730771066,-0.102827004626702,-0.0737571183804762,1.36879423787534e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,FBP1,"Fructose-1,6-bisphosphatase 1",29478,0.0579826548235042,0.00487833205514181,0.0484211239954262,0.0675441856515821,1.66569404801564e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29594,0.0333145130969494,0.00280553814857174,0.0278156583257488,0.03881336786815,1.90204382820278e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,CD14,Monocyte differentiation antigen CD14,28954,0.0327868529828028,0.00276181351552071,0.0273736984923822,0.0382000074732234,1.97995744916579e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,NEK7,Serine/threonine-protein kinase Nek7,24445,0.0594969045985834,0.00501393886991035,0.0496695844135591,0.0693242247836077,2.17425153816913e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,MAN2B2,Epididymis-specific alpha-mannosidase,24922,0.0471501008134154,0.00397647423011736,0.0393562113223854,0.0549439903044454,2.41118354643752e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,SCG2,Secretogranin-2,29559,0.0257511043391631,0.00217300339323173,0.0214920176884289,0.0300101909898973,2.53324024365672e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,KIF22,Kinesin-like protein KIF22,24111,0.0975459093761562,0.00822961295737194,0.0814158679797072,0.113675950772605,2.55229698515801e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL19,C-C motif chemokine 19,29694,0.0969769417613362,0.00819050128955431,0.0809235592338098,0.113030324288863,2.86039784332997e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,FASLG,Tumor necrosis factor ligand superfamily member 6,29786,0.0289430107199028,0.00244889922483522,0.0241431682392257,0.0337428532005798,3.68416133448854e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,TPP1,Tripeptidyl-peptidase 1,29286,0.0360892569993096,0.0030579886256871,0.0300955992929629,0.0420829147056563,4.52624891645734e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,BOLA1,BolA-like protein 1,24101,0.0431274091382381,0.00365343340526609,0.0359666796639166,0.0502881386125597,4.52877959339824e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29478,0.038520482415722,0.00326636300843881,0.0321184109191819,0.0449225539122621,5.00245058449213e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,SLIT2,Slit homolog 2 protein,28774,0.0408810215961902,0.00347087791166967,0.0340781008893176,0.0476839423030628,5.9812990117971e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,INSR,Insulin receptor,24229,0.0133852946327553,0.00113696629965502,0.0111568406854315,0.0156137485800792,6.5855002967004e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,NAA10,N-alpha-acetyltransferase 10,24111,0.0400582194577504,0.00341036499572717,0.0333739040661251,0.0467425348493756,9.0373966531482e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,DENR,Density-regulated protein,24229,0.0450846380177257,0.00384578644749353,0.0375468965806384,0.052622379454813,1.18161142319843e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,PDIA3,Protein disulfide-isomerase A3,24381,0.0196046328888074,0.00167767741992557,0.0163163851457533,0.0228928806318615,1.83271098981041e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,IDO1,"Indoleamine 2,3-dioxygenase 1",24240,0.0499975901452168,0.00427971229880726,0.0416093540395546,0.058385826250879,1.90286816065231e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29820,0.0180197004416069,0.00154350788276313,0.0149944249913912,0.0210449758918226,2.01421813945765e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,LRG1,Leucine-rich alpha-2-glycoprotein,24966,-0.020312492125118,0.00174233724217626,-0.0237274731197835,-0.0168975111304526,2.51324372356928e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29566,-0.0270921420208432,0.00232486497088462,-0.0316488773637771,-0.0225354066779094,2.58747011073949e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,ACOT13,Acyl-coenzyme A thioesterase 13,24805,0.0884269969113738,0.00760390426350061,0.0735233445549126,0.103330649267835,3.53035141280824e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMP3,Lysosome-associated membrane glycoprotein 3,29760,0.0397007587348622,0.0034231231927268,0.0329914372771177,0.0464100801926067,4.93026384705233e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,CD86,T-lymphocyte activation antigen CD86,24805,0.0232045639546943,0.00200290108015348,0.0192788778375935,0.0271302500717952,5.86707745795791e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,FOLR2,Folate receptor beta,29694,-0.0225879335102136,0.00195241971595039,-0.0264146761534764,-0.0187611908669509,6.8768653152542e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29478,0.0487956693653777,0.00422329257250197,0.0405180159232738,0.0570733228074815,8.21697025790519e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL25,C-C motif chemokine 25,29786,0.0377496723704781,0.00327648868695397,0.0313277545440483,0.0441715901969079,1.1957790813908e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29349,0.0436809013275504,0.00379179451000333,0.0362489840879439,0.0511128185671569,1.21982994590264e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24867,0.0509829256307522,0.00442602660333176,0.042307913488222,0.0596579377732825,1.26750142999219e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK6,Kallikrein-6,29519,0.0235058140862311,0.00204189765440265,0.0195036946836019,0.0275079334888603,1.33828434754834e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,TEK,Angiopoietin-1 receptor,29566,0.0167310525398228,0.00145662372713405,0.01387607003464,0.0195860350450055,1.796718616527e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29443,0.0275200254850025,0.00239788760136783,0.0228201657863216,0.0322198851836835,2.00356056756628e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,NCAN,Neurocan core protein,29694,0.0285466672029498,0.00249186252794173,0.023662616648184,0.0334307177577155,2.54252854503927e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",24240,0.0701177668452186,0.00611974265678949,0.0581230712379112,0.082112462452526,2.57756214466748e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29443,0.0290979216478506,0.00255072025192522,0.0240985099540772,0.034097333341624,4.42578275470514e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,PSAP,Prosaposin,24761,0.021689521041381,0.00190116737661051,0.0179632329832244,0.0254158090995376,4.50755340126792e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,PTGES2,Prostaglandin E synthase 2,24037,0.0419551151992965,0.00368768839470056,0.0347272459456833,0.0491829844529096,6.48859481512082e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,CD276,CD276 antigen,29454,-0.0272562564626307,0.00239667537724105,-0.0319537402020231,-0.0225587727232382,6.6167113220827e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29536,0.0386378205390176,0.00340099201791627,0.0319718761839017,0.0453037648941335,7.56476442548681e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,PVALB,Parvalbumin alpha,29599,0.0849209137454216,0.00748306135335376,0.0702541134928482,0.0995877139979949,8.70304815019056e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,MDK,Midkine,29455,0.0384572008303591,0.00338909865732459,0.0318145674620029,0.0450998341987153,8.81829013803996e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24805,-0.0259867771443508,0.0022902043952451,-0.0304755777590312,-0.0214979765296705,9.09764523816944e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,FCN1,Ficolin-1,24919,0.0425101203937894,0.00374644123581407,0.0351670955715939,0.049853145215985,9.1035183137424e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28719,0.0362538494496763,0.00319858740285427,0.0299846181400819,0.0425230807592707,1.02603485079683e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,INSL3,Insulin-like 3,24845,0.0571730677119373,0.00504836656088628,0.0472782692526002,0.0670678661712744,1.16602680545175e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,NXPH3,Neurexophilin-3,24229,0.0229304077024237,0.0020270732900948,0.0189573440538379,0.0269034713510095,1.35688134165639e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",24240,0.0249526980104008,0.00220830059616159,0.020624428841924,0.0292809671788775,1.56457166693971e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,IL31RA,Interleukin-31 receptor subunit alpha,24134,0.0299312039618003,0.00264958969380808,0.0247380081619365,0.0351243997616642,1.61910588329753e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTSL4,ADAMTS-like protein 4,24240,0.0181463919068272,0.00160678991644531,0.0149970836705944,0.02129570014306,1.67331913456878e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,OXT,Oxytocin-neurophysin 1,29694,0.104483146739411,0.00926182305345275,0.0863299735546436,0.122636319924178,1.86897325599378e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP6,Gastrotropin,28872,0.0423418059420319,0.0037540286102504,0.0349839098659412,0.0496997020181227,1.91981932939609e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,HGFAC,Hepatocyte growth factor activator,24720,0.0211756374990146,0.00187811582003927,0.0174945304917376,0.0248567445062916,2.05916676111904e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP9,Caspase-9,24229,0.0474834904312415,0.00421759777332224,0.03921699879553,0.0557499820669531,2.4897800194136e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,DCTN2,Dynactin subunit 2,29349,0.0707834216470019,0.00628973770588386,0.0584555357434695,0.0831113075505343,2.54776614479802e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA2,Annexin A2,23907,0.0533902116138998,0.00474845087787999,0.044083247893255,0.0626971753345446,2.94571899951351e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,24229,0.0448759321540524,0.00399209393235107,0.0370514280466443,0.0527004362614606,3.02345642766196e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,CSNK1D,Casein kinase I isoform delta,24229,0.0480719166591649,0.00427841728256806,0.0396862187853315,0.0564576145329983,3.20915680077815e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,24230,0.0292279058773383,0.00260338673181292,0.024125267882985,0.0343305438716917,3.55272905214414e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,ABCA2,ATP-binding cassette sub-family A member 2,24111,0.0273885342287989,0.00244395832103366,0.0225983759195729,0.0321786925380248,4.46492481803986e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,AREG,Amphiregulin,29349,-0.0341279555798734,0.0030482137174954,-0.0401024544661644,-0.0281534566935824,4.88255240003787e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,FLT3LG,Fms-related tyrosine kinase 3 ligand,29786,0.0252984001227425,0.00226409380585192,0.0208607762632727,0.0297360239822122,6.25959193460018e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,GIP,Gastric inhibitory polypeptide,24240,0.0382063700543122,0.00342066291502725,0.0315018707408588,0.0449108693677656,6.78193239269908e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP6V1F,V-type proton ATPase subunit F,28719,0.0493326980027836,0.00442239146686602,0.0406648107277262,0.058000585277841,7.74217237369221e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24867,0.0436648605338718,0.00392941049754416,0.0359632159586852,0.0513665051090583,1.27651403699946e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,PVR,Poliovirus receptor,29694,0.0273651057517463,0.002468256856399,0.0225273223132042,0.0322028891902883,1.65384479348285e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24867,0.0351354154756136,0.00317526326500498,0.0289118994762039,0.0413589314750234,2.15218961725214e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,CD200R1,Cell surface glycoprotein CD200 receptor 1,29341,0.0257153571510262,0.00232626438660297,0.0211558789532844,0.0302748353487681,2.37584055138309e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,HSPB6,Heat shock protein beta-6,29725,0.028269431769469,0.00256233289632372,0.0232472592926745,0.0332916042462635,3.01585272981691e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,SCT,Secretin,24195,0.0346223359729674,0.00313985056159736,0.0284682288722366,0.0407764430736982,3.31504547636178e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,ACVRL1,Serine/threonine-protein kinase receptor R3,29169,0.0182623440744653,0.0016614872296028,0.0150058291044438,0.0215188590444868,4.76348800838458e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL20,C-C motif chemokine 20,29786,0.0642859398622101,0.00584994608011649,0.0528200455451817,0.0757518341792384,4.87925766648051e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,24111,0.0487310281513509,0.00443622192877245,0.0400360331709569,0.0574260231317449,5.27005871805461e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,IL12A_IL12B,Interleukin-12,29349,0.0568612392024987,0.00517891005316704,0.0467105754982913,0.0670119029067061,5.44423480956278e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSE,Cathepsin E,24381,0.0383574904485772,0.0034963357299662,0.0315046724178435,0.045210308479311,6.14059228278106e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,LBP,Lipopolysaccharide-binding protein,29594,-0.042643645258642,0.00389172969242715,-0.0502714354557992,-0.0350158550614848,6.92045599045623e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,29218,0.0259933848510086,0.00237324763415084,0.021341819488073,0.0306449502139443,7.3104620535154e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,IL6ST,Interleukin-6 receptor subunit beta,29478,0.0128712988342515,0.00117554514567386,0.0105672303487307,0.0151753673197723,7.58456675777652e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,DAPK2,Death-associated protein kinase 2,24229,0.0393467185873849,0.0035937217470363,0.0323030239631937,0.046390413211576,7.83098257574167e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24805,0.0861741247499328,0.00788360263578263,0.0707222635837989,0.101625985916067,9.50151992789163e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,SLITRK2,SLIT and NTRK-like protein 2,29725,0.0285103774972778,0.00260932259010789,0.0233961052206664,0.0336246497738893,9.73985362580766e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,DGKZ,Diacylglycerol kinase zeta,28931,0.0258670292447642,0.0023685591929359,0.0212246532266098,0.0305094052629185,1.03634725071746e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,STX6,Syntaxin-6,28797,0.0489882048269297,0.00448672268244284,0.0401942283693418,0.0577821812845177,1.0659361936685e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,GRN,Progranulin,29313,0.0179633721903622,0.00164531487065887,0.0147385550438709,0.0211881893368536,1.07049302419135e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHB4,Ephrin type-B receptor 4,29820,-0.0181652570160224,0.00166415203316216,-0.0214269950010203,-0.0149035190310246,1.09517892174863e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,MTUS1,Microtubule-associated tumor suppressor 1,24445,0.0409519827536363,0.00375604588208672,0.0335901328247463,0.0483138326825263,1.2919034023297e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,XG,Glycoprotein Xg,29693,0.023391034620336,0.00214770030003357,0.0191815420322702,0.0276005272084018,1.4316951028504e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,DHPS,Deoxyhypusine synthase,24793,0.0296215767841467,0.00272452457353193,0.0242815086200241,0.0349616449482693,1.80404772974628e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,APOB,Apolipoprotein B-100,24951,0.016373023133464,0.00150616426707396,0.0134209411699991,0.019325105096929,1.83265337329481e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,COL2A1,Collagen alpha-1(II) chain,24240,0.0586556844438316,0.00540060386439223,0.0480705008696228,0.0692408680180403,2.04615964264027e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,PTGR1,Prostaglandin reductase 1,24922,0.0592636921807772,0.00545805459611472,0.0485659051723924,0.0699614791891621,2.10404965917896e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFB103A_DEFB103B,Beta-defensin 103,24109,0.0300017772404447,0.00276649457497995,0.024579447873484,0.0354241066074054,2.44443849067034e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,NADK,NAD kinase,29478,0.0390268002699249,0.0036037351143535,0.031963479445792,0.0460901210940578,2.80740946307356e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,HDGF,Hepatoma-derived growth factor,29688,0.0674435011560311,0.00623406027099082,0.0552247430248892,0.0796622592871731,3.16108500520318e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,ECI2,Enoyl-CoA delta isomerase 2,24111,0.0446686423120739,0.00413764742416537,0.0365588533607098,0.052778431263438,4.16273227031046e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",29163,0.0690583585567086,0.00641040388408074,0.0564939669439103,0.0816227501695068,5.19923877943565e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,ERMAP,Erythroid membrane-associated protein,24229,0.0322127390665997,0.00299190178086344,0.0263486115761074,0.038076866557092,5.69433147473016e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,GLRX,Glutaredoxin-1,29291,0.0401803436164548,0.00373931864722381,0.0328512790678961,0.0475094081650135,6.99446480113487e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,SMS,Spermine synthase,24101,0.0459828904835649,0.00428133677372987,0.0375914704070543,0.0543743105600754,7.57170117960586e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,CHCHD6,MICOS complex subunit MIC25,24793,0.0207863720108513,0.0019394603474349,0.0169850297298789,0.0245877142918237,9.63178639208612e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,DSC2,Desmocollin-2,29135,-0.0245336966837207,0.00229331251220474,-0.029028589207642,-0.0200388041597994,1.16656749283327e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,RPE,Ribulose-phosphate 3-epimerase,24445,0.0505281470490132,0.00472246588478516,0.0412721139148343,0.0597841801831921,1.17205551424122e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX58,Antiviral innate immune response receptor RIG-I,28797,0.0405583107263281,0.00379536144052564,0.0331194023028979,0.0479972191497584,1.32378462932404e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,XCL1,Lymphotactin,29725,0.0394803875735697,0.00369799741975909,0.0322323126308419,0.0467284625162975,1.47055184006276e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A13,Protein S100-A13,24229,0.0251557604831765,0.00235594925539126,0.0205380999426096,0.0297734210237433,1.48556463904105e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,SFRP4,Secreted frizzled-related protein 4,24381,0.0295481517293927,0.00276907842538911,0.0241207580156301,0.0349755454431554,1.59641716980521e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,CD101,Immunoglobulin superfamily member 2,24805,0.030561334386086,0.00286591036870124,0.0249441500634316,0.0361785187087404,1.71691486266797e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",24240,0.0352303974201541,0.00331583715705969,0.0287313565923171,0.0417294382479911,2.60869267291015e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,PRTG,Protogenin,29725,0.0176430941438635,0.0016624378053758,0.0143847160453269,0.0209014722424001,2.89629711146022e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM3C,Protein FAM3C,29433,0.0212179094826186,0.00200053851889778,0.0172968539855789,0.0251389649796582,3.11360836488175e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,ELOB,Elongin-B,24111,0.0281345181482398,0.00265611153986915,0.0229285395300963,0.0333404967663834,3.69107111512463e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,CARHSP1,Calcium-regulated heat-stable protein 1,28774,0.0362184471525799,0.00342232274308897,0.0295106945761255,0.0429261997290343,3.99149522656574e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,APRT,Adenine phosphoribosyltransferase,29192,0.0336729563554013,0.00318694610825457,0.0274265419832224,0.0399193707275803,4.77937224114675e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA12,Serpin A12,28628,0.0787731293139833,0.00746230294619954,0.0641470155394322,0.0933992430885343,5.31221023607776e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,COMP,Cartilage oligomeric matrix protein,29214,0.0237041776249292,0.00224578944948491,0.0193024303039388,0.0281059249459196,5.36840853781244e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,MANSC1,MANSC domain-containing protein 1,29566,-0.0193987830272142,0.00183919101205919,-0.0230035974108502,-0.0157939686435781,5.8046187613777e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,AHCY,Adenosylhomocysteinase,29478,0.0474856297344073,0.00450345997742557,0.0386588481786532,0.0563124112901615,6.00673276810344e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS7_LGALS7B,Galectin-7,29320,0.0294964192124509,0.00279999439213415,0.0240084302038679,0.0349844082210338,6.66747965939504e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,SGSH,N-sulphoglucosamine sulphohydrolase,24571,0.0394744378515866,0.00374885623142739,0.0321266796379889,0.0468221960651843,7.15507993245439e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,GC,Vitamin D-binding protein,24966,0.0181887293600958,0.0017326920841299,0.0147926528752012,0.0215848058449904,1.00483779937265e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP3,Stromelysin-1,29443,-0.0343090179581742,0.00327151846559609,-0.0407211941507425,-0.0278968417656059,1.09814636899021e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,AK1,Adenylate kinase isoenzyme 1,29478,0.0439439545176092,0.00419229692747196,0.0357270525397642,0.0521608564954543,1.15880668740915e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,SMARCA2,Probable global transcription activator SNF2L2,28774,0.0512385535623703,0.00488820032932136,0.0416576809169004,0.0608194262078401,1.1615283232815e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,TXN,Thioredoxin,24647,0.0306604640442138,0.00293016726450599,0.0249173362057821,0.0364035918826455,1.43438084436762e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,NAP1L4,Nucleosome assembly protein 1-like 4,24764,0.0286648410579389,0.00274323657695974,0.0232880973670978,0.0340415847487799,1.66846452334937e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,EDF1,Endothelial differentiation-related factor 1,24867,0.0474922037704922,0.00455030743137263,0.0385736012050018,0.0564108063359825,1.89405585438499e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,BRK1,Protein BRICK1,28774,0.0311281544706514,0.00298664935729529,0.0252743217303526,0.0369819872109502,2.17385676743056e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,CD74,HLA class II histocompatibility antigen gamma chain,29694,0.0240783772580997,0.00231174989630131,0.0195473474613491,0.0286094070548503,2.3264449777602e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,PSG1,Pregnancy-specific beta-1-glycoprotein 1,29218,-0.0797845108032555,0.00766040746140949,-0.0947989094276181,-0.0647701121788928,2.34178553289378e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,24240,0.0294103886398648,0.00282492546456784,0.0238735347293118,0.0349472425504177,2.49741308699906e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,RBP2,Retinol-binding protein 2,29349,-0.053247752976552,0.00512881636286048,-0.0633002330477585,-0.0431952729053455,3.30866918423969e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,BCAN,Brevican core protein,29218,0.0235481498673579,0.00227036003128188,0.0190982442060454,0.0279980555286704,3.67743821622453e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,MCTS1,Malignant T-cell-amplified sequence 1,24805,0.0180690439100421,0.00174304916958299,0.0146526675376594,0.0214854202824248,3.970609342855e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL8,Interleukin-8,29218,0.0468582600452342,0.00452240195098931,0.0379943522212952,0.0557221678691733,4.10804550060641e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,VAMP5,Vesicle-associated membrane protein 5,28916,0.0373468713683459,0.00361052939549342,0.0302702337531788,0.044423508983513,4.93341282834167e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,STAM,Signal transducing adapter molecule 1,24793,0.0254630851732696,0.00246524511019105,0.0206312047572952,0.0302949655892441,5.86535625411099e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,24229,0.0248323378430363,0.00240477857492248,0.0201189718361882,0.0295457038498843,6.0407115001381e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,GPR15L,Protein GPR15L,24805,0.0420919877160084,0.00409234690687988,0.0340709877785239,0.050112987653493,9.18324321566822e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,CD302,CD302 antigen,29349,0.0209334873072236,0.00203729637790791,0.0169403864065241,0.0249265882079231,1.00467547975262e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,FES,Tyrosine-protein kinase Fes/Fps,28797,0.032512671602678,0.00316547678146186,0.0263083371110128,0.0387170060943433,1.05021458907557e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,CD300LF,CMRF35-like molecule 1,29725,0.0412945696895861,0.00402403988505097,0.0334074515148861,0.049181687864286,1.14956575441539e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,GFAP,Glial fibrillary acidic protein,28753,0.0315063964919626,0.00308555688336339,0.0254587050005704,0.0375540879833549,1.95041833434359e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,CDA,Cytidine deaminase,24890,0.0318911405409951,0.0031244058777902,0.0257673050205263,0.0380149760614639,2.05885458387214e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,LTA,Lymphotoxin-alpha,29434,0.0271983792906433,0.00267460161184319,0.0219561601314306,0.0324405984498559,2.98685729444911e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,HIP1R,Huntingtin-interacting protein 1-related protein,24788,0.029362200542549,0.00288756010832568,0.0237025827302306,0.0350218183548673,3.05815622135577e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,COL24A1,Collagen alpha-1(XXIV) chain,24805,0.0376488184011413,0.00371832137622515,0.03036090850374,0.0449367282985426,4.75604644170344e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,BSG,Basigin,29760,0.0138582990315302,0.00137004426109335,0.0111730122797872,0.0165435857832731,5.17231658494692e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,C2orf69,UPF0565 protein C2orf69,24195,0.0403630979059201,0.00398988603958339,0.0325429212683366,0.0481832745435035,5.21912773185685e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMG3,Proteasome assembly chaperone 3,29434,0.0339479570840167,0.00335981089635861,0.0273627277271539,0.0405331864408796,5.79582310986117e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,AKR7L,Aflatoxin B1 aldehyde reductase member 4,24229,0.0471098840709701,0.00466769874962682,0.0379611945217016,0.0562585736202387,6.632828781359e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,CRYM,Ketimine reductase mu-crystallin,24101,0.0514812681130287,0.0051079432152376,0.041469699411163,0.0614928368148945,7.65472635390893e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,PRDX1,Peroxiredoxin-1,28669,-0.0604242395384409,0.00602126751076255,-0.0722259238595355,-0.0486225552173462,1.16872787347813e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,GLO1,Lactoylglutathione lyase,28916,0.0387715317193246,0.00386463861692898,0.0311968400301438,0.0463462234085054,1.2007586242021e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,PRSS53,Serine protease 53,24845,0.0250675071034301,0.00249969129184955,0.020168112171405,0.0299669020354552,1.27036279820948e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,SV2A,Synaptic vesicle glycoprotein 2A,24195,0.0415540997658677,0.00414657744913694,0.0334268079655593,0.0496813915661761,1.36621326624709e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJB8,DnaJ homolog subfamily B member 8,28916,0.0384692381630158,0.0038405659034387,0.0309417289922759,0.0459967473337557,1.40861987090623e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,LACRT,Extracellular glycoprotein lacritin,24732,0.0330773590623623,0.00333138174557493,0.0265478508410354,0.0396068672836891,3.44043322367324e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,THBS4,Thrombospondin-4,29518,0.0299545235450864,0.00301744874936234,0.0240403239963362,0.0358687230938366,3.45070459531759e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK6,Serine protease inhibitor Kazal-type 6,29725,0.0356133826589827,0.00359151437490833,0.0285740144841623,0.042652750833803,3.85390576976987e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDH1,Protocadherin-1,29713,0.0140268318679633,0.00141647411292818,0.0112505426066241,0.0168031211293025,4.40259647391657e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,CPQ,Carboxypeptidase Q,24920,0.0244192567024494,0.00246719395281181,0.0195835565549383,0.0292549568499606,4.70380330337851e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24793,0.0359136372762723,0.0036296425219729,0.0287995379332054,0.0430277366193392,4.85099147781855e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,FEN1,Flap endonuclease 1,28797,0.0415389285968738,0.00420041050929078,0.0333061239986639,0.0497717331950837,5.04368206146965e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,LCP1,Plastin-2,24938,0.0313797777094063,0.0031736644310279,0.0251593954245916,0.037600159994221,5.19718330695676e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,NXPH1,Neurexophilin-1,28774,0.0251662857556994,0.00255063628035952,0.0201670386461947,0.030165532865204,6.31403741776619e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM3B,Protein FAM3B,29349,0.0234684446432957,0.0023792499587474,0.0188051147241508,0.0281317745624406,6.48596424912703e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24922,0.0222569962683873,0.00225787972940602,0.0178315519987515,0.0266824405380231,7.00718347094886e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,TPR,Nucleoprotein TPR,24111,0.0315310456358905,0.00319905157378433,0.0252609045512732,0.0378011867205078,7.10725188305674e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,CD28,T-cell-specific surface glycoprotein CD28,28797,0.0240059785041149,0.00243614630855357,0.0192311317393499,0.0287808252688799,7.15410256956387e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,TAFA5,Chemokine-like protein TAFA-5,29349,0.0238120660725567,0.00241883379175635,0.0190711518407142,0.0285529803043991,7.85927183152794e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,AFAP1,Actin filament-associated protein 1,24381,0.0553753215461981,0.00563263847060865,0.0443353501438051,0.066415292948591,9.11396990558741e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,CBS,Cystathionine beta-synthase,24240,0.0336700929824357,0.003428448100767,0.0269503347049324,0.040389851259939,1.0102078465221e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24845,0.056705918074576,0.00577900037681979,0.0453790773360092,0.0680327588131427,1.09486900739126e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,WASF3,Wiskott-Aldrich syndrome protein family member 3,28774,0.0551489502902918,0.00562129400580212,0.0441312140389196,0.0661666865416639,1.09895121534604e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,NPTX1,Neuronal pentraxin-1,29443,0.0265786454795555,0.00271365079146294,0.0212598899282881,0.0318974010308228,1.28834924549277e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24445,0.0249497451016883,0.00254901224492238,0.0199536811016404,0.0299458091017362,1.39493522613559e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,CST5,Cystatin-D,28890,0.0362835115809163,0.00370985729295674,0.0290121912867211,0.0435548318751115,1.4830254857768e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,CA12,Carbonic anhydrase 12,29349,-0.0212515702883177,0.00217698774272751,-0.0255184662640636,-0.0169846743125717,1.77482511783094e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,MENT,Protein MENT,24381,-0.0148203266641801,0.00151822287463609,-0.0177960434984669,-0.0118446098298934,1.80861180540691e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24922,0.034840215370754,0.00357135486725878,0.0278403598309268,0.0418400709105812,1.91758249911561e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,RANBP1,Ran-specific GTPase-activating protein,24240,0.0341260416185017,0.00350724860785408,0.0272518343471077,0.0410002488898958,2.46423555914571e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,MDM1,Nuclear protein MDM1,24195,0.0203681847502137,0.00209701774588423,0.0162580299682806,0.0244783395321468,2.91686522842627e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24805,0.066558827422465,0.00687461464914056,0.0530845827101495,0.0800330721347805,3.94248912130555e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP1,Interstitial collagenase,28424,0.0591083950215162,0.00610625953539975,0.0471401263321327,0.0710766637108997,3.9688010419491e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,TINAGL1,Tubulointerstitial nephritis antigen-like,29425,0.014343824812402,0.00148662104905692,0.0114300475562505,0.0172576020685536,5.37125423952339e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,AGER,Advanced glycosylation end product-specific receptor,29378,0.0262062030770366,0.00271658918612815,0.0208816882722255,0.0315307178818478,5.47086676605393e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,PPM1A,Protein phosphatase 1A,28797,0.0200266577185028,0.00207842115944421,0.0159529522459922,0.0241003631910135,6.10964422144323e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,WFDC1,WAP four-disulfide core domain protein 1,24326,0.0348878596699499,0.00363278173337864,0.0277676074725277,0.042008111867372,8.43795824675228e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF23,Fibroblast growth factor 23,29693,0.036370649464006,0.00378870833546502,0.0289447811264945,0.0437965178015174,8.62023452915206e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28797,0.050652235400419,0.00529452213347487,0.0402749720188082,0.0610294987820297,1.1862661827621e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29594,0.0273610813803062,0.00286366574041443,0.021748296529094,0.0329738662315185,1.33345183342164e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,CSTB,Cystatin-B,29030,0.027059332742063,0.00283919080740635,0.0214945187595466,0.0326241467245795,1.6805389878812e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,CRYGD,Gamma-crystallin D,24845,0.0617201035757733,0.0064753404491349,0.0490284362954689,0.0744117708560777,1.68632785769917e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",24240,0.0445366392482997,0.00467305275227777,0.0353774558538353,0.0536958226427641,1.70680396446017e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,SPRR3,Small proline-rich protein 3,24845,0.0433172877850811,0.00454582457671889,0.0344074716147121,0.0522271039554502,1.72783714753382e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,SLITRK6,SLIT and NTRK-like protein 6,28916,-0.0218182420583797,0.0022902282496243,-0.0263070894276434,-0.0173293946891161,1.74654079214541e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS4,Galectin-4,29454,-0.0345744855563312,0.00363725161106064,-0.0417034987140101,-0.0274454723986524,2.13344514196126e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,AMFR,E3 ubiquitin-protein ligase AMFR,28774,0.0404752081873197,0.00426196643635602,0.0321217539720619,0.0488286624025775,2.32538354477755e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,IGHMBP2,DNA-binding protein SMUBP-2,24111,0.035463352217839,0.00373521177123462,0.0281423371462191,0.0427843672894588,2.41511891272265e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,GOT1,"Aspartate aminotransferase, cytoplasmic",24938,0.0265679214106198,0.00279858659791276,0.0210826916787108,0.0320531511425288,2.43138801796344e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINB8,Serpin B8,29786,0.0356349427328598,0.00375563572426317,0.028273896713304,0.0429959887524156,2.51494324588935e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRL2,Fc receptor-like protein 2,29645,0.0311456362089438,0.00328890647580488,0.0246993795163663,0.0375918929015214,3.00169965917211e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRC25,Leucine-rich repeat-containing protein 25,29349,0.0246604045689163,0.00260558285438058,0.0195534621743304,0.0297673469635023,3.16436251825133e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,NPC2,NPC intracellular cholesterol transporter 2,24609,0.0201914384896036,0.00213400208341374,0.0160087944061127,0.0243740825730946,3.28999666283271e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNGR2,Interferon gamma receptor 2,29218,0.0328946492794855,0.00347728355473646,0.0260791735122021,0.039710125046769,3.30662665973804e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,ICOSLG,ICOS ligand,29349,0.0120635907729275,0.00127567952097344,0.00956325891181952,0.0145639226340354,3.41025462884722e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",24240,0.0488817794981809,0.00516927102353568,0.0387500082920509,0.0590135507043108,3.47294834812437e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,MZB1,Marginal zone B- and B1-cell-specific protein,29542,-0.0323330337097491,0.00342241910347248,-0.0390409751525552,-0.025625092266943,3.72020585108765e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,SNX5,Sorting nexin-5,24240,0.0188810345857622,0.00199823021814394,0.0149645033582001,0.0227975658133243,3.7244918031046e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,CFHR2,Complement factor H-related protein 2,24789,0.0361025986908124,0.00382118749251845,0.0286130712054762,0.0435921261761485,3.74862647812088e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,S100P,Protein S100-P,28916,0.033767013637765,0.00357568601449297,0.0267586690493588,0.0407753582261712,3.86720256086964e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,HEPH,Hephaestin,24922,0.0166814771451934,0.00176830005898945,0.0132156090295741,0.0201473452608127,4.2961818790212e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G15,Phospholipase A2 group XV,29566,0.0166906314693636,0.00176998544009806,0.0132214600067714,0.0201598029319558,4.39839325640084e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC5A,C-type lectin domain family 5 member A,29395,-0.0183263581266784,0.00195037299927048,-0.0221490892052486,-0.0145036270481083,6.04533765903251e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,29218,0.043778676816092,0.00466478034412602,0.034635707341605,0.052921646290579,6.73675765133374e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,PRSS8,Prostasin,29347,0.0256620034899098,0.00273501412491334,0.0203013758050796,0.0310226311747399,6.87445455854219e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,IGSF21,Immunoglobulin superfamily member 21,24240,0.0248718091841136,0.00265977271797346,0.0196586546568856,0.0300849637113415,9.40102004387127e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK4,Kallikrein-4,29725,-0.0392539761340943,0.00419897707959494,-0.0474839712101004,-0.0310239810580882,9.49614100701472e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,ADM,Pro-adrenomedullin,29725,0.0165448945420494,0.00177224719351927,0.0130712900427516,0.0200184990413472,1.07246196435615e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSH,Pro-cathepsin H,28852,0.0456881864895036,0.00489455571181642,0.0360948572943434,0.0552815156846638,1.08529635738339e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",24229,0.0278702244951696,0.00298991764915111,0.0220099859028334,0.0337304630875058,1.24318077503218e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,EFNA4,Ephrin-A4,29169,0.0191124880701678,0.00205312684715842,0.0150883594497373,0.0231366166905983,1.37853969018232e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,24195,0.03394806133443,0.0036486190332965,0.0267967680291689,0.0410993546396912,1.45895583181178e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24793,0.0230410377143562,0.00248182923465041,0.0181766524144414,0.027905423014271,1.7638756278306e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,STX7,Syntaxin-7,24229,0.0308831108172206,0.00332899264395619,0.0243582852350664,0.0374079363993747,1.88444143286643e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,RARRES1,Retinoic acid receptor responder protein 1,28797,0.0207158830782028,0.00223413809515894,0.0163369724116913,0.0250947937447144,1.94286311577747e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,CSDE1,Cold shock domain-containing protein E1,24111,0.0735681837649417,0.00793682620247511,0.0580120044080905,0.0891243631217929,2.02760056441455e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,GPNMB,Transmembrane glycoprotein NMB,28733,0.0177317530724993,0.00191387618022121,0.0139805557592657,0.0214829503857329,2.08597850026851e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,29218,0.0439957805806238,0.0047494900929697,0.0346867799984032,0.0533047811628444,2.11458495530161e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,COL9A1,Collagen alpha-1(IX) chain,29434,0.0288843203493514,0.00312550203344632,0.0227583363637966,0.0350103043349062,2.58955191181176e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,REPS1,RalBP1-associated Eps domain-containing protein 1,24229,0.0238948382309768,0.00258629929651495,0.0188256916098075,0.0289639848521461,2.68654212293161e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17RB,Interleukin-17 receptor B,29034,-0.0330321080955793,0.00358043243508354,-0.040049755668343,-0.0260144605228155,3.00168823756316e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,SCGB3A1,Secretoglobin family 3A member 1,24381,-0.0157480511874447,0.0017106155788073,-0.019100857721907,-0.0123952446529824,3.64713499832128e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRL3,Fc receptor-like protein 3,28931,0.0332609871298757,0.00361515412021516,0.026175285054254,0.0403466892054974,3.79795496662739e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28931,0.036611511625466,0.00398513728282235,0.0288006425511342,0.0444223806997979,4.30125676642593e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29683,0.0183466173936317,0.00199909134145075,0.0144283983643882,0.0222648364228751,4.69096355689276e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,SORCS2,VPS10 domain-containing receptor SorCS2,28797,0.0218971705263298,0.00238906582126081,0.0172146015166587,0.026579739536001,5.24670030941082e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,CABP2,Calcium-binding protein 2,24195,0.0400885984731593,0.00437436398287231,0.0315148450667296,0.048662351879589,5.36558997510713e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINI2,Serpin I2,24805,0.0348271616914526,0.00380072142583488,0.0273777476968163,0.042276575686089,5.41237650993203e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1R1,Interleukin-1 receptor type 1,29390,-0.0140703468795387,0.00153634110181481,-0.0170815754390958,-0.0110591183199817,5.60221321262954e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,COLEC12,Collectin-12,29454,0.0160606334657431,0.00175823049393186,0.0126145016976367,0.0195067652338495,6.97738901270813e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,PRELP,Prolargin,29454,0.0141736170008711,0.00155180487947559,0.0111320794370989,0.0172151545646433,7.0361658441288e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,LTB,Lymphotoxin-beta,24793,0.0213399377754593,0.00233735190229774,0.0167587280469557,0.0259211475039629,7.36095813835676e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,CYTL1,Cytokine-like protein 1,24938,0.0147540212708266,0.00161608745701442,0.0115864898550783,0.0179215526865748,7.39143805934114e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSC,Dipeptidyl peptidase 1,29446,0.0264098090389126,0.00289329475753893,0.0207389513141363,0.0320806667636889,7.41544101076174e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,CD300A,CMRF35-like molecule 8,24381,0.0183176326628036,0.00200860574289121,0.0143807654067368,0.0222544999188703,8.10895383745516e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,CRTAC1,Cartilage acidic protein 1,29820,0.0182954785593742,0.00200750682202071,0.0143607651882136,0.0222301919305348,8.46003167973633e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,CILP,Cartilage intermediate layer protein 1,24938,0.033194170464487,0.00364438488260495,0.0260511760945813,0.0403371648343927,8.97941628072685e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,PTGDS,Prostaglandin-H2 D-isomerase,29291,0.0185237776110931,0.00203458729176183,0.0145359865192399,0.0225115687029463,9.20716882558461e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,C2CD2L,Phospholipid transfer protein C2CD2L,28719,0.0257377615000773,0.00283045034200785,0.0201900788297419,0.0312854441704127,1.02230413390269e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,DSG4,Desmoglein-4,29242,0.0301069433294798,0.00331225305613206,0.023614927339461,0.0365989593194987,1.05549999125764e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,COPB2,Coatomer subunit beta',24111,0.0262262018722565,0.0028852716451724,0.0205710694477186,0.0318813342967944,1.06783317328656e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,ECM1,Extracellular matrix protein 1,24349,0.0223964624808958,0.00246459829392906,0.0175658498247948,0.0272270751369968,1.09096209250444e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,VSIG4,V-set and immunoglobulin domain-containing protein 4,29396,-0.0247803746091739,0.00273783862582992,-0.0301465383158006,-0.0194142109025473,1.50082702243253e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,LTBP2,Latent-transforming growth factor beta-binding protein 2,29820,-0.0192073966193034,0.00212347159594928,-0.023369400947364,-0.0150453922912428,1.58101715142997e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSF,Cathepsin F,29566,0.0241658694738193,0.00267580997102178,0.0189212819306166,0.0294104570170219,1.79799219614549e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,PZP,Pregnancy zone protein,24966,0.0322382967475868,0.00357359581918623,0.0252340489419817,0.0392425445531918,1.99009309433082e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,SNX2,Sorting nexin-2,24793,0.0490469902304127,0.00544267046132305,0.0383793561262195,0.0597146243346058,2.17430078019622e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,ENSA,Alpha-endosulfine,24793,0.0318352441707245,0.00353423585179873,0.024908141901199,0.03876234644025,2.25260979628683e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,NFIC,Nuclear factor 1 C-type,24867,0.0268101797355328,0.00297930434821589,0.0209707432130297,0.032649616258036,2.4410629926726e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,GNLY,Granulysin,29443,0.0313108974843999,0.00348315890697058,0.0244839060267375,0.0381378889420622,2.63514294605655e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,POSTN,Periostin,24938,-0.0227867793198388,0.00253658911409567,-0.0277584939834663,-0.0178150646562113,2.81076423049215e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,CXADR,Coxsackievirus and adenovirus receptor,29434,0.030651849565856,0.00342180320325982,0.0239451152874667,0.0373585838442452,3.50268121450602e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28797,0.0302161658258041,0.00337629385107757,0.023598629877692,0.0368337017739161,3.78016417616114e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP2,"Fatty acid-binding protein, intestinal",29478,-0.0464133627693539,0.00523586170808432,-0.0566756517171992,-0.0361510738215087,8.10722325007678e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,PRL,Prolactin,29694,-0.044726054008976,0.00505750213498347,-0.0546387581935436,-0.0348133498244084,9.77836964143041e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,RPL14,60S ribosomal protein L14,24240,0.0238143376804727,0.00269579699193764,0.018530575576275,0.0290980997846705,1.07825043434008e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,LYPD3,Ly6/PLAUR domain-containing protein 3,29340,0.0201790896490068,0.0022945085985812,0.0156818527957876,0.0246763265022259,1.51368523960339e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,SLAMF7,SLAM family member 7,29434,-0.0343848264835309,0.00391142502788104,-0.0420512195381777,-0.026718433428884,1.5632273799064e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,RABEPK,Rab9 effector protein with kelch motifs,28797,0.0345008794802433,0.00393517786265143,0.0267879308694465,0.0422138280910401,1.92878369532434e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,CAPG,Macrophage-capping protein,29174,0.0341162157090907,0.00389310984533061,0.0264857204122428,0.0417467110059387,1.99817596608231e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,LUZP2,Leucine zipper protein 2,24793,0.0261196873105452,0.00299754603980028,0.0202444970725366,0.0319948775485537,3.12193258871613e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,NAGA,Alpha-N-acetylgalactosaminidase,24177,0.0341468387590606,0.00392134873693481,0.0264609952346683,0.0418326822834528,3.2890861505359e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,GAS2,Growth arrest-specific protein 2,24445,0.0307896094008117,0.00353844275012241,0.0238542616105718,0.0377249571910517,3.47936929226841e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1B,Interleukin-1 beta,28745,0.0326923509281101,0.00375988312178405,0.0253229800094134,0.0400617218468068,3.64817856430727e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,24240,0.0214778691740069,0.00247139592925637,0.0166339331526645,0.0263218051953494,3.82995520464358e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,IL12B,Interleukin-12 subunit beta,29786,0.0315186726366877,0.00363262260784178,0.0243987323253178,0.0386386129480576,4.28300338713922e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,CHGA,Chromogranin-A,24938,-0.0508174293042785,0.00587800424551368,-0.0623383176254854,-0.0392965409830717,5.68081340677164e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,TF,Serotransferrin,24966,0.0124920480242585,0.00144764827564789,0.00965465740398866,0.0153294386445284,6.54009626258571e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28719,0.0270002175087038,0.00313621401144566,0.0208532380462703,0.0331471969711373,7.72867406494335e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A12,Protein S100-A12,29023,0.0430805041400131,0.00500887732902227,0.0332631045751294,0.0528979037048968,8.30614910897658e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QL2,Complement C1q-like protein 2,24229,0.0247379210756975,0.00288045475662244,0.0190922297527175,0.0303836123986775,9.35769254883637e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,GDF15,Growth/differentiation factor 15,29820,-0.0254323478055603,0.00296499160067898,-0.0312437313428911,-0.0196209642682295,1.01538445006978e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,DIPK2B,Divergent protein kinase domain 2B,24381,0.0161805192116978,0.00188832414209222,0.0124794038931971,0.0198816345301986,1.10746396478451e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,CD80,T-lymphocyte activation antigen CD80,24922,0.0196125800660982,0.00228954777887252,0.015125066419508,0.0241000937126883,1.13110303398582e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,YAP1,Transcriptional coactivator YAP1,24845,0.0154984166835086,0.00180992997147453,0.0119509539394185,0.0190458794275987,1.16250164240535e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,VSIG10,V-set and immunoglobulin domain-containing protein 10,24793,0.0201413201791236,0.00235374294300185,0.0155279840108399,0.0247546563474072,1.22294169842511e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,VWC2,Brorin,29114,0.022791989264646,0.00266438855728775,0.017569787692362,0.02801419083693,1.2431022488881e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL14,C-C motif chemokine 14,29435,0.022603561545985,0.00264310594709479,0.0174230738896792,0.0277840492022908,1.26862247134043e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,BGN,Biglycan,28750,-0.0683341804302608,0.00799406040460917,-0.0840025388232948,-0.0526658220372268,1.3121437723915e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB1BP1,Integrin beta-1-binding protein 1,28797,0.0233122792397666,0.00272748768631889,0.0179664033745815,0.0286581551049516,1.32293564983847e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,NME3,Nucleoside diphosphate kinase 3,29497,0.0136152829430976,0.00159486957727715,0.0104893385716344,0.0167412273145608,1.44356434085513e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,GRSF1,G-rich sequence factor 1,23862,0.0462156295907835,0.00541453029133864,0.0356031502197598,0.0568281089618072,1.47764730832379e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24445,0.0412983221361371,0.00484601668370566,0.031800129436074,0.0507965148362002,1.65577283189099e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,PDCD1,Programmed cell death protein 1,29661,0.024380078868214,0.00286334811013919,0.0187679165723412,0.0299922411640868,1.75038926518403e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,NPTXR,Neuronal pentraxin receptor,29478,0.019347089678413,0.00227283498010217,0.0148923331174128,0.0238018462394132,1.7846483441227e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,FGR,Tyrosine-protein kinase Fgr,28774,0.0322746961208807,0.00379153526890199,0.0248432869938328,0.0397061052479286,1.78684678915935e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,PNLIP,Pancreatic triacylglycerol lipase,24951,0.0359920048748592,0.0042282070204357,0.0277047191148053,0.0442792906349132,1.79886242654443e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28916,0.0325008471893989,0.00382181167735098,0.0250100963017909,0.0399915980770068,1.91798316119169e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,GIMAP8,GTPase IMAP family member 8,24016,0.029058588898882,0.00341852572145296,0.0223582784848342,0.0357588993129298,1.99898272911717e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,HLA_E,,29434,0.0164454883968184,0.00193635031191188,0.0126502417854711,0.0202407350081657,2.1065319573563e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,RCOR1,REST corepressor 1,28916,0.0253296878047264,0.00298317067488123,0.0194826732819592,0.0311767023274936,2.14793441583129e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29434,0.0212501628642777,0.00250747280473668,0.0163355161669938,0.0261648095615616,2.46457490705761e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,PECR,Peroxisomal trans-2-enoyl-CoA reductase,24240,0.015954200348953,0.00188358789926412,0.0122623680663953,0.0196460326315106,2.58883847060562e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,GCLM,Glutamate--cysteine ligase regulatory subunit,24111,0.0254987582466589,0.00301097822531777,0.019597240925036,0.0314002755682817,2.62340949288114e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29536,0.0502076269210069,0.00594317185451423,0.038559010086159,0.0618562437558548,3.09875442960322e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,LETM1,Mitochondrial proton/calcium exchanger protein,24867,0.0297524702682075,0.00352439806241133,0.0228446500658813,0.0366602904705337,3.29137568243998e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,EFHD1,EF-hand domain-containing protein D1,24867,0.0199271465783815,0.00236071081180252,0.0153001533872486,0.0245541397695145,3.31094812986432e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,ZBP1,Z-DNA-binding protein 1,24229,0.0229782883771747,0.0027283045519123,0.0176308114554266,0.0283257652989228,3.89753131875105e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPT2,Angiopoietin-2,29725,-0.0213935131729961,0.00254503272530339,-0.0263817773145908,-0.0164052490314015,4.42974147933378e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,ICAM5,Intercellular adhesion molecule 5,29478,0.0251435520959641,0.00300283617297914,0.019257993196925,0.0310291109950032,5.84939907430907e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,PRSS22,Brain-specific serine protease 4,24229,0.0196291767071773,0.00234632390091805,0.0150303818613779,0.0242279715529767,6.28214290408041e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,PBK,Lymphokine-activated killer T-cell-originated protein kinase,24016,-0.0171717587733599,0.00205264834898939,-0.0211949495373791,-0.0131485680093407,6.2992759190526e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,LIPF,Gastric triacylglycerol lipase,24240,0.034199125490444,0.00408965622860505,0.0261833992823781,0.0422148516985099,6.47511488053853e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRL5,Fc receptor-like protein 5,29443,-0.0320988851749084,0.00383979713173713,-0.0396248875531132,-0.0245728827967037,6.57109329546037e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28916,-0.0171536196815197,0.00205901935721828,-0.0211892976216675,-0.0131179417413718,8.36913262750233e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29378,0.0362914135373423,0.00436014629883616,0.0277455267916234,0.0448373002830612,8.91094961226022e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,ODAM,Odontogenic ameloblast-associated protein,28722,0.0297664268007717,0.00358327368273585,0.0227432103826094,0.036789643218934,1.02381597597224e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A11,Protein S100-A11,29208,0.025133476237166,0.00303779767883851,0.0191793927866426,0.0310875596876895,1.35461462776049e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,ZBTB17,Zinc finger and BTB domain-containing protein 17,28916,0.0227379870174775,0.00275956228785538,0.0173292449332809,0.028146729101674,1.79852056640531e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,NFASC,Neurofascin,29786,0.0155617941240203,0.00189096389246523,0.0118555048947885,0.0192680833532522,1.95495619569776e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CRH,Corticoliberin,28751,0.0476490731810385,0.00579931114547315,0.0362824233359111,0.0590157230261659,2.18546687345224e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP4,Insulin-like growth factor-binding protein 4,28967,0.02400261566058,0.00292810325676304,0.0182635332773244,0.0297416980438355,2.55845512229771e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CWC15,Spliceosome-associated protein CWC15 homolog,24681,0.0331738012920415,0.00404934887382582,0.0252370774993429,0.0411105250847401,2.68415313875049e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP12,Macrophage metalloelastase,29466,0.0289249713265643,0.00354431528553942,0.021978113366907,0.0358718292862215,3.45528561304172e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",24240,0.0203388395832895,0.00249301431967642,0.0154525315167237,0.0252251476498552,3.5602577388509e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,EBI3_IL27,Interleukin-27,29674,-0.0168243172536875,0.00206469215545742,-0.020871113878384,-0.0127775206289909,3.82554826414911e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,SFTPD,Pulmonary surfactant-associated protein D,29478,0.0362868993250673,0.00446341550096716,0.0275386049431717,0.0450351937069629,4.4652406395694e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CA9,Carbonic anhydrase 9,29725,-0.024735635128749,0.00305303126782084,-0.0307195764136779,-0.0187516938438202,5.61212016467616e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CD8A,T-cell surface glycoprotein CD8 alpha chain,29694,0.0267123188071194,0.00329839472990698,0.0202474651365017,0.0331771724777371,5.77154983641818e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29443,0.0273760991868025,0.00338624783080527,0.0207390534384242,0.0340131449351808,6.4797733152088e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CLPS,Colipase,29400,0.038251931161146,0.00473539667988823,0.028970553668565,0.0475333086537269,6.84091584720158e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,GSTT2B,Glutathione S-transferase theta-2B,24845,0.129191919405524,0.0160313239373054,0.0977705244884059,0.160613314322643,8.05414941733585e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,SORBS1,Sorbin and SH3 domain-containing protein 1,24867,0.0212353140912121,0.0026365018147602,0.0160677705342821,0.0264028576481421,8.34577970274156e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,L1CAM,Neural cell adhesion molecule L1,29566,0.0155645195783836,0.00193324825364399,0.0117753530012414,0.0193536861555258,8.52020748281159e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29434,0.0232419731338348,0.00289392220164831,0.0175698856186041,0.0289140606490655,1.00015052637916e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,AARSD1,Alanyl-tRNA editing protein Aarsd1,29349,0.0293659274599662,0.00365700539682444,0.0221981968821903,0.0365336580377421,1.01054182207391e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,MTPN,Myotrophin,28916,0.0175768777257434,0.002190677837544,0.0132831491641572,0.0218706062873297,1.06647415547515e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,COL28A1,Collagen alpha-1(XXVIII) chain,24195,0.0413706604048876,0.00515927703891312,0.0312584774086179,0.0514828434011574,1.11682093509974e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,VIPR1,Vasoactive intestinal polypeptide receptor 1,24240,-0.0133710514387071,0.00167094725546531,-0.0166461080594191,-0.0100959948179951,1.27781457414707e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,MILR1,Allergin-1,28931,-0.0269333145425542,0.00337059887768098,-0.0335396883428089,-0.0203269407422995,1.39176837149077e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,IL22RA1,Interleukin-22 receptor subunit alpha-1,28931,0.0229934087464554,0.00288241896079608,0.017343867583295,0.0286429499096157,1.55282321053924e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF3R,Granulocyte colony-stimulating factor receptor,24229,0.0164563768078252,0.00206688537206403,0.0124052814785798,0.0205074721370707,1.76781527329242e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,GALNT7,N-acetylgalactosaminyltransferase 7,29349,0.011114683930942,0.00140104390111738,0.00836863788475188,0.013860729977132,2.21225253283517e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,SFTPA1,Pulmonary surfactant-associated protein A1,28797,0.0304781614149144,0.00385833136125278,0.022915831946859,0.0380404908829699,2.90392691344709e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,TDP1,Tyrosyl-DNA phosphodiesterase 1,24793,0.03611652781411,0.00457737921788759,0.0271448645470503,0.0450881910811697,3.14054754671718e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,MCAM,Cell surface glycoprotein MUC18,29594,-0.0174888097522366,0.00221871651485827,-0.0218374941213588,-0.0131401253831144,3.32135226741086e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CA4,Carbonic anhydrase 4,29820,-0.012504473633185,0.00158734182480817,-0.015615663609809,-0.00939328365656098,3.44973873473422e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASE3,Eosinophil cationic protein,29343,0.0570468346614428,0.00725001334146589,0.0428368085121697,0.071256860810716,3.71168410004545e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMTOR5,Ragulator complex protein LAMTOR5,24793,0.0215152294128474,0.00273479741997762,0.0161550264696913,0.0268754323560036,3.77366269312288e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,29218,0.015628289024167,0.00198827109881705,0.0117312776704856,0.0195253003778484,3.96529312920985e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CD27,CD27 antigen,29566,-0.0218050405164385,0.00277768658265863,-0.0272493062184494,-0.0163607748144276,4.29797051750232e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA3,Alpha-1-antichymotrypsin,24883,0.0077876794780055,0.000993281113076018,0.00584084849637651,0.0097345104596345,4.67200996305991e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,MYOM3,Myomesin-3,24381,-0.0490008381284044,0.00625876378841805,-0.0612680151537038,-0.036733661103105,5.11062428411248e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,SCN4B,Sodium channel subunit beta-4,24240,0.0223821391134648,0.00285985015924707,0.0167768328013406,0.0279874454255891,5.22756114449143e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,DCTPP1,dCTP pyrophosphatase 1,29478,0.0165584500494101,0.00212135352904716,0.0124005971324776,0.0207163029663425,6.117114577035e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CBLIF,Cobalamin binding intrinsic factor,29433,0.0388055340197395,0.00497156203317325,0.0290612724347199,0.048549795604759,6.12249251047606e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,NEO1,Neogenin,24867,0.0114133453906209,0.00146851170285154,0.00853506245303192,0.01429162832821,8.02052971503511e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CIT,Citron Rho-interacting kinase,24195,0.0235766815536633,0.00303701661377158,0.017624128990671,0.0295292341166556,8.61464529298657e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,24240,-0.0182577431228409,0.00235656231456288,-0.0228766052593841,-0.0136388809862976,9.72932160135412e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CCN5,CCN family member 5,29443,0.0201169165687223,0.00259736771969294,0.0150260758381241,0.0252077572993204,9.85536311690467e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,PLAU,Urokinase-type plasminogen activator,29443,0.0150124687184152,0.00194254030829421,0.0112050897141586,0.0188198477226719,1.12483953549971e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTN2,Contactin-2,29725,0.022965350297237,0.00297986091502483,0.0171248229037884,0.0288058776906857,1.32970039757062e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,TPM3,Tropomyosin alpha-3 chain,24111,-0.022821285051719,0.00296238126557283,-0.0286275523322418,-0.0170150177711963,1.37264702843888e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29462,0.0298773964444807,0.00387919336178814,0.0222741774553759,0.0374806154335854,1.38189356323635e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,CD59,CD59 glycoprotein,28277,0.011844099194699,0.00153978668919082,0.00882611728388503,0.0148620811055131,1.4951147353487e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA7,Thyroxine-binding globulin,24966,0.00954498749999947,0.00124120227914921,0.00711223103286702,0.0119777439671319,1.52416418796702e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,JAM2,Junctional adhesion molecule B,29694,0.0137094906453159,0.00178299246703395,0.0102148254099294,0.0172041558807024,1.52823950706122e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,AGT,Angiotensinogen,24951,0.0118990817988125,0.00154740362615001,0.00886617069155846,0.0149319929060665,1.52903660184885e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,SLITRK1,SLIT and NTRK-like protein 1,24229,0.0166799320202503,0.00217365942284355,0.0124195595514769,0.0209403044890236,1.73442695139553e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,TDO2,"Tryptophan 2,3-dioxygenase",24195,0.0200136873387262,0.00261300333143261,0.0148922008091183,0.0251351738683341,1.93994194308083e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28931,0.0186343926904343,0.00243336486838906,0.0138649975483917,0.0234037878324768,1.94934539515045e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,SAA4,Serum amyloid A-4 protein,24966,0.0168045984846529,0.0021943359517805,0.0125037000191631,0.0211054969501426,1.95430426956456e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28774,0.0153972058844565,0.00201808246724597,0.0114417642486544,0.0193526475202586,2.42715472240972e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,TMPRSS11D,Transmembrane protease serine 11D,24801,0.0196270310650102,0.00257309577595666,0.0145837633441351,0.0246702987858852,2.4738371010126e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,CA7,Carbonic anhydrase 7,24445,-0.0175715691571963,0.00230398219275407,-0.0220873742549943,-0.0130557640593984,2.49781657493451e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKD2,Serine/threonine-protein kinase D2,24111,0.0233675969047783,0.00306693904937541,0.0173563963680025,0.0293787974415541,2.64652787305399e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFA,Protransforming growth factor alpha,29434,0.0237326710371642,0.00311908602294744,0.0176192624321872,0.0298460796421412,2.84793003185369e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,DSG3,Desmoglein-3,29589,0.0173753923128147,0.00228393254481702,0.0128988845249733,0.0218519001006561,2.87377004401799e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,BRD1,Bromodomain-containing protein 1,24445,-0.0156458469809438,0.00205665423931761,-0.0196768892900063,-0.0116148046718813,2.89679630570723e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,KIF1C,Kinesin-like protein KIF1C,24111,0.0184245271929391,0.0024366512003132,0.0136486908403253,0.023200363545553,4.12929976410325e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTN5,Contactin-5,29511,0.018700582639102,0.00247523114027169,0.0138491296041695,0.0235520356740345,4.30702361470769e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC4M,C-type lectin domain family 4 member M,24888,0.0247227950333627,0.00327951571298283,0.0182949442359163,0.031150645830809,4.914343433142e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,BAX,Apoptosis regulator BAX,28722,0.0454566948748071,0.00603132156610252,0.0336353046052462,0.0572780851443681,4.95943940244368e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29454,0.0147771448073513,0.00197212140030204,0.0109117868627593,0.0186425027519433,6.91957943911619e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRH,Receptor-type tyrosine-protein phosphatase H,24805,0.02459355674409,0.00328264800013592,0.0181595666638236,0.0310275468243564,7.01037239097013e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,KLRF1,Killer cell lectin-like receptor subfamily F member 1,24229,0.0218997839127621,0.00292602079878093,0.0161647831471514,0.0276347846783727,7.42698981615859e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDHB15,Protocadherin beta-15,24793,-0.0199507182156924,0.00268110658302084,-0.0252056871184133,-0.0146957493129716,1.0299892084823e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,FLT1,Vascular endothelial growth factor receptor 1,29288,0.0111410106914836,0.00150244958382191,0.00819620950719268,0.0140858118757746,1.24700729699106e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,TOR1AIP1,Torsin-1A-interacting protein 1,24240,0.0254383680896201,0.00343176849646295,0.0187121018365527,0.0321646343426875,1.27892470815193e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29786,0.0172877896278327,0.00233603785783118,0.0127091554264836,0.0218664238291818,1.39282086562823e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL2,Apoptosis regulator Bcl-2,24805,0.02649547186956,0.00359609705425859,0.0194471216432131,0.0335438220959068,1.78830080596765e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,DDR1,Epithelial discoidin domain-containing receptor 1,29694,0.0114520045899137,0.00155640296456464,0.00840145477936705,0.0145025544004604,1.91527681863455e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,GPC1,Glypican-1,29725,0.0144650501354672,0.00196646666667551,0.0106107754687832,0.0183193248021512,1.94605357985135e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,DUSP3,Dual specificity protein phosphatase 3,28774,0.0418339448331351,0.00569044322628916,0.0306806761096083,0.0529872135566618,2.01043602734691e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,PLXNB2,Plexin-B2,29701,0.0116848088005574,0.00159352280242715,0.00856150410780014,0.0148081134933146,2.31338290784603e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,CD300E,CMRF35-like molecule 2,29642,0.0199290665448561,0.00271973282675615,0.014598390204414,0.0252597428852981,2.40320772224415e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,SEZ6L,Seizure 6-like protein,29566,0.013448384297067,0.00183623363043749,0.00984936638140956,0.0170474022127245,2.47022844677571e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,MEPE,Matrix extracellular phosphoglycoprotein,29454,0.0122615070798428,0.00168211216724255,0.00896456723204736,0.0155584469276382,3.19283624866615e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,NELL1,Protein kinase C-binding protein NELL1,29566,0.0204506464177623,0.00282398850940894,0.0149156289393207,0.0259856638962038,4.53711571994993e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,SYT1,Synaptotagmin-1,24845,0.0191400307547215,0.00264760653862399,0.0139507219390184,0.0243293395704245,4.99958934129373e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,PCSK7,Proprotein convertase subtilisin/kexin type 7,24793,0.0217485283182761,0.00301333776600442,0.0158423862969075,0.0276546703396448,5.45078006943629e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,LHB,Lutropin subunit beta,28797,0.0418985451065354,0.00580864190311441,0.0305136069764312,0.0532834832366397,5.60256773899509e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,PRUNE2,Protein prune homolog 2,24445,0.0141298800486098,0.00195884473328996,0.0102905443713615,0.0179692157258581,5.61724944415939e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,GSN,Gelsolin,24845,0.00920552607992845,0.00127741650470159,0.00670178973071332,0.0117092624291436,5.91070984643875e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP6V1G2,V-type proton ATPase subunit G 2,24111,0.0480018182380768,0.00667304862992808,0.0349226429234177,0.0610809935527358,6.50505656852976e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,TYRO3,Tyrosine-protein kinase receptor TYRO3,29478,0.0136155961385777,0.00189378017645945,0.00990378699271714,0.0173274052844382,6.65084021977695e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24867,-0.018221928636088,0.00253451477845635,-0.0231895776018625,-0.0132542796703136,6.68600829642533e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,SOD2,"Superoxide dismutase [Mn], mitochondrial",29443,0.0180392454499622,0.0025125912155471,0.0131145666674899,0.0229639242324345,7.16040524833491e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29786,0.0181917269006788,0.00253467905145126,0.0132237559598343,0.0231596978415232,7.28533015046142e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,MST1,Hepatocyte growth factor-like protein,24615,0.0308306770276973,0.00430108507502975,0.022400550280639,0.0392608037747555,7.81823647967842e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17C,Interleukin-17C,28931,-0.0337204850196286,0.00470615366474141,-0.0429445462025218,-0.0244964238367354,7.9536970935401e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF16,Fibroblast growth factor 16,24229,0.0230213943059925,0.00321338637466274,0.0167231570116535,0.0293196316003315,8.04712207021622e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29725,0.0154025411501512,0.00215165696801131,0.011185293492849,0.0196197888074533,8.34829454090271e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,EGFLAM,Pikachurin,24805,0.0147686005782657,0.00206400317770577,0.0107231543499624,0.018814046806569,8.57994320012335e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,LXN,Latexin,29117,-0.0321417166944008,0.00449418785935687,-0.0409503248987403,-0.0233331084900614,8.7641733917191e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,NELL2,Protein kinase C-binding protein NELL2,29581,0.0135858934505764,0.00190730044505712,0.00984758457826441,0.0173242023228883,1.07936771758861e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,IL12RB1,Interleukin-12 receptor subunit beta-1,28931,0.0179921853790368,0.00252670837247897,0.0130398369689781,0.0229445337890956,1.09806588712166e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,PPME1,Protein phosphatase methylesterase 1,29349,0.0282600035481102,0.00399340998438667,0.0204329199787123,0.036087087117508,1.50984629675583e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,BMP10,Bone morphogenetic protein 10,24381,0.0135202998402652,0.00191315941217389,0.00977050739240438,0.017270092288126,1.62580555995832e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,HSD17B3,Testosterone 17-beta-dehydrogenase 3,24111,0.0229136289216639,0.00324276305664946,0.016557813330631,0.0292694445126969,1.63707233503771e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29497,0.0159253456776064,0.00226113003269497,0.0114935308135243,0.0203571605416886,1.92140530532387e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,DPP10,Inactive dipeptidyl peptidase 10,29434,0.016541835519205,0.00235565738241098,0.0119247470496795,0.0211589239887306,2.23183150843388e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24845,0.0296024923398865,0.00421636543242852,0.0213384160923266,0.0378665685874464,2.26189678306346e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNGR1,Interferon gamma receptor 1,29581,0.00985606311558817,0.00140446665014508,0.00710330848130382,0.0126088177498725,2.30481376418023e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,MYOM2,Myomesin-2,24111,-0.0239915165828848,0.00342514535477597,-0.0307048014782457,-0.0172782316875239,2.54339842044399e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CD55,Complement decay-accelerating factor,28490,0.0122815584318679,0.00175603502367998,0.00883972978545516,0.0157233870782807,2.73221389394424e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,PDGFRB,Platelet-derived growth factor receptor beta,29820,0.01623255005792,0.00232184378811802,0.0116817362332086,0.0207833638826313,2.78216273108818e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,24016,0.0313162216765342,0.00448021736165286,0.0225349956476946,0.0400974477053739,2.82304820550118e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,DGCR6,Protein DGCR6,24101,0.0204875821257502,0.00293525162823157,0.0147344889344163,0.0262406753170841,3.03183422439809e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29349,0.0252520578196102,0.00361850383757408,0.0181597902979649,0.0323443253412554,3.0448662108455e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH17,Cadherin-17,29478,-0.0315519055008211,0.00453756951595229,-0.0404455417520875,-0.0226582692495546,3.63807208536547e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP9,Fatty acid-binding protein 9,29434,0.0259875789486314,0.00374072173551138,0.0186557643470291,0.0333193935502337,3.80330288845476e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,HSPA2,Heat shock-related 70 kDa protein 2,24793,0.0158366371358063,0.00228117102829955,0.0113655419203392,0.0203077323512734,3.95204897222451e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,GZMB,Granzyme B,29434,0.0301289455401233,0.00435543898337554,0.0215922851327073,0.0386656059475394,4.68934160735195e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,LMNB2,Lamin-B2,24845,0.0129594353066773,0.00187505553549604,0.00928432645710508,0.0166345441562496,4.91173744999509e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24805,0.0380338344718984,0.00550844781542147,0.0272372767536724,0.0488303921901245,5.15462921989618e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,NFYA,Nuclear transcription factor Y subunit alpha,24111,0.0177866438722904,0.00257779653803754,0.0127341626577369,0.022839125086844,5.33125148401738e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,PIGR,Polymeric immunoglobulin receptor,29115,0.0166607901537665,0.00241588169445707,0.0119256620326306,0.0213959182749023,5.4441590579166e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,MNDA,Myeloid cell nuclear differentiation antigen,29426,0.0447496962692977,0.0064967999858174,0.0320159682970957,0.0574834242414998,5.77364639628788e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,RLN1,Prorelaxin H1,24867,-0.031781333072494,0.00461455354337804,-0.0408258580175149,-0.022736808127473,5.82588173849601e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,GM2A,Ganglioside GM2 activator,24421,0.0177146005051515,0.00257209312333272,0.0126732979834193,0.0227559030268836,5.82692500201636e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CAT,Catalase,24587,0.0246569866339209,0.00358600190982685,0.0176284228906602,0.0316855503771815,6.3075245687665e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,IL34,Interleukin-34,28722,0.0165921818838309,0.00241501633175112,0.0118587498735987,0.0213256138940631,6.53180774453276e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,FSTL1,Follistatin-related protein 1,24240,-0.0105069836089389,0.00153096290332205,-0.0135076708994501,-0.00750629631842772,6.90597754560805e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP6,Insulin-like growth factor-binding protein 6,29394,0.0137331367590884,0.00200555751860337,0.00980224402262585,0.017664029495551,7.66080609849965e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,DMP1,Dentin matrix acidic phosphoprotein 1,24240,-0.0278562784425287,0.00407690295843969,-0.0358470082410705,-0.0198655486439869,8.53020570899114e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,SCGB1A1,Uteroglobin,29523,0.0251525242306925,0.00369136248493791,0.0179174537602142,0.0323875947011708,9.68211684506201e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CPA2,Carboxypeptidase A2,29577,0.0296095023371343,0.0043548965156535,0.0210739051664534,0.0381450995078151,1.07254084127454e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,ATXN2,Ataxin-2,24101,0.0503622203757603,0.00743597488177776,0.0357877096074758,0.0649367311440447,1.29238583326414e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,DPP7,Dipeptidyl peptidase 2,29279,0.0271729782068062,0.00401862484335499,0.0192964735138304,0.035049482899782,1.38886178481368e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,MYL3,Myosin light chain 3,24240,-0.0330816578083361,0.00490041776435204,-0.0426864766264661,-0.0234768389902062,1.50370763590289e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,NCAM1,Neural cell adhesion molecule 1,29594,0.013613020120906,0.00201741644597099,0.00965888388680289,0.0175671563550092,1.52924152771081e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,MRC1,Macrophage mannose receptor 1,24951,0.0127881439100794,0.00189790752097414,0.00906824516897006,0.0165080426511887,1.64052496992146e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CEBPA,CCAAT/enhancer-binding protein alpha,24229,0.0169337321510964,0.00251313972028816,0.0120079782993316,0.0218594860028612,1.64095093162707e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,SELENOP,Selenoprotein P,24966,0.0102153723885535,0.00151729201270496,0.00724148004365179,0.0131892647334552,1.7023267455321e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,LEPR,Leptin receptor,29478,-0.0139484749243414,0.00207335156955933,-0.0180122440006777,-0.0098847058480051,1.75758131106624e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,KIAA0319,Dyslexia-associated protein KIAA0319,24845,0.0138536623410345,0.00206395968887092,0.0098083013508475,0.0178990233312215,1.95871903796153e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,29114,0.0149238279943277,0.00222541303602185,0.0105620184437248,0.0192856375449305,2.03559273244735e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPTL4,Angiopoietin-related protein 4,29536,-0.020209982829741,0.00301461799203431,-0.0261186340941282,-0.0143013315653537,2.06448365378738e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,LTA4H,Leukotriene A-4 hydrolase,29725,0.0262374453722928,0.00391551987659253,0.0185630264141714,0.0339118643304141,2.10860647933064e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24805,0.0177971594300914,0.00265960368671099,0.0125843362041378,0.0230099826560449,2.25358347278543e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,MET,Hepatocyte growth factor receptor,29507,0.00883074723242611,0.00132086121222042,0.00624185925647408,0.0114196352083781,2.34082776012908e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CD300C,CMRF35-like molecule 6,29694,0.0154298642892007,0.00230871759181867,0.0109047778092362,0.0199549507691653,2.3774438126721e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,TPPP3,Tubulin polymerization-promoting protein family member 3,28774,0.0175028055619674,0.00261953836159541,0.0123685103732404,0.0226371007506944,2.40596922184502e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,NINJ1,Ninjurin-1,28797,0.0247044872524069,0.00369773765493083,0.0174569214487424,0.0319520530560713,2.41684431319266e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,NECTIN1,Nectin-1,24229,0.0145063187186677,0.00217215257006686,0.0102488996813366,0.0187637377559987,2.4693915798646e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,ARID4B,AT-rich interactive domain-containing protein 4B,28774,0.0183628585439151,0.00275098748999058,0.0129709230635336,0.0237547940242967,2.51713397705895e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,SART1,U4/U6.U5 tri-snRNP-associated protein 1,24111,0.0163365441529355,0.00245022174629359,0.0115341095302001,0.021138978775671,2.66051612312203e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF1R,Macrophage colony-stimulating factor 1 receptor,24951,0.0178825504385513,0.00268515340014387,0.0126196497742694,0.0231454511028333,2.79925665090967e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,24195,0.0461103104627056,0.00694543950268503,0.032497249037443,0.0597233718879683,3.22654081119485e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29581,0.0188760300357813,0.00284366086872843,0.0133024547330736,0.0244496053384891,3.23611084477028e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH5,Cadherin-5,29820,-0.0134498444459164,0.00202815734885721,-0.0174250328496765,-0.00947465604215628,3.37833827356768e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,MUC2,Mucin-2,24938,0.040552913892214,0.00612982735605388,0.0285384522743484,0.0525673755100796,3.773677652353e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,UXS1,UDP-glucuronic acid decarboxylase 1,28797,0.0231618874710628,0.00351332341923552,0.0162757735693611,0.0300480013727644,4.39701274969413e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,SPTLC1,Serine palmitoyltransferase 1,24845,0.0163802024648613,0.00248556752654256,0.0115084901128379,0.0212519148168847,4.48256994526437e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,REG1A,Lithostathine-1-alpha,29353,-0.0215579337382909,0.00328776354397744,-0.0280019502844867,-0.0151139171920951,5.58044659568574e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL15,C-C motif chemokine 15,29820,0.0192434656251516,0.00293866560977255,0.0134836810299974,0.0250032502203058,5.91142840803971e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,APLP1,Amyloid-like protein 1,29478,-0.0224759949883844,0.00343457096639194,-0.0292077540825126,-0.0157442358942561,6.08576664417112e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,PFDN2,Prefoldin subunit 2,28774,0.0242956003481096,0.00371690455712463,0.0170104674161453,0.0315807332800739,6.40222825215567e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CST1,Cystatin-SN,21656,0.0458836333597981,0.00706130014987108,0.0320434850660508,0.0597237816535454,8.32208013785153e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTSL2,ADAMTS-like protein 2,24938,0.0142928605777052,0.00220165927568868,0.00997760839735539,0.018608112758055,8.63783312858311e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,LY9,T-lymphocyte surface antigen Ly-9,29116,0.0127409008084294,0.00196598469034984,0.00888757081534368,0.0165942308015151,9.2774423961641e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29581,0.0116434608631446,0.00179808414924349,0.00811921593062733,0.0151677057956618,9.59915279054765e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,PSPN,Persephin,29434,0.040643494260421,0.00627678285767532,0.0283409998593774,0.0529459886614647,9.61708695973841e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,REG3A,Regenerating islet-derived protein 3-alpha,29820,-0.0267385812024529,0.00413607861397218,-0.0348452952858384,-0.0186318671190675,1.03055772695263e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,NECTIN2,Nectin-2,29433,0.0128517524899796,0.00198990469228119,0.00895153929310852,0.0167519656868508,1.07411510213031e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29365,-0.0287827731250513,0.00445973595733223,-0.0375238556014225,-0.0200416906486802,1.10693112685624e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,GBP4,Guanylate-binding protein 4,28774,0.0211430048678987,0.00328176571326348,0.0147107440699023,0.0275752656658952,1.19323086909369e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,GART,Trifunctional purine biosynthetic protein adenosine-3,24867,0.0116303528386452,0.00180560252256992,0.00809137189440812,0.0151693337828822,1.20653577204611e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,LYZL2,Lysozyme-like protein 2,24016,0.0155789761854095,0.00241883644116281,0.0108380567607304,0.0203198956100886,1.21183316712766e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,MELTF,Melanotransferrin,24922,0.0127825513816955,0.00198487545802115,0.00889219548397403,0.0166729072794169,1.21670594974774e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,GFRA2,GDNF family receptor alpha-2,29349,0.00905406106734351,0.00140668729996917,0.00629695395940393,0.0118111681752831,1.24193687776443e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF149,E3 ubiquitin-protein ligase RNF149,24240,0.0132678108123153,0.00206747095922957,0.00921556773222539,0.0173200538924053,1.41174589387864e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CLC,Galectin-10,29426,-0.0284145067516056,0.00442875257573248,-0.0370948618000413,-0.01973415170317,1.4210525679708e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,SPON1,Spondin-1,29497,0.0140206620372562,0.00219234916984306,0.00972365766436378,0.0183176664101486,1.62664120747836e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,SELL,L-selectin,24966,0.00991994021988767,0.0015560216864176,0.00687013771450918,0.0129697427252662,1.85927208333383e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,OMG,Oligodendrocyte-myelin glycoprotein,29349,0.0279237851337178,0.00439075730369573,0.0193179008184742,0.0365296694489615,2.05157926860324e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CA2,Carbonic anhydrase 2,29368,0.0291454806994972,0.00458390057325167,0.020161035575924,0.0381299258230705,2.07094702086308e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CRLF1,Cytokine receptor-like factor 1,29581,0.01091567051628,0.00172271512785817,0.00753914886567796,0.014292192166882,2.38707727011133e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,LMNB1,Lamin-B1,24756,0.024942679251782,0.00394114357710008,0.0172180378406658,0.0326673206628981,2.51322038150123e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,EDA2R,Tumor necrosis factor receptor superfamily member 27,29725,-0.0162223561966487,0.00256398471010695,-0.0212477662284583,-0.0111969461648391,2.53516621085204e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CD93,Complement component C1q receptor,28353,-0.0132553962712746,0.00210361128367793,-0.0173784743872833,-0.00913231815526584,2.99578980825058e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24922,0.0116074325808858,0.00184409213879689,0.00799301198884393,0.0152218531729277,3.13755835292807e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CTRC,Chymotrypsin-C,29456,0.0267503553886114,0.00426409716115314,0.0183927249527512,0.0351079858244715,3.58173895026473e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CRISP3,Cysteine-rich secretory protein 3,24738,-0.0113726258699149,0.00181791635218733,-0.0149357419202021,-0.00780950981962777,4.01815279092461e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,IL32,Interleukin-32,29434,-0.0181531651540842,0.00290800563011297,-0.0238528561891056,-0.0124534741190627,4.36563036121506e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,SDC1,Syndecan-1,29478,0.016745741242601,0.00268509771315797,0.0114829497248114,0.0220085327603907,4.53401166148576e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,USP47,Ubiquitin carboxyl-terminal hydrolase 47,24111,0.0356840116769055,0.00574529370639138,0.0244232360123784,0.0469447873414326,5.35095148127439e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,PDGFRA,Platelet-derived growth factor receptor alpha,29478,-0.0118078968919673,0.00190255482767238,-0.0155369043542051,-0.00807888942972938,5.49556917520164e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,24111,0.0213543790605964,0.00345167702877712,0.0145890920841933,0.0281196660369996,6.24383460912938e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,VASN,Vasorin,29065,0.0113544448615535,0.00183755542537292,0.00775283622782256,0.0149560534952844,6.53222413648023e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,NCF2,Neutrophil cytosol factor 2,29395,0.0342224890525384,0.00554214050410574,0.0233598936644911,0.0450850844405856,6.70468364600365e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CNPY2,Protein canopy homolog 2,28916,0.0250487461771096,0.00407204831064974,0.0170675314882361,0.0330299608659831,7.78148037448939e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CRTAP,Cartilage-associated protein,24195,0.0200676426423012,0.00327001290444528,0.0136584173495885,0.026476867935014,8.54711611344652e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,BTN2A1,Butyrophilin subfamily 2 member A1,29581,0.0108283722014179,0.00176588915534448,0.00736722945694275,0.0142895149458931,8.78978862955586e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,ACTN2,Alpha-actinin-2,24111,-0.0243265099174063,0.00397810762550963,-0.0321236008634052,-0.0165294189714074,9.79826588897882e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM171B,Protein FAM171B,24793,0.0111020143325891,0.00181907555420493,0.00753662624634745,0.0146674024188308,1.05568857063255e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,LYAR,Cell growth-regulating nucleolar protein,28797,0.0215432901566191,0.00353089182192599,0.0146227421856442,0.0284638381275941,1.0650118263131e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPL46,"39S ribosomal protein L46, mitochondrial",28774,0.0112093587470544,0.00184711788323941,0.00758900769590511,0.0148297097982036,1.30668379291391e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29349,0.0182104597070646,0.00300242449187332,0.0123257077029929,0.0240952117111363,1.33356896881945e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,DLL4,Delta-like protein 4,24240,0.0349265266223428,0.00576099188117946,0.0236349825352311,0.0462180707094545,1.35927913577068e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,EXTL1,Exostosin-like 1,24111,0.0193253539498461,0.00319615626381037,0.0130608876727778,0.0255898202269145,1.50263358907445e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CR2,Complement receptor type 2,29594,0.0187948031125903,0.00311065568864575,0.0126979179628446,0.0248916882623359,1.53964191411492e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28916,0.0142611818920634,0.00236030830197237,0.00963497762019759,0.0188873861639293,1.53994446925215e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,INSL5,Insulin-like peptide INSL5,24805,0.0394857244775914,0.00654706284399526,0.0266534813033607,0.0523179676518221,1.65193719026443e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,NTF3,Neurotrophin-3,29434,0.0139200324005926,0.00231896871106605,0.00937485372690314,0.0184652110742821,1.9635428822376e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,24229,0.0125568548069547,0.00209477907344423,0.00845108782300403,0.0166626217909054,2.07181901834717e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CREBZF,CREB/ATF bZIP transcription factor,24016,-0.010535802619908,0.00176025699317366,-0.0139859063265284,-0.00708569891328764,2.18952314947165e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,FOSB,Protein fosB,28774,0.0154738109619805,0.00258971413138292,0.01039797126447,0.020549650659491,2.32645998508561e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,MUC16,Mucin-16,29349,0.0753938372223657,0.0126326136129538,0.0506339145409764,0.100153759903755,2.42651394849684e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,RHOC,Rho-related GTP-binding protein RhoC,29089,0.0464255881063235,0.00778937348025639,0.031158416085021,0.061692760127626,2.54956585793604e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,MFAP4,Microfibril-associated glycoprotein 4,24381,-0.012866702321437,0.00215971982891324,-0.0170997531861069,-0.00863365145676701,2.59514944538307e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,RPA2,Replication protein A 32 kDa subunit,24229,0.0126743241374508,0.0021358564293737,0.00848804553587831,0.0168606027390232,2.99532278861531e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CCND2,G1/S-specific cyclin-D2,24445,0.0146535895160672,0.00247150211630674,0.00980944536810603,0.0194977336640285,3.08838658319742e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CGREF1,Cell growth regulator with EF hand domain protein 1,29478,0.0168354316720473,0.00284354676332463,0.011262080015931,0.0224087833281635,3.24368190050992e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CCN3,CCN family member 3,29795,0.0133323860124984,0.00226104376068857,0.00890074024154884,0.017764031783448,3.75151110564904e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,SDK2,Protein sidekick-2,24381,0.0153077617532291,0.00259904879395287,0.0102136261170814,0.0204018973893767,3.91842984400374e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,GLYR1,Putative oxidoreductase GLYR1,24793,0.0233704435652794,0.00397395621421223,0.0155814893854234,0.0311593977451353,4.13272977559858e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL12,Stromal cell-derived factor 1,28931,0.0156852373127987,0.00267688435379505,0.0104385439793604,0.020931930646237,4.69254543634313e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,VWF,von Willebrand factor,29820,-0.0283904730279297,0.00484549328516203,-0.0378876398668473,-0.0188933061890122,4.70127170586602e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,COL6A3,Collagen alpha-3(VI) chain,29820,0.0136745476973291,0.00233678271910172,0.00909445356788975,0.0182546418267685,4.91157238235536e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,GBA,Lysosomal acid glucosylceramidase,24195,0.0211399289620602,0.00361677212461948,0.014051055597806,0.0282288023263144,5.13158672252167e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,NAAA,N-acylethanolamine-hydrolyzing acid amidase,29087,0.0231915424829944,0.00397366478557823,0.0154031595032611,0.0309799254627278,5.39352288554881e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29640,0.011291765704979,0.00193636311265498,0.00749649400417518,0.0150870374057827,5.55243304846788e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,SSH3,Protein phosphatase Slingshot homolog 3,24016,0.0114603522524082,0.00197062566110103,0.00759792595665014,0.0153227785481662,6.1186177535095e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,ITM2A,Integral membrane protein 2A,29434,-0.023440477935355,0.00403325489802118,-0.0313456575354765,-0.0155352983352335,6.24410178964277e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC14A,C-type lectin domain family 14 member A,29443,-0.01232504664059,0.00212080535000936,-0.0164818251266084,-0.00816826815457166,6.25557767179058e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,PDIA5,Protein disulfide-isomerase A5,24016,0.0239128047521457,0.00412091849400539,0.0158358045038951,0.0319898050003962,6.60421483056889e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB37,Ras-related protein Rab-37,28931,0.0317265857493704,0.00549636215742461,0.0209537159208181,0.0424994555779226,7.90008067830218e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,LEO1,RNA polymerase-associated protein LEO1,24867,0.0116402939720073,0.0020169159187459,0.00768713877126535,0.0155934491727493,7.95812011498047e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CLASP1,CLIP-associating protein 1,24016,0.0282061807129513,0.0049013253926214,0.0185995829434133,0.0378127784824892,8.77963937286255e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA4C,Semaphorin-4C,29349,0.0107886836781521,0.00188174207698643,0.00710046920725868,0.0144768981490455,9.94320622648691e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29786,0.0105377943109257,0.00183856167617668,0.00693421342561942,0.014141375196232,1.00481422509846e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,AHNAK2,Protein AHNAK2,24240,0.0113741682319959,0.00199428521741331,0.00746536920586581,0.015282967258126,1.18821183572715e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,RALY,RNA-binding protein Raly,24793,0.018367637204825,0.0032235506066982,0.0120494780156965,0.0246857963939534,1.22629591587749e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFB2,Transforming growth factor beta-2 proprotein,24793,0.0199434167918559,0.0035127352962507,0.0130584556112045,0.0268283779725073,1.38236946744349e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,NOTCH2,Neurogenic locus notch homolog protein 2,24938,0.00817298520415454,0.00144397699226578,0.00534279029931362,0.0110031801089955,1.52988458769557e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,SEL1L,Protein sel-1 homolog 1,24240,0.0121151265004057,0.00214094162859818,0.00791888090835326,0.0163113720924581,1.54169972114756e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,NRCAM,Neuronal cell adhesion molecule,29478,0.0107049418089265,0.00189251343339197,0.00699561547947826,0.0144142681383748,1.55950314295637e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,FOLH1,Glutamate carboxypeptidase 2,24229,0.0402200024206153,0.00712227765514429,0.0262603382165325,0.0541796666246981,1.65033334871897e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,DDC,Aromatic-L-amino-acid decarboxylase,29433,-0.0182144420290051,0.00322667876785372,-0.0245387324139984,-0.0118901516440118,1.66748719118669e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,29274,0.00982867077628207,0.00174574965921272,0.00640700144422513,0.013250340108339,1.81798853106968e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,GZMH,Granzyme H,28916,0.0287500253902075,0.00511009825017812,0.0187342328198584,0.0387658179605566,1.86011859492303e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK8,Kallikrein-8,28443,0.0135315700772751,0.00240593797261864,0.00881593165094258,0.0182472085036077,1.88076313309521e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,HSBP1,Heat shock factor-binding protein 1,24240,0.0359349562494084,0.00641275656753547,0.0233659533770389,0.0485039591217779,2.12143059958546e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,COL9A2,Collagen alpha-2(IX) chain,24445,0.0170824868506901,0.00305124054451286,0.0111020553834449,0.0230629183179353,2.18487190985787e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,B4GALT1,"Beta-1,4-galactosyltransferase 1",29581,0.010306095708503,0.00184135252083873,0.00669704476765912,0.013915146649347,2.1999217377733e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,SCGN,Secretagogin,28931,-0.0164879059089891,0.00294844774977371,-0.0222668634985456,-0.0107089483194327,2.26411675385792e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,GGT5,Glutathione hydrolase 5 proenzyme,29218,0.00869047787694769,0.00155802627117984,0.0056367463854352,0.0117442093684602,2.4562617975152e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29725,0.0124527389799643,0.00224591561715696,0.00805074437033669,0.016854733589592,2.97102653038459e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CALCB,Calcitonin gene-related peptide 2,24845,0.0148923750990344,0.00269159089060726,0.00961685695344419,0.0201678932446247,3.18107623864535e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CLGN,Calmegin,24195,0.0166231491743279,0.00301354984601187,0.0107165914761446,0.0225297068725111,3.50082561136203e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,24229,0.0124832297046608,0.002264089057214,0.00804561515252136,0.0169208442568002,3.55200567044833e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHX2,Bifunctional epoxide hydrolase 2,28916,0.0227792362023279,0.00413170630073684,0.0146810918528837,0.0308773805517721,3.55224099238914e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CRNN,Cornulin,28580,0.0246084085351277,0.00446935427973974,0.0158484741468378,0.0333683429234176,3.70167022206615e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,SAT2,Thialysine N-epsilon-acetyltransferase,24445,0.0256411261887122,0.0046647995248533,0.0164981191199997,0.0347841332574246,3.90772978729993e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF2,Granulocyte-macrophage colony-stimulating factor,24111,0.0131698232346034,0.00240636662630256,0.00845334464705036,0.0178863018221564,4.47120349409394e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSV,Cathepsin L2,29618,0.0150770019884723,0.00276880869734079,0.00965013694168437,0.0205038670352603,5.21282023999143e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29820,0.0254070167592346,0.00467795913422272,0.0162382168561581,0.0345758166623112,5.64078863873294e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29443,-0.0132349083790658,0.00244112834050414,-0.0180195199264539,-0.00845029683167771,5.95202376548547e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,PREB,Prolactin regulatory element-binding protein,28931,0.0105122604562347,0.00193941007477943,0.00671101670966704,0.0143135042028024,5.99613697323912e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,PEAR1,Platelet endothelial aggregation receptor 1,29820,0.00821398961213782,0.00151911153809955,0.0052365309974627,0.0111914482268129,6.45447954720402e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28393,0.0230034221836477,0.00427089960843286,0.0146324589511193,0.0313743854161761,7.25815381915332e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,VEGFB,Vascular endothelial growth factor B,24229,0.010454609577815,0.0019417257853709,0.00664882703848804,0.014260392117142,7.34508737397646e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,UMOD,Uromodulin,29750,-0.0193952003429968,0.003603520896984,-0.0264581013010855,-0.0123322993849082,7.40994502504672e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,TSPAN8,Tetraspanin-8,24805,0.0361278524637621,0.00671279816843771,0.0229707680536242,0.0492849368739,7.43572444279694e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29566,0.0162598915311629,0.00302353832507079,0.0103337564140242,0.0221860266483017,7.59861631525471e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,FUCA1,Tissue alpha-L-fucosidase,29623,0.0294080367538315,0.00549264893662783,0.018642444838041,0.0401736286696221,8.66364086272668e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29820,0.00978975950595162,0.00183312453700721,0.00619683541341748,0.0133826835984858,9.33805893990644e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,WIF1,Wnt inhibitory factor 1,29725,0.0121515585974783,0.00227553004449964,0.00769151971025904,0.0166115974846976,9.35768658627772e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29517,-0.0175193715189903,0.00328596582868035,-0.0239598645432038,-0.0110788784947768,9.80799537731216e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24938,0.0129426734076747,0.00242865382219881,0.00818251191616503,0.0177028348991844,9.95273590106335e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,GBP2,Guanylate-binding protein 2,28931,0.0213377491983397,0.00400702804731379,0.0134839742256047,0.0291915241710748,1.01660615766182e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24951,0.0153708332690823,0.00289311582317898,0.00970032625565152,0.0210413402825131,1.0881993473443e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,LAG3,Lymphocyte activation gene 3 protein,29349,-0.0145034445946188,0.00273128780257604,-0.0198567686876679,-0.00915012050156981,1.10354452859918e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CPTP,Ceramide-1-phosphate transfer protein,24111,-0.0141999974467631,0.00267527854502356,-0.0194435433950092,-0.00895645149851687,1.11902196272856e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDH12,Protocadherin-12,24867,0.00908039752510684,0.00171217141834163,0.00572454154515723,0.0124362535050564,1.14612033822318e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,BRD3,Bromodomain-containing protein 3,24111,0.0170571644105862,0.00321671686753197,0.0107523993502235,0.0233619294709488,1.15131134267807e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX25,ATP-dependent RNA helicase DDX25,24195,-0.0133987106444502,0.00252751949727668,-0.0183526488591125,-0.00844477242978795,1.16097036522294e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CPA4,Carboxypeptidase A4,23902,0.0155807070799391,0.00294315098057769,0.00981213115800682,0.0213492830018714,1.20801169946109e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,SIL1,Nucleotide exchange factor SIL1,24240,0.0113354984301029,0.00216624694718461,0.00708965441362109,0.0155813424465847,1.68367177118602e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,PMS1,PMS1 protein homolog 1,24195,0.0177871170204752,0.00340558247134457,0.0111121753766399,0.0244620586643106,1.77572285594158e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA1,Annexin A1,24281,0.0149718954613713,0.00286906921216745,0.00934851980552309,0.0205952711172195,1.81977866229311e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,DKK3,Dickkopf-related protein 3,29820,-0.0102606211008551,0.00196636375180707,-0.014114694054397,-0.00640654814731326,1.82007414996064e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF3,Granulocyte colony-stimulating factor,28931,0.0168752546483581,0.0032364419266617,0.0105318284721012,0.023218680824615,1.85943268165756e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ERC2,ERC protein 2,24195,0.0262389409794809,0.00505746643495732,0.0163263067669645,0.0361515751919972,2.14096043815134e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,RCC1,Regulator of chromosome condensation,24793,0.0177085120974774,0.00345025736266039,0.010946007666663,0.0244710165282918,2.88047545278492e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB7,Integrin beta-7,29725,0.0157150187868561,0.00306240932542889,0.00971269650901547,0.0217173410646967,2.89116410412765e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,MYL4,Myosin light chain 4,24240,-0.0178913526390092,0.00348980525989186,-0.0247313709483972,-0.0110513343296211,2.97055633286145e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,LSM1,U6 snRNA-associated Sm-like protein LSm1,28797,0.0190127645812224,0.00371434302890674,0.0117326522445652,0.0262928769178796,3.09557157034122e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,TACSTD2,Tumor-associated calcium signal transducer 2,25976,-0.0106610018397931,0.00208996787471206,-0.0147573388742287,-0.00656466480535744,3.4017484341375e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,RSPO3,R-spondin-3,29725,0.0096408702134143,0.00189446502653349,0.00592771876140866,0.0133540216654199,3.62210768306769e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,FGFR4,Fibroblast growth factor receptor 4,24381,0.0180549107009287,0.00355133321735376,0.0110942975949153,0.025015523806942,3.72339514685301e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,TPSAB1,Tryptase alpha/beta-1,29753,0.0177773621134127,0.00349736198286758,0.0109225326269923,0.0246321915998332,3.73616609149169e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,KLRK1,NKG2-D type II integral membrane protein,24845,0.0157842536787223,0.0031141724562792,0.0096804756644151,0.0218880316930296,4.0379183829208e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,24240,0.0213228573546652,0.00420738323756677,0.0130763862090344,0.0295693285002961,4.0505423333759e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CENPF,Centromere protein F,24445,0.0184081124001967,0.00363590323156408,0.0112817420663311,0.0255344827340623,4.15986195320059e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CA1,Carbonic anhydrase 1,28867,0.020185929154515,0.0039903514622808,0.0123648402884446,0.0280070180205854,4.24744843017158e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL9,C-X-C motif chemokine 9,29581,0.0224349738542981,0.00443742770847669,0.0137376155456838,0.0311323321629124,4.31031325900492e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,MPO,Myeloperoxidase,29443,0.0154907720706076,0.00306634742169621,0.00948073112408301,0.0215008130171322,4.40131791331853e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNG,Interferon gamma,28931,0.0381634956921231,0.00760294584508499,0.0232617218357565,0.0530652695484897,5.20952879383426e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CA14,Carbonic anhydrase 14,29725,0.011894730554978,0.00237633242861743,0.00723711899488785,0.0165523421150682,5.6035562898062e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,SATB1,DNA-binding protein SATB1,24867,0.00994797743739285,0.00198978293044578,0.00604800289371912,0.0138479519810666,5.78612409057793e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ACP1,Low molecular weight phosphotyrosine protein phosphatase,24229,0.0147209118177099,0.00295258364635276,0.00893384787085853,0.0205079757645613,6.21406521940012e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ACE,Angiotensin-converting enzyme,24951,-0.00874640927839898,0.00175616766795274,-0.0121884979075863,-0.00530432064921161,6.387811596371e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,INHBB,Inhibin beta B chain,24381,0.0173263822278207,0.00347899037081442,0.0105075611010244,0.024145203354617,6.39226840596533e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB5,Integrin beta-5,29566,0.0125316426056898,0.00251807101169661,0.00759622342276444,0.0174670617886152,6.504610875639e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24793,0.0222869079033759,0.00448051081691746,0.0135051067022177,0.0310687091045341,6.59594218764909e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,SCARF2,Scavenger receptor class F member 2,29694,-0.00966846809730175,0.00194836264238084,-0.0134872588763682,-0.0058496773182353,7.00283926693726e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,REG3G,Regenerating islet-derived protein 3-gamma,24793,0.0132646931107735,0.00267893600739309,0.00801397853628307,0.018515407685264,7.41357009169187e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,29218,0.0128584639579856,0.00260102318074407,0.00776045852372727,0.017956469392244,7.71106887648426e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,REG4,Regenerating islet-derived protein 4,29497,0.0163020424773973,0.00331858875842968,0.00979760851087509,0.0228064764439194,9.04766135032647e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,BAMBI,BMP and activin membrane-bound inhibitor homolog,28797,0.00984976792259645,0.00200521151009864,0.00591955336280312,0.0137799824823898,9.06072434696062e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,IL4R,Interleukin-4 receptor subunit alpha,29434,-0.0120655585525639,0.00245865349831139,-0.0168845194092543,-0.00724659769587363,9.27920006391628e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,DNPEP,Aspartyl aminopeptidase,24845,0.0191662619509566,0.00390546545176927,0.0115115496654889,0.0268209742364244,9.28058208698226e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CX3CL1,Fractalkine,29218,-0.0110669685855871,0.00225858591259144,-0.0154937969742663,-0.00664014019690784,9.63716939120217e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,KIAA1549L,UPF0606 protein KIAA1549L,24445,-0.00926754891776892,0.0018941777467823,-0.0129801373014622,-0.0055549605340756,1.0012014282644e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,SNU13,NHP2-like protein 1,24111,0.0205477628896554,0.00420103059664449,0.0123137429202322,0.0287817828590786,1.00907574842529e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CD209,CD209 antigen,29527,0.0126621946283789,0.00259827735147142,0.00756957101949488,0.0177548182372628,1.10316290109609e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,ROBO4,Roundabout homolog 4,24240,-0.00588385225449025,0.00120733646680216,-0.00825023172942248,-0.00351747277955801,1.10378322711066e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,AKR1C4,Aldo-keto reductase family 1 member C4,28916,0.0173736914366914,0.00356569262883488,0.010384933884175,0.0243624489892077,1.10800819181055e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,EP300,Histone acetyltransferase p300,24229,0.00987104977523532,0.00202816274941222,0.00589585078638737,0.0138462487640833,1.14022932800685e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,TK1,"Thymidine kinase, cytosolic",24445,0.014913868714096,0.00307011947791015,0.00889643453739214,0.0209313028907999,1.19462773972321e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24793,0.0146126805141372,0.00301067638868525,0.0087117547923141,0.0205136062359603,1.21964908947992e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CKAP4,Cytoskeleton-associated protein 4,29678,0.0087957238142854,0.00181576388177008,0.00523682660601605,0.0123546210225548,1.27834241177849e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,LRP1,Prolow-density lipoprotein receptor-related protein 1,29349,0.00858039060600202,0.00177576942965721,0.00509988252387388,0.0120608986881302,1.35899410631255e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,SRPX,Sushi repeat-containing protein SRPX,24922,-0.0114357697071841,0.00237690567133203,-0.0160945048229949,-0.0067770345913733,1.50903888992308e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CALB1,Calbindin,29349,0.0140318863114801,0.00291944248463542,0.00830977904159468,0.0197539935813655,1.54464492449056e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,MERTK,Tyrosine-protein kinase Mer,29786,0.00816985143922828,0.00170069129248069,0.00483649650596614,0.0115032063724904,1.56406898113167e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",24111,-0.0131652110800612,0.0027413632896203,-0.018538283127717,-0.00779213903240541,1.57691039306316e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,NEFL,Neurofilament light polypeptide,28674,0.0143659519833084,0.00299613334641173,0.00849353062434145,0.0202383733422754,1.63628846625772e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,QSOX1,Sulfhydryl oxidase 1,24502,0.013718514374137,0.0028613753282227,0.00811021873082047,0.0193268100174535,1.6413826481005e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,SIRT1,NAD-dependent protein deacetylase sirtuin-1,24229,0.0279696860175044,0.00583962589469161,0.0165240192639088,0.0394153527710999,1.68071601991151e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,HAVCR2,Hepatitis A virus cellular receptor 2,29443,-0.0112488582987975,0.00235024368761784,-0.0158553359265285,-0.00664238067106653,1.7074895125443e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,UBAC1,Ubiquitin-associated domain-containing protein 1,29349,0.0110003384754049,0.00229876986079601,0.00649474954824468,0.015505927402565,1.71549225368221e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,NTF4,Neurotrophin-4,28797,0.0125919163585167,0.00263776040245791,0.00742190596969923,0.0177619267473342,1.81746213148298e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,GLP1R,Glucagon-like peptide 1 receptor,24101,-0.0121063888394463,0.00254445162382924,-0.0170935140221516,-0.00711926365674102,1.96696328904017e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29345,0.0587703897850537,0.0123845600278108,0.0344966521305444,0.0830441274395629,2.09016298002146e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,LIF,Leukemia inhibitory factor,28774,0.0162473344715573,0.0034358371880999,0.00951309358288153,0.0229815753602331,2.26937803379258e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,MSLN,Mesothelin,29293,0.0176750233990687,0.00374307678738166,0.0103385928958006,0.0250114539023367,2.34551331381561e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,TSC1,Hamartin,24229,0.0238063684515709,0.00504186609924366,0.0139243108970533,0.0336884260060884,2.35147047453692e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP6V1D,V-type proton ATPase subunit D,29349,0.008221896705893,0.00174495598938671,0.00480178296669505,0.0116420104450909,2.46654012704668e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA7A,Semaphorin-7A,29736,0.00869839329676486,0.0018473032468128,0.00507767893301177,0.0123191076605179,2.50428276291379e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,SOX9,Transcription factor SOX-9,24195,0.00863157565343205,0.00183332659924729,0.00503825551890735,0.0122248957879567,2.51361352331857e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,SLURP1,Secreted Ly-6/uPAR-related protein 1,24801,0.0117505703156842,0.00250238912326447,0.00684588763408584,0.0166552529972826,2.67064245122942e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,PROCR,Endothelial protein C receptor,24111,-0.0112581071970325,0.00240783934446012,-0.0159774723121743,-0.00653874208189069,2.94674645499875e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,TIE1,Tyrosine-protein kinase receptor Tie-1,29820,0.0127918457148234,0.0027478786579409,0.00740600354525925,0.0181776878843876,3.25104657141744e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,RBPMS,RNA-binding protein with multiple splicing,24229,0.0200797338357456,0.00432679822038408,0.0115992093237928,0.0285602583476984,3.48908177698146e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24445,0.017317720585652,0.00373981971146683,0.00998767395117703,0.024647767220127,3.66431420505657e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CAPS,Calcyphosin,24845,0.0293913821625107,0.00635182590515811,0.0169418033884008,0.0418409609366206,3.72453676187602e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,MYOC,Myocilin,29443,0.0141087522517647,0.00305204760925166,0.0081267389376314,0.0200907655658979,3.80353436814684e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,ULBP2,UL16-binding protein 2,29218,0.0117730345560793,0.00255283158981919,0.00676948464003366,0.0167765844721249,4.00974725407267e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CLSTN1,Calsyntenin-1,28774,0.0159085217338715,0.00345410356706178,0.00913847874243045,0.0226785647253126,4.12865231132701e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,TLR4,Toll-like receptor 4,24229,0.00876654951789352,0.00190473885702599,0.00503326135812259,0.0124998376776645,4.19578796053683e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT19,"Keratin, type I cytoskeletal 19",29378,-0.0208011999775273,0.00453056282811977,-0.0296811031206421,-0.0119212968344126,4.42305902805769e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28931,0.0130630870572036,0.00284716703284711,0.0074826396728233,0.018643534441584,4.49175065444239e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24938,-0.0121969218603612,0.00266104772773999,-0.0174125754067316,-0.00698126831399084,4.59466797412944e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29694,0.0217767804343384,0.00475367123869753,0.0124595848064912,0.0310939760621855,4.6453894598507e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB2,Integrin beta-2,29274,0.0087948233648817,0.00192086432628966,0.00502992928535396,0.0125597174444094,4.70077694794139e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,ARTN,Artemin,28931,0.0136976716077012,0.00299355721232665,0.00783029947154097,0.0195650437438614,4.76561646833821e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24445,0.0199054200587783,0.00435020580638358,0.0113790166782665,0.0284318234392902,4.76867684490317e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,NEDD9,Enhancer of filamentation 1,24229,0.010238979657754,0.00223894569923,0.00585064608726321,0.0146273132282448,4.82880319279081e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,IL18BP,Interleukin-18-binding protein,29594,0.0094096507412935,0.00206242862786678,0.00536729063067461,0.0134520108519124,5.07720859952705e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,UROS,Uroporphyrinogen-III synthase,24195,0.0208663157166719,0.00457844343113323,0.0118925665916507,0.029840064841693,5.20160819080058e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CELA2A,Chymotrypsin-like elastase family member 2A,24938,0.018712956195996,0.00411065955510634,0.0106560634679876,0.0267698489240045,5.3313263889615e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,LMOD1,Leiomodin-1,24867,-0.0108197725180129,0.00237840614238475,-0.015481448557087,-0.00615809647893876,5.41125918300145e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP152,Centrosomal protein of 152 kDa,24016,0.0127368181012691,0.00280243145753013,0.00724405244451005,0.0182295837580282,5.52249110627608e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,TDGF1,Teratocarcinoma-derived growth factor 1,28774,0.0440735157683384,0.00969940354877459,0.0250626848127403,0.0630843467239366,5.54365936143903e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CFC1,Cryptic protein,28797,0.0142719485967982,0.00314419062513653,0.0081093349715306,0.0204345622220658,5.67102931488286e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24805,-0.00917923977870596,0.00202422199928544,-0.0131467148973054,-0.00521176466010651,5.79553563148597e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC28A1,Sodium/nucleoside cotransporter 1,24016,0.018081922614125,0.0039883029689488,0.0102648487949854,0.0258989964332647,5.82286847780139e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,OBP2B,Odorant-binding protein 2b,29137,-0.0189840128701549,0.00418753528359789,-0.0271915820260068,-0.0107764437143031,5.82568395980708e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA1,Alpha-1-antitrypsin,24548,-0.00247004756772026,0.000546015451952616,-0.00354023785354739,-0.00139985728189313,6.10327802407057e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,MAEA,E3 ubiquitin-protein transferase MAEA,28797,0.0120165749755718,0.00266288221399727,0.00679732583613713,0.0172358241150064,6.42850146468542e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,NPR1,Atrial natriuretic peptide receptor 1,24111,-0.0125193372860345,0.00277451290430992,-0.0179573825784819,-0.00708129199358702,6.4442023526875e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,BCAM,Basal cell adhesion molecule,29443,-0.0072522605402106,0.00160857251916792,-0.0104050626777797,-0.00409945840264148,6.55370679644974e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17RA,Interleukin-17 receptor A,29443,0.0132620412465773,0.00294448178131723,0.00749085695519554,0.0190332255379591,6.69320964931189e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,IGLC2,Immunoglobulin lambda constant 2,24915,-0.0074750474958254,0.00166787517291201,-0.0107440828347329,-0.00420601215691787,7.43531971184345e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,STX3,Syntaxin-3,24845,0.0115164187272295,0.00257209490243102,0.0064751127184647,0.0165577247359943,7.58771480728902e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,STX5,Syntaxin-5,24229,0.0122837351794945,0.00274367690494539,0.00690612844580152,0.0176613419131875,7.60065280598655e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC13A1,Solute carrier family 13 member 1,24793,0.0182858169602843,0.00409313326003889,0.0102632757706081,0.0263083581499605,7.95121681552676e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29349,0.0116139024789491,0.00260018441348209,0.00651754102852424,0.016710263929374,7.97806970929228e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,TMOD4,Tropomodulin-4,24016,-0.0122580160428273,0.00275442959190895,-0.0176566980429688,-0.00685933404268577,8.61393568649905e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRC38,Leucine-rich repeat-containing protein 38,24195,0.0144260509506918,0.00324196836332036,0.00807179295858392,0.0207803089427997,8.63413186999575e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,TRAF3,"TNF receptor-associated factor 3, Isoform 2",24229,0.0107840260701839,0.00242548351000724,0.00603007839056972,0.0155379737497981,8.7817627255519e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,SCGB2A2,Mammaglobin-A,24111,-0.00939525833626999,0.00212136969106899,-0.0135531429307652,-0.00523737374177477,9.5147314067748e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHB6,Ephrin type-B receptor 6,29163,0.00938968759268887,0.00213348801400169,0.00520805108524557,0.0135713241001322,1.08087205184503e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24381,-0.0188201891770523,0.00429840835707002,-0.0272450695569095,-0.010395308797195,1.20046633350926e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,24101,0.0181140155389456,0.00414395475244972,0.00999186422414419,0.0262361668537471,1.24088105330905e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LCN2,Neutrophil gelatinase-associated lipocalin,28586,-0.0112010648484844,0.00256731718495566,-0.0162330065309975,-0.00616912316597133,1.28772335667807e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ICAM4,Intercellular adhesion molecule 4,29434,-0.0153293568005611,0.00351550458418848,-0.0222197457855705,-0.00843896781555169,1.30206123972888e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFBR2,TGF-beta receptor type-2,29566,0.00953836473765342,0.00218886195302495,0.00524819530972452,0.0138285341655823,1.31890069265294e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29349,0.010053876098423,0.00231123953600156,0.00552384660785999,0.0145839055889861,1.36600909869112e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF5,Eukaryotic translation initiation factor 5,24111,0.0128744692178484,0.00295986934355176,0.00707312530448698,0.0186758131312099,1.3689926045409e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CPVL,Probable serine carboxypeptidase CPVL,29662,0.011830259295817,0.00272184831808593,0.00649543659236863,0.0171650819992655,1.38846277797546e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29786,0.0112616881522501,0.00259241469270798,0.00618055535454246,0.0163428209499577,1.40315137168025e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,NTRK3,NT-3 growth factor receptor,29694,0.00627089386319047,0.00144680396499275,0.00343515809180468,0.00910662963457625,1.4670008168034e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PDRG1,p53 and DNA damage-regulated protein 1,24195,0.0151928425445489,0.00350743260083597,0.00831827464691042,0.0220674104421874,1.48616591746591e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM26,Tripartite motif-containing protein 26,24016,0.0162816816186778,0.00376328196240852,0.00890564897235708,0.0236577142649985,1.52138038021977e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,EDN1,Endothelin-1,24240,0.00844569756832765,0.00195729398573513,0.00460940135628678,0.0122819937803685,1.6024462834523e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,GSAP,Gamma-secretase-activating protein,28797,0.0250664618212874,0.00581054386528716,0.0136777958453245,0.0364551277972502,1.60888891346852e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,AIF1L,Allograft inflammatory factor 1-like,24240,0.016513983653342,0.00384354002747761,0.00898064519948588,0.0240473221071981,1.74148317996698e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,MANSC4,MANSC domain-containing protein 4,24111,0.0191690247114362,0.00447420909129509,0.0103995748924978,0.0279384745303746,1.83994160435835e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CENPJ,Centromere protein J,24445,0.0206202290500478,0.00481790118769109,0.0111771427221732,0.0300633153779223,1.87672668320935e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ATXN10,Ataxin-10,28774,0.0207839441949413,0.00486231079479924,0.0112538150371348,0.0303140733527478,1.92183648356454e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LY96,Lymphocyte antigen 96,29218,-0.0101640361018847,0.00237884303675571,-0.0148265684539259,-0.00550150374984355,1.93748114849628e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24966,0.00535367883731989,0.00125311988675231,0.00289756385928536,0.00780979381535443,1.94200787636097e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,GPR158,Probable G-protein coupled receptor 158,24867,0.0102479467888561,0.00240441602216946,0.005535291385404,0.0149606021923083,2.03228387753409e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SULT1A1,Sulfotransferase 1A1,29694,-0.0365245920301358,0.00857493935443874,-0.0533314731648357,-0.0197177108954358,2.05553754134473e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC4A1,Band 3 anion transport protein,24938,-0.0133509259680977,0.00313531958970913,-0.0194961523639276,-0.00720569957226778,2.06801847249036e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,REG1B,Lithostathine-1-beta,29820,-0.0160058519875117,0.003765857463963,-0.0233869326168792,-0.00862477135814422,2.1417658108097e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,MNAT1,CDK-activating kinase assembly factor MAT1,24445,0.0124534351818693,0.0029439899929491,0.00668321479568909,0.0182236555680495,2.34415504310014e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24867,0.0201611151493867,0.004779489030513,0.0107933166495812,0.0295289136491922,2.4706931790683e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,28301,0.0106355664052512,0.00252440082369597,0.00568774079080708,0.0155833920196953,2.52663388313868e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,24111,-0.00889960743093657,0.00211810822329171,-0.0130510995485883,-0.00474811531328481,2.6589764412138e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP1,Caspase-1,28774,0.0190676090060001,0.00454016003339854,0.010168895340539,0.0279663226714612,2.67994955781737e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24845,0.0154397690158616,0.00368003145104342,0.00822690737181654,0.0226526306599067,2.73150962609033e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,AXL,Tyrosine-protein kinase receptor UFO,29594,0.00773816456919923,0.00184495852421665,0.0041220458617346,0.0113542832766639,2.7460725075614e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,EFNA1,Ephrin-A1,29390,0.00791140768637537,0.00188839241813397,0.00421015854683278,0.011612656825918,2.80393600264484e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SBSN,Suprabasin,24905,-0.00967767754619216,0.00231039736894199,-0.0142060563893185,-0.00514929870306586,2.8146033189344e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,RPS10,40S ribosomal protein S10,24111,-0.0117894019121041,0.00281815608245002,-0.0173129878337062,-0.00626581599050209,2.88230047022834e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29694,0.00769489138173458,0.00184414189028953,0.00408037327676709,0.0113094094867021,3.01981850773954e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,JCHAIN,Immunoglobulin J chain,28931,-0.0171789882962033,0.00411924142671715,-0.0252527014925689,-0.00910527509983767,3.04917522837035e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28498,-0.0238465841675472,0.00571871503183346,-0.0350552656299407,-0.0126379027051536,3.05607344889286e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA6C,Semaphorin-6C,24229,0.00731578270451429,0.00175967157062408,0.0038668264260911,0.0107647389829375,3.22897283185853e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,NGF,Beta-nerve growth factor,29218,0.00337570851014386,0.000813587281482244,0.00178107743843866,0.00497033958184906,3.34633092731295e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,NDRG1,Protein NDRG1,28774,0.0187093097207112,0.00450965774257253,0.00987038054526907,0.0275482388961534,3.35298717360791e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,NMRK2,Nicotinamide riboside kinase 2,24016,-0.0115715881557625,0.0027919500504012,-0.0170438102545489,-0.00609936605697617,3.41536075944714e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,AHSP,Alpha-hemoglobin-stabilizing protein,29400,0.0233817113567006,0.00564171071587073,0.012323958353594,0.0344394643598072,3.4160402987038e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,HMOX1,Heme oxygenase 1,29165,-0.0132938440174108,0.00321020948749158,-0.0195858546128943,-0.00700183342192732,3.4659518891684e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,29218,-0.00789814591569251,0.0019110556463315,-0.0116438149825023,-0.00415247684888276,3.59258731081625e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24966,-0.00538932237911352,0.00130436327903621,-0.0079458744060245,-0.00283277035220254,3.61161809568177e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SAFB2,Scaffold attachment factor B2,24867,0.00759862459766709,0.00183935245366681,0.00399349378848015,0.011203755406854,3.62147312133274e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,THBS2,Thrombospondin-2,29443,-0.0102999062166476,0.00250005189953371,-0.0152000079397337,-0.00539980449356158,3.80110689975758e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,NAMPT,Nicotinamide phosphoribosyltransferase,28797,0.0142032680304677,0.00345054501163264,0.00744019980766772,0.0209663362532677,3.86177364283164e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,RANBP2,E3 SUMO-protein ligase RanBP2,24101,-0.00916232793938208,0.0022273942687879,-0.0135280207062064,-0.0047966351725578,3.91043229715616e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24867,0.0072138362068797,0.00175677702680366,0.00377055323434452,0.0106571191794149,4.03349432230428e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CA6,Carbonic anhydrase 6,29372,-0.0173025275800954,0.00422197470479522,-0.025577598001494,-0.00902745715869675,4.17480247895107e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,IL2RA,Interleukin-2 receptor subunit alpha,29223,-0.0110751474057651,0.00270323234875597,-0.0163734828093268,-0.00577681200220343,4.19664168870089e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGAP5,Rho GTPase-activating protein 5,24016,0.0210944223089326,0.00514874340465999,0.011002885235799,0.0311859593820662,4.19904978490328e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29372,0.0162002609956058,0.003974846273808,0.00840956229894216,0.0239909596922695,4.59977546042865e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SMPD1,Sphingomyelin phosphodiesterase,29530,-0.013405801169412,0.00329137585874934,-0.0198568978525607,-0.0069547044862633,4.6530846066691e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF43,E3 ubiquitin-protein ligase RNF43,24445,0.0158791747501205,0.00390509216301945,0.0082251941106024,0.0235331553896387,4.79204170303397e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,KIAA1549,UPF0606 protein KIAA1549,24445,0.0189625201788883,0.00467241964410318,0.00980457767644608,0.0281204626813306,4.95649925788223e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,UNC5D,Netrin receptor UNC5D,24229,0.00719898752282952,0.00177393473037408,0.00372207545129632,0.0106758995943627,4.96068663079772e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ALPP,"Alkaline phosphatase, placental type",29349,0.0280674715563839,0.00691992622370567,0.0145044161579208,0.041630526954847,5.00414754930723e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SEPTIN3,Neuronal-specific septin-3,24867,-0.0205736235152885,0.00507668581977939,-0.0305239277220561,-0.0106233193085209,5.0812121015949e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CD79B,B-cell antigen receptor complex-associated protein beta chain,29786,-0.0120899723020024,0.00299142922702746,-0.0179531735869762,-0.00622677101702857,5.32353284273017e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMP2,Metalloproteinase inhibitor 2,24922,-0.00719843239719537,0.00178216424665528,-0.0106914743206397,-0.00370539047375102,5.38054772201752e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28931,0.0150185254035546,0.00372364110975072,0.00772018882844321,0.022316861978666,5.51423922385561e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A14,Protein S100-A14,24867,0.0142946488946601,0.00354420070949879,0.00734801550404246,0.0212412822852777,5.51748501038859e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,24240,-0.00705427354142935,0.0017536499936761,-0.0104914275290345,-0.00361711955382419,5.77280070597328e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB39B,Ras-related protein Rab-39B,24111,0.024356321682562,0.00606906361631739,0.0124609569945799,0.0362516863705441,6.00839870594018e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SEPTIN8,Septin-8,24801,0.00860108187381903,0.0021557980642013,0.00437571766798447,0.0128264460796536,6.63347467985609e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PGA4,Pepsin A-4,24951,0.0189993548946047,0.00476903750718194,0.00965204138052807,0.0283466684086813,6.79867531377285e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CHRM1,Muscarinic acetylcholine receptor M1,24195,-0.00987009702149816,0.00247842277786862,-0.0147278056661207,-0.00501238837687565,6.84193208939809e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29673,0.00915676817781235,0.0023103020865366,0.00462857608820062,0.0136849602674241,7.40471198708236e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,QPCT,Glutaminyl-peptide cyclotransferase,29517,0.00709633796138895,0.00179765862098747,0.0035729270642535,0.0106197488585244,7.91397767457813e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFB104A_DEFB104B,Beta-defensin 104,24101,0.0149144111905661,0.00377833993801162,0.00750886491206329,0.0223199574690688,7.92470262277308e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKCQ,Protein kinase C theta type,28931,0.0114948178270978,0.00291395766525529,0.00578346080319746,0.0172061748509982,8.0073617836551e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,APOD,Apolipoprotein D,23787,-0.0114677881713298,0.00292118366312307,-0.017193308151051,-0.00574226819160856,8.67095360503377e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC16A1,Monocarboxylate transporter 1,28774,0.0151094610304523,0.00386237624014782,0.00753920359976257,0.022679718461142,9.17604951120238e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,DPEP2,Dipeptidase 2,29349,0.00765337211864015,0.00195929056089131,0.00381316261929319,0.0114935816179871,9.39706993897483e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,FMR1,Synaptic functional regulator FMR1,28797,0.00927691676929569,0.00237517550423276,0.00462157278099949,0.0139322607575919,9.41356910932998e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PLB1,"Phospholipase B1, membrane-associated",24845,0.0156679698772324,0.00402101124440111,0.00778678783820623,0.0235491519162586,9.78387470003971e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TNXB,Tenascin-X,29443,0.00669530811336099,0.00172542074524539,0.00331348345268002,0.010077132774042,0.000104515575873955
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK11,Kallikrein-11,29296,0.00799102259605939,0.00206165479995292,0.00395017918815168,0.0120318660039671,0.000106408838730553
NMR metabolomics,X23428.Concentration of VLDL Particles,BABAM1,BRISC and BRCA1-A complex member 1,24229,0.00761592363916585,0.00197630615101315,0.00374236358318009,0.0114894836951516,0.000116686588614267
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP9,Matrix metalloproteinase-9,29411,-0.0155778652161118,0.00404322565835891,-0.0235025875064953,-0.00765314292572836,0.000117007800975179
NMR metabolomics,X23428.Concentration of VLDL Particles,CTRL,Chymotrypsin-like protease CTRL-1,24845,-0.0175627530685622,0.00456316724684948,-0.0265065608723872,-0.00861894526473719,0.00011899127916994
NMR metabolomics,X23428.Concentration of VLDL Particles,CLIC5,Chloride intracellular channel protein 5,24195,-0.0081740069389132,0.00213886322989385,-0.0123661788695052,-0.00398183500832126,0.000132888420952333
NMR metabolomics,X23428.Concentration of VLDL Particles,IL15RA,Interleukin-15 receptor subunit alpha,28931,0.00898304883022064,0.00235224300082983,0.00437265254859418,0.0135934451118471,0.000134312103158107
NMR metabolomics,X23428.Concentration of VLDL Particles,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",24229,0.0158168610870829,0.00416104533967047,0.00766121222132881,0.0239725099528371,0.00014436432223977
NMR metabolomics,X23428.Concentration of VLDL Particles,MYOM1,Myomesin-1,24101,0.0121546526895461,0.00320280087310671,0.0058771629782569,0.0184321424008352,0.000148000422911121
NMR metabolomics,X23428.Concentration of VLDL Particles,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29478,0.00804542955143724,0.00212815064787651,0.00387425428159927,0.0122166048212752,0.000156835325696585
NMR metabolomics,X23428.Concentration of VLDL Particles,DRAXIN,Draxin,29218,0.0107773003762482,0.00286966008034537,0.00515276661877128,0.0164018341337251,0.000173261039805774
NMR metabolomics,X23428.Concentration of VLDL Particles,SNX18,Sorting nexin-18,24805,0.0112160687428775,0.00299211650828029,0.00535152038664811,0.0170806170991069,0.000178270640014711
NMR metabolomics,X23428.Concentration of VLDL Particles,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,29218,0.0261410201385643,0.00699352266880741,0.0124337157077018,0.0398483245694268,0.000185924653427346
NMR metabolomics,X23428.Concentration of VLDL Particles,TERF1,Telomeric repeat-binding factor 1,24229,-0.00735557862333114,0.00197251124062766,-0.0112217006549613,-0.00348945659170093,0.000192646599071786
NMR metabolomics,X23428.Concentration of VLDL Particles,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28916,0.00678128671416794,0.00182446342770321,0.00320533839586965,0.0103572350324662,0.000202089442560486
NMR metabolomics,X23428.Concentration of VLDL Particles,IL10RA,Interleukin-10 receptor subunit alpha,28931,0.0144668752257825,0.00389488659496572,0.00683289749964973,0.0221008529519153,0.000204129709430453
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29694,-0.0112968020527241,0.00304155357661158,-0.0172582470628828,-0.00533535704256542,0.00020425699458031
NMR metabolomics,X23428.Concentration of VLDL Particles,LAYN,Layilin,29163,-0.00868541765684254,0.00233854911756603,-0.013268973927272,-0.00410186138641312,0.000204373158206954
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP3,"Fatty acid-binding protein, heart",24922,0.0125997897506067,0.0033959518453011,0.00594372413381654,0.0192558553673968,0.000207514540539502
NMR metabolomics,X23428.Concentration of VLDL Particles,VIM,Vimentin,28916,0.0288945280120335,0.00779891919721164,0.0136086463854987,0.0441804096385684,0.000211834670550793
NMR metabolomics,X23428.Concentration of VLDL Particles,GUCA2A,Guanylin,29333,-0.00847378288075063,0.00228903096259345,-0.0129602835674338,-0.00398728219406747,0.00021437568781807
NMR metabolomics,X23428.Concentration of VLDL Particles,ADA2,Adenosine deaminase 2,29328,-0.0105685179388559,0.00286052545247511,-0.0161751478257072,-0.0049618880520047,0.000220627271915118
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK15,Kallikrein-15,24754,0.01281076134585,0.003469382128307,0.00601077237436831,0.0196107503173317,0.000222520529383079
NMR metabolomics,X23428.Concentration of VLDL Particles,B2M,Beta-2-microglobulin,24966,0.00770203204776541,0.00208632907827136,0.00361282705435354,0.0117912370411773,0.000223263491815087
NMR metabolomics,X23428.Concentration of VLDL Particles,TBC1D17,TBC1 domain family member 17,28774,0.010992048592493,0.00298270569301594,0.00514594543418181,0.0168381517508043,0.000228887785500473
NMR metabolomics,X23428.Concentration of VLDL Particles,ARG1,Arginase-1,29216,0.012752454029225,0.00346291272932738,0.00596514507974337,0.0195397629787067,0.000231301313724861
NMR metabolomics,X23428.Concentration of VLDL Particles,CDKL5,Cyclin-dependent kinase-like 5,24101,-0.0131511528590634,0.0035763186836127,-0.0201607374789442,-0.00614156823918246,0.000236239492070845
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPL52,"39S ribosomal protein L52, mitochondrial",23975,0.00635121398736516,0.00173583108893618,0.00294898505305025,0.00975344292168007,0.000253853820800314
NMR metabolomics,X23428.Concentration of VLDL Particles,TMEM25,Transmembrane protein 25,24867,-0.0110816961575671,0.00303022341545733,-0.0170209340518635,-0.00514245826327074,0.000255655307856931
NMR metabolomics,X23428.Concentration of VLDL Particles,CD58,Lymphocyte function-associated antigen 3,29409,0.00430445619201193,0.00117832795229328,0.00199493340551711,0.00661397897850675,0.000259623765995327
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTSL5,ADAMTS-like protein 5,24922,-0.00961863684274081,0.00264282059081008,-0.0147985652007286,-0.00443870848475305,0.000273683622068307
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29433,0.00778998221740253,0.00214287964650837,0.00358993811024612,0.0119900263245589,0.000278144773368152
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRE1,Adhesion G protein-coupled receptor E1,24805,0.0133287682994211,0.00367614253085056,0.006123528938954,0.0205340076598882,0.000288702793957971
NMR metabolomics,X23428.Concentration of VLDL Particles,PODXL2,Podocalyxin-like protein 2,29566,0.00675652412986217,0.00186485924468795,0.00310140001027378,0.0104116482494506,0.000291609620052705
NMR metabolomics,X23428.Concentration of VLDL Particles,NMI,N-myc-interactor,24706,0.01741340413591,0.00483019581464621,0.00794622033920347,0.0268805879326166,0.000312630754271432
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF31,E3 ubiquitin-protein ligase RNF31,24229,0.00884963391506284,0.00245692366390129,0.00403406353381631,0.0136652042963094,0.000316511796985463
NMR metabolomics,X23428.Concentration of VLDL Particles,TCN1,Transcobalamin-1,24546,0.00825828055754037,0.00229323115522963,0.00376354749329029,0.0127530136217904,0.000317431914136019
NMR metabolomics,X23428.Concentration of VLDL Particles,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28774,0.0114249449783225,0.0031766425246208,0.00519872563006577,0.0176511643265793,0.000323009138246607
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24805,0.00517036581175762,0.00143822090897117,0.00235145283017412,0.00798927879334112,0.000325054228307378
NMR metabolomics,X23428.Concentration of VLDL Particles,LIFR,Leukemia inhibitory factor receptor,29434,-0.00582267386512189,0.00162446225695006,-0.009006619888744,-0.00263872784149977,0.000338439015906083
NMR metabolomics,X23428.Concentration of VLDL Particles,MYO6,Unconventional myosin-VI,24867,0.00897825852196172,0.00250535025453502,0.00406777202307308,0.0138887450208504,0.000339494766486851
NMR metabolomics,X23428.Concentration of VLDL Particles,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28797,-0.00768372592111646,0.00215040827315656,-0.0118985261365033,-0.00346892570572959,0.000353292031993176
NMR metabolomics,X23428.Concentration of VLDL Particles,C1GALT1C1,C1GALT1-specific chaperone 1,24111,0.00780820253617281,0.00219439677333496,0.00350718486043629,0.0121092202119093,0.000374057334827612
NMR metabolomics,X23428.Concentration of VLDL Particles,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24845,-0.00612447068847249,0.00172307602616116,-0.00950169969974837,-0.00274724167719661,0.000379571587198777
NMR metabolomics,X23428.Concentration of VLDL Particles,NRTN,Neurturin,28931,0.0117515788128852,0.00330674905457649,0.00527035066591531,0.0182328069598552,0.000380289111640435
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29434,0.00806904267981334,0.00227079233758196,0.00361828969815271,0.012519795661474,0.00038087507060786
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29478,0.0080348718975842,0.00226522006156234,0.00359504057692201,0.0124747032182464,0.000390160309103804
NMR metabolomics,X23428.Concentration of VLDL Particles,VWC2L,von Willebrand factor C domain-containing protein 2-like,24867,0.0110799475164366,0.00312494801432976,0.00495504940835031,0.017204845624523,0.00039237740400598
NMR metabolomics,X23428.Concentration of VLDL Particles,CDHR1,Cadherin-related family member 1,28774,0.0100899570043272,0.00285987889628816,0.0044845943676024,0.015695319641052,0.000419196347518392
NMR metabolomics,X23428.Concentration of VLDL Particles,CD7,T-cell antigen CD7,24177,0.0103404711245276,0.00293232615731624,0.00459311185618782,0.0160878303928675,0.000422076015387379
NMR metabolomics,X23428.Concentration of VLDL Particles,ENO1,Alpha-enolase,29392,0.0185434526745318,0.00527012729337966,0.00821400317950771,0.028872902169556,0.000434491032697549
NMR metabolomics,X23428.Concentration of VLDL Particles,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28774,0.0117267648662238,0.00334941182016833,0.00516191769869387,0.0182916120337537,0.000463971501110781
NMR metabolomics,X23428.Concentration of VLDL Particles,CCDC28A,Coiled-coil domain-containing protein 28A,24195,0.00696202007306769,0.0019954044029229,0.00305102744333881,0.0108730127027966,0.000485644247466501
NMR metabolomics,X23428.Concentration of VLDL Particles,COL3A1,Collagen alpha-1(III) chain,24938,-0.00544486640526252,0.00156216992341306,-0.00850671945515212,-0.00238301335537292,0.000492153157019583
NMR metabolomics,X23428.Concentration of VLDL Particles,NUP50,Nuclear pore complex protein Nup50,24111,-0.00791290235918744,0.00227110224704263,-0.012364262763391,-0.00346154195498389,0.000494545616388847
NMR metabolomics,X23428.Concentration of VLDL Particles,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24445,0.0122004283167536,0.00350768650189763,0.0053253627730342,0.0190754938604729,0.00050567527039726
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA3G,Semaphorin-3G,24381,0.0103023840449539,0.00296928042086306,0.0044825944200623,0.0161221736698455,0.000522024705854223
NMR metabolomics,X23428.Concentration of VLDL Particles,APOF,Apolipoprotein F,24951,0.00580024342234512,0.00167640433787661,0.00251449092010697,0.00908599592458327,0.000541216979532847
NMR metabolomics,X23428.Concentration of VLDL Particles,SPESP1,Sperm equatorial segment protein 1,24922,0.00704045437951186,0.00203618231260154,0.00304953704681284,0.0110313717122109,0.00054577023319541
NMR metabolomics,X23428.Concentration of VLDL Particles,NME1,Nucleoside diphosphate kinase A,24229,-0.00507104612675472,0.0014713971862443,-0.00795498461179355,-0.00218710764171588,0.000569039955547852
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF9,Fibroblast growth factor 9,23970,0.00944015589411691,0.00274332590943927,0.00406323711161593,0.0148170746766179,0.000580266412625351
NMR metabolomics,X23428.Concentration of VLDL Particles,PADI4,Protein-arginine deiminase type-4,28722,0.0163400028896898,0.00474911224016968,0.00703174289895726,0.0256482628804224,0.000581157584462534
NMR metabolomics,X23428.Concentration of VLDL Particles,MB,Myoglobin,29820,-0.0120603213666455,0.0035065481762006,-0.0189331557919987,-0.00518748694129233,0.000583864348824322
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24867,0.011229279652022,0.00327169985007997,0.00481674794586526,0.0176418113581787,0.000599578179909349
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL28,C-C motif chemokine 28,29327,0.0135719354186717,0.00396002966122181,0.00581027728267693,0.0213335935546664,0.000610607682456022
NMR metabolomics,X23428.Concentration of VLDL Particles,MYBPC1,"Myosin-binding protein C, slow-type",24922,-0.015935516572247,0.00468303300697967,-0.0251142612659271,-0.00675677187856684,0.000667992171323444
NMR metabolomics,X23428.Concentration of VLDL Particles,CRISP2,Cysteine-rich secretory protein 2,29725,0.0130029736062138,0.00384851156986619,0.00545989092927608,0.0205460562831515,0.000729224515868469
NMR metabolomics,X23428.Concentration of VLDL Particles,TTN,Titin,24111,-0.0152491175096515,0.00451335830243309,-0.0240952997824203,-0.00640293523688264,0.000729545401539969
NMR metabolomics,X23428.Concentration of VLDL Particles,NAPRT,Nicotinate phosphoribosyltransferase,24845,0.00752347782859237,0.00222842030796159,0.00315577402498766,0.0118911816321971,0.000736208932283219
NMR metabolomics,X23428.Concentration of VLDL Particles,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28774,0.0121368209714715,0.00360549629989639,0.00507004822367455,0.0192035937192684,0.000763112178350931
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF1,Macrophage colony-stimulating factor 1,29581,0.00604722753620436,0.00180400940164717,0.00251136910897591,0.0095830859634328,0.000803003324676082
NMR metabolomics,X23428.Concentration of VLDL Particles,RBFOX3,RNA binding protein fox-1 homolog 3,24867,0.00863083088526888,0.00258006162004355,0.00357391010998352,0.0136877516605542,0.000823439178906734
NMR metabolomics,X23428.Concentration of VLDL Particles,HMBS,Porphobilinogen deaminase,29725,0.0096070169507066,0.00287835077509711,0.00396544943151627,0.0152485844698969,0.000845843437121171
NMR metabolomics,X23428.Concentration of VLDL Particles,AZU1,Azurocidin,28534,0.0170615195747196,0.00511501266549323,0.00703609475035288,0.0270869443990863,0.000852311093102307
NMR metabolomics,X23428.Concentration of VLDL Particles,POF1B,Protein POF1B,24229,-0.0102695514699866,0.00308259817651278,-0.0163114438959516,-0.00422765904402153,0.000865210397865013
NMR metabolomics,X23428.Concentration of VLDL Particles,PRR4,Proline-rich protein 4,24203,-0.015498182127775,0.00467994892405193,-0.0246708820189168,-0.00632548223663318,0.000928954480472026
NMR metabolomics,X23428.Concentration of VLDL Particles,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29820,0.00602313669014439,0.00181993749313129,0.00245605920360707,0.00959021417668172,0.000935637475832102
NMR metabolomics,X23428.Concentration of VLDL Particles,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29632,-0.0157320915121443,0.00475496470012022,-0.02505182232438,-0.00641236069990871,0.000938884754954969
NMR metabolomics,X23428.Concentration of VLDL Particles,METAP1,Methionine aminopeptidase 1,28774,0.00660990216852648,0.00200020476416935,0.00268950083075455,0.0105303035062984,0.000952239408504161
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPS16,"28S ribosomal protein S16, mitochondrial",24229,0.00647052720773397,0.0019583696327388,0.00263212272756591,0.010308931687902,0.000954412445610243
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINT1,Kunitz-type protease inhibitor 1,29333,0.00576258601551185,0.00174416406837021,0.00234402444150624,0.00918114758951746,0.000954557839632079
NMR metabolomics,X23428.Concentration of VLDL Particles,PPM1B,Protein phosphatase 1B,24229,0.0138603528582908,0.00419943972056674,0.00562945100597999,0.0220912547106016,0.000966437956556419
NMR metabolomics,X23428.Concentration of VLDL Particles,M6PR,Cation-dependent mannose-6-phosphate receptor,24240,0.00899579638923032,0.00272752582270846,0.00364984577672174,0.0143417470017389,0.000974634126346912
NMR metabolomics,X23428.Concentration of VLDL Particles,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24793,0.0109137510090488,0.00330933931908849,0.00442744594363533,0.0174000560744622,0.00097560461556518
NMR metabolomics,X23428.Concentration of VLDL Particles,AMBN,Ameloblastin,28931,-0.00629588526990699,0.00191228015712223,-0.0100439543778666,-0.00254781616194741,0.000994748952738675
NMR metabolomics,X23428.Concentration of VLDL Particles,ALPI,Intestinal-type alkaline phosphatase,24229,-0.0270422982642045,0.00825972056647974,-0.0432313505745048,-0.0108532459539043,0.00106186539952092
NMR metabolomics,X23428.Concentration of VLDL Particles,DDA1,DET1- and DDB1-associated protein 1,24111,0.00878983656674136,0.00268503308971685,0.00352717171089634,0.0140525014225864,0.00106320668024721
NMR metabolomics,X23428.Concentration of VLDL Particles,FRMD7,FERM domain-containing protein 7,24195,0.00735454131272849,0.00225191739448885,0.00294078321953034,0.0117682994059266,0.00109267884312398
NMR metabolomics,X23428.Concentration of VLDL Particles,NPTN,Neuroplastin,28797,0.0178069017076514,0.005458306162837,0.00710862162849092,0.0285051817868119,0.00110621522092228
NMR metabolomics,X23428.Concentration of VLDL Particles,RETN,Resistin,29362,-0.00919569093448349,0.00282138531377097,-0.0147256061494746,-0.00366577571949238,0.00111821605323497
NMR metabolomics,X23428.Concentration of VLDL Particles,GSTP1,Glutathione S-transferase P,28604,-0.0151901317282213,0.00466452581597267,-0.0243326023275277,-0.00604766112891487,0.00112917457198122
NMR metabolomics,X23428.Concentration of VLDL Particles,KIT,Mast/stem cell growth factor receptor Kit,29545,0.00638741596510466,0.00196450912080423,0.00253697808832837,0.010237853841881,0.00114964610870471
NMR metabolomics,X23428.Concentration of VLDL Particles,CLSPN,Claspin,28719,0.00750429529302001,0.00232337493199822,0.0029504804263035,0.0120581101597365,0.00123967892414619
NMR metabolomics,X23428.Concentration of VLDL Particles,DCC,Netrin receptor DCC,24195,0.00494442707040144,0.00153527828937339,0.0019352816232296,0.00795357251757329,0.00128117861293428
NMR metabolomics,X23428.Concentration of VLDL Particles,KIF20B,Kinesin-like protein KIF20B,24101,0.0165407332586088,0.00513608858670482,0.00647399962866734,0.0266074668885502,0.00128140438411938
NMR metabolomics,X23428.Concentration of VLDL Particles,TEF,Thyrotroph embryonic factor,24111,0.00926961957023588,0.00288013346636767,0.00362455797615526,0.0149146811643165,0.0012904751232777
NMR metabolomics,X23428.Concentration of VLDL Particles,TFF3,Trefoil factor 3,29426,-0.00995394274667798,0.00309676979506296,-0.0160236115450014,-0.00388427394835457,0.0013090467125032
NMR metabolomics,X23428.Concentration of VLDL Particles,LEG1,Protein LEG1 homolog,23603,-0.0151101386496546,0.00470161457969127,-0.0243253032258495,-0.0058949740734597,0.00131158252879876
NMR metabolomics,X23428.Concentration of VLDL Particles,FDX2,"Ferredoxin-2, mitochondrial",24111,0.0121163851691284,0.00378898044745038,0.00468998349212567,0.0195427868461311,0.00138661284767715
NMR metabolomics,X23428.Concentration of VLDL Particles,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24445,0.0150854601837042,0.00472708813001418,0.00582036744887639,0.024350552918532,0.00141823242220979
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB44,Ras-related protein Rab-44,24793,0.00900917715814164,0.00282340243208147,0.00347530839126195,0.0145430459250213,0.00142010209000024
NMR metabolomics,X23428.Concentration of VLDL Particles,SLAMF1,Signaling lymphocytic activation molecule,28931,-0.0126904347940726,0.00398015985454517,-0.0204915481089811,-0.00488932147916405,0.00143203245642423
NMR metabolomics,X23428.Concentration of VLDL Particles,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24867,0.00902117025993614,0.00283216597539522,0.00347012494816152,0.0145722155717108,0.00144805162636059
NMR metabolomics,X23428.Concentration of VLDL Particles,IL22,Interleukin-22,24793,-0.0144079323529282,0.00453497690089164,-0.0232964870786758,-0.00551937762718055,0.00148954364531261
NMR metabolomics,X23428.Concentration of VLDL Particles,SCP2,Non-specific lipid-transfer protein,28797,0.0161738823533726,0.00509333229795617,0.0061909510493785,0.0261568136573667,0.00149735604738082
NMR metabolomics,X23428.Concentration of VLDL Particles,CUZD1,CUB and zona pellucida-like domain-containing protein 1,24195,0.00810708643629639,0.00255369325175335,0.00310184766285983,0.0131123252097329,0.00150204523536745
NMR metabolomics,X23428.Concentration of VLDL Particles,SUMF1,Formylglycine-generating enzyme,24229,0.0141681781343802,0.00446695893248431,0.00541293862671097,0.0229234176420495,0.00151700581941194
NMR metabolomics,X23428.Concentration of VLDL Particles,IL11,Interleukin-11,28931,0.0132405566295683,0.00417533821011206,0.00505689373774866,0.0214242195213879,0.0015200361883514
NMR metabolomics,X23428.Concentration of VLDL Particles,SCN2B,Sodium channel subunit beta-2,24195,-0.0061500613713793,0.00194412960272414,-0.00996055539271861,-0.00233956735003999,0.00156130338893168
NMR metabolomics,X23428.Concentration of VLDL Particles,PI16,Peptidase inhibitor 16,24951,0.00520681095061707,0.0016460298747842,0.00198059239604004,0.00843302950519411,0.00156203155035568
NMR metabolomics,X23428.Concentration of VLDL Particles,SAG,S-arrestin,24101,-0.011213032427105,0.00354521615614742,-0.0181616560931539,-0.00426440876105606,0.00156419827128356
NMR metabolomics,X23428.Concentration of VLDL Particles,YY1,Transcriptional repressor protein YY1,24229,0.00593604091795914,0.0018772883881848,0.00225655567711692,0.00961552615880135,0.00156867037934425
NMR metabolomics,X23428.Concentration of VLDL Particles,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",24016,0.010834595283138,0.00343420116765165,0.00410356099454073,0.0175656295717352,0.00160745807438524
NMR metabolomics,X23428.Concentration of VLDL Particles,RBM19,Probable RNA-binding protein 19,24111,-0.0101125256353342,0.00321601392931651,-0.0164159129367946,-0.00380913833387387,0.00166613682029714
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASE6,Ribonuclease K6,24828,0.00647384983806467,0.00205965909052506,0.00243691802063555,0.0105107816554938,0.00167327980524048
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29594,-0.00917084308889671,0.00291908117954744,-0.0148922422008097,-0.00344944397698372,0.00168142397965353
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,24173,0.00809330368213502,0.00258605916444867,0.00302462771981563,0.0131619796444544,0.00175259081991009
NMR metabolomics,X23428.Concentration of VLDL Particles,KIRREL2,Kin of IRRE-like protein 2,28774,0.0083508838368921,0.0026732170747819,0.00311137837031957,0.0135903893034646,0.00178643578538743
NMR metabolomics,X23428.Concentration of VLDL Particles,PDCD1LG2,Programmed cell death 1 ligand 2,29349,0.00652561450155548,0.00209222309285011,0.00242485723956926,0.0106263717635417,0.00181650273895179
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28916,0.00661218169622014,0.00212700309738707,0.00244325562534148,0.0107811077670988,0.00188104651339246
NMR metabolomics,X23428.Concentration of VLDL Particles,PLXDC2,Plexin domain-containing protein 2,24845,0.00563781303393683,0.00181408343326302,0.0020822095047413,0.00919341656313236,0.00188696728069267
NMR metabolomics,X23428.Concentration of VLDL Particles,CLMP,CXADR-like membrane protein,29725,0.00439422867641152,0.0014152856001348,0.0016202689001473,0.00716818845267573,0.00190563971246149
NMR metabolomics,X23428.Concentration of VLDL Particles,MYH7B,Myosin-7B,24016,-0.00925444902920416,0.00298228637266134,-0.0150997303196204,-0.00340916773878793,0.00191702078175852
NMR metabolomics,X23428.Concentration of VLDL Particles,LTO1,Protein LTO1 homolog,28931,0.00851116377493438,0.00275303864678414,0.00311520802723746,0.0139071195226313,0.00199302008536644
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP164,Centrosomal protein of 164 kDa,28931,0.0129158385505348,0.00421871008914777,0.00464716677580517,0.0211845103252644,0.00220388066941996
NMR metabolomics,X23428.Concentration of VLDL Particles,UNG,Uracil-DNA glycosylase,24793,0.00702216696042163,0.00230861301278147,0.00249728545536995,0.0115470484654733,0.00235472251656366
NMR metabolomics,X23428.Concentration of VLDL Particles,BMP4,Bone morphogenetic protein 4,29169,-0.00940319057931709,0.00309329554491995,-0.0154660498473602,-0.00334033131127399,0.00236896648945736
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASE10,Inactive ribonuclease-like protein 10,24240,-0.00975646333877805,0.00322563573366736,-0.0160787093767661,-0.00343421730079003,0.00249170465286066
NMR metabolomics,X23428.Concentration of VLDL Particles,CD3D,T-cell surface glycoprotein CD3 delta chain,24101,-0.00696599689533179,0.00230346395962411,-0.0114807862561951,-0.00245120753446853,0.00249603777247497
NMR metabolomics,X23428.Concentration of VLDL Particles,GAST,Gastrin,24845,0.0263917698472049,0.00872865399318634,0.0092836080205597,0.0434999316738501,0.00250059244844003
NMR metabolomics,X23428.Concentration of VLDL Particles,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",24111,0.0101330106490746,0.00335281807378372,0.00356148722445851,0.0167045340736907,0.0025117753575306
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF5A,Eukaryotic translation initiation factor 5A-1,28931,0.00605732777126343,0.0020043116598598,0.00212887691793822,0.00998577862458865,0.00251206853489391
NMR metabolomics,X23428.Concentration of VLDL Particles,CFD,Complement factor D,24966,0.00396595740456479,0.00131241047227193,0.00139363287891181,0.00653828193021778,0.00251458138801816
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK14,Kallikrein-14,29725,0.00931047829496952,0.00308123809787942,0.00327125162312585,0.0153497049668132,0.0025160010552839
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17A,Interleukin-17A,28879,-0.00862796364328325,0.00285770894723714,-0.014229073179868,-0.00302685410669845,0.00253673648521317
NMR metabolomics,X23428.Concentration of VLDL Particles,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28774,0.0137285645813464,0.00455029943650151,0.00480997768580349,0.0226471514768894,0.00255455369868261
NMR metabolomics,X23428.Concentration of VLDL Particles,SHPK,Sedoheptulokinase,24445,-0.00840282440797483,0.00278538930913979,-0.0138621874538888,-0.00294346136206084,0.00255762940624813
NMR metabolomics,X23428.Concentration of VLDL Particles,WASL,Neural Wiskott-Aldrich syndrome protein,24229,-0.0122932856763837,0.00408105894390192,-0.0202921612064315,-0.00429441014633596,0.00259562381596263
NMR metabolomics,X23428.Concentration of VLDL Particles,DDI2,Protein DDI1 homolog 2,24381,0.0154779756784258,0.00514219713072845,0.00539926930219806,0.0255566820546536,0.00261521291792908
NMR metabolomics,X23428.Concentration of VLDL Particles,AMPD3,AMP deaminase 3,24845,0.0142910302075149,0.00474990000768502,0.00498122619245228,0.0236008342225776,0.00262629956115258
NMR metabolomics,X23428.Concentration of VLDL Particles,OSBPL2,Oxysterol-binding protein-related protein 2,24845,0.00787920124603383,0.00262500368642518,0.00273419402064047,0.0130242084714272,0.00268835022468681
NMR metabolomics,X23428.Concentration of VLDL Particles,ABO,Histo-blood group ABO system transferase,24951,0.0289144708552026,0.00967833584110222,0.00994493260664221,0.0478840091037629,0.0028150080080141
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24805,0.0101300391778697,0.00339845621170897,0.00346906500292009,0.0167910133528192,0.00287797362915634
NMR metabolomics,X23428.Concentration of VLDL Particles,AGBL2,Cytosolic carboxypeptidase 2,24101,0.0182550839577262,0.00612898517804986,0.00624227300874851,0.030267894906704,0.00289966734333426
NMR metabolomics,X23428.Concentration of VLDL Particles,ENG,Endoglin,29820,0.0034239745802967,0.00115042193929371,0.00116914757928102,0.00567880158131237,0.00292005216424158
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGAM,Integrin alpha-M,29443,-0.00628460462628659,0.00211432632328851,-0.0104286842199321,-0.00214052503264111,0.00295729159252803
NMR metabolomics,X23428.Concentration of VLDL Particles,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",24229,0.00705380326225603,0.00237541606889677,0.00239798776721836,0.0117096187572937,0.0029857496201
NMR metabolomics,X23428.Concentration of VLDL Particles,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",24229,0.00559582322753435,0.0018871967144086,0.0018969176672935,0.0092947287877752,0.00302829272845208
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK4,Serine protease inhibitor Kazal-type 4,29434,-0.0129742491467625,0.00437966316031803,-0.0215583889409858,-0.00439010935253916,0.00305509719581226
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1RL1,Interleukin-1 receptor-like 1,29736,-0.00920311313675633,0.00310722573145579,-0.0152932755704097,-0.00311295070310298,0.00306046040312115
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP290,Centrosomal protein of 290 kDa,24445,0.0105272250268614,0.0035618621051726,0.00354597530072306,0.0175084747529997,0.00312420466291491
NMR metabolomics,X23428.Concentration of VLDL Particles,CD48,CD48 antigen,29536,0.0058831697002146,0.00200128319159979,0.00196065464467901,0.00980568475575019,0.00328786018240022
NMR metabolomics,X23428.Concentration of VLDL Particles,APOBR,Apolipoprotein B receptor,24240,-0.00835079550186345,0.00285633072092644,-0.0139492037148793,-0.00275238728884762,0.00346318774150473
NMR metabolomics,X23428.Concentration of VLDL Particles,TNN,Tenascin-N,24938,0.0084907503115357,0.0029155076996733,0.00277635522017602,0.0142051454028954,0.00359128730935449
NMR metabolomics,X23428.Concentration of VLDL Particles,UBE2B,Ubiquitin-conjugating enzyme E2 B,24793,0.00558528587929701,0.00191865665249861,0.00182471884039973,0.00934585291819429,0.00360549008938171
NMR metabolomics,X23428.Concentration of VLDL Particles,NECTIN4,Nectin-4,29566,-0.00621628169257636,0.00213640292734191,-0.0104036314301665,-0.00202893195498622,0.00362050952062952
NMR metabolomics,X23428.Concentration of VLDL Particles,OLFM4,Olfactomedin-4,23498,0.0240164803339422,0.00827288646770557,0.00780162285723929,0.0402313378106451,0.0036990903706636
NMR metabolomics,X23428.Concentration of VLDL Particles,CLSTN2,Calsyntenin-2,29786,-0.00766123266306615,0.00264550447771661,-0.0128464214393907,-0.0024760438867416,0.00378294928093284
NMR metabolomics,X23428.Concentration of VLDL Particles,PTTG1,Securin,24445,0.00802142621152011,0.00277707703061698,0.00257835523151083,0.0134644971915294,0.00387495320753173
NMR metabolomics,X23428.Concentration of VLDL Particles,GPR101,Probable G-protein coupled receptor 101,24101,-0.011953192382396,0.00413869996849095,-0.0200650443206382,-0.00384134044415371,0.00387858292793695
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,24195,-0.00614112622850249,0.0021299718028441,-0.0103158709620769,-0.00196638149492807,0.00394009404587316
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL21,C-C motif chemokine 21,29581,0.0078108367383195,0.00271170015040524,0.00249590444352523,0.0131257690331138,0.00397430384909181
NMR metabolomics,X23428.Concentration of VLDL Particles,NOS1,"Nitric oxide synthase, brain",28774,-0.0103979034462639,0.00362095405303526,-0.017494973390213,-0.0033008335023148,0.00408707906459419
NMR metabolomics,X23428.Concentration of VLDL Particles,TFF1,Trefoil factor 1,29319,-0.0151454339252814,0.00527604862935971,-0.0254864892388265,-0.00480437861173641,0.00409984740614456
NMR metabolomics,X23428.Concentration of VLDL Particles,TNR,Tenascin-R,29218,0.00809741324205074,0.00282272874736068,0.00256486489722381,0.0136299615868777,0.00412526585276274
NMR metabolomics,X23428.Concentration of VLDL Particles,STX1B,Syntaxin-1B,24195,0.00801842206422198,0.00279561656981717,0.00253901358738033,0.0134978305410636,0.00413155405926099
NMR metabolomics,X23428.Concentration of VLDL Particles,CYB5A,Cytochrome b5,24016,0.0138841197915599,0.00485810009448914,0.00436224360636121,0.0234059959767586,0.00426778541528647
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP1B4,Protein ATP1B4,24016,-0.00805582067641787,0.00282639413700935,-0.0135955531849562,-0.00251608816787954,0.00437274015171186
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,29218,0.00794098543186627,0.00279443077955529,0.00246390110393791,0.0134180697597946,0.00449021780012759
NMR metabolomics,X23428.Concentration of VLDL Particles,INSL4,Early placenta insulin-like peptide,24793,-0.00979462669840778,0.00344780211815671,-0.0165523188499949,-0.00303693454682062,0.00450326911688615
NMR metabolomics,X23428.Concentration of VLDL Particles,RAD51,DNA repair protein RAD51 homolog 1,24445,0.0100807462079969,0.0035842761364428,0.003055564980569,0.0171059274354248,0.00491985257435595
NMR metabolomics,X23428.Concentration of VLDL Particles,CD70,CD70 antigen,29434,0.00802522579013286,0.00285675692296586,0.00242598222111977,0.013624469359146,0.00496962242752172
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24922,0.0138994301469704,0.00495411403215592,0.00418936664394485,0.023609493649996,0.00502566528889404
NMR metabolomics,X23428.Concentration of VLDL Particles,GKN1,Gastrokine-1,28114,0.0052745438447015,0.00188006556640225,0.00158961533455308,0.00895947235484992,0.00502714524583175
NMR metabolomics,X23428.Concentration of VLDL Particles,TYMP,Thymidine phosphorylase,29301,0.0124483593618525,0.00444393062143482,0.00373825534384029,0.0211584633798648,0.0050945593618287
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH1,Cadherin-1,28477,0.00750931115273944,0.00268236538450494,0.00225187499910975,0.0127667473063691,0.00512145405477763
NMR metabolomics,X23428.Concentration of VLDL Particles,CD33,Myeloid cell surface antigen CD33,29566,0.0147977049989766,0.00529854188252691,0.00441256290922382,0.0251828470887293,0.00522894905936816
NMR metabolomics,X23428.Concentration of VLDL Particles,SH3GL3,Endophilin-A3,24307,0.0156480785491702,0.00562199111510428,0.00462897596356581,0.0266671811347746,0.00538390581211315
NMR metabolomics,X23428.Concentration of VLDL Particles,MKI67,Proliferation marker protein Ki-67,24229,0.00727678619428931,0.00262149238866169,0.00213866111251239,0.0124149112760662,0.00551052500625932
NMR metabolomics,X23428.Concentration of VLDL Particles,OGN,Mimecan,29443,-0.00780517176986189,0.0028145305532994,-0.0133216516543287,-0.00228869188539507,0.00555480396164873
NMR metabolomics,X23428.Concentration of VLDL Particles,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28931,0.0218825708555059,0.00789218357437651,0.00641389104972793,0.0373512506612838,0.00556307998657321
NMR metabolomics,X23428.Concentration of VLDL Particles,CD5L,CD5 antigen-like,24833,0.0087844326942469,0.00317291898200071,0.0025655114895255,0.0150033538989683,0.0056345500373269
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,24111,-0.00746196847937745,0.00269794682578495,-0.0127499442579159,-0.00217399270083895,0.00568274010742767
NMR metabolomics,X23428.Concentration of VLDL Particles,TMPRSS5,Transmembrane protease serine 5,29079,0.00703959672172875,0.00254929149492491,0.00204298539167593,0.0120362080517816,0.00575914142108651
NMR metabolomics,X23428.Concentration of VLDL Particles,NRXN3,Neurexin-3,24195,0.00653925151137663,0.00236922227420635,0.00189557585393218,0.0111829271688211,0.00578300827612143
NMR metabolomics,X23428.Concentration of VLDL Particles,CSPG4,Chondroitin sulfate proteoglycan 4,24938,-0.00609867870133631,0.0022139951120208,-0.0104381091208971,-0.00175924828177555,0.00588059179590181
NMR metabolomics,X23428.Concentration of VLDL Particles,PON1,Serum paraoxonase/arylesterase 1,24951,0.00487732649228911,0.00177339424299578,0.00140147377601738,0.00835317920856084,0.00595877130322216
NMR metabolomics,X23428.Concentration of VLDL Particles,APOA4,Apolipoprotein A-IV,24966,0.00657279602680622,0.00239892852613508,0.00187089611558146,0.011274695938031,0.00615037565508143
NMR metabolomics,X23428.Concentration of VLDL Particles,PRND,Prion-like protein doppel,24845,-0.0094352722553839,0.00345595913278434,-0.0162089521556412,-0.0026615923551266,0.00633509549608781
NMR metabolomics,X23428.Concentration of VLDL Particles,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23494,0.00912229676001491,0.00335491059216178,0.00254667199937782,0.015697921520652,0.00655103124550083
NMR metabolomics,X23428.Concentration of VLDL Particles,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24867,-0.00540042512415232,0.00198858222437414,-0.00929804628392563,-0.00150280396437902,0.00661782691698538
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX39A,ATP-dependent RNA helicase DDX39A,24229,0.00424614756446072,0.00156812692202788,0.00117261879728608,0.00731967633163535,0.0067781819084011
NMR metabolomics,X23428.Concentration of VLDL Particles,NPTX2,Neuronal pentraxin-2,24938,-0.00605346282843761,0.00223562325531193,-0.010435284408849,-0.00167164124802623,0.0067791427493959
NMR metabolomics,X23428.Concentration of VLDL Particles,TXNDC15,Thioredoxin domain-containing protein 15,29566,0.00493166856710225,0.0018273559314602,0.00135005094144026,0.00851328619276424,0.00696294898204948
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24867,0.0122791679385781,0.00457199338338682,0.00331806090713998,0.0212402749700163,0.00724182755020224
NMR metabolomics,X23428.Concentration of VLDL Particles,PRRT3,Proline-rich transmembrane protein 3,24240,0.00684076564369321,0.00255180584851645,0.00183922618060096,0.0118423051067855,0.00735060460301991
NMR metabolomics,X23428.Concentration of VLDL Particles,IL2RG,Cytokine receptor common subunit gamma,24793,0.00667069371202223,0.00249613991006605,0.00177825948829277,0.0115631279357517,0.00753592503182458
NMR metabolomics,X23428.Concentration of VLDL Particles,CRHR1,Corticotropin-releasing factor receptor 1,28916,0.0109081472751227,0.00408621877064969,0.0028991584846493,0.0189171360655961,0.00760074841362487
NMR metabolomics,X23428.Concentration of VLDL Particles,GGA1,ADP-ribosylation factor-binding protein GGA1,28774,0.0121181405868513,0.00455412400963844,0.00319205752795992,0.0210442236457426,0.00779717012582441
NMR metabolomics,X23428.Concentration of VLDL Particles,GUK1,Guanylate kinase,24111,-0.00714937080841286,0.0026957882656964,-0.0124331158091778,-0.00186562580764791,0.00800565883708746
NMR metabolomics,X23428.Concentration of VLDL Particles,LPO,Lactoperoxidase,28452,-0.0106403479694345,0.00403188555894929,-0.0185428436649751,-0.00273785227389388,0.0083184015711791
NMR metabolomics,X23428.Concentration of VLDL Particles,MYBPC2,"Myosin-binding protein C, fast-type",24240,-0.0150013296017388,0.0057016639563714,-0.0261765909562268,-0.00382606824725089,0.00851768611614252
NMR metabolomics,X23428.Concentration of VLDL Particles,CTHRC1,Collagen triple helix repeat-containing protein 1,24938,0.004950564095503,0.00188242609099808,0.00126100895714676,0.00864011923385924,0.00854662336946482
NMR metabolomics,X23428.Concentration of VLDL Particles,NLGN2,Neuroligin-2,24101,-0.00836858690119985,0.00319108838966459,-0.0146231201449424,-0.00211405365745726,0.00873456049815619
NMR metabolomics,X23428.Concentration of VLDL Particles,ERBB4,Receptor tyrosine-protein kinase erbB-4,29566,-0.00417720654551496,0.00159997965954273,-0.00731316667821873,-0.0010412464128112,0.00903796658810695
NMR metabolomics,X23428.Concentration of VLDL Particles,ENOPH1,Enolase-phosphatase E1,24793,0.00967653996930833,0.00371732357611131,0.00239058576013016,0.0169624941784865,0.00924418587167494
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,29218,0.0106110730106854,0.00407708196944175,0.0026199923505796,0.0186021536707913,0.00925626280872979
NMR metabolomics,X23428.Concentration of VLDL Particles,SAT1,Diamine acetyltransferase 1,24111,-0.00880920041597409,0.0033890988125967,-0.0154518340886636,-0.00216656674328455,0.00934777859302145
NMR metabolomics,X23428.Concentration of VLDL Particles,CHL1,Neural cell adhesion molecule L1-like protein,29542,0.00536621598378769,0.00206594456347772,0.00131696463937135,0.00941546732820403,0.00939616416160755
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29760,0.00658800560586407,0.00254417525384792,0.00160142210832214,0.011574589103406,0.00961771937337076
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24381,0.00653333786064868,0.00252623600016847,0.00158191530031847,0.0114847604209789,0.00970995757076758
NMR metabolomics,X23428.Concentration of VLDL Particles,PNMA2,Paraneoplastic antigen Ma2,24101,0.00761105503941346,0.00294396596607267,0.00184088174591102,0.0133812283329159,0.0097350592795823
NMR metabolomics,X23428.Concentration of VLDL Particles,LY6D,Lymphocyte antigen 6D,29283,0.00660387172685354,0.00256726401829424,0.00157203425099683,0.0116357092027103,0.010106295214306
NMR metabolomics,X23428.Concentration of VLDL Particles,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29536,0.0111092477830375,0.00432398546513523,0.00263423627137247,0.0195842592947026,0.0101977882096478
NMR metabolomics,X23428.Concentration of VLDL Particles,KEL,Kell blood group glycoprotein,28774,0.00616530285466576,0.00240024802801667,0.00146081671975309,0.0108697889895784,0.0102157067136743
NMR metabolomics,X23428.Concentration of VLDL Particles,PRTN3,Myeloblastin,28671,-0.00809963363339966,0.0031746847268284,-0.0143220156979833,-0.001877251568816,0.0107367507723642
NMR metabolomics,X23428.Concentration of VLDL Particles,RALB,Ras-related protein Ral-B,24229,0.00506173279665606,0.00198641507359846,0.00116835925240308,0.00895510634090905,0.0108349403261724
NMR metabolomics,X23428.Concentration of VLDL Particles,AKAP12,A-kinase anchor protein 12,24381,0.00368152460516158,0.00144594840380904,0.000847465733695861,0.0065155834766273,0.0108995981629698
NMR metabolomics,X23428.Concentration of VLDL Particles,PDCD6,Programmed cell death protein 6,29478,-0.0118889429916657,0.00468076046000514,-0.0210632334932758,-0.00271465249005559,0.0110916147157438
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC4C,C-type lectin domain family 4 member C,29434,0.00792779967421448,0.00313407154002217,0.00178501945577104,0.0140705798926579,0.0114259728016957
NMR metabolomics,X23428.Concentration of VLDL Particles,JUN,Transcription factor AP-1,28931,0.00847811109322619,0.00335397367509372,0.0019043226900425,0.0150518994964099,0.0114838710955213
NMR metabolomics,X23428.Concentration of VLDL Particles,ID4,DNA-binding protein inhibitor ID-4,24445,-0.00741202036323509,0.00294485200932396,-0.01318393030151,-0.00164011042496013,0.0118441946800109
NMR metabolomics,X23428.Concentration of VLDL Particles,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28797,0.00595696239255314,0.00236932727622759,0.00131308093114706,0.0106008438539592,0.0119356882862335
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRLB,Fc receptor-like B,28797,0.0102882089538766,0.00409361611657042,0.00226472136539856,0.0183116965423546,0.0119684640557504
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,24101,0.00975418137869596,0.00388207865826633,0.00214530720849394,0.017363055548898,0.0119903747010778
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX53,Probable ATP-dependent RNA helicase DDX53,24195,0.00601510963221709,0.00239558685801286,0.00131975939051189,0.0107104598739223,0.0120484139305148
NMR metabolomics,X23428.Concentration of VLDL Particles,CD109,CD109 antigen,29443,-0.00564359884285185,0.00225554791094148,-0.0100644727482972,-0.00122272493740654,0.0123514042684234
NMR metabolomics,X23428.Concentration of VLDL Particles,LCN15,Lipocalin-15,24867,-0.0104338725642593,0.00417667637570585,-0.0186201582606427,-0.00224758686787582,0.0124915164113664
NMR metabolomics,X23428.Concentration of VLDL Particles,IL20RA,Interleukin-20 receptor subunit alpha,28931,0.0075654600973859,0.00303037312420187,0.00162592877395024,0.0135049914208216,0.0125465285062825
NMR metabolomics,X23428.Concentration of VLDL Particles,OSMR,Oncostatin-M-specific receptor subunit beta,29628,0.00336810221245703,0.00135295129870472,0.000716317666995776,0.00601988675791828,0.0127995995848814
NMR metabolomics,X23428.Concentration of VLDL Particles,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,24111,0.00764612179337454,0.00307892104478231,0.00161143654560122,0.0136808070411479,0.0130210739235007
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP112,Centrosomal protein of 112 kDa,24111,0.00764926471036114,0.00308225797989945,0.00160803906975822,0.0136904903509641,0.0130821958382495
NMR metabolomics,X23428.Concentration of VLDL Particles,TMEM132A,Transmembrane protein 132A,24240,0.0104236516439435,0.00420501340344412,0.002181825373193,0.0186654779146939,0.0131869503725172
NMR metabolomics,X23428.Concentration of VLDL Particles,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,24240,0.00348735806882836,0.00140871309006993,0.000726280412291302,0.00624843572536543,0.0133094120848429
NMR metabolomics,X23428.Concentration of VLDL Particles,GBP6,Guanylate-binding protein 6,24111,-0.00767321744157926,0.00310160003042202,-0.0137523535012064,-0.0015940813819521,0.0133695065847334
NMR metabolomics,X23428.Concentration of VLDL Particles,SUSD2,Sushi domain-containing protein 2,29443,-0.00471372097716127,0.00190899823958664,-0.0084553575267511,-0.000972084427571449,0.0135467386155519
NMR metabolomics,X23428.Concentration of VLDL Particles,PSME2,Proteasome activator complex subunit 2,29081,0.0059200984878699,0.00242119314496241,0.00117455992374358,0.0106656370519962,0.0144864425599129
NMR metabolomics,X23428.Concentration of VLDL Particles,PLAUR,Urokinase plasminogen activator surface receptor,29278,-0.0044707603765765,0.00183755193220681,-0.00807236216370184,-0.000869158589451156,0.0149803273998865
NMR metabolomics,X23428.Concentration of VLDL Particles,ACSL1,Long-chain-fatty-acid--CoA ligase 1,24111,-0.00615692686707615,0.00253062938067182,-0.0111169604531929,-0.00119689328095939,0.0149830681544399
NMR metabolomics,X23428.Concentration of VLDL Particles,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24793,-0.0141594928457215,0.00582677849683643,-0.0255799786995209,-0.00273900699192204,0.0151028645900662
NMR metabolomics,X23428.Concentration of VLDL Particles,VSIG2,V-set and immunoglobulin domain-containing protein 2,24793,0.00968797167201427,0.00398760114888882,0.00187227342019218,0.0175036699238364,0.0151257318478079
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP5PO,"ATP synthase subunit O, mitochondrial",28774,0.00684176526426678,0.00283565490459777,0.00128388165125515,0.0123996488772784,0.0158382939536425
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC12A,C-type lectin domain family 12 member A,24229,0.0033026889503225,0.00136990702090935,0.000617671189340174,0.00598770671130482,0.0159212431572897
NMR metabolomics,X23428.Concentration of VLDL Particles,GRIK2,"Glutamate receptor ionotropic, kainate 2",24867,0.00677772294861653,0.00281133392359004,0.00126750845838006,0.012287937438853,0.0159223136806585
NMR metabolomics,X23428.Concentration of VLDL Particles,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",24101,0.0051611785878982,0.00215701827203123,0.000933422774716995,0.00938893440107941,0.0167308115621799
NMR metabolomics,X23428.Concentration of VLDL Particles,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,24111,-0.00941401368665529,0.00394116452995541,-0.0171386961653679,-0.00168933120794269,0.0169186241296329
NMR metabolomics,X23428.Concentration of VLDL Particles,ELAVL4,ELAV-like protein 4,24101,0.0135132322891136,0.00568463350116391,0.00237135062683236,0.0246551139513949,0.0174547061159831
NMR metabolomics,X23428.Concentration of VLDL Particles,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24793,0.00824011511696282,0.00348034611371939,0.00141863673407283,0.0150615934998528,0.0179108533836732
NMR metabolomics,X23428.Concentration of VLDL Particles,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",24016,0.00909541826491319,0.00385316567527665,0.00154321354137097,0.0166476229884554,0.0182580051737844
NMR metabolomics,X23428.Concentration of VLDL Particles,AGR2,Anterior gradient protein 2 homolog,28553,0.0158756810435122,0.00674196175310642,0.00266143600742365,0.0290899260796008,0.0185415600403734
NMR metabolomics,X23428.Concentration of VLDL Particles,SPP1,Osteopontin,29757,-0.0072507601353515,0.00308118012256206,-0.0132898731755731,-0.00121164709512986,0.0186170287550121
NMR metabolomics,X23428.Concentration of VLDL Particles,MTR,Methionine synthase,24111,0.0102818632598433,0.00438598690729498,0.00168532892154517,0.0188783975981415,0.0190733070040574
NMR metabolomics,X23428.Concentration of VLDL Particles,MAPK13,Mitogen-activated protein kinase 13,24016,0.0066580595596269,0.00284113577661644,0.00108943343745868,0.0122266856817951,0.0191144406911123
NMR metabolomics,X23428.Concentration of VLDL Particles,TNC,Tenascin,29594,-0.00746906497364563,0.00318768915909386,-0.0137169357254696,-0.00122119422182167,0.019130997716241
NMR metabolomics,X23428.Concentration of VLDL Particles,DOCK9,Dedicator of cytokinesis protein 9,24101,0.0186252291453081,0.00794935982170571,0.00304448389476486,0.0342059743958513,0.0191382551900159
NMR metabolomics,X23428.Concentration of VLDL Particles,CDK1,Cyclin-dependent kinase 1,24016,0.00572631889310119,0.00245226365686076,0.000919882125654094,0.0105327556605483,0.0195455845851809
NMR metabolomics,X23428.Concentration of VLDL Particles,GH2,Growth hormone variant,28797,0.025803532856395,0.0110661576672537,0.00411386382857781,0.0474932018842122,0.0197206156873094
NMR metabolomics,X23428.Concentration of VLDL Particles,PNLIPRP2,Pancreatic lipase-related protein 2,29454,0.0459647172622799,0.0197221776075969,0.00730924915138998,0.0846201853731697,0.0197806177152371
NMR metabolomics,X23428.Concentration of VLDL Particles,CCNE1,G1/S-specific cyclin-E1,24229,0.014442094361828,0.00621747805449154,0.00225583737502454,0.0266283513486314,0.0201969637746308
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP7,Insulin-like growth factor-binding protein 7,29820,0.00469752489621372,0.00202883496298913,0.000721008368755019,0.00867404142367242,0.0205988730790312
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRF,Receptor-type tyrosine-protein phosphatase F,29820,0.00446391009744581,0.00192930471725168,0.000682472851632515,0.0082453473432591,0.0206887389883063
NMR metabolomics,X23428.Concentration of VLDL Particles,PGLYRP4,Peptidoglycan recognition protein 4,24111,0.00942060785726578,0.00409936860275921,0.00138584539585773,0.0174553703186738,0.021566718591507
NMR metabolomics,X23428.Concentration of VLDL Particles,VCPKMT,Protein-lysine methyltransferase METTL21D,24016,0.0133110282110617,0.00581427550242527,0.00191504822630813,0.0247070081958152,0.0220665009189611
NMR metabolomics,X23428.Concentration of VLDL Particles,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29566,0.00411947485834289,0.00180128505286119,0.000588956154734955,0.00764999356195082,0.022204935296226
NMR metabolomics,X23428.Concentration of VLDL Particles,NCAM2,Neural cell adhesion molecule 2,29443,-0.00411337272156907,0.00180111114762939,-0.00764355057092268,-0.000583194872215467,0.0223905389775586
NMR metabolomics,X23428.Concentration of VLDL Particles,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",24195,-0.00746160112215551,0.00329005494147248,-0.0139101088074416,-0.00101309343686946,0.0233424994462391
NMR metabolomics,X23428.Concentration of VLDL Particles,BATF,Basic leucine zipper transcriptional factor ATF-like,24195,0.0127323241097329,0.00563786166854555,0.00168211523938363,0.0237825329800822,0.0239320661487516
NMR metabolomics,X23428.Concentration of VLDL Particles,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",24101,-0.0082178495733726,0.00364904743922938,-0.0153699825542622,-0.00106571659248302,0.024327867735415
NMR metabolomics,X23428.Concentration of VLDL Particles,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,24101,-0.00927880140963673,0.00412175713766116,-0.0173574453994526,-0.00120015741982085,0.0243833585627997
NMR metabolomics,X23428.Concentration of VLDL Particles,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28916,0.00471458504371945,0.00209532895778602,0.000607740286458844,0.00882142980098005,0.0244535606499482
NMR metabolomics,X23428.Concentration of VLDL Particles,SLAMF8,SLAM family member 8,28797,0.00802161163338835,0.00358268966298479,0.000999539893938158,0.0150436833728385,0.0251640796059162
NMR metabolomics,X23428.Concentration of VLDL Particles,VEGFD,Vascular endothelial growth factor D,29732,-0.00535310245749113,0.00239186078996581,-0.0100411496058241,-0.000665055309158138,0.0252252148677439
NMR metabolomics,X23428.Concentration of VLDL Particles,CCAR2,Cell cycle and apoptosis regulator protein 2,24845,0.00837382794570591,0.00375466737204131,0.00101467989650495,0.0157329759949069,0.0257400865302983
NMR metabolomics,X23428.Concentration of VLDL Particles,CD200,OX-2 membrane glycoprotein,29434,0.00395424494917736,0.00177342703442482,0.000478327961704713,0.00743016193665,0.0257735829830647
NMR metabolomics,X23428.Concentration of VLDL Particles,HTR1B,5-hydroxytryptamine receptor 1B,24101,-0.00643420022059028,0.00288681466137272,-0.0120923569568808,-0.000776043484299746,0.0258348432188867
NMR metabolomics,X23428.Concentration of VLDL Particles,EPN1,Epsin-1,24445,0.00653395735169519,0.00293334293799896,0.000784605193217233,0.0122833095101732,0.0259244059185233
NMR metabolomics,X23428.Concentration of VLDL Particles,MORF4L2,Mortality factor 4-like protein 2,24016,-0.00553034139113751,0.00248454712969646,-0.0104000537653426,-0.000660629016932445,0.0260304555019908
NMR metabolomics,X23428.Concentration of VLDL Particles,SCARB1,Scavenger receptor class B member 1,28774,0.00854901719202724,0.00384670193559788,0.00100948139825539,0.0160885529857991,0.0262621575571383
NMR metabolomics,X23428.Concentration of VLDL Particles,MATN3,Matrilin-3,29169,-0.00477144902163524,0.00215073300235694,-0.00898688570625484,-0.00055601233701564,0.0265269167171838
NMR metabolomics,X23428.Concentration of VLDL Particles,CSPG5,Chondroitin sulfate proteoglycan 5,24101,-0.00743468048447211,0.00335715328112006,-0.0140147009154674,-0.000854660053476787,0.0267983127263084
NMR metabolomics,X23428.Concentration of VLDL Particles,LYPD8,Ly6/PLAUR domain-containing protein 8,28797,0.00764542644407883,0.00345704606131436,0.000869616163902684,0.014421236724255,0.0270056757826279
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH23,Cadherin-23,24845,-0.00393381598845239,0.00177910241027107,-0.00742085671258369,-0.000446775264321097,0.0270363297964942
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC11A,C-type lectin domain family 11 member A,29388,0.00710592140227672,0.00321871187404145,0.000797246129155486,0.013414596675398,0.0272735162154873
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMD5,26S proteasome non-ATPase regulatory subunit 5,24195,-0.00823933606733784,0.00373590026046731,-0.0155617005778538,-0.000916971556821916,0.0274320033036859
NMR metabolomics,X23428.Concentration of VLDL Particles,NOP56,Nucleolar protein 56,24111,0.0164497915992372,0.00746213745254581,0.00182400219224738,0.0310755810062269,0.0275032330386799
NMR metabolomics,X23428.Concentration of VLDL Particles,THY1,Thy-1 membrane glycoprotein,29694,-0.00420613702684382,0.00190832773828768,-0.00794645939388768,-0.000465814659799959,0.0275252593635918
NMR metabolomics,X23428.Concentration of VLDL Particles,CPE,Carboxypeptidase E,29468,0.00568256834294956,0.0025813896535203,0.000623044622049766,0.0107420920638494,0.0277182639361403
NMR metabolomics,X23428.Concentration of VLDL Particles,EDDM3B,Epididymal secretory protein E3-beta,24793,0.00768586828929581,0.00349185886738327,0.000841824909224595,0.014529911669367,0.0277393947355342
NMR metabolomics,X23428.Concentration of VLDL Particles,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28797,0.0183970265028762,0.00836336285354427,0.00200483530992942,0.0347892176958229,0.0278349418572271
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC12A2,Solute carrier family 12 member 2,24111,-0.00407509596441682,0.00185314122348218,-0.00770725276244189,-0.00044293916639175,0.0278859151282634
NMR metabolomics,X23428.Concentration of VLDL Particles,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28797,0.0180851145102789,0.0082484549313041,0.00191814284492287,0.0342520861756349,0.028348102205252
NMR metabolomics,X23428.Concentration of VLDL Particles,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24445,0.00519098787263988,0.00237817057511315,0.000529773545418119,0.00985220219986165,0.0290625957802663
NMR metabolomics,X23428.Concentration of VLDL Particles,HDAC8,Histone deacetylase 8,24229,0.00897175965778775,0.00412340876415333,0.000889878480047216,0.0170536408355283,0.0295790043774722
NMR metabolomics,X23428.Concentration of VLDL Particles,DLL1,Delta-like protein 1,29566,-0.00432124880253276,0.00199832929657752,-0.00823797422382469,-0.000404523381240826,0.0305929827317041
NMR metabolomics,X23428.Concentration of VLDL Particles,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,24111,-0.00695025813279289,0.00321852697472292,-0.0132585710032498,-0.00064194526233598,0.0308248642859632
NMR metabolomics,X23428.Concentration of VLDL Particles,ACHE,Acetylcholinesterase,24381,0.00476566468928395,0.00221735672392064,0.000419645510399488,0.00911168386816842,0.0316240209736653
NMR metabolomics,X23428.Concentration of VLDL Particles,TPSG1,Tryptase gamma,24229,0.00385911582767406,0.00179727168895482,0.000336463317322609,0.00738176833802551,0.0317866379119032
NMR metabolomics,X23428.Concentration of VLDL Particles,CST7,Cystatin-F,29498,0.0133007653160394,0.0062134001191437,0.00112250108251778,0.0254790295495611,0.0323097968956623
NMR metabolomics,X23428.Concentration of VLDL Particles,TXNL1,Thioredoxin-like protein 1,24069,0.0140960297315931,0.00658717868237382,0.00118515951414041,0.0270068999490458,0.0323713319147963
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASET2,Ribonuclease T2,29697,0.00379229854352975,0.00177412714098896,0.000315009347191383,0.00726958773986811,0.0325608302872631
NMR metabolomics,X23428.Concentration of VLDL Particles,AMIGO1,Amphoterin-induced protein 1,24195,0.0071939019884738,0.00337115007396417,0.000586447843504035,0.0138013561334436,0.0328560239348367
NMR metabolomics,X23428.Concentration of VLDL Particles,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29497,0.00480005742952464,0.00225262617256371,0.000384910131299768,0.00921520472774951,0.033107960936518
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK5,Serine protease inhibitor Kazal-type 5,29443,-0.00482548689947255,0.00226635822427707,-0.0092675490190556,-0.000383424779889496,0.033247564779258
NMR metabolomics,X23428.Concentration of VLDL Particles,DCUN1D1,DCN1-like protein 1,24101,-0.0105726533786294,0.00503142418176475,-0.0204342447748883,-0.000711061982370456,0.0356228785175626
NMR metabolomics,X23428.Concentration of VLDL Particles,SOX2,Transcription factor SOX-2,24826,0.00335851721548505,0.00159885836583808,0.000224754818442416,0.00649227961252768,0.0356886136890601
NMR metabolomics,X23428.Concentration of VLDL Particles,STOML2,"Stomatin-like protein 2, mitochondrial",24016,0.013036530748939,0.00622057605535719,0.000844201680438869,0.025228859817439,0.0361182675935648
NMR metabolomics,X23428.Concentration of VLDL Particles,ICAM2,Intercellular adhesion molecule 2,29820,-0.00443278338444635,0.00212810980322846,-0.00860387859877414,-0.000261688170118565,0.0372626962160821
NMR metabolomics,X23428.Concentration of VLDL Particles,AIDA,"Axin interactor, dorsalization-associated protein",24195,0.0117773046409554,0.00566614763673572,0.000671655272953426,0.0228829540089575,0.0376703297760095
NMR metabolomics,X23428.Concentration of VLDL Particles,TRPV3,Transient receptor potential cation channel subfamily V member 3,24111,-0.00703591825396105,0.00338530797920199,-0.0136711218931969,-0.000400714614725159,0.0376859672663354
NMR metabolomics,X23428.Concentration of VLDL Particles,SEPTIN7,Septin-7,24445,0.00734973756970074,0.00353801350798522,0.000415231094049712,0.0142842440453518,0.0377785100999271
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1A,Interleukin-1 alpha,28931,0.00771238037979731,0.00372289013436584,0.000415515716440272,0.0150092450431543,0.0383105731843757
NMR metabolomics,X23428.Concentration of VLDL Particles,HEPACAM2,HEPACAM family member 2,24845,-0.00580663802204015,0.00281678288781964,-0.0113275324821666,-0.000285743561913653,0.0392711590895063
NMR metabolomics,X23428.Concentration of VLDL Particles,VNN2,Vascular non-inflammatory molecule 2,29349,-0.00632802962939013,0.00307381749669826,-0.0123527119229187,-0.000303347335861539,0.0395329950680124
NMR metabolomics,X23428.Concentration of VLDL Particles,RGMA,Repulsive guidance molecule A,29694,-0.00430580296157418,0.0021030596197152,-0.00842779981621597,-0.000183806106932396,0.040627671395027
NMR metabolomics,X23428.Concentration of VLDL Particles,WNT9A,Protein Wnt-9a,28931,0.00393655404751688,0.00193026717001997,0.000153230394277728,0.00771987770075602,0.0414208893389927
NMR metabolomics,X23428.Concentration of VLDL Particles,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23970,-0.00716694486180801,0.00352171877176512,-0.0140695136544676,-0.000264376069148367,0.0418547974877953
NMR metabolomics,X23428.Concentration of VLDL Particles,CHP1,Calcineurin B homologous protein 1,24101,0.00996668011219951,0.00491780453952081,0.000327783214738715,0.0196055770096603,0.0427089738453035
NMR metabolomics,X23428.Concentration of VLDL Particles,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,24016,0.00360812813996159,0.00178324796367176,0.000112962131164931,0.00710329414875825,0.0430485188135644
NMR metabolomics,X23428.Concentration of VLDL Particles,TCL1B,T-cell leukemia/lymphoma protein 1B,28916,0.010570885994199,0.00522589662337094,0.000328128612391967,0.0208136433760061,0.0431040995726041
NMR metabolomics,X23428.Concentration of VLDL Particles,PGM2,Phosphoglucomutase-2,24195,0.00816254271012943,0.00404164345317502,0.000240921541906393,0.0160841638783525,0.0434348870487951
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFB118,Beta-defensin 118,24101,0.00781068210464228,0.00386760336046474,0.000230179518131384,0.0153911846911532,0.043444796445772
NMR metabolomics,X23428.Concentration of VLDL Particles,DENND2B,DENN domain-containing protein 2B,24111,-0.00689754563567232,0.00341674271906302,-0.0135943613650358,-0.000200729906308809,0.0435243778705131
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGA11,Integrin alpha-11,29434,0.00461871303320312,0.00229018978182685,0.000129941060822496,0.00910748500558375,0.0437319169542843
NMR metabolomics,X23428.Concentration of VLDL Particles,CD177,CD177 antigen,29413,-0.0172301792826951,0.00855913756572683,-0.0340060889115197,-0.000454269653870479,0.0441159183878265
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHA4,Ephrin type-A receptor 4,24381,0.00384201857318283,0.0019210035853118,7.68515459717008e-05,0.00760718560039396,0.0455107018245758
NMR metabolomics,X23428.Concentration of VLDL Particles,SCN2A,Sodium channel protein type 2 subunit alpha,24101,0.00657400762338121,0.00330015155937724,0.000105710567001824,0.0130423046797606,0.0463788130797488
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH6,Cadherin-6,29478,-0.0050195947930847,0.00256410983123901,-0.0100452500623132,6.06047614375854e-06,0.0502821159409558
NMR metabolomics,X23428.Concentration of VLDL Particles,GHRHR,Growth hormone-releasing hormone receptor,28774,0.00719288860321534,0.00367948153344689,-1.8895202340558e-05,0.0144046724087712,0.0506087139377196
NMR metabolomics,X23428.Concentration of VLDL Particles,ADRA2A,Alpha-2A adrenergic receptor,24111,-0.00927583480459604,0.00475227025067212,-0.0185902844959134,3.86148867213103e-05,0.0509646811231111
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINT3,Kunitz-type protease inhibitor 3,24805,0.0192019472579522,0.00988162585813071,-0.000166039423984014,0.0385699339398883,0.0520036454433773
NMR metabolomics,X23428.Concentration of VLDL Particles,IL4,Interleukin-4,28931,0.011919157149074,0.00614197297818937,-0.000119109888177147,0.0239574241863252,0.0523156431174774
NMR metabolomics,X23428.Concentration of VLDL Particles,ART3,Ecto-ADP-ribosyltransferase 3,29594,-0.00445903536754352,0.00230037643718171,-0.00896777318441967,4.97024493326228e-05,0.0525847007571799
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK3,Prostate-specific antigen,24938,-0.0115296181562883,0.00596276159894641,-0.0232166308902233,0.000157394577646651,0.0531731756837899
NMR metabolomics,X23428.Concentration of VLDL Particles,DBH,Dopamine beta-hydroxylase,24919,0.0141452925596708,0.00733069193576884,-0.000222863634436138,0.0285134487537777,0.0536679430301074
NMR metabolomics,X23428.Concentration of VLDL Particles,PGLYRP1,Peptidoglycan recognition protein 1,29673,-0.00546225726263189,0.00283223209821599,-0.0110134321751352,8.89176498714414e-05,0.0537894377561954
NMR metabolomics,X23428.Concentration of VLDL Particles,PXDNL,Peroxidasin-like protein,24793,0.00745188461066353,0.00388107264535538,-0.000155017774233009,0.0150587869955601,0.0548620393324492
NMR metabolomics,X23428.Concentration of VLDL Particles,TLR1,Toll-like receptor 1,24229,0.00338081298316724,0.00177310513638526,-9.44730841478578e-05,0.00685609905048234,0.0565688281306237
NMR metabolomics,X23428.Concentration of VLDL Particles,PKLR,Pyruvate kinase PKLR,29491,-0.00812510537043846,0.0043121418091358,-0.0165769033163446,0.00032669257546771,0.0595424987109321
NMR metabolomics,X23428.Concentration of VLDL Particles,CEND1,Cell cycle exit and neuronal differentiation protein 1,24101,0.00742564752348894,0.00395819870066733,-0.000332421929819032,0.0151837169767969,0.0606650472226674
NMR metabolomics,X23428.Concentration of VLDL Particles,TSPAN1,Tetraspanin-1,28916,-0.00712031223773977,0.00379634551665612,-0.0145611494503858,0.000320524974906234,0.0607244043535188
NMR metabolomics,X23428.Concentration of VLDL Particles,CHGB,Secretogranin-1,29590,0.00512440165656775,0.0027513634054084,-0.000268270618032706,0.0105170739311682,0.0625432025903337
NMR metabolomics,X23428.Concentration of VLDL Particles,PCNA,Proliferating cell nuclear antigen,24016,0.00786843510189131,0.00425598943452073,-0.000473304189769312,0.0162101743935519,0.0645002822727591
NMR metabolomics,X23428.Concentration of VLDL Particles,OMD,Osteomodulin,29581,0.00529724089954678,0.0028815912783963,-0.000350678006109971,0.0109451598052035,0.0660276405736263
NMR metabolomics,X23428.Concentration of VLDL Particles,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,24111,0.00319219572593418,0.00173991720253862,-0.000218041991041517,0.00660243344290988,0.0665650604733487
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH15,Cadherin-15,29639,0.00708309827762367,0.00386308828727314,-0.000488554765431675,0.014654751320679,0.066733433325179
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G1B,Phospholipase A2,29787,-0.00526981204991732,0.00288048398880983,-0.0109155606679846,0.000375936568149935,0.0673364702066874
NMR metabolomics,X23428.Concentration of VLDL Particles,GFRA3,GDNF family receptor alpha-3,29157,0.00344763471388257,0.00188477650255595,-0.000246527231127093,0.00714179665889224,0.0673797428467149
NMR metabolomics,X23428.Concentration of VLDL Particles,TFRC,Transferrin receptor protein 1,29565,-0.00470459747411168,0.0025772810656287,-0.00975606836274394,0.000346873414520579,0.0679491030786951
NMR metabolomics,X23428.Concentration of VLDL Particles,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29443,-0.00337046486299412,0.00185012462126363,-0.00699670912067083,0.000255779394682582,0.06850304606086
NMR metabolomics,X23428.Concentration of VLDL Particles,OPTC,Opticin,29349,0.00550037725778725,0.00302007504337914,-0.000418969827235856,0.0114197243428104,0.0685757441583121
NMR metabolomics,X23428.Concentration of VLDL Particles,IL20,Interleukin-20,28931,0.00595873434356066,0.003276871150096,-0.000463933110627493,0.0123814017977488,0.0690100101534633
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT14,"Keratin, type I cytoskeletal 14",27986,0.00353258078110174,0.0019481610716363,-0.000285814919305408,0.00735097648150889,0.0697978340069097
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHA10,Ephrin type-A receptor 10,28774,0.00793714440139912,0.00437742272258589,-0.00064260413486923,0.0165168929376675,0.0698113458265108
NMR metabolomics,X23428.Concentration of VLDL Particles,HBQ1,Hemoglobin subunit theta-1,29725,-0.00728610013600538,0.00402025064629229,-0.0151657914027383,0.000593591130727519,0.0699422660770668
NMR metabolomics,X23428.Concentration of VLDL Particles,PAPPA,Pappalysin-1,28931,0.00571712221296313,0.00315455740491048,-0.000465810300661408,0.0119000547265877,0.0699444531821545
NMR metabolomics,X23428.Concentration of VLDL Particles,DCN,Decorin,28916,-0.00277144784873614,0.0015312430900515,-0.00577268430523708,0.000229788607764805,0.0703165147536797
NMR metabolomics,X23428.Concentration of VLDL Particles,ACTN4,Alpha-actinin-4,28931,0.00386483592723239,0.00214103783917845,-0.000331598237557365,0.00806127009202215,0.0710658866173915
NMR metabolomics,X23428.Concentration of VLDL Particles,EPO,Erythropoietin,29434,-0.00915464251618247,0.00507200934836392,-0.0190957808389757,0.000786495806610809,0.0710952187042893
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A3,Protein S100-A3,24793,0.00537319178078032,0.00297853161870236,-0.0004647301918763,0.0112111137534369,0.0712476178807694
NMR metabolomics,X23428.Concentration of VLDL Particles,STC2,Stanniocalcin-2,29396,-0.00311589560861517,0.00173423622419331,-0.00651499860803406,0.00028320739080372,0.0723941319141646
NMR metabolomics,X23428.Concentration of VLDL Particles,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24867,-0.00287043096059922,0.00159767366039776,-0.00600187133497882,0.000261009413780388,0.0724062650294591
NMR metabolomics,X23428.Concentration of VLDL Particles,APOH,Beta-2-glycoprotein 1,29443,-0.00430890506224916,0.00240217721672569,-0.00901717240703152,0.000399362282533195,0.0728633644291717
NMR metabolomics,X23428.Concentration of VLDL Particles,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24793,0.00570291114021002,0.0031804956046085,-0.000530860244822636,0.0119366825252427,0.0729709128201198
NMR metabolomics,X23428.Concentration of VLDL Particles,EDNRB,Endothelin receptor type B,24229,0.00547205375146386,0.00307160625060333,-0.000548294499718667,0.0114924020026464,0.0748440138739181
NMR metabolomics,X23428.Concentration of VLDL Particles,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28797,-0.00919935978261633,0.00517263994879999,-0.0193377340822643,0.000939014517031647,0.0753380467083899
NMR metabolomics,X23428.Concentration of VLDL Particles,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",24101,-0.00540488989389386,0.00305974417607682,-0.0114019884790044,0.000592208691216697,0.0773327839535661
NMR metabolomics,X23428.Concentration of VLDL Particles,IL19,Interleukin-19,28654,-0.00830762006872802,0.00470561298087507,-0.0175306215112431,0.000915381373787112,0.0774954076785513
NMR metabolomics,X23428.Concentration of VLDL Particles,GNPDA1,Glucosamine-6-phosphate isomerase 1,24240,0.00392661859413612,0.0022243355240379,-0.000433079032978169,0.00828631622125041,0.077526023920785
NMR metabolomics,X23428.Concentration of VLDL Particles,WFDC2,WAP four-disulfide core domain protein 2,27939,0.00471707507569051,0.00267452446843895,-0.000524992882449834,0.00995914303383086,0.0777924097260369
NMR metabolomics,X23428.Concentration of VLDL Particles,LPA,Apolipoprotein(a),24484,-0.0211342652916529,0.0119831025513335,-0.0446211462922666,0.00235261570896076,0.0777996550691745
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPL24,"39S ribosomal protein L24, mitochondrial",24111,0.00465788208181306,0.00264775620092484,-0.000531720071999618,0.00984748423562574,0.078559480307595
NMR metabolomics,X23428.Concentration of VLDL Particles,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29694,0.00552268285216058,0.00314193643941324,-0.000635512569089378,0.0116808782734105,0.0788033935755556
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC51B,Organic solute transporter subunit beta,24111,-0.00899776279642438,0.00513508591594868,-0.0190625311916838,0.00106700559883504,0.0797499576706335
NMR metabolomics,X23428.Concentration of VLDL Particles,PALM3,Paralemmin-3,24111,0.00869714623707606,0.00496378297582628,-0.00103186839554345,0.0184261608696956,0.0797657972959203
NMR metabolomics,X23428.Concentration of VLDL Particles,FBN2,Fibrillin-2,24195,0.00707636215228542,0.00405808947780295,-0.000877493224208362,0.0150302175287792,0.0812124502985042
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH4,Cadherin-4,24101,0.00561071980325857,0.00323066890143101,-0.000721391243546217,0.0119428308500634,0.0824519863506486
NMR metabolomics,X23428.Concentration of VLDL Particles,VSTM1,V-set and transmembrane domain-containing protein 1,28774,0.00571457091481188,0.00329805024389771,-0.000749607563227639,0.0121787493928514,0.0831576075975533
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL2L15,Bcl-2-like protein 15,24229,0.00652256002290121,0.00378909988978373,-0.000904075761074901,0.0139491958068773,0.0851908704240613
NMR metabolomics,X23428.Concentration of VLDL Particles,DUSP29,Dual specificity phosphatase 29,24195,-0.00770831171250138,0.00448894289847346,-0.0165066397935094,0.00109001636850661,0.0859595513687615
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK8,Serine protease inhibitor Kazal-type 8,24111,0.00432838322329018,0.0025220910274779,-0.00061491519056651,0.00927168163714688,0.0861404287173558
NMR metabolomics,X23428.Concentration of VLDL Particles,GIMAP7,GTPase IMAP family member 7,24381,-0.00371475351440957,0.00216887380972041,-0.00796574618146157,0.000536239152642429,0.0867699998788001
NMR metabolomics,X23428.Concentration of VLDL Particles,HIF1A,Hypoxia-inducible factor 1-alpha,24229,0.0075346859823583,0.00440964408475513,-0.00110821642376175,0.0161775883884784,0.0875224114730347
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC10A,C-type lectin domain family 10 member A,29218,-0.00413412905345932,0.0024225343685359,-0.00888229641578969,0.000614038308871053,0.087919963605376
NMR metabolomics,X23428.Concentration of VLDL Particles,FLT3,Receptor-type tyrosine-protein kinase FLT3,28797,0.0034888577691763,0.00204596626680652,-0.000521236113764493,0.00749895165211708,0.0881609867679132
NMR metabolomics,X23428.Concentration of VLDL Particles,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,24195,-0.00541784984447666,0.00317917228555344,-0.0116490275241614,0.000813327835208079,0.088362190532709
NMR metabolomics,X23428.Concentration of VLDL Particles,GIPC2,PDZ domain-containing protein GIPC2,24845,0.00339737795384503,0.00199600275899765,-0.000514787453790354,0.00730954336148042,0.0887508636107956
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRS,Receptor-type tyrosine-protein phosphatase S,29820,-0.00279743012629252,0.00164583019833269,-0.00602325731502459,0.000428397062439541,0.0891963696278021
NMR metabolomics,X23428.Concentration of VLDL Particles,MN1,Transcriptional activator MN1,24195,-0.00675778665253567,0.00397652612975727,-0.0145517778668599,0.00103620456178858,0.0892530037044787
NMR metabolomics,X23428.Concentration of VLDL Particles,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28774,-0.00540497136177045,0.00318130562757072,-0.0116403303918091,0.00083038766826816,0.0893339612195441
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDH17,Protocadherin-17,29478,-0.00408115419728657,0.00240877872949201,-0.00880236050709092,0.000640052112517769,0.0902219817252307
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF12,Fibroblast growth factor 12,24229,0.00532867482026041,0.00314654980653459,-0.000838562800547391,0.0114959124410682,0.0903736362956197
NMR metabolomics,X23428.Concentration of VLDL Particles,COPE,Coatomer subunit epsilon,28774,0.00535370873757936,0.00316901192623688,-0.000857554637844925,0.0115649721130036,0.0911548492893441
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGBL1,Integrin beta-like protein 1,24938,0.00420606626738712,0.00249724441320706,-0.000688532782498716,0.00910066531727295,0.092139513735283
NMR metabolomics,X23428.Concentration of VLDL Particles,DOC2B,Double C2-like domain-containing protein beta,24195,0.00409781730570006,0.00243534454975841,-0.000675458011826413,0.00887109262322654,0.092456985624699
NMR metabolomics,X23428.Concentration of VLDL Particles,CLNS1A,Methylosome subunit pICln,24195,-0.00377007206239982,0.00225131198277836,-0.00818264354864541,0.000642499423845769,0.0940234890619565
NMR metabolomics,X23428.Concentration of VLDL Particles,ACRV1,Acrosomal protein SP-10,24229,-0.00862294248087732,0.00516024764785351,-0.0187370278706702,0.00149114290891557,0.0947281442801136
NMR metabolomics,X23428.Concentration of VLDL Particles,IL6,Interleukin-6,29349,0.00823974148877453,0.00493140558731352,-0.00142581346235997,0.017905296439909,0.0947578718049602
NMR metabolomics,X23428.Concentration of VLDL Particles,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24793,0.0108488936063087,0.00651520020401019,-0.00192089879355127,0.0236186860061687,0.0958921694793179
NMR metabolomics,X23428.Concentration of VLDL Particles,PRR5,Proline-rich protein 5,24229,0.00533302679013121,0.00320299333874651,-0.000944840153811944,0.0116108937340744,0.0959230215979034
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC1,Sialoadhesin,29581,0.00469204665034191,0.0028369969069777,-0.000868467287334369,0.0102525605880182,0.0981629275149908
NMR metabolomics,X23428.Concentration of VLDL Particles,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24793,0.00688574415541357,0.00418160529762132,-0.00131020222792422,0.0150816905387514,0.0996375832556291
NMR metabolomics,X23428.Concentration of VLDL Particles,SSB,Lupus La protein,28774,0.00652637436384508,0.00398783686317999,-0.00128978588798769,0.0143425346156779,0.101731279977634
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,24111,-0.00558360685490976,0.00341492396911428,-0.0122768578343737,0.00110964412455423,0.102049453911485
NMR metabolomics,X23428.Concentration of VLDL Particles,HIP1,Huntingtin-interacting protein 1,24111,0.00367434611654986,0.00224997155902134,-0.000735598139131962,0.00808429037223167,0.102468736344577
NMR metabolomics,X23428.Concentration of VLDL Particles,CSH1,Chorionic somatomammotropin hormone 1,24951,0.00351617423896309,0.00215625951391044,-0.000710094408301367,0.00774244288622755,0.102970000475026
NMR metabolomics,X23428.Concentration of VLDL Particles,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29632,0.00372726061851277,0.00230144810945427,-0.000783577676017599,0.00823809891304314,0.105344263594607
NMR metabolomics,X23428.Concentration of VLDL Particles,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,24111,-0.00364379315684775,0.00226325315060371,-0.00807976933203102,0.000792183018335521,0.107415239149318
NMR metabolomics,X23428.Concentration of VLDL Particles,SPRING1,SREBP regulating gene protein,24016,0.00644403968808722,0.00400377934992129,-0.0014033678377585,0.0142914472139329,0.10752256207593
NMR metabolomics,X23428.Concentration of VLDL Particles,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23970,0.00944164048545301,0.00589821692285618,-0.00211886468334511,0.0210021456542511,0.109442867791524
NMR metabolomics,X23428.Concentration of VLDL Particles,HLA_DRA,,29322,-0.00386521718374116,0.00241567752243996,-0.00859994512772348,0.00086951076024117,0.109597135040561
NMR metabolomics,X23428.Concentration of VLDL Particles,FZD8,Frizzled-8,24101,0.00471887731658692,0.0029551858195049,-0.00107328688964268,0.0105110415228165,0.110320652448101
NMR metabolomics,X23428.Concentration of VLDL Particles,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",24111,-0.00716664064356895,0.00450464280618525,-0.0159957405436921,0.00166245925655415,0.111634987119924
NMR metabolomics,X23428.Concentration of VLDL Particles,RYR1,Ryanodine receptor 1,24111,-0.0036432495095936,0.00229353450336518,-0.00813857713618936,0.000852078117002152,0.112189400958445
NMR metabolomics,X23428.Concentration of VLDL Particles,IL20RB,Interleukin-20 receptor subunit beta,24229,0.00445882671675401,0.00283892868157328,-0.00110547349912963,0.0100231269326376,0.116288219261205
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24322,0.00512543978255313,0.00327446629179391,-0.00129251414936293,0.0115433937144692,0.117531491309902
NMR metabolomics,X23428.Concentration of VLDL Particles,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,24016,-0.00881844491776142,0.00564321527653108,-0.0198791468597623,0.0022422570242395,0.118145015095074
NMR metabolomics,X23428.Concentration of VLDL Particles,SMPD3,Sphingomyelin phosphodiesterase 3,24229,0.00604650336302617,0.00388327380108714,-0.00156471328710462,0.013657720013157,0.119468511001737
NMR metabolomics,X23428.Concentration of VLDL Particles,SMC3,Structural maintenance of chromosomes protein 3,24016,0.00564058425800128,0.00363609530714814,-0.00148616254400906,0.0127673310600116,0.120848946272405
NMR metabolomics,X23428.Concentration of VLDL Particles,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29427,-0.0076294980061081,0.00492158854267949,-0.0172758115497599,0.00201681553754371,0.121101770654093
NMR metabolomics,X23428.Concentration of VLDL Particles,FDX1,"Adrenodoxin, mitochondrial",24111,0.00652175924806691,0.00421995176679777,-0.00174934621485673,0.0147928647109905,0.122248593327945
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A16,Protein S100-A16,28722,-0.00635399147239353,0.00411475140174976,-0.0144189042198231,0.001710921275036,0.122551361156131
NMR metabolomics,X23428.Concentration of VLDL Particles,DUOX2,Dual oxidase 2,28916,0.00730699578029523,0.00477581895948342,-0.00205360938029226,0.0166676009408827,0.126028047741272
NMR metabolomics,X23428.Concentration of VLDL Particles,IL36G,Interleukin-36 gamma,24149,0.00695208588724829,0.00457392160670378,-0.00201280046189111,0.0159169722363877,0.128539184146451
NMR metabolomics,X23428.Concentration of VLDL Particles,IL5,Interleukin-5,28931,0.0144328635883287,0.00950992319589298,-0.00420658587562152,0.0330723130522789,0.129110174706024
NMR metabolomics,X23428.Concentration of VLDL Particles,MYH4,Myosin-4,24111,-0.00476047121542661,0.00313893651214133,-0.0109127867792236,0.00139184434837039,0.129384034167402
NMR metabolomics,X23428.Concentration of VLDL Particles,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",24195,0.0079014508971033,0.00522061491511212,-0.00233095433651645,0.0181338561307231,0.130163328793431
NMR metabolomics,X23428.Concentration of VLDL Particles,APOA1,Apolipoprotein A-I,24966,-0.00278976756458831,0.00184352288056329,-0.00640307241049236,0.000823537281315733,0.130221042560521
NMR metabolomics,X23428.Concentration of VLDL Particles,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29443,0.00426694457701782,0.00282604623452559,-0.00127210604265233,0.00980599519668798,0.131088947151875
NMR metabolomics,X23428.Concentration of VLDL Particles,SHISA5,Protein shisa-5,24938,0.00256224992139052,0.0016972743716943,-0.000764407847130305,0.00588890768991135,0.131151499226861
NMR metabolomics,X23428.Concentration of VLDL Particles,BLVRB,Flavin reductase,29443,0.00656580990785088,0.004350130116385,-0.00196044512026372,0.0150920649359655,0.13122356226395
NMR metabolomics,X23428.Concentration of VLDL Particles,PSCA,Prostate stem cell antigen,24805,0.0261548177055217,0.0174032341124473,-0.00795552115487488,0.0602651565659184,0.132885022650469
NMR metabolomics,X23428.Concentration of VLDL Particles,COL1A1,Collagen alpha-1(I) chain,29820,-0.00251132765561266,0.00167132370286172,-0.00578712211322162,0.000764466801996308,0.132953333229008
NMR metabolomics,X23428.Concentration of VLDL Particles,MSMB,Beta-microseminoprotein,29313,0.00695880639382929,0.00465034137645043,-0.00215586270401356,0.0160734754916721,0.134558229610426
NMR metabolomics,X23428.Concentration of VLDL Particles,RAC3,Ras-related C3 botulinum toxin substrate 3,24195,0.00696799287024344,0.00466889597495729,-0.00218304324067286,0.0161190289811597,0.135599924992529
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTN1,Contactin-1,29820,0.00271523407012414,0.00182190195953959,-0.00085569377057346,0.00628616191082174,0.136148225195312
NMR metabolomics,X23428.Concentration of VLDL Particles,DHODH,Dihydroorotate dehydrogenase,24111,0.00472526332153308,0.0031859493369317,-0.00151919737885305,0.0109697240219192,0.138045759156782
NMR metabolomics,X23428.Concentration of VLDL Particles,H2AP,Huntingtin-interacting protein M,24016,-0.00510037602862122,0.00344517459493116,-0.0118529182346863,0.00165216617744385,0.138768851879945
NMR metabolomics,X23428.Concentration of VLDL Particles,GPHA2,Glycoprotein hormone alpha-2,24805,0.00462527077255466,0.00312458565887379,-0.00149891711883797,0.0107494586639473,0.138810467968344
NMR metabolomics,X23428.Concentration of VLDL Particles,CTNNA1,Catenin alpha-1,24101,-0.00349102242083309,0.00235904555971736,-0.00811475171787912,0.00113270687621293,0.138927621773222
NMR metabolomics,X23428.Concentration of VLDL Particles,ZNF830,Zinc finger protein 830,24793,-0.00781647181240895,0.00531512994220656,-0.0182341264991338,0.00260118287431591,0.141409897679022
NMR metabolomics,X23428.Concentration of VLDL Particles,HRAS,GTPase Hras,24421,0.00972635124116698,0.00661505735003667,-0.00323916116490489,0.0226918636472388,0.141483900412304
NMR metabolomics,X23428.Concentration of VLDL Particles,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,24240,-0.00395813707457343,0.00270096878482981,-0.00925203589283986,0.001335761743693,0.142810923174594
NMR metabolomics,X23428.Concentration of VLDL Particles,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24805,-0.00691902996479502,0.00472771322116642,-0.0161853478782812,0.00234728794869117,0.143342039009566
NMR metabolomics,X23428.Concentration of VLDL Particles,GID8,Glucose-induced degradation protein 8 homolog,24867,0.00331438048497017,0.00226903878197344,-0.00113293552769778,0.00776169649763812,0.144110970529759
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFA1_DEFA1B,Neutrophil defensin 1,28862,0.00510126492890932,0.00350720453680729,-0.00177285596323297,0.0119753858210516,0.145815775115551
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB6B,Ras-related protein Rab-6B,28774,0.00466799737674855,0.00321465650283475,-0.00163272936880757,0.0109687241223047,0.146485171692531
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24867,0.0031122714013533,0.00215652149752733,-0.00111451073380027,0.00733905353650687,0.148979410221365
NMR metabolomics,X23428.Concentration of VLDL Particles,SIRPB1,Signal-regulatory protein beta-1,29409,0.00444678649821278,0.00308358881057754,-0.0015970475705192,0.0104906205669448,0.149290026175511
NMR metabolomics,X23428.Concentration of VLDL Particles,IL18RAP,Interleukin-18 receptor accessory protein,29038,0.0164635624214443,0.0115017696608268,-0.00607990611377633,0.0390070309566649,0.152328135745407
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,29218,0.00313974910082327,0.0021950984055816,-0.00116264377411667,0.00744214197576321,0.152628583957112
NMR metabolomics,X23428.Concentration of VLDL Particles,UBQLN3,Ubiquilin-3,24111,-0.00481787146061373,0.00338450355891472,-0.0114514984360866,0.00181575551485912,0.154601586378236
NMR metabolomics,X23428.Concentration of VLDL Particles,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",24111,-0.00413794603236447,0.00291442634788784,-0.00985022167422465,0.0015743296094957,0.155674504599844
NMR metabolomics,X23428.Concentration of VLDL Particles,CSRP3,Cysteine and glycine-rich protein 3,24111,-0.00935316826618251,0.00662308904911242,-0.0223344228024429,0.00362808627007784,0.157902131405339
NMR metabolomics,X23428.Concentration of VLDL Particles,MFAP3,Microfibril-associated glycoprotein 3,28916,0.00457764015591699,0.0032661214540147,-0.00182395789395182,0.0109792382057858,0.161059706795824
NMR metabolomics,X23428.Concentration of VLDL Particles,LYPLA2,Acyl-protein thioesterase 2,24101,0.010183778041247,0.00726654691631838,-0.00405865391473705,0.024426209997231,0.161089313868195
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT6C,"Keratin, type II cytoskeletal 6C",24111,-0.00374643771278054,0.00267482037561671,-0.00898908564898929,0.00149621022342821,0.161337168446902
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFB116,Beta-defensin 116,24101,-0.00724273152428376,0.00518332538482612,-0.017402049278543,0.00291658622997545,0.162332131153529
NMR metabolomics,X23428.Concentration of VLDL Particles,PSAPL1,Proactivator polypeptide-like 1,24805,0.00471518385615814,0.00337859534367485,-0.00190686301744456,0.0113372307297608,0.162846037627416
NMR metabolomics,X23428.Concentration of VLDL Particles,CST6,Cystatin-M,28830,0.00454566628561823,0.00326211180747413,-0.00184807285703106,0.0109394054282675,0.16348740710764
NMR metabolomics,X23428.Concentration of VLDL Particles,VCAN,Versican core protein,29694,0.00279732624203853,0.00200821201890138,-0.00113876931500818,0.00673342179908524,0.163647254953948
NMR metabolomics,X23428.Concentration of VLDL Particles,CDAN1,Codanin-1,24845,0.00210675036906743,0.0015137546042739,-0.000860208655309426,0.00507370939344428,0.164014104125758
NMR metabolomics,X23428.Concentration of VLDL Particles,RELB,Transcription factor RelB,24229,0.00460906293642023,0.00331942050660063,-0.00189700125651701,0.0111151271293575,0.164993256531321
NMR metabolomics,X23428.Concentration of VLDL Particles,FHIP2A,FHF complex subunit HOOK interacting protein 2A,24111,0.00437159918123495,0.00315011000851452,-0.00180261643545352,0.0105458147979234,0.165222727238688
NMR metabolomics,X23428.Concentration of VLDL Particles,ENPEP,Glutamyl aminopeptidase,24111,0.00415220505155713,0.00299460227807255,-0.00171721541346507,0.0100216255165793,0.165587850682484
NMR metabolomics,X23428.Concentration of VLDL Particles,IL7R,Interleukin-7 receptor subunit alpha,29443,-0.00484826942038171,0.00350445789012036,-0.0117170068850176,0.0020204680442542,0.166535048174099
NMR metabolomics,X23428.Concentration of VLDL Particles,MUCL3,Mucin-like protein 3,24016,-0.00407268155147201,0.0029518492695748,-0.00985830611983862,0.0017129430168946,0.167690308356482
NMR metabolomics,X23428.Concentration of VLDL Particles,CORO6,Coronin-6,24101,-0.00346166839706785,0.00252355943496434,-0.00840784488959796,0.00148450809546226,0.170157047223391
NMR metabolomics,X23428.Concentration of VLDL Particles,TNPO1,Transportin-1,24445,0.00324262286706788,0.00237677895947817,-0.00141586389350933,0.00790110962764509,0.172487939029584
NMR metabolomics,X23428.Concentration of VLDL Particles,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24445,0.00333004484939682,0.00244543763528333,-0.0014630129157585,0.00812310261455215,0.173293206030316
NMR metabolomics,X23428.Concentration of VLDL Particles,TJP3,Tight junction protein ZO-3,24101,-0.00389785109356481,0.00287645128758524,-0.00953569561723188,0.00173999343010226,0.175401512518665
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24938,-0.0125293596110073,0.00924716990409631,-0.0306538126230361,0.00559509340102147,0.175448981278192
NMR metabolomics,X23428.Concentration of VLDL Particles,HCG22,Protein PBMUCL2,24111,-0.00503120509717254,0.00372729797461643,-0.0123367091274207,0.00227429893307565,0.177084363459243
NMR metabolomics,X23428.Concentration of VLDL Particles,SCN3B,Sodium channel subunit beta-3,24101,0.00417217894598596,0.00309793967667189,-0.00189978282029094,0.0102441407122629,0.178070450872964
NMR metabolomics,X23428.Concentration of VLDL Particles,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",24111,-0.00552202722647504,0.00410043055252509,-0.0135588711094242,0.00251481665647412,0.178091313636361
NMR metabolomics,X23428.Concentration of VLDL Particles,HLA_A,,24867,0.00295132556066827,0.00219276359439848,-0.00134649108435275,0.00724914220568929,0.178334537442571
NMR metabolomics,X23428.Concentration of VLDL Particles,CDSN,Corneodesmosin,29676,0.00389518649138026,0.00289938794431007,-0.00178761387946749,0.009577986862228,0.179136164052078
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMC3,26S proteasome regulatory subunit 6A,24016,-0.00272865999539005,0.00203389706434628,-0.00671509824150876,0.00125777825072866,0.179741019672455
NMR metabolomics,X23428.Concentration of VLDL Particles,BTLA,B- and T-lymphocyte attenuator,24016,0.00782438275071191,0.00586919622376087,-0.00367924184785939,0.0193280073492832,0.182502850455399
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24381,-0.00365747116880592,0.00274941053760219,-0.0090463158225062,0.00173137348489437,0.183440242833368
NMR metabolomics,X23428.Concentration of VLDL Particles,KIAA2013,Uncharacterized protein KIAA2013,24793,0.00496630183786432,0.00373721353416604,-0.00235863668910112,0.0122912403648298,0.183900371963586
NMR metabolomics,X23428.Concentration of VLDL Particles,NRP2,Neuropilin-2,29443,-0.00254493987963943,0.00191530978796212,-0.00629894706404519,0.00120906730476633,0.183945590316656
NMR metabolomics,X23428.Concentration of VLDL Particles,CRTAM,Cytotoxic and regulatory T-cell molecule,29218,0.0044744568499666,0.00339623068165583,-0.00218215528607882,0.011131068986012,0.187689018760802
NMR metabolomics,X23428.Concentration of VLDL Particles,PTK7,Inactive tyrosine-protein kinase 7,28774,0.00338262676039195,0.00256897548461036,-0.00165256518944436,0.00841781871022825,0.187942289519769
NMR metabolomics,X23428.Concentration of VLDL Particles,REXO2,"Oligoribonuclease, mitochondrial",24111,-0.00423207331495444,0.00321477841023777,-0.0105330389990205,0.0020688923691116,0.188037837486145
NMR metabolomics,X23428.Concentration of VLDL Particles,ERCC1,DNA excision repair protein ERCC-1,24016,0.00295398523737875,0.00224936661802175,-0.00145477333394389,0.00736274380870138,0.189110596966197
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL14,C-X-C motif chemokine 14,28931,0.00521926929192739,0.00398186757263626,-0.00258519115043969,0.0130237297342945,0.189949562623064
NMR metabolomics,X23428.Concentration of VLDL Particles,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",24016,-0.00483157968404177,0.0037016928783763,-0.0120868977256593,0.00242373835757577,0.191825298268166
NMR metabolomics,X23428.Concentration of VLDL Particles,BEX3,Protein BEX3,24016,-0.00413186847099622,0.00317594549253199,-0.0103567216363589,0.00209298469436649,0.19327489007056
NMR metabolomics,X23428.Concentration of VLDL Particles,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,24195,-0.00428017891694954,0.00330949094132588,-0.0107667811619483,0.00220642332804918,0.195918183370677
NMR metabolomics,X23428.Concentration of VLDL Particles,SHH,Sonic hedgehog protein,24229,-0.00373697886231459,0.00288972430624909,-0.0094008385025628,0.00192688077793362,0.195955741384989
NMR metabolomics,X23428.Concentration of VLDL Particles,MORF4L1,Mortality factor 4-like protein 1,24445,-0.00346762906385716,0.00269454567790317,-0.00874893859254738,0.00181368046483306,0.198138979655522
NMR metabolomics,X23428.Concentration of VLDL Particles,RPGR,X-linked retinitis pigmentosa GTPase regulator,24195,0.00360023978878447,0.00280241336916402,-0.001892490414777,0.00909296999234594,0.198912022683954
NMR metabolomics,X23428.Concentration of VLDL Particles,WFDC12,WAP four-disulfide core domain protein 12,29662,-0.00544375281986766,0.00425961210947717,-0.0137925925544429,0.00290508691470759,0.201262035736363
NMR metabolomics,X23428.Concentration of VLDL Particles,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,24016,0.00491160169870414,0.00386015287691486,-0.002654297940049,0.0124775013374573,0.20324858758364
NMR metabolomics,X23428.Concentration of VLDL Particles,RBP7,Retinoid-binding protein 7,24805,0.0051179318178082,0.00403763492509129,-0.00279583263537072,0.0130316962709871,0.204968154203051
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTNAP2,Contactin-associated protein-like 2,29434,0.00349768817090898,0.00276693011304879,-0.00192549485066666,0.00892087119248461,0.206202619309814
NMR metabolomics,X23428.Concentration of VLDL Particles,PYDC1,Pyrin domain-containing protein 1,24240,-0.00355577315366806,0.002816604178771,-0.00907631734405922,0.00196477103672311,0.206805289220444
NMR metabolomics,X23428.Concentration of VLDL Particles,ZPR1,Zinc finger protein ZPR1,24101,0.0081666831162462,0.00649122603772487,-0.00455611991769454,0.0208894861501869,0.208363798122189
NMR metabolomics,X23428.Concentration of VLDL Particles,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",24229,0.00413319024542436,0.00328887714895509,-0.00231300896652762,0.0105793894573763,0.208867985742814
NMR metabolomics,X23428.Concentration of VLDL Particles,PI3,Elafin,29014,0.00461511844990786,0.00368129676529663,-0.00260022321007354,0.0118304601098893,0.209973353564813
NMR metabolomics,X23428.Concentration of VLDL Particles,KCNC4,Potassium voltage-gated channel subfamily C member 4,24101,0.0047145374645867,0.00376796481174644,-0.00267067356643633,0.0120997484956097,0.210867872642351
NMR metabolomics,X23428.Concentration of VLDL Particles,TCN2,Transcobalamin-2,29757,-0.00250448085669291,0.00200528877150029,-0.00643484684883349,0.00142588513544766,0.211697670558897
NMR metabolomics,X23428.Concentration of VLDL Particles,ESR1,Estrogen receptor,24229,0.00480778606859589,0.00387124943126596,-0.00277986281668539,0.0123954349538772,0.214277729497497
NMR metabolomics,X23428.Concentration of VLDL Particles,PADI2,Protein-arginine deiminase type-2,28931,0.00466226394243318,0.00377427952105219,-0.00273532391882911,0.0120598518036955,0.216739116791509
NMR metabolomics,X23428.Concentration of VLDL Particles,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,24111,0.0046158780102005,0.00377431013652814,-0.00278176985739465,0.0120135258777957,0.221351992627773
NMR metabolomics,X23428.Concentration of VLDL Particles,FSTL3,Follistatin-related protein 3,29351,0.00259280847321188,0.00213079904437155,-0.00158355765375635,0.00676917460018012,0.223680786719029
NMR metabolomics,X23428.Concentration of VLDL Particles,OSTN,Osteocrin,24195,-0.00340999296592962,0.00280829443228315,-0.00891425005320459,0.00209426412134535,0.224661214688822
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP350,Centrosome-associated protein 350,24016,0.00300280423234248,0.00248767796151885,-0.00187304457223447,0.00787865303691943,0.227416649890555
NMR metabolomics,X23428.Concentration of VLDL Particles,HSP90B1,Endoplasmin,28626,0.00538764431671004,0.00448835278649288,-0.00340952714481601,0.0141848157782361,0.230009047978642
NMR metabolomics,X23428.Concentration of VLDL Particles,LRP2,Low-density lipoprotein receptor-related protein 2,24195,0.00292101222466832,0.00243559138967469,-0.00185274689909407,0.0076947713484307,0.230421874299065
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK1,Serine protease inhibitor Kazal-type 1,29443,-0.00341153344809817,0.00285897200449108,-0.00901511857690069,0.00219205168070435,0.232772182142695
NMR metabolomics,X23428.Concentration of VLDL Particles,RLN2,Prorelaxin H2,24326,-0.00906230521884439,0.00761826444388407,-0.0239941035288572,0.00586949309116837,0.234234989289673
NMR metabolomics,X23428.Concentration of VLDL Particles,MEGF11,Multiple epidermal growth factor-like domains protein 11,24111,0.00260158527012841,0.00218814227631268,-0.00168717359144445,0.00689034413170126,0.234472226082721
NMR metabolomics,X23428.Concentration of VLDL Particles,IL25,Interleukin-25,23913,0.00274964112453671,0.00232642828232858,-0.00181015830882731,0.00730944055790073,0.237251079893152
NMR metabolomics,X23428.Concentration of VLDL Particles,HMCN2,Hemicentin-2,24343,-0.0045605125679913,0.00387010570378657,-0.012145919747413,0.00302489461143038,0.238650761653851
NMR metabolomics,X23428.Concentration of VLDL Particles,OTOA,Otoancorin,24101,-0.00422331323498695,0.00360692475326278,-0.011292885751382,0.0028462592814081,0.241654454699457
NMR metabolomics,X23428.Concentration of VLDL Particles,AKR1B10,Aldo-keto reductase family 1 member B10,24195,0.00490104603995923,0.00419134204815364,-0.00331398437442191,0.0131160764543404,0.242283760131152
NMR metabolomics,X23428.Concentration of VLDL Particles,RTKN2,Rhotekin-2,24111,-0.0040609833195991,0.00348103803805022,-0.0108838178741775,0.00276185123497933,0.24338298413735
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC44A4,Choline transporter-like protein 4,24195,-0.00542597213196481,0.00465875921854542,-0.0145571402003138,0.00370519593638422,0.244159303421583
NMR metabolomics,X23428.Concentration of VLDL Particles,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24445,-0.00504168942617014,0.0043324199474316,-0.0135332325231361,0.00344985367079579,0.244552077279325
NMR metabolomics,X23428.Concentration of VLDL Particles,COL5A1,Collagen alpha-1(V) chain,24381,-0.00315118482219973,0.00271116933784901,-0.00846507672438379,0.00216270707998432,0.245126103430291
NMR metabolomics,X23428.Concentration of VLDL Particles,PGR,Progesterone receptor,24229,0.00792157001869282,0.0068437073368403,-0.00549209636151417,0.0213352363988998,0.24708082269046
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC4D,C-type lectin domain family 4 member D,29434,0.00475040285114011,0.00410835961219308,-0.00330198198875832,0.0128027876910385,0.247577150330047
NMR metabolomics,X23428.Concentration of VLDL Particles,MAPT,Microtubule-associated protein tau,28774,0.00406922730669304,0.00353943514828451,-0.00286806558394459,0.0110065201973307,0.25028414838876
NMR metabolomics,X23428.Concentration of VLDL Particles,HNF1A,Hepatocyte nuclear factor 1-alpha,24195,0.00549431556519821,0.00478843087825844,-0.00389100895618832,0.0148796400865847,0.251221656512925
NMR metabolomics,X23428.Concentration of VLDL Particles,DPEP1,Dipeptidase 1,29163,-0.00372732524702709,0.00324897366951244,-0.0100953136392715,0.00264066314521728,0.251295332653938
NMR metabolomics,X23428.Concentration of VLDL Particles,PALLD,Palladin,24229,0.00307168462187004,0.00268376642956099,-0.00218849758006949,0.00833186682380957,0.252410053840167
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,24229,0.00269595024784904,0.00236048478085866,-0.00193059992263393,0.00732250041833201,0.253416603597403
NMR metabolomics,X23428.Concentration of VLDL Particles,GUCY2C,Heat-stable enterotoxin receptor,24445,-0.00636931845437218,0.00559709061734099,-0.0173396160643605,0.00460097915561616,0.255144374535462
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGAP30,Rho GTPase-activating protein 30,24445,0.00296038715448194,0.00260297366175715,-0.00214144122256207,0.00806221553152594,0.255420001616653
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28774,0.00596735991575096,0.00525076105388707,-0.0043241317498677,0.0162588515813696,0.255767192662931
NMR metabolomics,X23428.Concentration of VLDL Particles,UPK3BL1,Uroplakin-3b-like protein 1,24404,-0.00413433976487115,0.00364838533343242,-0.0112851750183987,0.0030164954886564,0.257142620885763
NMR metabolomics,X23428.Concentration of VLDL Particles,CADPS,Calcium-dependent secretion activator 1,24195,-0.00326369276033105,0.0028944578935278,-0.00893683023164554,0.00240944471098345,0.259514374684161
NMR metabolomics,X23428.Concentration of VLDL Particles,TPPP2,Tubulin polymerization-promoting protein family member 2,24445,-0.00600779472230927,0.00534058336631262,-0.016475338120282,0.00445974867566346,0.260628775649619
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJA4,DnaJ homolog subfamily A member 4,24845,-0.00528100477197549,0.00470487192060075,-0.014502553736353,0.00394054419240198,0.261680086014086
NMR metabolomics,X23428.Concentration of VLDL Particles,PLXDC1,Plexin domain-containing protein 1,28797,0.00245056540158887,0.00221855337065267,-0.00189779920489037,0.00679893000806811,0.269351691163859
NMR metabolomics,X23428.Concentration of VLDL Particles,CINP,Cyclin-dependent kinase 2-interacting protein,24445,0.00321839249487422,0.00292961933148822,-0.00252366139484268,0.00896044638459113,0.271966407987977
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJA1,DnaJ homolog subfamily A member 1,24016,-0.0034546287224125,0.00314842402424475,-0.00962553980993222,0.00271628236510721,0.272540289071259
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFBR1,TGF-beta receptor type-1,24229,0.00159239165318895,0.00145775642263378,-0.00126481093517326,0.00444959424155117,0.274686715169589
NMR metabolomics,X23428.Concentration of VLDL Particles,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28916,-0.00156074604016669,0.00143470191683714,-0.00437276179716748,0.0012512697168341,0.276668692662151
NMR metabolomics,X23428.Concentration of VLDL Particles,ZNF75D,Zinc finger protein 75D,24445,0.00436269301762373,0.00403721703341728,-0.00355025236787414,0.0122756384031216,0.279877340117624
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP1,"Fatty acid-binding protein, liver",29454,-0.00676210952274495,0.00627735279836862,-0.0190657210075474,0.00554150196205754,0.281389428658163
NMR metabolomics,X23428.Concentration of VLDL Particles,NCR1,Natural cytotoxicity triggering receptor 1,29375,0.00265103340049892,0.00247562545987579,-0.00220119250085764,0.00750325930185548,0.284243889091066
NMR metabolomics,X23428.Concentration of VLDL Particles,TAP1,Antigen peptide transporter 1,24445,-0.00431486816102246,0.0040316885831601,-0.0122169777840163,0.00358724146197135,0.284522562090353
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP15,Matrix metalloproteinase-15,24922,0.00350958571093501,0.00330148366708561,-0.00296132227655278,0.0099804936984228,0.287777343905561
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT8,"Keratin, type II cytoskeletal 8",24101,-0.00518650089410015,0.00488273108585515,-0.0147566538223763,0.00438365203417596,0.288149606309112
NMR metabolomics,X23428.Concentration of VLDL Particles,ACTA2,"Actin, aortic smooth muscle",28916,-0.00308903918356291,0.00291513332036644,-0.00880270049148113,0.00262462212435532,0.289309877801862
NMR metabolomics,X23428.Concentration of VLDL Particles,MAG,Myelin-associated glycoprotein,24195,0.00335723259030097,0.00318680703585188,-0.00288890919996871,0.00960337438057066,0.292132284541299
NMR metabolomics,X23428.Concentration of VLDL Particles,NGFR,Tumor necrosis factor receptor superfamily member 16,24922,-0.00209464481715055,0.00199343827303465,-0.00600178383229848,0.00181249419799737,0.293374504737815
NMR metabolomics,X23428.Concentration of VLDL Particles,IL33,Interleukin-33,28931,0.00273507883158304,0.00260710198090654,-0.00237484105099378,0.00784499871415986,0.294146487109824
NMR metabolomics,X23428.Concentration of VLDL Particles,MSLNL,Mesothelin-like protein,24195,-0.00265176856659651,0.00253029678799434,-0.00761115027106541,0.00230761313787239,0.294645889091598
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP8,Neutrophil collagenase,29640,-0.00506924276247214,0.00483808038554354,-0.0145518803181375,0.00441339479319319,0.294748632055436
NMR metabolomics,X23428.Concentration of VLDL Particles,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,24016,-0.00310966204831311,0.00297600992008862,-0.00894264149168681,0.0027233173950606,0.296075164822205
NMR metabolomics,X23428.Concentration of VLDL Particles,NEB,Nebulin,24111,-0.0026623448882366,0.00254864493698461,-0.00765768896472644,0.00233299918825324,0.296212845666521
NMR metabolomics,X23428.Concentration of VLDL Particles,ZP4,Zona pellucida sperm-binding protein 4,24016,-0.00224007505359586,0.00214451590870737,-0.0064433262346623,0.00196317612747058,0.296236999004987
NMR metabolomics,X23428.Concentration of VLDL Particles,SPARCL1,SPARC-like protein 1,29489,0.00190875437692523,0.00183655799592365,-0.00169089929508514,0.00550840804893559,0.298668785274516
NMR metabolomics,X23428.Concentration of VLDL Particles,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,24101,0.0051204259778968,0.00494885953749274,-0.00457933871558897,0.0148201906713826,0.300834431530007
NMR metabolomics,X23428.Concentration of VLDL Particles,CA11,Carbonic anhydrase-related protein 11,28797,0.00220069369347996,0.00213265987107452,-0.0019793196538261,0.00638070704078601,0.302127203018792
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMA1,Laminin subunit alpha-1,24111,-0.00372726390711058,0.00363394995102622,-0.010849805811122,0.00339527799690081,0.30505350322138
NMR metabolomics,X23428.Concentration of VLDL Particles,GLI2,Zinc finger protein GLI2,24229,-0.00229733013973382,0.00224276569534767,-0.00669315090261525,0.00209849062314761,0.305690095727606
NMR metabolomics,X23428.Concentration of VLDL Particles,CD99,CD99 antigen,29443,0.00133660283363929,0.00131488918782399,-0.00124057997449573,0.00391378564177431,0.309393198078361
NMR metabolomics,X23428.Concentration of VLDL Particles,GAMT,Guanidinoacetate N-methyltransferase,24111,-0.00252207983709858,0.00250671049837802,-0.00743523241391949,0.00239107273972234,0.314362527388875
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNW1,Interferon omega-1,24111,-0.0024108782252146,0.00242335500175971,-0.00716065402866363,0.00233889757823443,0.319818510670394
NMR metabolomics,X23428.Concentration of VLDL Particles,SLK,STE20-like serine/threonine-protein kinase,24445,0.00521110752521642,0.0052441634563988,-0.00506745284932523,0.0154896678997581,0.320380428083961
NMR metabolomics,X23428.Concentration of VLDL Particles,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29434,-0.00259647548796096,0.00261481119270799,-0.00772150542566862,0.00252855444974669,0.320724090110607
NMR metabolomics,X23428.Concentration of VLDL Particles,BRD2,Bromodomain-containing protein 2,24101,0.00231396377673071,0.00233039795196347,-0.00225361620911769,0.00688154376257911,0.320745314422317
NMR metabolomics,X23428.Concentration of VLDL Particles,CHEK2,Serine/threonine-protein kinase Chk2,28916,0.00221213170514615,0.0022339304291581,-0.00216637193600373,0.00659063534629603,0.322064144967247
NMR metabolomics,X23428.Concentration of VLDL Particles,VSTM2B,V-set and transmembrane domain-containing protein 2B,24445,0.00271842859595919,0.00275555392796582,-0.00268245710285381,0.0081193142947722,0.323884298649449
NMR metabolomics,X23428.Concentration of VLDL Particles,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,24101,-0.00430618958831891,0.00436507763256115,-0.0128617417481388,0.00424936257150095,0.323893173303916
NMR metabolomics,X23428.Concentration of VLDL Particles,KCNIP4,Kv channel-interacting protein 4,28774,0.00336140974910653,0.00341601810629097,-0.00333398573922376,0.0100568052374368,0.325116891618891
NMR metabolomics,X23428.Concentration of VLDL Particles,SCN3A,Sodium channel protein type 3 subunit alpha,24195,-0.00246783336646376,0.0025383326330984,-0.00744296532733663,0.00250729859440912,0.330947778246515
NMR metabolomics,X23428.Concentration of VLDL Particles,CA3,Carbonic anhydrase 3,29761,-0.00389537266896994,0.00401116822051683,-0.0117572623811829,0.00396651704324305,0.33149058907949
NMR metabolomics,X23428.Concentration of VLDL Particles,TSLP,Thymic stromal lymphopoietin,28916,0.00390522347616294,0.00404778769109035,-0.00402844039837414,0.0118388873507,0.334663227797489
NMR metabolomics,X23428.Concentration of VLDL Particles,FCAR,Immunoglobulin alpha Fc receptor,29434,0.00307672364622484,0.00319117966156319,-0.00317798849043901,0.0093314357828887,0.334986856250192
NMR metabolomics,X23428.Concentration of VLDL Particles,ANK2,Ankyrin-2,24111,0.00465051467713881,0.00485100718669193,-0.00485745940877738,0.014158488763055,0.337734674244628
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRV1,Adhesion G-protein coupled receptor V1,24101,-0.00450350826276939,0.00471036289223688,-0.0137358195315537,0.00472880300601489,0.339038785147846
NMR metabolomics,X23428.Concentration of VLDL Particles,SCG3,Secretogranin-3,29497,-0.00211629204753574,0.00222254649428094,-0.00647248317632638,0.0022398990812549,0.341007182473314
NMR metabolomics,X23428.Concentration of VLDL Particles,EVPL,Envoplakin,24445,0.00215972917098678,0.00227836635827335,-0.00230586889122899,0.00662532723320255,0.343175059552728
NMR metabolomics,X23428.Concentration of VLDL Particles,CPLX2,Complexin-2,24016,-0.00195029159108847,0.00206973768934948,-0.00600697746221344,0.00210639428003651,0.346054050321499
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA10,Annexin A10,28774,-0.0051599297174703,0.00549055892053194,-0.0159214252017129,0.00560156576677229,0.347337167292268
NMR metabolomics,X23428.Concentration of VLDL Particles,NRN1,Neuritin,24867,-0.0022518225897129,0.00239671058690373,-0.00694937534004422,0.00244573016061842,0.347459029715999
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24445,0.00278424939754334,0.0029698311447973,-0.00303661964625937,0.00860511844134604,0.3485050303072
NMR metabolomics,X23428.Concentration of VLDL Particles,TCP11,T-complex protein 11 homolog,24445,-0.00371400739877446,0.0039853718969148,-0.0115253363167275,0.00409732151917854,0.351392316284854
NMR metabolomics,X23428.Concentration of VLDL Particles,TEX33,Testis-expressed protein 33,24445,-0.0024373118025026,0.00261801204371143,-0.00756861540817701,0.0026939918031718,0.351874106811491
NMR metabolomics,X23428.Concentration of VLDL Particles,IZUMO1,Izumo sperm-egg fusion protein 1,24016,-0.00306719815373516,0.00329704704248497,-0.0095294103570057,0.00339501404953538,0.352232153234258
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1RAP,Interleukin-1 receptor accessory protein,29443,-0.00272521029963121,0.00293001383581066,-0.00846803741782011,0.00301761681855769,0.352326157077528
NMR metabolomics,X23428.Concentration of VLDL Particles,NXPE4,NXPE family member 4,24111,-0.00214620082294605,0.00231186611668408,-0.00667745841164684,0.00238505676575474,0.353239849730674
NMR metabolomics,X23428.Concentration of VLDL Particles,ARNT,Aryl hydrocarbon receptor nuclear translocator,28931,0.00231164932586668,0.0024909519860433,-0.00257061656677818,0.00719391521851155,0.353405760707777
NMR metabolomics,X23428.Concentration of VLDL Particles,TUBB3,Tubulin beta-3 chain,24101,-0.00173769450792627,0.00188901889278031,-0.00544017153777568,0.00196478252192313,0.357638096416055
NMR metabolomics,X23428.Concentration of VLDL Particles,FOS,Proto-oncogene c-Fos,23970,-0.00218754321136271,0.00238667187869469,-0.00686542009360429,0.00249033367087887,0.359379133477999
NMR metabolomics,X23428.Concentration of VLDL Particles,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,24016,0.00353944483933664,0.00387964723221198,-0.00406466373579884,0.0111435534144721,0.361614189264263
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF3,Fibroblast growth factor 3,24229,0.00183854760055568,0.00201811216431737,-0.00211695224150636,0.00579404744261772,0.362292062089291
NMR metabolomics,X23428.Concentration of VLDL Particles,STEAP4,Metalloreductase STEAP4,24101,0.00444590795337003,0.00497516554178354,-0.0053054165085257,0.0141972324152658,0.371534113882723
NMR metabolomics,X23428.Concentration of VLDL Particles,CAPN3,Calpain-3,24793,0.0022616661831978,0.0025448161543052,-0.0027261734792404,0.00724950584563599,0.374154354972334
NMR metabolomics,X23428.Concentration of VLDL Particles,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,24101,0.00293011554497484,0.00329824630195706,-0.003534447206861,0.00939467829681068,0.37434207266076
NMR metabolomics,X23428.Concentration of VLDL Particles,IMPG1,Interphotoreceptor matrix proteoglycan 1,24101,-0.00179316418574456,0.00202013170549488,-0.00575262232851452,0.0021662939570254,0.374739436590349
NMR metabolomics,X23428.Concentration of VLDL Particles,CLINT1,Clathrin interactor 1,24016,0.00283598469680737,0.0032076566779423,-0.00345102239195954,0.00912299178557428,0.376635031127739
NMR metabolomics,X23428.Concentration of VLDL Particles,TPT1,Translationally-controlled tumor protein,28931,0.00385896683934505,0.00436851232715231,-0.00470331732187347,0.0124212510005636,0.377049412360974
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTN4,Contactin-4,29443,0.00142008551977309,0.00160899840825109,-0.00173355136039905,0.00457372239994523,0.37746517196669
NMR metabolomics,X23428.Concentration of VLDL Particles,SUSD4,Sushi domain-containing protein 4,24793,0.00247579770985937,0.00280988865659959,-0.00303158405707582,0.00798317947679456,0.378271315977453
NMR metabolomics,X23428.Concentration of VLDL Particles,TG,Thyroglobulin,24793,-0.0065796027235848,0.00748888484630509,-0.0212578170223428,0.00809861157517317,0.379636239351341
NMR metabolomics,X23428.Concentration of VLDL Particles,CA8,Carbonic anhydrase-related protein,24229,0.0016039428208072,0.00183064925006275,-0.00198412970931578,0.00519201535093019,0.380951401091425
NMR metabolomics,X23428.Concentration of VLDL Particles,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24867,0.00247133400320522,0.00283292468546876,-0.00308119838031356,0.00802386638672399,0.383019706142366
NMR metabolomics,X23428.Concentration of VLDL Particles,DTX2,Probable E3 ubiquitin-protein ligase DTX2,24195,-0.00367985159864834,0.00423195380122772,-0.0119744810490547,0.00461477785175798,0.384560665296928
NMR metabolomics,X23428.Concentration of VLDL Particles,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,24111,0.00306676333718777,0.00352958549448638,-0.00385122423200555,0.00998475090638108,0.384924973756612
NMR metabolomics,X23428.Concentration of VLDL Particles,FH,"Fumarate hydratase, mitochondrial",24101,0.00489601845980104,0.00563871748523079,-0.0061558678112513,0.0159479047308534,0.385246531290471
NMR metabolomics,X23428.Concentration of VLDL Particles,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24445,0.00366261650385386,0.00423429839318056,-0.00463660834678003,0.0119618413544878,0.38705397130772
NMR metabolomics,X23428.Concentration of VLDL Particles,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24938,-0.00146183658171548,0.00170412631776234,-0.00480192416452966,0.00187825100109871,0.390999158856302
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28916,0.00278914356239128,0.00325473789431288,-0.00359014271046196,0.00916842983524453,0.391480315518443
NMR metabolomics,X23428.Concentration of VLDL Particles,ICAM3,Intercellular adhesion molecule 3,29820,-0.00149002287117909,0.00174357312166654,-0.00490742618964551,0.00192738044728733,0.392790523586773
NMR metabolomics,X23428.Concentration of VLDL Particles,UPK3A,Uroplakin-3a,24101,0.00282153980749258,0.00330780714824961,-0.00366176220307666,0.00930484181806182,0.39367108698361
NMR metabolomics,X23428.Concentration of VLDL Particles,PRG3,Proteoglycan 3,24938,0.00285402346501509,0.00334694038865843,-0.00370597969675542,0.0094140266267856,0.393819400919582
NMR metabolomics,X23428.Concentration of VLDL Particles,TP73,Tumor protein p73,24195,0.00197600973764564,0.00232263392791073,-0.00257635276105939,0.00652837223635067,0.394909747009309
NMR metabolomics,X23428.Concentration of VLDL Particles,GIPR,Gastric inhibitory polypeptide receptor,24229,0.00269477974401424,0.00316917940203651,-0.00351681188397733,0.0089063713720058,0.395162076455693
NMR metabolomics,X23428.Concentration of VLDL Particles,CHRDL2,Chordin-like protein 2,29478,0.00301246910746539,0.0035685542270745,-0.00398189717760064,0.0100068353925314,0.398580849358924
NMR metabolomics,X23428.Concentration of VLDL Particles,ENDOU,Poly(U)-specific endoribonuclease,23037,0.0030116668230504,0.00357209696427564,-0.00398964322692984,0.0100129768730306,0.399176287912438
NMR metabolomics,X23428.Concentration of VLDL Particles,THSD1,Thrombospondin type-1 domain-containing protein 1,24059,0.00193966153362065,0.00231513400375367,-0.00259800111373654,0.00647732418097784,0.40214111159393
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC123,Cell division cycle protein 123 homolog,24016,0.00356660683792295,0.00426260386612,-0.00478809673967225,0.0119213104155181,0.402758181882904
NMR metabolomics,X23428.Concentration of VLDL Particles,POLR2A,DNA-directed RNA polymerase II subunit RPB1,24229,0.00165799654387998,0.00198602652952976,-0.00223461545399835,0.00555060854175832,0.403821096399461
NMR metabolomics,X23428.Concentration of VLDL Particles,DIPK1C,Divergent protein kinase domain 1C,24195,0.00237377005015466,0.00284976839854268,-0.00321177601098899,0.0079593161112983,0.404870179183401
NMR metabolomics,X23428.Concentration of VLDL Particles,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24867,0.00637505223935698,0.00774576628271749,-0.0088066496747693,0.0215567541534833,0.410494850233595
NMR metabolomics,X23428.Concentration of VLDL Particles,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29434,0.00824547146511507,0.0100265323959416,-0.0114065320309305,0.0278974749611606,0.410875735726315
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24445,0.00378179080311845,0.00461646029176764,-0.00526647136874613,0.012830052974983,0.412681970054986
NMR metabolomics,X23428.Concentration of VLDL Particles,PDIA2,Protein disulfide-isomerase A2,24016,0.0022343027164279,0.00274272221552301,-0.0031414328259972,0.00761003825885299,0.415292441122198
NMR metabolomics,X23428.Concentration of VLDL Particles,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,24101,-0.00312831328764541,0.00384886340916876,-0.0106720855696162,0.00441545899432536,0.416347159084875
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC1A,C-type lectin domain family 1 member A,28916,0.00181802305965794,0.00224066461783417,-0.00257367959129702,0.0062097257106129,0.417156058156674
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH22,Cadherin-22,24445,-0.00154616031784118,0.0019184583128414,-0.00530633861101032,0.00221401797532796,0.420285883700849
NMR metabolomics,X23428.Concentration of VLDL Particles,MYL6B,Myosin light chain 6B,24195,-0.00492743611971894,0.00616336063633702,-0.0170076229669395,0.00715275072750161,0.424024453637357
NMR metabolomics,X23428.Concentration of VLDL Particles,MAPRE3,Microtubule-associated protein RP/EB family member 3,24016,-0.00770876806354823,0.00965657571944908,-0.0266356564736684,0.011218120346572,0.424708902415606
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,24111,0.00261101450325601,0.00327475782299616,-0.00380751082981647,0.0090295398363285,0.425275795077165
NMR metabolomics,X23428.Concentration of VLDL Particles,RASA1,Ras GTPase-activating protein 1,28774,0.00172918237284929,0.00217639967979637,-0.0025365609995516,0.00599492574525018,0.426902187573635
NMR metabolomics,X23428.Concentration of VLDL Particles,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24793,0.00237343126695942,0.00299281123004989,-0.00349247874393836,0.00823934127785721,0.427759726894201
NMR metabolomics,X23428.Concentration of VLDL Particles,ZNF174,Zinc finger protein 174,24229,0.00200507119361272,0.00254206419408068,-0.00297737462678542,0.00698751701401086,0.430261706837383
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP13,Collagenase 3,28774,-0.00172543532613047,0.00219040173860616,-0.00601862273379854,0.00256775208153759,0.430863772693653
NMR metabolomics,X23428.Concentration of VLDL Particles,IL2RB,Interleukin-2 receptor subunit beta,28931,0.00196682186742662,0.00251957592983476,-0.00297154695504951,0.00690519068990276,0.435034632165203
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29434,0.0044231463200759,0.00568219609307534,-0.00671395802235177,0.0155602506625036,0.436326546872577
NMR metabolomics,X23428.Concentration of VLDL Particles,CGN,Cingulin,24195,0.00207296151754638,0.00268050125036542,-0.00318082093316983,0.0073267439682626,0.439323742363214
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC7A,C-type lectin domain family 7 member A,29786,0.00303215185558117,0.00393724025769476,-0.00468483904950056,0.0107491427606629,0.441234162694686
NMR metabolomics,X23428.Concentration of VLDL Particles,TAGLN3,Transgelin-3,24016,-0.00312152456014787,0.00406450631508153,-0.0110879569377077,0.00484490781741194,0.442497121366392
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASE1,Ribonuclease pancreatic,24951,0.00125165618624716,0.00163534735304967,-0.0019536246257302,0.00445693699822452,0.444054715861407
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF5,Fibroblast growth factor 5,28931,-0.0016749729495723,0.00221451521907021,-0.0060154227789499,0.00266547687980531,0.449438944759401
NMR metabolomics,X23428.Concentration of VLDL Particles,PRAME,Melanoma antigen preferentially expressed in tumors,24016,-0.00128847863947383,0.00171001148650938,-0.00464010115303221,0.00206314387408455,0.451162176923128
NMR metabolomics,X23428.Concentration of VLDL Particles,PILRB,Paired immunoglobulin-like type 2 receptor beta,29478,0.00286927352047383,0.00384211883486529,-0.00466127939586213,0.0103998264368098,0.455193526870045
NMR metabolomics,X23428.Concentration of VLDL Particles,CBLN1,Cerebellin-1,24101,0.00472805626908992,0.00641604667407189,-0.00784739521209099,0.0173035077502708,0.461183566434347
NMR metabolomics,X23428.Concentration of VLDL Particles,RSPO1,R-spondin-1,29218,0.0017224056426653,0.0023452731040594,-0.00287432964129113,0.00631914092662172,0.462701251505034
NMR metabolomics,X23428.Concentration of VLDL Particles,KCNH2,Potassium voltage-gated channel subfamily H member 2,24195,0.00384496356903956,0.00525175617944888,-0.00644847854268025,0.0141384056807594,0.464096864310152
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGAX,Integrin alpha-X,24445,0.00261222348529303,0.0035943440389881,-0.00443269083112364,0.0096571378017097,0.467380292835467
NMR metabolomics,X23428.Concentration of VLDL Particles,PDCL2,Phosducin-like protein 2,24016,0.00255548468878349,0.00356782563707915,-0.00443745355989165,0.00954842293745864,0.473838845209295
NMR metabolomics,X23428.Concentration of VLDL Particles,AOC3,Membrane primary amine oxidase,29594,-0.00142012406789119,0.00201793712897892,-0.00537528084068988,0.0025350327049075,0.481593764925243
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHA2,Ephrin type-A receptor 2,28347,0.00148108457724148,0.00210515739661892,-0.0026450239201316,0.00560719307461456,0.481718517096821
NMR metabolomics,X23428.Concentration of VLDL Particles,PITHD1,PITH domain-containing protein 1,23970,-0.00377124840540248,0.00536498114283161,-0.0142866114453524,0.00674411463454748,0.482101301531879
NMR metabolomics,X23428.Concentration of VLDL Particles,DKKL1,Dickkopf-like protein 1,29349,-0.00402307203542537,0.0057455734909615,-0.0152843960777099,0.00723825200685917,0.48380563043845
NMR metabolomics,X23428.Concentration of VLDL Particles,GAL,Galanin peptides,29581,-0.00300641236722377,0.00430911252965039,-0.0114522729253385,0.005439448190891,0.485378362805919
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH3,Cadherin-3,29694,0.00167487691090858,0.00241946432216882,-0.00306727316054231,0.00641702698235947,0.488785049998946
NMR metabolomics,X23428.Concentration of VLDL Particles,AMY2A,Pancreatic alpha-amylase,28334,0.00219860946090509,0.00320563936238393,-0.00408444368936741,0.00848166261117759,0.492809047197629
NMR metabolomics,X23428.Concentration of VLDL Particles,CREB3,Cyclic AMP-responsive element-binding protein 3,24016,-0.00260232978478026,0.00382037352188299,-0.0100902618876709,0.0048856023181104,0.495769514039995
NMR metabolomics,X23428.Concentration of VLDL Particles,TPRKB,EKC/KEOPS complex subunit TPRKB,24016,-0.00301519049209609,0.00443177649766911,-0.0117014724275275,0.00567109144333536,0.496284956342692
NMR metabolomics,X23428.Concentration of VLDL Particles,IKZF2,Zinc finger protein Helios,28797,0.00413599430400713,0.00611012312700491,-0.0078398470249225,0.0161118356329368,0.498469448209349
NMR metabolomics,X23428.Concentration of VLDL Particles,BSND,Barttin,24016,-0.00153692529976237,0.00227895265979221,-0.0060036725129551,0.00292982191343036,0.500063642256358
NMR metabolomics,X23428.Concentration of VLDL Particles,LSM8,U6 snRNA-associated Sm-like protein LSm8,24445,0.0038560577836728,0.0058008459976208,-0.00751360037166396,0.0152257159390096,0.506222702505631
NMR metabolomics,X23428.Concentration of VLDL Particles,PHLDB2,Pleckstrin homology-like domain family B member 2,24016,-0.00415968054954403,0.00628969225469351,-0.0164874773687433,0.00816811626965525,0.508394988141055
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G2A,"Phospholipase A2, membrane associated",29402,-0.00244118724971969,0.00372160750311728,-0.00973553795582956,0.00485316345639018,0.511861637048278
NMR metabolomics,X23428.Concentration of VLDL Particles,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,24101,-0.00144027166069816,0.00220121241180373,-0.00575464798783347,0.00287410466643716,0.512919414573552
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,24111,-0.00289152681770699,0.00442499440687175,-0.0115645158551756,0.00578146221976164,0.513470377018156
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP5F1D,"ATP synthase subunit delta, mitochondrial",24111,-0.00224827205712497,0.0034483918312599,-0.00900712004639437,0.00451057593214443,0.514422247751027
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP2B4,Plasma membrane calcium-transporting ATPase 4,24111,-0.00274184929426262,0.00420765434569153,-0.010988851811818,0.00550515322329278,0.514643728433752
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTNAP4,Contactin-associated protein-like 4,24195,0.00449192299463859,0.00692704952422862,-0.00908509407284951,0.0180689400621267,0.516692842118539
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGEF5,Rho guanine nucleotide exchange factor 5,24101,-0.00324233983575794,0.00500747187188524,-0.013056984704653,0.00657230503313714,0.517314333095859
NMR metabolomics,X23428.Concentration of VLDL Particles,DCLRE1C,Protein artemis,24016,-0.00135450462386584,0.0020920086449926,-0.00545484156805134,0.00274583232031965,0.517336537188731
NMR metabolomics,X23428.Concentration of VLDL Particles,RGS8,Regulator of G-protein signaling 8,28931,0.00281257243356482,0.0043618568621724,-0.00573666701629307,0.0113618118834227,0.519054914397928
NMR metabolomics,X23428.Concentration of VLDL Particles,NENF,Neudesin,24793,0.0047304958444413,0.00737183158717436,-0.00971829406642045,0.019179285755303,0.521074672454604
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMG4,Proteasome assembly chaperone 4,24229,-0.00241780974060247,0.00377010308382791,-0.00980721178490517,0.00497159230370022,0.521326513344554
NMR metabolomics,X23428.Concentration of VLDL Particles,MED21,Mediator of RNA polymerase II transcription subunit 21,24111,0.002095009694587,0.00326781012778144,-0.00430989815586462,0.00849991754503861,0.521460506814134
NMR metabolomics,X23428.Concentration of VLDL Particles,PMCH,Pro-MCH,24111,-0.00359471695560654,0.00562593936445712,-0.0146215581099425,0.00743212419872942,0.52285887310799
NMR metabolomics,X23428.Concentration of VLDL Particles,ATRAID,All-trans retinoic acid-induced differentiation factor,24805,0.001203005661931,0.0019006464829067,-0.00252226144456612,0.00492827276842813,0.52677506369622
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF7,Fibroblast growth factor 7,24016,-0.00331753764862079,0.00534014160601675,-0.0137842151964136,0.00714913989917205,0.534444165497258
NMR metabolomics,X23428.Concentration of VLDL Particles,TMPRSS11B,Transmembrane protease serine 11B,24101,0.00321890822359398,0.0051884238690147,-0.00695040255967484,0.0133882190068628,0.534999066378915
NMR metabolomics,X23428.Concentration of VLDL Particles,DCUN1D2,DCN1-like protein 2,24016,-0.00334192976236745,0.0053956845794847,-0.0139174715381575,0.00723361201342255,0.535677956570028
NMR metabolomics,X23428.Concentration of VLDL Particles,PPT1,Palmitoyl-protein thioesterase 1,24195,0.00322839515042761,0.00521370872859729,-0.00699047395762308,0.0134472642584783,0.535782017995292
NMR metabolomics,X23428.Concentration of VLDL Particles,TOP1MT,"DNA topoisomerase I, mitochondrial",24016,-0.00202630313751134,0.00328415433900112,-0.00846324564195353,0.00441063936693085,0.537244613021545
NMR metabolomics,X23428.Concentration of VLDL Particles,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,24101,-0.00246318960243832,0.00399991056346331,-0.0103030143068264,0.00537663510194977,0.538024973351828
NMR metabolomics,X23428.Concentration of VLDL Particles,BHLHE40,Class E basic helix-loop-helix protein 40,24101,-0.00291968387780209,0.00475595528271374,-0.012241356231921,0.00640198847631684,0.539286800725924
NMR metabolomics,X23428.Concentration of VLDL Particles,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24845,0.00151134942029104,0.00248013926852823,-0.00334972354602428,0.00637242238660636,0.542277591666391
NMR metabolomics,X23428.Concentration of VLDL Particles,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29454,-0.00157289896352441,0.00260034283714789,-0.00666957092433428,0.00352377299728546,0.545262478017222
NMR metabolomics,X23428.Concentration of VLDL Particles,COMMD9,COMM domain-containing protein 9,24793,0.00159810599283672,0.0026459996543274,-0.00358805332964498,0.00678426531531843,0.545868719512644
NMR metabolomics,X23428.Concentration of VLDL Particles,ARMCX2,Armadillo repeat-containing X-linked protein 2,24101,-0.00253602664072259,0.00420136756850884,-0.0107707070749999,0.00569865379355474,0.546102448181951
NMR metabolomics,X23428.Concentration of VLDL Particles,BRME1,Break repair meiotic recombinase recruitment factor 1,24101,-0.00164835799475987,0.00276959312414908,-0.00707676051809206,0.00378004452857232,0.551740438846789
NMR metabolomics,X23428.Concentration of VLDL Particles,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,24111,-0.000814820411871415,0.00137345269881418,-0.00350678770154721,0.00187714687780438,0.553009875069375
NMR metabolomics,X23428.Concentration of VLDL Particles,TFF2,Trefoil factor 2,29536,0.00228453979552563,0.00385260733018008,-0.00526657057162732,0.00983565016267859,0.553195483422925
NMR metabolomics,X23428.Concentration of VLDL Particles,TPSD1,Tryptase delta,24867,-0.00146010714935208,0.00250877110695845,-0.00637729851899064,0.00345708422028647,0.560571324975937
NMR metabolomics,X23428.Concentration of VLDL Particles,TPBGL,Trophoblast glycoprotein-like,24195,-0.00159038112422436,0.00276570173324253,-0.00701115652137972,0.003830394272931,0.565271551389961
NMR metabolomics,X23428.Concentration of VLDL Particles,RBM25,RNA-binding protein 25,24016,-0.00178571039524732,0.00312430154509745,-0.00790934142363832,0.00433792063314367,0.567628792226682
NMR metabolomics,X23428.Concentration of VLDL Particles,CTLA4,Cytotoxic T-lymphocyte protein 4,24938,0.00112130888345524,0.00199863346801009,-0.00279601271384455,0.00503863048075502,0.574776826337089
NMR metabolomics,X23428.Concentration of VLDL Particles,TMED10,Transmembrane emp24 domain-containing protein 10,24111,-0.00186714084558137,0.00333819999658989,-0.00841001283889755,0.00467573114773482,0.575944698883335
NMR metabolomics,X23428.Concentration of VLDL Particles,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29527,0.00212691177858144,0.00383360831770694,-0.00538696052412416,0.00964078408128703,0.579031052879001
NMR metabolomics,X23428.Concentration of VLDL Particles,SUSD5,Sushi domain-containing protein 5,24273,0.0012657843533274,0.00230317414910274,-0.00324843697891397,0.00578000568556876,0.582610780035564
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA5,Annexin A5,28650,0.00110735735865104,0.00203669678338614,-0.0028845683367858,0.00509928305408788,0.586650368136005
NMR metabolomics,X23428.Concentration of VLDL Particles,SHD,SH2 domain-containing adapter protein D,24059,0.00311529492364474,0.00573167232721089,-0.0081187828376886,0.0143493726849781,0.586774896070809
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRL6,Fc receptor-like protein 6,29434,-0.00244100472308128,0.00454084080450666,-0.0113410526999143,0.00645904325375177,0.590880303670507
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNL2,Interferon lambda-2,24101,-0.00223495239435775,0.00415808522195231,-0.0103847994293843,0.00591489464066876,0.590930308233997
NMR metabolomics,X23428.Concentration of VLDL Particles,DPP6,Dipeptidyl aminopeptidase-like protein 6,29349,-0.00120331898026361,0.00224263594539253,-0.00559888543323297,0.00319224747270575,0.591572495369628
NMR metabolomics,X23428.Concentration of VLDL Particles,CD248,Endosialin,24938,0.00143937920467307,0.00269656678733596,-0.0038458916985054,0.00672465010785155,0.593497028397255
NMR metabolomics,X23428.Concentration of VLDL Particles,CALY,Neuron-specific vesicular protein calcyon,24111,-0.00136482558805375,0.0025844175764994,-0.00643028403799256,0.00370063286188507,0.597436226253488
NMR metabolomics,X23428.Concentration of VLDL Particles,TSPAN15,Tetraspanin-15,24111,-0.0017956885189942,0.00340124777515831,-0.00846213415830448,0.00487075712031609,0.597538951035241
NMR metabolomics,X23428.Concentration of VLDL Particles,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,24111,-0.00130881364054382,0.00249608788154219,-0.00620114588836651,0.00358351860727886,0.600042746439782
NMR metabolomics,X23428.Concentration of VLDL Particles,HYAL1,Hyaluronidase-1,29265,0.000797105402194881,0.00153765269851041,-0.00221669388688552,0.00381090469127528,0.60418937663618
NMR metabolomics,X23428.Concentration of VLDL Particles,SHC1,SHC-transforming protein 1,24016,-0.00403708149947076,0.00784616318288291,-0.0194155613379213,0.0113413983389797,0.606886660404274
NMR metabolomics,X23428.Concentration of VLDL Particles,FBLN2,Fibulin-2,24938,0.00107864292365223,0.0021057416102457,-0.00304861063242935,0.0052058964797338,0.608488307821824
NMR metabolomics,X23428.Concentration of VLDL Particles,REST,RE1-silencing transcription factor,24016,-0.00118989742186329,0.00235800759081222,-0.00581159229985524,0.00343179745612866,0.613830502161143
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM171A2,Protein FAM171A2,24867,0.00533208903488416,0.0106276464974949,-0.0154980981002058,0.0261622761699741,0.615869849542081
NMR metabolomics,X23428.Concentration of VLDL Particles,PRDX2,Peroxiredoxin-2,24556,0.00206655385982682,0.00413391275241943,-0.00603591513491525,0.0101690228545689,0.617148121774301
NMR metabolomics,X23428.Concentration of VLDL Particles,UHRF2,E3 ubiquitin-protein ligase UHRF2,24111,-0.0011853683612845,0.00237355572975972,-0.00583753759161355,0.00346680086904454,0.617497837331272
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRE5,Adhesion G protein-coupled receptor E5,29673,-0.00101040325844238,0.00203468561365966,-0.00499838706121531,0.00297758054433055,0.619482327233765
NMR metabolomics,X23428.Concentration of VLDL Particles,GSTM4,Glutathione S-transferase Mu 4,24111,-0.00242944149401983,0.00489912446587638,-0.0120317254471375,0.00717284245909788,0.619974432783745
NMR metabolomics,X23428.Concentration of VLDL Particles,HTR1A,5-hydroxytryptamine receptor 1A,24101,-0.00256309498125893,0.00517395859710145,-0.0127040538315778,0.00757786386905991,0.620333786498768
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT17,"Keratin, type I cytoskeletal 17",24111,0.00129117713916641,0.00263371108971082,-0.00387089659666679,0.00645325087499962,0.623961392544205
NMR metabolomics,X23428.Concentration of VLDL Particles,CRX,Cone-rod homeobox protein,28916,0.00351775435567171,0.00718105480520911,-0.0105571130625382,0.0175926217738816,0.624232465242017
NMR metabolomics,X23428.Concentration of VLDL Particles,PFDN6,Prefoldin subunit 6,24195,0.00215061744666052,0.00439450221434472,-0.00646260689345513,0.0107638417867762,0.624571340831577
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC1A4,Neutral amino acid transporter A,24195,-0.00169190822052476,0.00346956345078153,-0.00849225258405656,0.00510843614300704,0.625807175598056
NMR metabolomics,X23428.Concentration of VLDL Particles,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24805,-0.00560414627901955,0.0115730526249833,-0.0282873294239869,0.0170790368659478,0.62821913844747
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL7A,B-cell CLL/lymphoma 7 protein family member A,24016,0.00206729458154339,0.00429122368104304,-0.00634350383330096,0.0104780929963878,0.629988346420111
NMR metabolomics,X23428.Concentration of VLDL Particles,CD164L2,CD164 sialomucin-like 2 protein,24195,0.0011780430381879,0.00246081221561169,-0.00364514890441101,0.00600123498078681,0.632141292646978
NMR metabolomics,X23428.Concentration of VLDL Particles,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,24195,-0.00131761335564688,0.00278397335837895,-0.00677420113806961,0.00413897442677586,0.636014000157765
NMR metabolomics,X23428.Concentration of VLDL Particles,FZD10,Frizzled-10,24195,0.00190498825352271,0.00404487073929635,-0.00602295839549814,0.00983293490254355,0.637670735698537
NMR metabolomics,X23428.Concentration of VLDL Particles,UGDH,UDP-glucose 6-dehydrogenase,24111,0.00310756634047905,0.00659859006372859,-0.00982567018442898,0.0160408028653871,0.637684995212396
NMR metabolomics,X23428.Concentration of VLDL Particles,OMP,Olfactory marker protein,24101,-0.00155679490301963,0.00331513928503019,-0.0080544679016788,0.00494087809563954,0.638643891211371
NMR metabolomics,X23428.Concentration of VLDL Particles,ZP3,Zona pellucida sperm-binding protein 3,24240,-0.00820769539074179,0.0177116760778418,-0.0429225805033118,0.0265071897218282,0.643077605459877
NMR metabolomics,X23428.Concentration of VLDL Particles,NPHS2,Podocin,24229,-0.00320116341586005,0.00694452267354304,-0.0168124278560044,0.0104101010242843,0.644829765063272
NMR metabolomics,X23428.Concentration of VLDL Particles,GFRAL,GDNF family receptor alpha-like,24025,0.00191527981497742,0.00420780373732169,-0.0063320155101731,0.0101625751401279,0.648988699790253
NMR metabolomics,X23428.Concentration of VLDL Particles,ESPL1,Separin,24016,-0.00168875004137589,0.00372941413486448,-0.00899840174571026,0.00562090166295848,0.650683084626746
NMR metabolomics,X23428.Concentration of VLDL Particles,LELP1,Late cornified envelope-like proline-rich protein 1,24101,-0.00219696754802872,0.00492312391414807,-0.0118462904197589,0.0074523553237015,0.655417232823321
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFL4,Insulin growth factor-like family member 4,24229,0.00225624252375538,0.00506433248955313,-0.00766984915576875,0.0121823342032795,0.655950687002215
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC39A14,Zinc transporter ZIP14,28774,0.000995861869421616,0.00224207832190614,-0.00339861164151441,0.00539033538035764,0.656923685943676
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF168,E3 ubiquitin-protein ligase RNF168,24229,0.00121124195509589,0.00274419295868279,-0.00416737624392237,0.00658986015411416,0.658939204407303
NMR metabolomics,X23428.Concentration of VLDL Particles,TNNI3,"Troponin I, cardiac muscle",28916,0.00248502518420661,0.00563549139784588,-0.00856053795557132,0.0135305883239845,0.659245395238214
NMR metabolomics,X23428.Concentration of VLDL Particles,BTN1A1,Butyrophilin subfamily 1 member A1,24751,0.00118911608986919,0.00270569840567742,-0.00411405278525856,0.00649228496499694,0.660313391574668
NMR metabolomics,X23428.Concentration of VLDL Particles,HEBP1,Heme-binding protein 1,28916,-0.00154978190136478,0.0035649548769922,-0.00853709346026949,0.00543752965753992,0.663763891877957
NMR metabolomics,X23428.Concentration of VLDL Particles,IL21R,Interleukin-21 receptor,24229,0.00157632595255741,0.00369966394201797,-0.00567501537379782,0.00882766727891264,0.670058630245484
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMA1,Proteasome subunit alpha type-1,28797,-0.00132081351617169,0.00310037284647113,-0.00739754429525511,0.00475591726291173,0.670098179488399
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFBR3,Transforming growth factor beta receptor type 3,29820,-0.000900412911423522,0.00211645650384797,-0.00504866765896554,0.00324784183611849,0.670523274184945
NMR metabolomics,X23428.Concentration of VLDL Particles,SKIV2L,Helicase SKI2W,24111,-0.00114287513358623,0.0026919257827145,-0.00641904966770665,0.00413329940053419,0.671163652252447
NMR metabolomics,X23428.Concentration of VLDL Particles,ECSCR,Endothelial cell-specific chemotaxis regulator,24101,0.00142204021973913,0.00337245159533477,-0.00518796490711701,0.00803204534659527,0.673274309538424
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF2RB,Cytokine receptor common subunit beta,24229,0.00122294315471194,0.00291822331006874,-0.00449677453302279,0.00694266084244668,0.675167862577275
NMR metabolomics,X23428.Concentration of VLDL Particles,RANGAP1,Ran GTPase-activating protein 1,28797,-0.00137186362772678,0.00327541293210944,-0.00779167297466129,0.00504794571920773,0.675338498530481
NMR metabolomics,X23428.Concentration of VLDL Particles,HDDC2,5'-deoxynucleotidase HDDC2,24805,0.00120828573523355,0.00292320963608057,-0.00452120515148437,0.00693777662195146,0.679359532746385
NMR metabolomics,X23428.Concentration of VLDL Particles,OSM,Oncostatin-M,29293,-0.00195126913976589,0.00474835453947235,-0.0112580440371317,0.00735550575759991,0.681122576716492
NMR metabolomics,X23428.Concentration of VLDL Particles,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24793,-0.00208985414431948,0.00514126623569098,-0.0121667359662738,0.00798702767763485,0.684388852457532
NMR metabolomics,X23428.Concentration of VLDL Particles,FOLR1,Folate receptor alpha,29383,0.000783742574292817,0.00193064939473934,-0.00300033023939628,0.00456781538798192,0.684784027062502
NMR metabolomics,X23428.Concentration of VLDL Particles,GAGE2A,G antigen 2A,24016,0.00173252427617395,0.0042741614243391,-0.0066448321155307,0.0101098806678786,0.685225084696365
NMR metabolomics,X23428.Concentration of VLDL Particles,CNGB3,Cyclic nucleotide-gated cation channel beta-3,24101,0.00147013600654655,0.00364654304650253,-0.0056770883645984,0.00861736037769151,0.686834967078092
NMR metabolomics,X23428.Concentration of VLDL Particles,IL36A,Interleukin-36 alpha,24229,-0.00156527724906811,0.00391457866585292,-0.00923785143413984,0.00610729693600361,0.689264324376183
NMR metabolomics,X23428.Concentration of VLDL Particles,CASQ2,Calsequestrin-2,24111,0.00130706120886961,0.00328688749624732,-0.00513523828377515,0.00774936070151436,0.690884903425406
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC6A,C-type lectin domain family 6 member A,28797,-0.00124526358371642,0.00314541430890288,-0.00741027562916606,0.00491974846173323,0.692183128975225
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF6,Fibroblast growth factor 6,24229,0.001091358115012,0.00276811205488402,-0.00433414151256068,0.00651685774258467,0.693391962113236
NMR metabolomics,X23428.Concentration of VLDL Particles,S100G,Protein S100-G,24867,0.00120067320569899,0.00311501239244794,-0.00490475108349898,0.00730609749489695,0.699909321752914
NMR metabolomics,X23428.Concentration of VLDL Particles,GJA8,Gap junction alpha-8 protein,24016,-0.00160336403891759,0.00418350851181429,-0.00980304072207361,0.00659631264423842,0.701531705993948
NMR metabolomics,X23428.Concentration of VLDL Particles,ARID3A,AT-rich interactive domain-containing protein 3A,24101,0.00103013852767387,0.00269690766712838,-0.00425580049989775,0.00631607755524549,0.702486792525419
NMR metabolomics,X23428.Concentration of VLDL Particles,RAP1A,Ras-related protein Rap-1A,24229,-0.00176892479463651,0.00465859142776196,-0.01089976399305,0.00736191440377693,0.704162266284026
NMR metabolomics,X23428.Concentration of VLDL Particles,KDM3A,Lysine-specific demethylase 3A,24229,-0.00228944784369495,0.00609230279681498,-0.0142303613254523,0.00965146563806241,0.707073705950696
NMR metabolomics,X23428.Concentration of VLDL Particles,GAD2,Glutamate decarboxylase 2,24229,-0.00113726403812351,0.00311480397774684,-0.00724227983450732,0.00496775175826029,0.715028181866415
NMR metabolomics,X23428.Concentration of VLDL Particles,ART5,Ecto-ADP-ribosyltransferase 5,24101,-0.00153317729894017,0.00421835480868099,-0.00980115272395492,0.00673479812607457,0.716269070599961
NMR metabolomics,X23428.Concentration of VLDL Particles,MORC3,MORC family CW-type zinc finger protein 3,24845,-0.000679344713560368,0.0018858520459093,-0.00437561472354261,0.00301692529642187,0.718676528062349
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM3D,Protein FAM3D,24805,0.00203207841500068,0.00567110802137479,-0.00908329330689392,0.0131474501368953,0.720105981428198
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSB,Cathepsin B,29480,0.00124032787070647,0.00350523111367969,-0.00562992511210572,0.00811058085351866,0.723453438028938
NMR metabolomics,X23428.Concentration of VLDL Particles,CD3G,T-cell surface glycoprotein CD3 gamma chain,24229,0.00215505872472034,0.00609803505143521,-0.00979708997609267,0.0141072074255333,0.723790047401785
NMR metabolomics,X23428.Concentration of VLDL Particles,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",24229,-0.0010376104603491,0.00298179203027665,-0.00688192283969133,0.00480670191899313,0.727856598959213
NMR metabolomics,X23428.Concentration of VLDL Particles,IL2,Interleukin-2,28931,-0.000729912830229686,0.0021125921981111,-0.00487059353852745,0.00341076787806807,0.729716673606211
NMR metabolomics,X23428.Concentration of VLDL Particles,ANKRA2,Ankyrin repeat family A protein 2,24016,0.00129180542351786,0.00374597734533758,-0.0060503101733438,0.00863392102037952,0.730209132327074
NMR metabolomics,X23428.Concentration of VLDL Particles,ISM2,Isthmin-2,24938,0.00101157985047342,0.00294905997316841,-0.00476857769693666,0.00679173739788351,0.731588016608764
NMR metabolomics,X23428.Concentration of VLDL Particles,SEZ6,Seizure protein 6 homolog,24195,0.000706603182973409,0.00209729739693177,-0.00340409971501287,0.00481730608095968,0.736186693995552
NMR metabolomics,X23428.Concentration of VLDL Particles,CCDC50,Coiled-coil domain-containing protein 50,24867,0.00172758104168126,0.00513078622665397,-0.00832875996256052,0.0117839220459231,0.736339247190127
NMR metabolomics,X23428.Concentration of VLDL Particles,HBZ,Hemoglobin subunit zeta,24922,0.00236365970718309,0.00710302695068179,-0.0115582731161532,0.0162855925305194,0.739312254550814
NMR metabolomics,X23428.Concentration of VLDL Particles,IL13RA2,Interleukin-13 receptor subunit alpha-2,24101,-0.000636540176425697,0.00193964471410883,-0.004438243816079,0.00316516346322761,0.742783264904287
NMR metabolomics,X23428.Concentration of VLDL Particles,CBX2,Chromobox protein homolog 2,24111,-0.000883202315162869,0.00270902163171427,-0.00619288471332283,0.00442648008299709,0.744410076268273
NMR metabolomics,X23428.Concentration of VLDL Particles,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24938,-0.000578284386382832,0.00177406769546973,-0.00405545706950351,0.00289888829673785,0.744453397790497
NMR metabolomics,X23428.Concentration of VLDL Particles,CHIT1,Chitotriosidase-1,29579,0.00331971886082904,0.0101896265436366,-0.0166519491646987,0.0232913868863568,0.744582548761557
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK1,Kallikrein-1,29199,0.00277248634618387,0.00852497862472857,-0.0139364717582841,0.0194814444506519,0.745017543538141
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP4,Caspase-4,24445,-0.00364488537080175,0.0113013849442518,-0.0257955998615352,0.0185058291199317,0.747064048589663
NMR metabolomics,X23428.Concentration of VLDL Particles,HDAC9,Histone deacetylase 9,24101,-0.00139739651806789,0.00435413053112831,-0.00993149235907939,0.00713669932294361,0.748261801083663
NMR metabolomics,X23428.Concentration of VLDL Particles,RRP15,RRP15-like protein,24101,-0.001952565529451,0.0061134921504966,-0.0139350101444243,0.0100298790855223,0.749436381520637
NMR metabolomics,X23428.Concentration of VLDL Particles,MORN4,MORN repeat-containing protein 4,24016,-0.00163314392153896,0.0052766966611924,-0.0119754693774761,0.00870918153439814,0.756942990092901
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC34A3,Sodium-dependent phosphate transport protein 2C,24016,-0.00102840919421231,0.00332345516313509,-0.00754238131395709,0.00548556292553246,0.756989709497209
NMR metabolomics,X23428.Concentration of VLDL Particles,TMED4,Transmembrane emp24 domain-containing protein 4,24111,-0.00117630028636835,0.00381296572818012,-0.00864971311360138,0.00629711254086469,0.757704495337571
NMR metabolomics,X23428.Concentration of VLDL Particles,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,24195,-0.00103346504001268,0.00344538233009517,-0.00778641440699922,0.00571948432697385,0.764212867293998
NMR metabolomics,X23428.Concentration of VLDL Particles,MLLT1,Protein ENL,24016,0.00139508692310191,0.00465200251107295,-0.00772283799860107,0.0105130118448049,0.76426400524384
NMR metabolomics,X23428.Concentration of VLDL Particles,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29508,0.000970708261408647,0.00329199433348911,-0.00548160063223001,0.0074230171550473,0.768095754571676
NMR metabolomics,X23428.Concentration of VLDL Particles,KLHL41,Kelch-like protein 41,24867,0.000971787701532471,0.00333543677314218,-0.0055656683738262,0.00750924377689115,0.770784202673864
NMR metabolomics,X23428.Concentration of VLDL Particles,KIRREL1,Kin of IRRE-like protein 1,24101,0.00115300585806278,0.00396433702538197,-0.00661709471168589,0.00892310642781145,0.771172707849892
NMR metabolomics,X23428.Concentration of VLDL Particles,KHDC3L,KH domain-containing protein 3,24016,-0.0013165872205307,0.00454529001273926,-0.0102253556454997,0.00759218120443825,0.772079112235307
NMR metabolomics,X23428.Concentration of VLDL Particles,PCARE,Photoreceptor cilium actin regulator,24101,0.00163277296595419,0.00568824100411421,-0.00951617940210967,0.0127817253340181,0.774081433583486
NMR metabolomics,X23428.Concentration of VLDL Particles,OFD1,Oral-facial-digital syndrome 1 protein,24445,0.00128686645649098,0.00449852979103886,-0.00753025193394518,0.0101039848469271,0.774831694224577
NMR metabolomics,X23428.Concentration of VLDL Particles,SCIN,Adseverin,24101,-0.00139334101768768,0.00493389145250357,-0.0110637682645947,0.00827708622921931,0.777637676383679
NMR metabolomics,X23428.Concentration of VLDL Particles,PFDN4,Prefoldin subunit 4,24016,0.00101600051774834,0.00360006387244782,-0.00604012467224938,0.00807212570774607,0.777779281991095
NMR metabolomics,X23428.Concentration of VLDL Particles,TBR1,T-box brain protein 1,24195,0.000915813157850715,0.00324550093216146,-0.00544536866918575,0.00727699498488718,0.777808450328897
NMR metabolomics,X23428.Concentration of VLDL Particles,LRP2BP,LRP2-binding protein,24195,-0.00152877166346713,0.00555365501496737,-0.0124139354928032,0.00935639216586892,0.783108804850977
NMR metabolomics,X23428.Concentration of VLDL Particles,GPA33,Cell surface A33 antigen,29349,-0.0024783889838806,0.00902705133511653,-0.020171409600709,0.0152146316329478,0.783662893237288
NMR metabolomics,X23428.Concentration of VLDL Particles,ARG2,"Arginase-2, mitochondrial",24793,-0.000793973192826186,0.00290737014073029,-0.00649241866865755,0.00490447228300518,0.784786446557801
NMR metabolomics,X23428.Concentration of VLDL Particles,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",24111,0.00156415179352213,0.00580298213331313,-0.0098096931877716,0.0129379967748159,0.78751435313035
NMR metabolomics,X23428.Concentration of VLDL Particles,TP53BP1,TP53-binding protein 1,24229,0.00157691238607961,0.00587492126677705,-0.00993793329680342,0.0130917580689626,0.788382784547645
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNL1,Interferon lambda-1,28774,-0.00080650840158373,0.0030314534760279,-0.00674815721459841,0.00513514041143096,0.790205097474616
NMR metabolomics,X23428.Concentration of VLDL Particles,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",24101,-0.00100597253870078,0.00379308962362725,-0.0084404282010102,0.00642848312360864,0.790848491053361
NMR metabolomics,X23428.Concentration of VLDL Particles,GAD1,Glutamate decarboxylase 1,24016,-0.000461233900396001,0.00175003629458016,-0.00389130503777312,0.00296883723698112,0.792123741604959
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINB5,Serpin B5,28916,0.00085457401724653,0.00325647355493151,-0.00552811415041922,0.00723726218491228,0.79299710445098
NMR metabolomics,X23428.Concentration of VLDL Particles,MFAP3L,Microfibrillar-associated protein 3-like,24195,-0.00114746462720394,0.00441991644409923,-0.00981050085763843,0.00751557160323054,0.79516506583074
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX1,ATP-dependent RNA helicase DDX1,24805,-0.000868668443637883,0.00335926605913729,-0.00745282991954696,0.0057154930322712,0.795954703583825
NMR metabolomics,X23428.Concentration of VLDL Particles,PRC1,Protein regulator of cytokinesis 1,24793,0.000754598593615647,0.00304670955263725,-0.00521695212955337,0.00672614931678466,0.804386708193442
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29443,0.00196436308988151,0.00794020776621885,-0.0135984441319074,0.0175271703116704,0.804604718537703
NMR metabolomics,X23428.Concentration of VLDL Particles,TGOLN2,Trans-Golgi network integral membrane protein 2,24951,0.000425743159181076,0.00174018438537023,-0.00298501823614458,0.00383650455450674,0.806726321925246
NMR metabolomics,X23428.Concentration of VLDL Particles,IL3,Interleukin-3,24016,0.000985814388765412,0.00407270073784081,-0.00699667905740257,0.0089683078349334,0.808740220814955
NMR metabolomics,X23428.Concentration of VLDL Particles,MBL2,Mannose-binding protein C,24610,-0.00172695827328438,0.00725630839498144,-0.015949322727448,0.0124954061808792,0.811887686144634
NMR metabolomics,X23428.Concentration of VLDL Particles,EPGN,Epigen,24793,-0.000753155183915783,0.00321900188626441,-0.00706239888099403,0.00555608851316246,0.81500892050746
NMR metabolomics,X23428.Concentration of VLDL Particles,ERVV_1,,24111,0.000723266749085404,0.00310300467409064,-0.00535862241213225,0.00680515591030305,0.815696655305371
NMR metabolomics,X23428.Concentration of VLDL Particles,TLR2,Toll-like receptor 2,24445,0.000351611290805864,0.00154479941165861,-0.002676195556045,0.00337941813765673,0.819951603059639
NMR metabolomics,X23428.Concentration of VLDL Particles,EXOSC10,Exosome component 10,24111,0.000916989057907887,0.00407929410814325,-0.00707842739405288,0.00891240550986865,0.822143686931357
NMR metabolomics,X23428.Concentration of VLDL Particles,MAGEA3,Melanoma-associated antigen 3,24445,-0.00125348904331283,0.00571327775204788,-0.0124515134373267,0.00994453535070102,0.826340861271205
NMR metabolomics,X23428.Concentration of VLDL Particles,IGLON5,IgLON family member 5,24016,-0.00135979629403316,0.0062760684733158,-0.0136608905017321,0.0109412979136658,0.828472271016271
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRB3,Adhesion G protein-coupled receptor B3,29169,0.000486773787595698,0.00224965868456724,-0.00392255723415609,0.00489610480934749,0.828695618006736
NMR metabolomics,X23428.Concentration of VLDL Particles,ATF4,Cyclic AMP-dependent transcription factor ATF-4,24016,0.00048229600897251,0.00228802524184353,-0.0040022334650408,0.00496682548298582,0.833051850946068
NMR metabolomics,X23428.Concentration of VLDL Particles,CHI3L1,Chitinase-3-like protein 1,28935,0.00109925667287805,0.00526046652232953,-0.00921125771088782,0.0114097710566439,0.834476545423792
NMR metabolomics,X23428.Concentration of VLDL Particles,IL10,Interleukin-10,28931,0.00109964797348344,0.0054740876044381,-0.00962956373121525,0.0118288596781821,0.840791925959532
NMR metabolomics,X23428.Concentration of VLDL Particles,NLGN1,Neuroligin-1,24195,-0.000922275235092495,0.00459614214877334,-0.00993071384668824,0.00808616337650325,0.840963854865657
NMR metabolomics,X23428.Concentration of VLDL Particles,CD82,CD82 antigen,24445,-0.000540951717466728,0.00279231751734557,-0.00601389405146405,0.0049319906165306,0.846390019962331
NMR metabolomics,X23428.Concentration of VLDL Particles,CD2,T-cell surface antigen CD2,24111,0.000498669465849326,0.00258353197125134,-0.0045650531978033,0.00556239212950195,0.846946106311093
NMR metabolomics,X23428.Concentration of VLDL Particles,PPIE,Peptidyl-prolyl cis-trans isomerase E,24445,0.000809969141240721,0.00422787319075397,-0.00747666231263706,0.0090966005951185,0.84807406290828
NMR metabolomics,X23428.Concentration of VLDL Particles,IL15,Interleukin-15,29434,-0.000419085075720493,0.00219240474970925,-0.00471619838515062,0.00387802823370963,0.848406926053549
NMR metabolomics,X23428.Concentration of VLDL Particles,MAMDC2,MAM domain-containing protein 2,24922,0.00044277210630345,0.002324151736745,-0.00411256529771675,0.00499810951032365,0.848911748507478
NMR metabolomics,X23428.Concentration of VLDL Particles,HK2,Hexokinase-2,28916,0.000348939207629902,0.00183673180005331,-0.00325105512047459,0.00394893353573439,0.849327459442631
NMR metabolomics,X23428.Concentration of VLDL Particles,TMED1,Transmembrane emp24 domain-containing protein 1,24445,-0.000688084334957711,0.00362529587784615,-0.00779366425553617,0.00641749558562075,0.849466745903344
NMR metabolomics,X23428.Concentration of VLDL Particles,TFAP2A,Transcription factor AP-2-alpha,24101,0.000746394108388746,0.00403163478910728,-0.00715561007826152,0.00864839829503901,0.853125214287408
NMR metabolomics,X23428.Concentration of VLDL Particles,CRYBB2,Beta-crystallin B2,24845,0.000847119261202212,0.00463970590319182,-0.00824670430905376,0.00994094283145818,0.855128771538029
NMR metabolomics,X23428.Concentration of VLDL Particles,IL12RB2,Interleukin-12 receptor subunit beta-2,24229,0.000508120994515026,0.0027995841965205,-0.00497906403066515,0.0059953060196952,0.855977643886688
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF20,Fibroblast growth factor 20,24229,0.000533183455470496,0.00295182105118899,-0.00525238580485993,0.00631875271580092,0.85666057687359
NMR metabolomics,X23428.Concentration of VLDL Particles,DCDC2C,Doublecortin domain-containing protein 2C,24016,0.00074167880315037,0.00426126988141087,-0.00761041016441493,0.00909376777071567,0.861826753811106
NMR metabolomics,X23428.Concentration of VLDL Particles,TET2,Methylcytosine dioxygenase TET2,24421,-0.00114851440398337,0.00673900956910684,-0.0143569731594328,0.012059944351466,0.864675143304937
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX4,Probable ATP-dependent RNA helicase DDX4,24229,0.000622162893104628,0.00366009666923198,-0.00655162657859006,0.00779595236479931,0.865023060888179
NMR metabolomics,X23428.Concentration of VLDL Particles,CTAG1A_CTAG1B,Cancer/testis antigen 1,24396,-0.000574655883113142,0.00338493974385986,-0.00720913778107846,0.00605982601485218,0.865193669463319
NMR metabolomics,X23428.Concentration of VLDL Particles,EFNB2,Ephrin-B2,24195,-0.000638365991887916,0.00387951467708166,-0.00824221475896797,0.00696548277519214,0.869301217467328
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRE2,Adhesion G protein-coupled receptor E2,29581,-0.000309672707670527,0.00188565420266361,-0.0040055549448912,0.00338620952955014,0.8695546651858
NMR metabolomics,X23428.Concentration of VLDL Particles,F3,Tissue factor,29541,0.000299681444262483,0.00182633016648145,-0.00327992568204115,0.00387928857056612,0.869661879485405
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29443,0.000325192250720072,0.00199516041706333,-0.00358532216672405,0.0042357066681642,0.870527011287104
NMR metabolomics,X23428.Concentration of VLDL Particles,THRAP3,Thyroid hormone receptor-associated protein 3,24111,0.00124166805011005,0.00761927065740666,-0.013692102438407,0.0161754385386271,0.870548019318348
NMR metabolomics,X23428.Concentration of VLDL Particles,TOP1,DNA topoisomerase 1,24805,-0.00122600134026829,0.00759938841171131,-0.0161208026272225,0.0136687999466859,0.871835639056558
NMR metabolomics,X23428.Concentration of VLDL Particles,BOC,Brother of CDO,28916,0.000251745724090947,0.00156761490599624,-0.00282077949166168,0.00332427093984357,0.872416224687051
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTF,Ciliary neurotrophic factor,24101,0.000362375721250449,0.00229148772250764,-0.00412894021486452,0.00485369165736542,0.87434785799614
NMR metabolomics,X23428.Concentration of VLDL Particles,TSPAN7,Tetraspanin-7,24101,-0.00100002461597533,0.00632552210580069,-0.0133980479433447,0.011397998711394,0.874384362144305
NMR metabolomics,X23428.Concentration of VLDL Particles,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29349,0.00044590441232796,0.00282375795288252,-0.00508866117532177,0.0059804699999777,0.874527467159136
NMR metabolomics,X23428.Concentration of VLDL Particles,CYTH3,Cytohesin-3,24016,-0.000757673147585949,0.00493223688029286,-0.01042485743296,0.00890951113778806,0.877913388772536
NMR metabolomics,X23428.Concentration of VLDL Particles,IL13,Interleukin-13,28931,-0.000492171501845772,0.00322318489671802,-0.0068096138994131,0.00582527089572155,0.878638087092399
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK12,Kallikrein-12,28797,-0.00134729747040485,0.00926828466675524,-0.0195131354172451,0.0168185404764354,0.884422584579828
NMR metabolomics,X23428.Concentration of VLDL Particles,PROK1,Prokineticin-1,29434,-0.000591989001065265,0.00410403876765883,-0.00863590498567658,0.00745192698354605,0.885307624482789
NMR metabolomics,X23428.Concentration of VLDL Particles,ALMS1,Alstrom syndrome protein 1,24445,-0.000422230759611881,0.00299924724975949,-0.00630075536914048,0.00545629384991672,0.888045764875068
NMR metabolomics,X23428.Concentration of VLDL Particles,DAND5,DAN domain family member 5,24229,0.000513298328371918,0.00365875471961882,-0.00665786092208098,0.00768445757882481,0.88842952078568
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17F,Interleukin-17F,28931,0.000696835717742025,0.00512804088111748,-0.00935412440924824,0.0107477958447323,0.891911307781018
NMR metabolomics,X23428.Concentration of VLDL Particles,TXK,Tyrosine-protein kinase TXK,24445,0.000664181753788899,0.00500380764136966,-0.00914328122329564,0.0104716447308734,0.894403842099524
NMR metabolomics,X23428.Concentration of VLDL Particles,CD160,CD160 antigen,29786,-0.000410414538640125,0.00313440265301301,-0.00655384373854562,0.00573301466126537,0.895824702420042
NMR metabolomics,X23428.Concentration of VLDL Particles,LMOD2,Leiomodin-2,24101,-0.000551113159353924,0.00425370251799654,-0.00888837009462715,0.0077861437759193,0.896914989830971
NMR metabolomics,X23428.Concentration of VLDL Particles,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24445,0.000424182424762259,0.00331052534297459,-0.00606444724746794,0.00691281209699246,0.898045999361356
NMR metabolomics,X23428.Concentration of VLDL Particles,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24445,-0.00059137694971378,0.00479952989179996,-0.00999845553764169,0.00881570163821413,0.901937387173992
NMR metabolomics,X23428.Concentration of VLDL Particles,ZCCHC8,Zinc finger CCHC domain-containing protein 8,24111,-0.000474857714773834,0.00399951122736728,-0.0083138997204137,0.00736418429086603,0.90549110030416
NMR metabolomics,X23428.Concentration of VLDL Particles,SEZ6L2,Seizure 6-like protein 2,29349,0.000180890511216591,0.00160384081888967,-0.00296263749380715,0.00332441851624034,0.910201127749542
NMR metabolomics,X23428.Concentration of VLDL Particles,DNLZ,DNL-type zinc finger protein,24101,0.00066089060949772,0.00606532141413093,-0.0112271393621989,0.0125489205811943,0.91323339978365
NMR metabolomics,X23428.Concentration of VLDL Particles,RUVBL1,RuvB-like 1,28797,-0.000752598130819864,0.00691935231786468,-0.0143145286738346,0.0128093324121949,0.913387949426894
NMR metabolomics,X23428.Concentration of VLDL Particles,LYPD1,Ly6/PLAUR domain-containing protein 1,28774,-0.000438696345985324,0.0042248773094437,-0.00871945587249497,0.00784206318052432,0.91729984804576
NMR metabolomics,X23428.Concentration of VLDL Particles,IL9,Interleukin-9,24445,0.00038801622911457,0.00381186797700313,-0.00708324500581156,0.0078592774640407,0.918922910129399
NMR metabolomics,X23428.Concentration of VLDL Particles,NCLN,Nicalin,28931,0.000328967726501192,0.00350040450346704,-0.00653182510029422,0.0071897605532966,0.92512576074237
NMR metabolomics,X23428.Concentration of VLDL Particles,VWA5A,von Willebrand factor A domain-containing protein 5A,24016,-0.000478796073610388,0.00536400307866169,-0.0109922421077873,0.0100346499605665,0.928875262943941
NMR metabolomics,X23428.Concentration of VLDL Particles,IL31,Interleukin-31,24229,-0.000340735133359284,0.00382595345298834,-0.00783960390121643,0.00715813363449786,0.929035852195078
NMR metabolomics,X23428.Concentration of VLDL Particles,PLIN3,Perilipin-3,29478,-0.00024971915518476,0.00284406502196133,-0.00582408659822896,0.00532464828785944,0.930033371007904
NMR metabolomics,X23428.Concentration of VLDL Particles,HMMR,Hyaluronan mediated motility receptor,23975,-0.000269977011742847,0.00325808351029985,-0.00665582069193055,0.00611586666844486,0.933960571763386
NMR metabolomics,X23428.Concentration of VLDL Particles,FOLR3,Folate receptor gamma,29461,-0.0010190980239871,0.0125329140554454,-0.02558360957266,0.0235454135246858,0.93519300562759
NMR metabolomics,X23428.Concentration of VLDL Particles,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29497,0.000172355510199106,0.00226966725371649,-0.00427619230708521,0.00462090332748343,0.939468407538932
NMR metabolomics,X23428.Concentration of VLDL Particles,RICTOR,Rapamycin-insensitive companion of mTOR,24229,0.000245752750428828,0.00324935795314239,-0.00612298883773027,0.00661449433858792,0.939713160549086
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA11,Serpin A11,29820,-0.000184522264841116,0.00273699201191612,-0.00554902660819671,0.00517998207851448,0.946249468447635
NMR metabolomics,X23428.Concentration of VLDL Particles,BTNL10,Butyrophilin-like protein 10,24016,0.000185129682976127,0.00275035688541024,-0.00520556981242795,0.00557582917838021,0.946334561809203
NMR metabolomics,X23428.Concentration of VLDL Particles,SOD3,Extracellular superoxide dismutase,24951,-0.000238833953617439,0.00401814254474129,-0.00811439334131037,0.00763672543407549,0.952603010205212
NMR metabolomics,X23428.Concentration of VLDL Particles,AMY2B,Alpha-amylase 2B,27585,0.000172955616193362,0.00328281598419825,-0.00626136371283521,0.00660727494522194,0.957983161693302
NMR metabolomics,X23428.Concentration of VLDL Particles,DLGAP5,Disks large-associated protein 5,24867,0.000174154644379928,0.00347032426332587,-0.00662768091173877,0.00697599020049863,0.959976189824097
NMR metabolomics,X23428.Concentration of VLDL Particles,IL3RA,Interleukin-3 receptor subunit alpha,28931,8.6444624280294e-05,0.0021153876589033,-0.00405971518717017,0.00423260443573076,0.967404063144171
NMR metabolomics,X23428.Concentration of VLDL Particles,SAP18,Histone deacetylase complex subunit SAP18,24445,-0.000199683922326326,0.00493155477338897,-0.00986553127816871,0.00946616343351606,0.967701958343473
NMR metabolomics,X23428.Concentration of VLDL Particles,NOS2,"Nitric oxide synthase, inducible",24111,0.000105310569114262,0.00266699571925628,-0.00512200104062804,0.00533262217885656,0.968502771143656
NMR metabolomics,X23428.Concentration of VLDL Particles,EVI2B,Protein EVI2B,24016,-0.000105224318730188,0.0027632484211077,-0.00552119122410129,0.00531074258664091,0.969624266393355
NMR metabolomics,X23428.Concentration of VLDL Particles,SPRR1B,Cornifin-B,24445,-0.000209086644985751,0.00574552657438608,-0.0114703187307825,0.011052145440811,0.97097072291652
NMR metabolomics,X23428.Concentration of VLDL Particles,EPB41L5,Band 4.1-like protein 5,24195,0.000149694445698784,0.00422423553395854,-0.00812980720085995,0.00842919609225752,0.971731534156191
NMR metabolomics,X23428.Concentration of VLDL Particles,LTBR,Tumor necrosis factor receptor superfamily member 3,29326,6.37419928862502e-05,0.00190301268811336,-0.00366616287581593,0.00379364686158843,0.973279836826991
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC25A,M-phase inducer phosphatase 1,24016,-8.40706134739557e-05,0.00272196941199279,-0.00541913066097981,0.0052509894340319,0.975360750978373
NMR metabolomics,X23428.Concentration of VLDL Particles,C9orf40,Uncharacterized protein C9orf40,24805,-0.000139908158335766,0.00538067841306406,-0.0106860378479413,0.0104062215312698,0.979255988344288
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF4,E3 ubiquitin-protein ligase RNF4,24445,-9.08859845497789e-05,0.00444592256931241,-0.00880489422040211,0.00862312225130255,0.983690509652977
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,24101,4.37633783741546e-05,0.00214560396458106,-0.00416162039220473,0.00424914714895304,0.983727033964449
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC2L,C-type lectin domain family 2 member L,24195,-6.76479978664059e-05,0.00337475278706663,-0.00668216346051701,0.0065468674647842,0.98400738546856
NMR metabolomics,X23428.Concentration of VLDL Particles,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,24111,7.90216483317223e-05,0.00466356742057781,-0.00906157049600078,0.00921961379266422,0.986481061322319
NMR metabolomics,X23428.Concentration of VLDL Particles,OLR1,Oxidized low-density lipoprotein receptor 1,29216,-3.53637440714732e-05,0.00390144351552056,-0.00768219303449178,0.00761146554634883,0.992767918502057
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPL28,"39S ribosomal protein L28, mitochondrial",24867,1.74310796709688e-05,0.00245029381766363,-0.00478514480294975,0.00482000696229169,0.994324055329412
NMR metabolomics,X23428.Concentration of VLDL Particles,IL24,Interleukin-24,28931,1.7010944593193e-05,0.00326103008808607,-0.0063746080280555,0.00640862991724188,0.995837943597428
NMR metabolomics,X23428.Concentration of VLDL Particles,COL4A4,Collagen alpha-4(IV) chain,24405,-8.93457642053809e-06,0.00354976743274146,-0.0069664787445938,0.00694860959175273,0.997991789568151
NMR metabolomics,X23428.Concentration of VLDL Particles,RBP1,Retinol-binding protein 1,24195,-1.00532091377208e-05,0.00466022319297706,-0.00914409066737276,0.00912398424909732,0.998278792479589
NMR metabolomics,X23428.Concentration of VLDL Particles,TEX101,Testis-expressed protein 101,24195,3.29147461540342e-06,0.00340131324046497,-0.00666328247669595,0.00666986542592675,0.99922788963238
